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Abstract 
Abstract 
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common causes 
of nosocomial infection. These infections are an enormous burden on the healthcare 
system, and they still occur despite implementation of infection control programmes. 
Identifying MRSA transmission events in the hospital setting is critical for instituting 
timely preventative measures, for feeding back rates of infection to frontline staff and 
for measuring the success of control efforts. The increasing prevalence of MRSA 
colonisation and infection both within hospitals and in the community makes it 
difficult to determine whether an infection diagnosed in a hospital inpatient is due to 
nosocomial acquisition of MRSA or not. A highly discriminatory molecular typing 
method has the potential to aid surveillance efforts for MRSA, and accurately identify 
transmission events. To be useful in a high prevalence setting, it needs to be rapid , 
high throughput and inexpensive enough for routine, prospective use. The aim of this 
project was to explore the utility of routine molecular typing for surveillance and 
control of nosocomial MRSA infections. We hypothesised that a high-throughput, 
highly-discriminatory and inexpensive MRSA typing method could be developed that 
would fulfil the requirements for routine typing, and that once implemented in a high-
prevalence tertiary referral hospital, this typing method could rapidly and reliably 
identify nosocomial transmission events and thereby facilitate directed infection 
control interventions. 
This thesis is presented as a combination of published (Chapters 3, 4, 6, 7 and 8), or 
submitted (Chapter 5) peer-reviewed journal articles, a published book chapter 
(Chapter 1) and an unpublished literature review (Chapter 2). 
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To explore the first hypothesis, a review of the literature was undertaken, initially, 
exploring the current state of knowledge on the utility of molecular typing for hospital 
infection control, with particular reference to routine, prospective typing, and the 
major methods that are used in strain typing-based nosocomial surveillance for a 
variety of pathogens. The examination of the literature subsequently focussed on the 
molecular epidemiology and typing methods for MRSA. The key attributes of an ideal 
typing method were identified and methods analysed with reference to these. 
Potential genetic targets for typing of MRSA were also reviewed, with an emphasis on 
those that may allow conclusions regarding virulence of a particular strain to be 
drawn. Existing strain typing methods for MRSA were analysed in detail in an effort to 
determine which method would be best to adapt for the work in this project. 
Binary typing using multiplex-PeR based reverse line blot hybridization (mPCR/RLB) 
was identified from the review of the literature as the most promising for further 
work. mPCR/RLB is inexpensive, high-throughput, rapid and provides results in a 
numerical format that are ideal for inter-run and inter-laboratory comparisons. It is 
highly flexible, allowing for the incorporation of up to 43 different targets into the 
assay. The methodology of mPCR/RLB is described in detail using a filmed experiment 
supported by a written procedure. 
We further hypothesised that targets based on mobile genetic elements could confer 
a high level of discriminatory power to the mPCR-RLB based binary typing system 
under development. We explored a set of such targets, phage-derived open reading 
frames, by adapting phage-derived open reading frame (PDORF) typing to the 
mPCR/RLB platform and assessing the ability of POORF typing to identify nosocomial 
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transmission events and compared its utility to other existing typing methods such as 
pulsed field gel electrophoresis (PFGE). 
Selection of targets to incorporate into a novel binary typing method requires 
assessment of discriminatory power and concordance with existing typing systems. 
With the large array of potential targets available, intelligent selection of the best 
combination requires computerised methods. We developed software specifically for 
this purpose and validated it using binary targets for MRSA, multilocus variable 
number of tandem repeat targets in Streptococcus pneumoniae and multilocus 
sequence typing targets in Cryptococcus spp. 
When mobile genetic elements are utilised as targets in a typing system, there is a 
danger that the typing system will be unstable. Assessment of stability becomes a 
crucial part of the evaluation of such typing systems. We hypothesised that utilising 
Kaplan-Meier survival analysis for the assessment of in vivo stability of several major 
MRSA typing methodologies would allow a robust comparison of stability of different 
methods while providing additional information about the kinetics of change which 
would be useful for developing interpretative guidelines for strain typing in the setting 
of outbreak investigation. 
The binary typing system that was ultimately developed for this project incorporated 
targets selected using the described software, from a large pool of potential binary 
targets, and included four toxin genes, nine phage-derived open reading frame targets 
and six targets located on SCCmec. The method was compared with PFGE and spa 
sequence typing and the hypothesis that it could be used for detecting nosocomial 
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transmission was confirmed by analysing all isolates collected over a 12-month period 
from the surgical wards at our hospital. 
The typing method was subsequently introduced routinely to prospectively type all 
MRSA isolates from patients in hospitals serviced by our laboratory. An outbreak of 
MRSA infection and colonisation in the neonatal intensive care unit, and the measures 
instituted to terminate transmission, as guided by the typing results, is described 
which confirms the hypothesis that prospective molecular typing, as an integral part of 
the surveillance and control efforts for nosocomial MRSA infection can help guide 
infection control interventions. 
In conclusion, we have shown that utilisation of a rapid, high-throughput, 
discriminatory and inexpensive binary typing system in a prospective, routine manner 
can reliably identify MRSA transmission events in a high prevalence nosocomial 
setting. Identification of transmission events can then assist in targeting infection 
control measures. Future research directions will include ongoing prospective 
assessment of the typing system in a variety of settings, and correlation of detailed 
clinical information to assess strain to strain variations in virulence and 
transmissibility. Application of rapid mPCR/RLB-based binary typing systems to other 
nosocomial pathogens is another potential future research direction. 
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Chapter 1: Introduction 
Chapter 1: Introduction 
1.1 The problem of hospital acquired infection 
Nosocomial infections remain a major cause of morbidity and mortality around the 
world (1). Despite infection control interventions, rates of nosocomial infection 
remain steady, or are increasing, particularly with multi-resistant bacteria (2, 3). The 
most common ofthese, in many healthcare settings, is methicillin resistant 
Staphylococcus aureus (MRSA). 
Since first appearing over 50 years ago (4), MRSA has spread around the world and 
attained high-levels of endemicity in many hospital environments, and its 
epidemiology continues to evolve. New strains with varying virulence capacity 
periodically emerge (5) to replace those previously circulating in hospitals. More 
recently, highly virulent strains have emerged for the first time in the community and 
in Australia now account for 18% of S. aureus infections in that environment (6). 
As a result, identifying MRSA acquisition events in hospitals has become increasingly 
difficult. Nevertheless it remains an important task: not only to investigate outbreaks 
so that causative factors can be identified and removed, and for monitoring the 
response to infection control intervention, but also to monitor how much harm we are 
causing patients. 
Molecular typing methods are an effective way of identifying strains that are causing 
outbreaks of nosocomial transmission and differentiating them from unrelated 
isolates (7). Given the high prevalence of MRSA in many hospitals, routine typing of all 
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isolates may be necessary to determine strain relatedness and thereby identify 
transmission events. Additionally, this would permit the study of strain-specific 
variation in virulence, so that additional precautions could be taken against highly 
virulent strains. However, traditional typing techniques are too expensive, labour 
intensive and slow to be effectively employed on a routine basis. Recently, rapid and 
discriminatory PCR-based typing methods have been developed (8) and have the 
potential to provide strain typing results in 'real-time', but their utility for routine 
typing of all nosocomial isolates has not been established. This project will examine 
the impact of routine, real-time molecular typing on nosocomial MRSA control efforts. 
1.2 Hypothesis 
That routine prospective molecular typing of MRSA can be implemented in a hospital 
microbiology laboratory to rapidly identify nosocomial transmission events and 
outbreaks, and feedback of the results to infection control practitioners and clinical 
staff can assist the timely institution of infection control interventions. 
1.3 Research aims 
1) To identify an optimal combination of molecular targets in MRSA that will 
provide high discriminatory power while maintaining concordance with existing typing 
systems and have the potential to distinguish strains with increased virulence. 
2) To develop a rapid (<24 hour turn around) and inexpensive molecular typing 
protocol, which will reliably discriminate epidemic, endemic and sporadic MRSA 
strains in settings with a high prevalence of MRSA colonization and infection. 
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3} To use the typing method developed in 1) to study the epidemiology of MRSA 
transmission and infection within the hospital, and provide information regarding 
routes oftransmission, risk factors for colonisation and infection, and differences in 
virulence of strains. 
4) To implement routine prospective molecular typing to identify nosocomial 
transmission and outbreaks and feed back this information to infection control 
practitioners and clinicians to determine the utility of the typing system as a routine 
part of infection control. 
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Figure: Schematic overview of the structure of this thesis -
Chapter 3: Multiplex PCR-reverse line blot 
assay 
Chapter 5: Software for selection of 
informative targets 
Chapter 4: Phage-derived open reading 
frame typing 
Chapter 6: Assesment of typing system 
stability using survival analsyis 
Chapter 7: Development and assessment of a novel binary typing system for MRSA 
Chapter 8: Identification and control of an outbreak of MRSA using routine prospective 
binary typing 
1.4 Publication: Molecular Genotyping Systems for Infection Control 
Citation: 
O'Sullivan MV, 2010. Molecular Genotyping Systems for Infection Control, p. 
345-358. In Sintchenko V (ed .), Infectious Disease Informatics. Springer, New 
York. 
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Chapter 17 
Microbial Genotyping Systems 
for Infection Control 
Matthew O'Sullivan 
17.1 Introduction 
Chapter 1: Introduction 
It has long been recognized that admission to health care institutions is associated 
with a risk of acquiring infection (Best and Neuhauser 2004). Despite this and the 
institution of wide-ranging prevention measures, hospital acquired infections (HAl) 
are an increasing problem. While much of this can be explained by the changing 
demographics of the inpatient population, with an increase in the number of immu-
nosuppressed and elderly patients who are undergoing more invasive procedures 
with indwelling prosthetic devices, there is also evidence of the emergence of more 
virulent nosocomial pathogens, which have evolved to thrive in the modern hospital 
environment. This evolution is characterized not only by an acquisition of resis-
tance to a wide range of antibiotic and antiseptic agents, but also by other virulence 
mechanisms, which facilitate environmental persistence (Wagenvoort et al. 2000), 
and transmission from patient to patient (Casewell and Desai 1983; Papakyriacou 
et al. 2000; Phillips 1991). 
HAl is a major cause of preventable healthcare-associated morbidity and mortality 
(see also Chap. 15). In 2005-2006, 31,639 hospital separations in Australia, or 
0.5% of admissions, were coded as having the adverse event "infection following a 
procedure" (Australian Institute of Health and Welfare 2007). In the United States, 
it is estimated that there are 2 million nosocomial infections every year, resulting in 
90,000 deaths and excess healthcare costs of approximately $5 billion dollars 
(Burke 2003). This occurs in spite of extensive infection control measures aimed at 
preventing both colonization and infection by nosocomial pathogens. Nosocomial 
acquisition of, and infection by, bacterial pathogens is increasing but remains under 
recognized. Current infection control measures concentrate only on a handful of 
multiresistant pathogens, and are often unsuccessful. New approaches to the 
identification and prevention of nosocomial infection are clearly required. 
M. O'Sullivan(IBJ) 
Centre for Infectious Diseases and Microbiology, Sydney West Area Health Service, 
Sydney, Australia 
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17.2 Hospital Infection Control Surveillance 
An essential component of hospital infection control is surveillance for nosocomial 
infection. One function of surveillance is the reporting of specific infection rates for 
quality indicator purposes. A more valuable application of surveillance is the iden-
tification of clusters of infection, which may represent outbreaks of nosocomial 
transmission because of lapses in infection control precautions. Such clusters can 
then be investigated and measures instituted to terminate the outbreak. 
A cluster is identified when the observed rate of infection is noted to be higher 
than the endemic, baseline rate. For a condition that is rare (i.e. the baseline rate is 
essentially zero), any two cases occurring contemporaneously may warrant investi-
gation, and so a simple observation of laboratory notifications may be all that is 
necessary to identify clusters. Examples may vary from institution to institution, 
but could include vancomycin resistant Staphylococcus aureus. 
More commonly, nosocomial outbreaks are due to organisms that also pro-
duce sporadic infection. These conditions thus have a measurable background 
incidence. Examples include methicillin-resistant Staphylococcus aureus infec-
tion or colonization, or Clostridium di.ffi.cile diarrhea. In these examples, clus-
ters of nosocomial transmi ssion may be harder to discern because of randomly 
fluctuating background incidence. Here, the detection of clusters is greatly 
aided by statistical methods. Such methods identify a statistically significant 
increase in rate above the background incidence, which should prompt further 
investigation. A number of methods to perform these calculations have been 
described, including comparing the number of episodes in the time period to the 
long term mean, looking for a I 00% increase compared to the previous time 
period or for a 50% increase compared to the mean of the previous three time 
periods (Hacek et at. 2004 ). 
A particularly effective method for the statistical analysis of surveillance data is 
the use of process control charts (discussed in Chap. 15). Specifically, Shewhart 
and Exponentially Weighted Moving Average (EWMA) charts are particularly 
applicable to monitoring nosocomial infection events. These plot the incidence of 
the outcome of interest against time, with control limits for either the incidence 
(Shewhart) or its moving average (EWMA), which, if crossed, indicate an increase 
in the event rate beyond what would be expected by chance (Morton et al. 200 I). 
Figure 17.1 gives an example of EWMA for MRSA incidence in an intensive care 
unit. Such methods have the ability to identify clusters of transmission or infection 
early and accurately (Wright et al. 2004). Separate charts may be generated for 
different wards or units in a hospital, allowing the detection of temporospatial 
clusters. 
In an effort to improve interest in and compliance with infection control 
measures, the graphical presentation of incidence data to departmental staff, 
such as in the form of control charts, can highlight areas of concern and give 
positive feedback, which may itself be an effective intervention. This has been 
evaluated as an intervention to reduce nosocomial infection rates. To be effective, 
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Statistical process control chart for methicillin-resistantS. aureuslncldence in the 
Intensive Care Unit 
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Fig. 17.1 Shewhart and exponentially weighted moving average (EWMA) control charts for 
MRSA incidence in and intensive care unit. Both the plot of incidence an EWMA cross their 
respective upper control limits in April/May 2008, indicating a statistically significant increase in 
incidence, which would alert staff to a possible cluster of transmission. 
such strategies require an effective surveillance program with timely data entry 
and frequent feedback of the most current results. One study demonstrated a 
reduction in MRSA transmission with the introduction of such feedback (Curran 
et al. 2002). 
17.3 Targeted Genotyping to Confirm Nosocomial Outbreaks 
Traditionally, the molecular typing of organisms as an aid to infection control has 
been limited to investigating clusters identified by surveillance methods to see if 
the involved isolates are clonal. If clonality is established, then the clonal cluster 
is assumed to represent a true outbreak, and it is then investigated to identify 
infection control breaches and to institute measures to prevent further transmis-
sion. Often some cases can be excluded from the cluster when they are distinct 
from the clonal isolates, making the investigation of the outbreak more efficient 
(Hacek et al. 2004; Macfarlane et al. 1999; Peterson et al. 1993; Pfaller et al. 
1991 ). If the clonality of a cluster is not established by molecular typing, then the 
cluster is usually presumed to be a "pseudo-outbreak," occurring by chance, with 
no further investigation being necessary (Hartstein et al. 1997; Imataki et al. 
2006; Macfarlane et al. 1999). It is through these two factors - improving effi-
ciency of outbreak investigation and the ability to identify "pseudo-outbreaks" -
that molecular typing can improve the cost-effectiveness of nosocomial infection 
surveillance (Andrei and Zervos 2006). 
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The utility of molecular typing to confirm clusters depends on the background 
incidence of the organism in question. When the organism is not endemic and 
rarely isolated, then temporospatial clusters have a high probability of representing 
true outbreaks, and molecular typing may not be necessary. In fact, typing may be 
misleading in this circumstance if false negative results occur, leading to a true 
outbreak being mistakenly called a pseudo-outbreak. 
Molecular typing can also be misleading, where the transmissible element is not 
the organism, but genetic material passing horizontally from one organism to 
another. Such genetic material will frequently encode antimicrobial resistance, but 
it is feasible that other virulence factors such as exotoxins could cause outbreaks in 
this way. An increasingly recognized example of this is the transmission of genetic 
material encoding carbapenemases conferring high-level resistance to a variety of 
gram-negative organisms. Molecular typing of the responsible organisms of such 
outbreaks will be misleading, since a single outbreak will be due to a variety of 
strains, or indeed a variety of species, all carrying the same genetic element (Peleg 
et al. 2005). This scenario is discussed further in Chap. 12. 
When there is a low level but measurable background incidence of the organ-
ism in question, then targeted molecular typing becomes useful. This is com-
monly the case for organisms that may be community acquired, but may also 
spread in the hospital environment, or for organisms wherein long-term coloniza-
tion may occur. Pimentel et al. were able to demonstrate, using molecular typing 
by pulsed field gel electrophoresis (PFGE), that what appeared to be a single 
large outbreak of multiresistant Acinetobacter baumanii was in fact two distinct 
outbreaks, one centered on a surgical unit and the other in ICU (Pimentel et al. 
2005). Such information is valuable since it allows different infection control 
interventions targeted to each specific outbreak. In this case, the ICU outbreak 
was associated with contaminated respiratory ventilation equipment; in the surgi-
cal unit, complete ward closure and decontamination were required to terminate 
the outbreak. Mascini et al. describe the utilization of PFGE to determine whether 
cases of vancomycin resistant Enterococcus species (VRE) colonization were 
part of an evolving nosocomial epidemic or not; this allowed the targeting of 
infection control measures toward epidemic strains and led to successful termina-
tion of the outbreak (Mascini et al. 2006). Molecular typing with PFGE is also 
frequently used to confirm nosocomial outbreaks of methicillin-resistant 
Staphylococcus aureus (MRSA) (lmataki et al. 2006). Molecular typing can 
verify the termination of an MRSA outbreak and the effectiveness of infection 
control interventions (Hartstein et al. 1995). 
When the organism in question is highly endemic in the hospital, molecular 
typing is still useful to confirm clusters, but the results must be interpreted with 
caution. This is because pseudo-outbreaks will occur more commonly, so the 
probability that a cluster represents a true nosocomial outbreak is lower. Yet, 
because of the high background incidence, there is a greater risk that the strains 
will appear clonally related by chance. In this case, the typing method utilized 
must have high discriminatory to avoid false positive results (Dziekan et al. 
2000; Weber et al. 1997). A case in point is MRSA. In institutions with low 
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baseline levels of MRSA colonization, targeted typing, even employing methods 
with a relatively low discriminatory power such as spa typing, has been success-
fully used to confirm outbreaks (Mellmann et al. 2006). However, many institu-
tions have high endemic rates of MRSA colonization and infection, and 
increasing numbers of patients admitted to hospital from the community are 
already colonized with MRSA. Often these isolates may belong to only a 
restricted number of spa types. In this circumstance, a much more discrimina-
tory typing method such as PFGE is required to distinguish true outbreaks from 
pseudo-outbreaks. 
17.4 Universal Genotyping in Hospital Infection Control 
Universal typing refers to the routine typing of all isolates as a primary part of 
cluster detection. This is in contrast to targeted typing, described earlier, that is 
only performed once a spatiotemporal cluster has been identified. Such an 
approach has found a place in the domain of community public health, wherein 
control programs for several organisms rely on typing for the initial identifica-
tion of outbreaks. Clark and colleagues describe the success of the universal 
typing of Mycobacterium tuberculosis in identifying both laboratory contamina-
tion events and otherwise unknown transmission routes, which permitted more 
extensive case-finding and improved tuberculosis control (Clark et al. 2006). 
However, universal typing has only rarely been employed in hospital infection 
control. This is partly because, until recently, the available typing methods, such 
as PFGE, were expensive, slow, cumbersome, and low-throughput. With the 
development of PCR-based methods, rapid, high throughput typing is now pos-
sible using a variety of platforms. As the costs of these rapid methods continue 
to fall, universal typing with results available in real-time is becoming increas-
ingly feasible. Some experts have argued against the use of universal typing in 
hospital infection control, arguing that it is likely to lead to the mis-identifica-
tion of clonal clusters occurring by random chance (rather than representing true 
outbreaks) because of the imperfect discriminatory power of many molecular 
typing methods (Pfaller and Herwaldt 1997). This is a valid concern, but if the 
performance characteristics of the method being used are well defined and the 
results are interpreted appropriately, as discussed later, mis-identification should 
be able to be minimized. 
For highly endemic organisms, outbreaks may be difficult to identify against the 
naturally fluctuating background incidence, so targeted molecular typing may be 
problematic. In this situation, cluster detection may be impossible without universal 
typing. This concept is illustrated with an example below (Figure 17.2). 
It has been shown in short-duration studies of universal typing that frequent 
nosocomial transmission occurs in many organisms for which surveillance is not routinely 
performed. One such example examined nosocomial Candida sp. infection. In a 
retrospective study, Asmundsd6ttir et al. performed typing using PCR-fingerprinting 
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Fig. 17.2 Demonstration of utility of molecular typing for cluster detection using mock data from 
nosocomial surveillance of new MRSA acquisition in a hospital with high endemicity for MRSA. 
Horizontal axes - time in weeks. Vertical axes - count of new cases of MRSA. Solid line -
Exponentially weighted moving average (EWMA). Chart A: surveillance without genotyping 
does not show any discemable clusters, and there is no obvious deviation of the EWMA. Chart B: 
graph of surveillance data incorporating genotyping information. Epidemic strain A is shown in 
light gray, epidemic strain B is shown in dark gray, and all other strains remain black. Two distinct 
temporal clusters are now discernable due to epidemic strains A and B, respectively. Charts C and 
D: surveillance data for epidemic strains A and B further highlighting the temporal clustering and 
demonstrating the deviation of the EWMA. Chart E: nonepidemic strains in the same period - no 
clustering is evident, and there is no deviation of the EWMA. 
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on all bloodstream isolates of Candida collected in Iceland over a 16-year period. 
Between 19 and 40% of isolates were suspected to have been acquired by nosocomial 
transmission on the basis of similar typing results and temporospatial occurrence 
(Asmundsdottir et al. 2008). · • 
Other organisms for which frequent, unidentified transmission may occur in 
hospitals include, but are not limited to, methicillin susceptible Staphylococcus 
aureus (MSSA) (Chaves et al. 2005; Wilcox et al. 2000), Staphylococcus epider-
midis (Muldrew et al. 2008), Streptococcus pyogenes (Ramage et at. 1996), 
Streptococcus agalactiae (Easmon et al. 198 I; Kim et al. 2006), various gram nega-
tive bacilli (Almuneef et al. 2001; Prospera et a1. 2006), and Pneumocystis jiroveci 
(Schmoldt et al. 2008). 
Although not yet in wide routine use, several universal typing systems have been 
applied for hospital infection control. MRSA is one important organism for which 
traditional surveillance with targeted molecular typing fails to identify nosocomial 
outbreaks. This is largely because of MRSA's changing epidemiology, with the 
rising prevalence of this organism as a community pathogen (Otter and French 
2006) and the high rates of endemicity of MRSA in many hospitals. In 1993, a 
study that used restriction enzyme analysis (REA) of plasmid DNA (REAP) typing 
found that the routine typing of all hospital MRSA isolates led to the identification 
of small clusters that would have gone unobserved if only traditional epidemiologic 
surveillance was used (Trilla et al. 1993 ). 
Hacek et al. described universal typing by REA of genomic DNA with con-
ventional electrophoresis in a tertiary facility for isolates of MRSA, VRE, and 
fluoroquinolone-resistant Pseudomonas aeruginosa. A 10% decrease in nosoco-
mial infections was observed in the 24 months after the introduction of the 
system, compared with the 24 months prior, with an estimated cost saving of 
US$4,368, 100 (Hacek et al. 1999). Mascini et al. used PFGE to distinguish 
epidemic from sporadic strains during a hospital outbreak of vancomycin resis-
tant Enterococcus faecium, enabling infection control measures to be withheld 
for a large number of patients while still successfully terminating the outbreak 
(Mascini et al. 2006). 
Microbial subpopulations differ in their virulence, which may manifest as an 
increased severity of a disease, or an enhanced ability to spread in the hospital 
environment and colonize the host. Genotyping data linked to clinical data have 
been able to establish the presence of hypervirulent clones in a number of microbial 
species. For example, some MRSA strains spread more easily and are more difficult 
to control than others (Amaral et al. 2005). In a study from the UK, colonization 
with one hypervirulent MRSA strain (sequence type [STJ 239) conferred a 4.5 
times higher risk of intravenous-line associated BSI, compared with colonization 
with other MRSA strains (Edgeworth et al. 2007). Molecular typing using PFGE 
has demonstrated the emergence of the highly virulent USA300 clone of MRSA as 
a nosocomial pathogen in the United States (Patel et al. 2008). 
Another clear example of molecular typing identifying a hypervirulent clone in 
a problematic nosocomial pathogen is Clostridium difficile. In 2003, it was reported 
that there had been an increasing number of cases and deaths from C. difficile diarrhea 
13 
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in Quebec, Canada, over the previous years. Subsequent molecular typing studies 
demonstrated that this increase was due the emergence of a clone, identified as 
ribotype 027 (Loo et al. 2005), which subsequently spread worldwide. Using 
PCR-ribotyping and multivariate analysis, Labbe et al. confirmed that this strain 
was more virulent, with a twofold increase in the risk of30-day mortality compared 
with other ribotypes (Labbe et al. 2008). 
Universal genotyping, when linked with clinical data (such as progression from 
colonization to infection, disease severity, complications and death) may be a 
powerful tool for the continuous monitoring for the emergence of new, hyperviru-
lent strains of nosocomial pathogens. Such system, if had been in place in Quebec 
in 2002, could have identified the hypervirulent C. dif.ficile ribotype 027 clone 
earlier, facilitating more timely, aggressive infection control measures that may 
have averted the subsequent world-wide epidemic. 
17.5 Analysis of Genotyping Results 
Traditionally, molecular typing results in infection control have been used to con-
firm or refute suspected outbreaks. In this scenario, an outbreak is considered 
confirmed ifthe strains are found to be indistinguishable (or closely related) by the 
typing method, and it is refuted if the strains are found to be unrelated by the typing 
method. However, for many organisms, such as MRSA, the population structure is 
very clonal, and indistinguishable results with even the most discriminatory typing 
method may not be sufficient to confirm an outbreak if the strain identified is one 
that is commonly circulating in the institution in question, or in the community 
in general. This has led to the criticism that universal typing may lead to the 
mis-identification of outbreaks (Pfaller and Herwaldt 1997). It follows, then, that a 
better way to utilize a typing result is to determine the probability that a set of 
indistinguishable strains represent an outbreak. This probability can be determined 
from both the surveillance data (using the magnitude of the increase in case 
frequency over the background rate) and the known molecular epidemiology of the 
organism in question (using the expected frequency of the particular strain type 
from the overall population). 
This approach is analogous to the interpretation of any diagnostic test- wherein 
the likelihood ratio of a test result is applied to the pretest probability (in this case, 
the chance of an outbreak being present based on temporospatial surveillance data 
alone) to determine the posttest probability. In this case, the post-test probability is 
the probability that an outbreak has occurred, based on the combination of temporal, 
spatial, and genotyping data (Jaeschke et al. 1994). After this probability is deter-
mined, it can be decided whether further action is required, based on a certain 
threshold probability that would vary according to cluster frequency and available 
resources. Such an approach, previously advocated for MRSA spa typing (Harmsen 
et al. 2003), has been outlined in detail using nosocomial norovirus transmission as 
an example (Lopman et al. 2006 ). 
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17.6 Choosing Typing Method for Genotyping Systems 
The choice of microbial genotyping method will be different for a particular organism 
in a given setting and will depend on the characteristi~ of the typing system, such 
as its discriminatory power, stability, ease of use, reproducibility, throughput, portability 
of results, and cost (Riley 2004). Rather than utilizing a single typing method, 
routine typing will often employ an initial, less discriminatory, typing method followed 
by more discriminatory methods for indistinguishable isolates. Selected methods 
referred to in this chapter are described in the Box 17 .1. 
Boxl7.1 'JYping ~thod$ 
Pulsed fidd gel elec(T(}phoresis of restriction enzyme~tJigested · genomic 
DNA (PFGE). This method cansists of digesting DNA using a restriction 
enzyme that recognizes specific short DNA motifs and cleaves the DNA 
strand at that site. Variation betw~en strains occursbeca~ of ll1U~tions 
that create or remove re~triction enzyme binding sites. Enzymes ~··chosen 
such that 1(~20 DNA fragments are produced. These are then visualized 
using gel electrophoresis. No DNA amplification is employed; ~ tech-
nique is labor-intensive, low throughput, and the results do not lend them~ 
selves to digitization ·to establish libraries of strain types; Howev'er;it is · a 
highly discriminatory method and remains the mainstay for the genotyping 
of many bacteria (Fig. 17.3a)~ 
Rep-PCR. Amplification of bacterial DNA is performed using primers 
speci:ijc for an element that is found repeatedly interspersed throughout the 
genome. Tile direction of the primers is such that the interVening sequence, 
not the repetitive sequence, is the element amplified. Only when two repeti-
tive elements are close together will a FCR product be produeed, but with a 
good choice of target 10-20, FCR products can be ·obtained. These are then 
visualized by electrophoresis; This method has been commercialized in an 
automated high-throughput system (DiversiLabni), which· also digitizes and 
analyses the results. It can be· used for a wide variety of bacteria (Carretto 
et al. 2008) (Fig. 17.3b). 
· Multilocus variable number of tandem repeats analysis (MLVA). In this 
· method, PCR is used to amplify a number oftargets that vary in their size by 
' virtue of short subunits that are repeated a variable number of tiines in a given 
isolate. The number of repeats at each locus is determined after the visualiza-
tion of the amplification products with electrophoresis. The results can then be 
presented in a numerical fortnat, rather than in a·fingerprint format With a 
good choice of targets, MLVA can be highly discriminatory. It is also high-
throughput and reproducible (Fig. 17.3c). 
(continued) 
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Box 17.1 (continued) 
Sequence typing. 'This jl),voli<'SpdR ampfi4CatiPn imd sequencing of one 
or more targets that vary between isOlateS in thw O:NA .sequence. Sequence 
typing is commonly used fQr ihe ·typitlg of vifl:t~s~ .often employing genes 
encoding surface pr.e>tetns ~t ate more :vanabie. atld iMt broadly correlate 
with viral · serotypitlg;·· spa typing is • ()De foan. Of sequence typing for 
Staphylococcus au~us. Sequence cyping is r6bUst ~~can. be highly discrimi-
natory if the COrreCt targets ate ~leef.e4 With .the ~r availability, faster 
turnaround time, and ]!)WeJ; c()St ofsecjuentlllg faCi}it,ies, sequence typing is 
becoming increasingly~ fOr hospital infeepOri eontrolapplications. Multi-
locus sequence typing (MLS'r) involves thesequefiCing of multiple targets. It 
is most conunonly used to explore evolutionary relationships and population 
structure, so the targets used are genes that evolve slowly and so are less 
discriminatory (Fig. 17 .3d). 
17.7 Integrating Genotyping with Surveillance Systems 
An ideal microbial genotyping system for infection control would integrate gena-
typing data with that from patient information systems, medical records, and labo-
ratory information systems. This would then be analyzed to alert infection control 
practitioners of spatio-temporal-genotypic clusters of infection, which are sugges-
tive of outbreaks and require further investigation and intervention. The addition of 
clinical outcome data from the medical record would allow continuous monitoring 
for the emergence of hypervirulent strains, which could prompt a higher level of 
infection control precautions. For such a system, the genotyping method used 
would ideally be inexpensive, rapid, and high throughput to allow universal gena-
typing when necessary. The method would so be highly discriminatory to reduce 
false positive cluster detection and to produce results that could easily be tracked in 
a database. The results would be expressed as a probability that isolates were 
related, as discussed earlier. The medical records would be electronic, and would 
automatically be screened for outcomes of interest, as discussed in detail in Chaps. 
15, 16, and 20. 
There are few publications describing such comprehensive genotype-based sur-
veillance systems for hospital infection control, and none which link typing informa-
tion to clinical outcome data. However, increasing progress is being made toward 
such systems. Mellman with colleagues successfully incorporated spa typing of 
MRSA with spatiotemporal epidemiologic data in a German tertiary care facility to 
automatically generate prospective "clonal alerts" that were found to identify clus-
ters of MRSA transmission more reliably than in the case of clusters identified by 
frequency data alone or by the infection control professionals after a review of the 
microbial data and patient information (Mellmann et a!. 2006). Fontana et a!. 
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Fig. 17.3 Molecular typing methods. (a) Pulsed field gel electrophoresis (PFGE) of restriction-
enzyme digested genomic DNA. (b) rep-PCR results and analysis using the automated DiversiLabTM 
system (figure courtesy of BioMerieux). (c) Multi locus variable number of tandem repeats analysis 
(MLVA) with product detection by capillary electrophoresis. (d ) Sequence based typin 
describe a system by which temporospatial clusters of nosocomial infections are 
identified in the Laboratory by software (VIGJ@ct), which takes data from the labo-
ratory information system and the patient information system. Rapid targeted typing 
performed by either fluorescent AFLPs or the DiversiLabTM rep-PCR typing system 
is then conducted to confirm clusters. This was found to be useful to identify noso-
comial clusters of a variety of pathogens (Fontana et al. 2007, 2008). 
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17.8 Conclusion 
Molecular typing is a valuable tool for the identification of nosocomial infection 
outbreaks. Recent advances have produced rapid, discrintinatory, high-throughput, and 
inexpensive typing methods that may permit the routine use of universal typing. 
This may prove to be invaluable for the surveillance of organisms with high 
endemicity, but typing results must be applied appropriately to avoid false conclusions. 
When combined with outcome information from electronic medical records, universal 
typing could facilitate continuous monitoring for the emergence of hypervirulent 
nosocomial pathogens. 
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2.1 Introductory Comments 
The previous chapter outlined the rationale for incorporating molecular typing into 
hospital infection surveillance and control programs. The case for pursuing 
prospective, or universal, molecular typing for key pathogens was presented. 
Methicillin resistant Staphylococcus aureus (MRSA} is one such pathogen, which is a 
major cause of hospital acquired morbidity and mortality and, in many institutions, 
occurs at such high prevalence that the identification of nosocomial transmission 
events is difficult without strain typing. The remainder of this work will focus on the 
development and implementation of a prospective MRSA strain typing system. This 
chapter outlines the epidemiology of MRSA and reviews the literature on strain typing 
methods for this organism. 
2.2 The problem of nosocomial infections 
It has been recognised for almost 200 years that admission to health care institutions 
is associated with a risk of acquiring infection (1}. Despite this recognition, and 
institution of wide-ranging prevention measures, hospital acquired infections are just 
as great a problem today. Much of this can be explained by the changing 
demographics of the inpatient population, with an increasingly immunosuppressed 
and elderly population, undergoing more invasive procedures with indwelling 
prosthetic devices. However there is also evidence of emergence of more virulent 
nosocomial pathogens, which have evolved to thrive in the modern hospital 
environment. This evolution is characterised, not only by acquisition of resistance to a 
wide range of antibiotic and antiseptic agents, but also by other virulence mechanisms 
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which facilitate environmental persistence (2), and transmission from patient to 
patient (3-5). 
Hospital-acquired infection is a major cause of preventable healthcare-associated 
morbidity and mortality. In 2010-2011 33,957 hospital .separations in Australia, or 0.4% 
of admissions were coded as having the adverse event 'infection following a procedure' 
(6). In the United States, it is estimated that there are 2 million nosocomial infections 
every year, resulting in 90,000 deaths and excess healthcare costs of approximately $5 
billion dollars (7). This is despite well-documented infection control measures aimed at 
preventing patients becoming colonised. 
MRSA is the largest contributor to the burden of nosocomial infection (7). Australia-wide 
there are thought to be over 1000 episodes of hospital-onset MRSA bacteraemia per 
year, with an estimated mortality rate of 34% (8), yet bacteraemia represents just a 
fraction of the morbidity associated with nosocomial MRSA infection . 
Nosocomial acquisition of, and infection by, bacterial pathogens is increasing, but 
remains under recognised. Current infection control measures concentrate only on a 
handful of multiresistant pathogens, and overall, have had little impact on infection 
rates. New approaches to identification and prevention of nosocomial infection are 
clearly required. The remainder of this discussion and the subsequent research will 
focus on MRSA. However the principles applied will be applicable to a number of 
nosocomial pathogens. 
2.2.1 MRSA as a nosocomial pathogen 
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Colonised patients are the major reservoir of MRSA in the hospital environment. Many 
body sites can be colonised with MRSA, but the most common are the nares, axillae 
and groin (9). The bacterial load can reach high levels in clinically infected wounds, 
which in turn leads to high amounts of environmental shedding (10). Such shedding 
takes the form of skin squames, contaminated with bacteria, which can be found on 
the floor, on equipment surrounding the patient and in the air (9). Viable bacteria can 
persist in the environment for weeks or months (11). 
The inoculum required to establish colonisation or infection in an exposed individual 
may be as few as 10 colony forming units, depending on the manner of inoculation 
onto the epidermis (9). The initiating exposure may be to contaminated surfaces in the 
hospital environment, or to the contaminated hands of a healthcare worker. 
Healthcare workers hands readily become contaminated when exposed to the 
environment or skin of colonised patients (12, 13). 
Clones of MRSA commonly associated with nosocomial infection appear to have 
evolved to have a survival advantage in the hospital environment. The acquisition of 
genes conferring resistance to commonly used antibiotics appears to confer an 
advantage with many nosocomial clones of MRSA being multi-drug resistant {14). 
Many such clones can also be shown to have greater resistance to desiccation, longer 
environmental persistence and greater ability to form biofilm (15, 16). They may also 
have increased tolerance to biocides commonly used for environmental cleaning (17, 
18). 
Patient risk factors for the nosocomial acquisition of MRSA are largely non-modifiable 
and include older age, renal failure, open wounds, trauma, and mechanical 
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ventilation. However, potentially modifiable risk factors include exposure to other 
patients colonised with MRSA and use of certain antimicrobial agents, particularly 
quinolones (19-21). 
2.2.2 Controlling nosocomial infections 
A number of strategies have been investigated in the search for a solution to the 
problem of nosocomial spread of MRSA. Studies in infection control are hampered by 
the difficulty in conducting unbiased prospective controlled trials and in general the 
evidence base for infection control strategies is poor (22). Many studies rely on 
historical MRSA rates to determine the outcome of an intervention, but these are 
known to fluctuate spontaneously due to changes over time in patient acuity, 
occupied bed days, referral patterns and possibly unknown bacterial factors. Many 
studies also examine the impact of several strategies introduced simultaneously, such 
that the impact of an individual intervention cannot be determined. Guidelines have 
been published for the conduct of future interventional infection control studies (23), 
but there is no high level of evidence for any one strategy to date. What evidence 
there is, however, suggests that the strategies of screening high risk patients for 
colonisation, isolation with barrier precautions for colonised patients and maintaining 
high levels of hand disinfection are important (24). 
2.2.2.1 Screening, Isolation and Barrier Precautions 
Screening for MRSA colonisation involves collection of swabs from one or more body 
sites followed by culture or nucleic-acid based detection. Sensitivity of screening 
increases with the number of body sites samples and the number of times an 
individual is screened (25). Nose swabs are usually reported to have the highest yield 
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(25, 26), and a pair of nose and perineal swabs, plus any wounds is usually 
recommended (27). Pooling of swabs prior to culture has been shown to reduce 
sensitivity of detection (26), but this may not be the case for PCR-based assays (28). 
Broth enrichment and chromogenic media have been developed to improve the 
performance of culture-based laboratory methods (29). However, nucleic acid 
detection techniques have become a prominent focus of attention recently. While 
probably offering modest gains in sensitivity over culture-based detection, the main 
benefit is a reduction in turn-around time allowing isolation measures to be put in 
place faster (30). Some studies have shown a reduction in MRSA transmission rates 
after a switch from culture-based screening to nucleic acid detection (31); however 
some have not, and the cost-effectiveness of such an approach has not been 
confirmed (32). 
Once a patient is found to be colonised, isolation and barrier precautions are required 
to have an impact on MRSA transmission. In one study, isolation for all patients 
regardless of colonisation status was thought to be instrumental in terminating an 
MRSA outbreak in a US burns unit (33). 
2.2.2.2 Hand hygiene 
The majority of MRSA transmission events in hospital are thought to arise by transfer 
of the organism from a health care workers hand to the patient. Mathematical 
modelling suggests that maintaining hand hygiene at high levels is one of the most 
effective approaches to reduce MRSA transmission (34), and these findings have been 
backed up by several clinical studies (35, 36). However, maintaining high hand hygiene 
compliance rate has proven to be problematic as education campaigns generally result 
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in a short-lived improvement in compliance. A standardised program of educational 
materials, audit and feedback has been successful in improving hand hygiene rates in 
Australia (37). Alcohol-based hand rubs appear to result in better hand hygiene than 
soap and water (35, 36}. Despite its recognised importance, a recent Cochrane review 
has concluded that there is insufficient evidence to. recommend any particular 
strategy to improve hand hygiene compliance in an effort to improve nosocomial 
infection rates {38}. 
2.2.2.3 Environmental cleaning 
The hospital environment appears to be an important reservoir of MRSA (39, 40). In 
one study from Dublin, isolates from patients were related by PFGE to isolates from 
their environment in 70% of cases (41). Another study from Birmingham found that 
environmental isolates matched patient isolates in 36% of cases (42). Epidemic MRSA 
strains appear to have longer environmental persistence (2). The best approach to 
environmental cleaning has not been firmly established, although some cleaning 
methods appear superior to others (43), and one study reported reduced MRSA 
infection rates after intensified environmental cleaning (22). Microbiological standards 
for assessing cleanliness have been proposed, but not widely adopted (44). The 
importance of environmental cleaning is emphasised by most infection control 
programme recommendations (27, 45). 
2.2.2.4 Decolonisation 
Decolonisation has been advocated as part of a ,search and destroy' strategy that has 
been employed in a number of European countries, most notably the Netherlands 
{46). It consists of a one to two week course of antiseptic skin wash and mupirocin 
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nasal ointment with or without a combination systemic antibiotic regimen, which 
includes rifampicin. In the 'search and destroy' strategy, decolonisation is 
recommended for all staff and patients who are found to be carriers who do not have 
contra-indications to the therapy. It appears to be a successful strategy in areas with a 
very low MRSA prevalence, but concerns regarding· compulsory screening and 
exclusion from work of colonised hospital staff, concerns about development of 
resistance and the questionable applicability of the strategy in institutions with high 
MRSA prevalence mean that it has not gained wide acceptance (46). Reflecting this, a 
Cochrane review has found there was insufficient evidence to support the use of 
decolonisation for MRSA carriage (47). Topical decolonisation measures for colonised 
patients were thought to have contributed to decreased MRSA transmission in several 
studies (48). Surveillance for resistance to mupirocin and chlorhexidine is 
recommended when decolonisation is practiced regularly (49). 
2.3 Epidemiology of MRSA 
MRSA first emerged in 1961, two years after the introduction of methicillin to treat 
beta-lactamase producing isolates of Staphylococcus aureus. It quickly spread around 
the world and was first isolated in Australia in 1965, becoming endemic in many large 
hospitals on the eastern seaboard by the 1980s (50). MRSA is thought to have arisen 
by the acquisition of resistance genes from coagulase negative staphylococci via the 
transmissible genetic element staphylococcal cassette chromosome mec (SCCmec) 
(51). This introduction of SCCmec into MSSA is a relatively infrequent event, and the 
MRSA strains produced by the event then spread in a clonal fashion. Hence the 
genetic variability in MRSA isolates is relatively limited. 
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The global molecular epidemiology of MRSA has become better understood with the 
development of new molecular typing tools, particularly multi locus sequence typing 
(MLST) and typing of the SCCmec element (52), both of which are discussed in more 
detail below. However, many other typing methods have been used in the past which 
has resulted in a confusing array of nomenclature systems for MRSA strains (53). For 
the purposes of this discussion, strains will be identified by the MLST clonal complex 
(CC), the MLST sequence type (ST), followed by the SCCmec type (preceded by 
'MRSA'), when present, for example CC8-ST239-MRSA-III. Commonly used identifiers 
from other nomenclature systems will follow in brackets when relevant. 
2.3.1 The start ofthe MRSA epidemic: EMRSA 
The first MRSA isolates, arising in the United Kingdom, have subsequently been 
classified by MlST/SCCmec typing into CC8-ST250-MRSA-I (Archaic). This strain 
appears to have arisen from CC8-ST8-MSSA by acquisition of the SCCmec element. 
ST8-MSSA was shown to have been widespread immediately prior to the emergence 
of MRSA and its MLST differs from ST250 of the archaic clone by a single point 
mutation in one housekeeping gene. A very closely related strain, CC8-ST247-MRSA-I 
(Iberian clone) remains a major cause of nosocomial MRSA infection in Europe (54). 
CC8-ST8-MSSA has been the source of several other clones of M RSA by acquisition of 
different SCCmec elements, such as CC8-ST8-MRSA-II (lrish-1 clone) and CC8-ST8-
MRSA-IV (UK eMRSA-2). CC8-ST239-MRSA-III, the major cause of nosocomial MRSA 
infection in Australia, also appears to have arisen from CC8-ST8-MSSA by a 
recombination event with ST30-MSSA and acquisition of SCCmec type Ill (55-57). 
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Other MSSA clones have served as progenitors for the emergence of new MRSA 
strains, and the majority of MRSA isolates belong to one of ten dominant lineages 
(58). One is CC22-ST22-MRSA-IV (UK eMRSA-15) which has emerged as the second 
most common hospital acquired MRSA strain in Australia (59-61). Between them, CC8-
ST239-MRSA-III and CC22-ST22-MRSA-IV accounted for around two-thirds of hospital 
acquired MRSA infections in Australia in 2005 (62). Another nosocomial pandemic 
clone CC30-ST36-MRSA-II (EMRSA-16) has not become established in Australia, but 
isolates are occasionally reported from Australian hospitals (62). 
It has been observed that hospital-associated MRSA clones may follow a dynamic 
pattern of emergence and then decline with replacement by another clone. The 
factors associated with this are not well understood, but microbial factors, host 
immune factors and infection control interventions probably all play a role (63). 
2.3.2 A new era of MRSA infection: Community MRSA 
In the 1990s, a new era in the evolution of MRSA was recognised, with the emergence 
of infections in individuals without any contact with hospitals or other healthcare 
institutions. The strains responsible for these infections were novel and generally 
carried SCCmec IV and V. These strains have proved to be genetically and 
geographically diverse, and not related to the major nosocomial clones that preceded 
them (64-67). The first such strain was first identified in remote Aboriginal 
communities of Western Australia (68). Several other clones have since emerged (69) 
or arrived in Australia, and commonly circulating community strains now include ST1-
MRSA-IV (WA-MRSA-1) ST30-MRSA-IV (South West Pacific strain) and ST93-MRSA-IV 
(Queensland strain) (65). The latter is particularly virulent, and while it shares 
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pathogenicity factors with another community-associated clone of worldwide 
importance (ST-8-MRSA-IV [USA300]), the clones do not seem to have evolved from a 
common ancestor, but rather to a have arisen with convergent evolution (70). ST93-
MRSA-IV has expanded in range rapidly since it was first recognised. It is now 
responsible for more than a quarter of all community onset MRSA infections in 
Australia (71). These and other strains are now prevalent in the community worldwide 
(54). In Australia in 2010, 18% of community onset infections due to S. aureus were 
caused by MRSA, a figure which has been steadily increasing (71, 72). 
The distinction between community- and hospital- associated clones in becoming 
increasingly blurred. Clones that traditionally have been hospital-associated are being 
identified in the community in persons without risk factors (73) and community-
associated clones are causing outbreaks in hospitals. In the last published survey of 
molecular epidemiology of MRSA isolates from hospital-onset infections in Australia, 
almost one third were due to clones normally associated with the community, 
predominantly STl-MRSA-IV, ST93-MRSA-IV and ST30-MRSA-IV (62). 
2.3.3 Livestock associated MRSA 
Even more recently, human MRSA infections with a newly identified clone of MRSA 
(CC398) have been recognised. A common risk factor has been contact with animals, 
in particular pig farmers in Western Europe and large-animal veterinarians (74) . These 
livestock-associated MRSA (LA-MRSA) clones have not yet been reported in Australia. 
They appear to be less well adapted to causing person-to-person transmission 
compared with clones typically associated with human infection (75-77). Apparently 
they have evolved from human-associated MSSA clones with loss of human-specific 
31 
Chapter 2: Review of Methicillin resistant Staphylococcus aureus strain typing methods 
pathogenicity factors and acquisition of SCCmec (78, 79). Colonisation and infections 
in humans with other clones of MRSA also found in livestock have been described; in 
particular, a novel mecA variant located on a new SCCmec type (XI) (harboured by 
CC130 strains), which is not detected by standard PCR tests, has recently been 
reported from the UK and Europe (80, 81). 
2.4 The role of strain typing in infection control 
Strain typing is the process of classifying micro-organisms into groups below a species 
level. Typing of multi-resistant bacteria as an aid to hospital infection control is 
generally advocated for two main purposes: (i) to confirm clinically suspected 
transmission events and (ii) to monitor the spread of virulent strains. Additionally, 
typing can aid the descriptive epidemiology of nosocomial pathogens. Whether 
performing typing of multi-resistant organisms (MROs) ultimately leads to a reduction 
in their rates of transmission and infection has not been well studied. This, in part, has 
been due to the fact that up until recently, typing methods that were discriminatory, 
rapid and inexpensive enough to allow routine typing were not available. An outline of 
the more important typing methods for MRSA is shown in Table 2.1. 
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Table 2.1. Outline of important typing methods for MRSA. 
Cia ssificat ion Method Target Output Advantages and Disadvantages 
Phenotypic Anti biotype Antibiotic Antibiotic Advantages 
susceptibility susceptibility • Often performed as part of 
pattern testing (numerous routine microbiology 
methods) Disadvantages 
• Very poor discriminat ory power 
Phage typing Bacteriophage Inoculation of Disadvantages 
lysis pattern phage suspensions • Specialised- requi res 
onto a lawn of maintenance of panels of phages 
isolate grown on • limited discriminatory power 
solid agar • Nontypeable isolates 
MALDI-TOF Bacterial proteins Spectral Advantages 
fingerprint of • Very rapid 
protein molecular • low cost per isolate 
weights • Equipment now found in many 
diagnostic microbiology labs 
Disadvantages 
• High initial capital outlay 
• Poor discriminatory power 
• Poor portability of results 
Raman Bacterial cell Spectral Advantages 
spectroscopy chemical fingerprint • Very rapid 
composition • Low cost per isolate 
Disadvantages 
• High initial capital outlay 
• Poor discrimi natory power 
• Poor portabil ity of results 
Genotypic RFLP of Size variation in Agarose gel Advantages 
without genomic DNA fragments of fingerprint • Highly discriminatory 
nucleic acid with pulsed genome digested Disadvantages 
amplification field gel by5mal • Slow 
electrophoresis restrict ion • low throughpu t 
(PFGE) enzyme • Labour intensive 
• Expensive 
• Interpretation of results not 
straightforward 
Genotypic Binary typing. Any targets in the Bands on agarose Advantages 
with nucleic Includes toxin genome; e.g. gel or probe • Potential for high discriminatory 
acid gene profiling, toxin genes, signals which can power depending on targets 
amplification SCCmec typing, resistance genes, be converted to a chosen 
phage-derived including numeric profile • Can provide information about 
open reading combinations of presence of virulence factors 
frame typing targets • Inexpensive 
and others • Rapid 
• High throughput 
• Simple result interpretat ion 
Multi locus Several genes in Bands on an Advantages 
variable the genome each agarose gel or a • Rapid 
number of of which vary in series of amplicon • Discriminatory 
tandem repeat length from strain sizes determined • Inexpensive 
analysis to strain by capillary Disadvantages 
(MLVA) electrophoresis • Can be hard t o optimise multiplex 
PCR 
• Gel-based results more difficult to 
analyse (capillary elect rophoresis 
superior) 
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Classification Method Target Output Advantages and Disadvantages 
Repetitive Short repetitive Bands on an Advantages 
sequence elements agarose gel • Rapid 
based PCR scattered • Has been commercialised 
throughout the (Diversilab) 
genome. Disadvantages 
Intervening • Poor discriminatory power for 
sequences are MRSA 
amplified by PCR • Commercial platform is expensive 
using primers • Result interpretation difficult 
targeting the 
repetitive 
elements 
Genotypic spa typing spa gene Sequence is Advantages 
with nucleic sequence ana lysed for • Rapid 
acid presence of • Online database of spa types 
amplification various 24 base available 
and sequence pair repeats, the • Interpretation straightforward 
based output order and number Disadvantages 
of these repeats is • Discriminatory power may not be 
converted to a sufficient in some settings 
numeric spa type. • Sequencing relatively expensive 
Sometimes (but price continues to fall) 
combined with 
Cl/8 sequencing to 
increase 
discriminatory 
power (double 
locus sequence 
typing) 
Multilocus Sequence of A numeric value is Advantages 
sequence seven assigned according • Online database of MLST types 
typing (MLST) housekeeping to unique available 
genes combination of • Interpretation straightforward 
sequences of the • Useful to study global 
seven target epidemiology of S. aureus 
genes. Disadvantages 
• Discriminatory power poor, not 
useful to identify transmission 
events 
• Expensive 
Whole genome Sequence of the Series of short Advantages 
sequencing whole bacterial sequences • Maximum possible discriminatory 
(WGS) genome covering the entire power 
genome which • Sequence based output ideal for 
much be comparison between laboratories 
assembled with and between runs 
reference to a Disadvantages 
previously • High cost (improving) 
sequences • Slow turnaround time (improving) 
bacterial genome • Vast amount of data requires 
bioinformatics resources to 
interpret 
• Guidelines for interpretation not 
established 
Table 2.1. Outline of important typing methods for MRSA. 
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2.4.1 Molecular typing to identify transmission 
When the outbreak strains of infrequently isolated organisms causing nosocomial 
infection have unique phenotypic characteristics, particularly multiresistant 
antibiograms, the outbreaks are relatively easy to identify. Such outbreaks frequently 
occur in Australian hospitals, as with vancomycin resistant Enterococcus sp. (82), 
multiresistant Acinetobacter baumanii (83), and metallo-beta-lactamase producing 
Gram negative organisms (84). 
Nosocomial outbreaks due to common species of which the outbreak strain has no 
defining phenotypic characteristics are reported less frequently, although they are 
arguably more common. Such outbreaks are more difficult to identify since they 
require a high level of suspicion followed by strain typing procedures to confirm. 
Organisms for which frequent, unidentified nosocomial transmission may be occurring 
include methicillin susceptible Staphylococcus aureus (MSSA) (85, 86), Streptococcus 
pyogenes (87), Pseudomonas aeruginosa {88} and Streptococcus agalactiae (89, 90). 
Increasingly, MRSA molecular typing techniques are needed to identify outbreaks 
because of its rising prevalence as a community pathogen (91), and high rates of 
endemicity in many hospitals. So many patients are now colonised with MRSA that it is 
difficult to establish whether they acquired the isolate in hospital or in the community 
without molecular typing. 
Thus, molecular typing in hospital infection control is generally performed to confirm 
outbreaks when they are suspected by virtue of an increase in isolation of a given 
organism above background rates. This is a very valuable application, as it helps 
narrow the case definition in the investigation which can greatly assist generation of 
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hypotheses regarding the source of the outbreak {92-95). It also facilitates the 
identification of pseudo-outbreaks, thus avoiding unnecessary investigation costs (94, 
96) and can be used to assess the impact of infection control interventions (97). 
However, typing can be misleading if the method cannot_distinguish epidemiologically-
unrelated strains (98, 99), so the selection of the appropriate technique and careful 
interpretation of the results is vital. Senn et al. demonstrated that an epidemiologic 
link cannot be automatically inferred between two patients harbouring the same 
molecular type of MRSA, even when that type is infrequent and the typing system has 
high discriminatory power (100). Hence typing results must always be interpreted in 
conjunction with clinical details which provides information about the spatiotemporal 
contact between individuals. 
2.4.2 Molecular typing to detect hypervirulent strains 
Bacterial subpopulations differ in their virulence, which may manifest as increased 
severity of disease, resistance to antimicrobial agents or an enhanced ability to spread 
in the hospit al environment and colonise the host. Examples include the evolving 
epidemic of hypervirulent nosocomial Clostridium difficile infection (101), nosocomial 
invasive Streptococcus pyogenes outbreaks (87), and toxic-shock syndrome associated 
MRSA (102). Some MRSA strains spread more easily and are more difficult to control 
than others (103), conversely livestock-associated MRSA appears to spread less easily 
(77). An increase in MRSA blood stream infection (BSI) rates in the UK was associated 
with the emergence oftwo epidemic MRSA strains (ST22-MRSA-IV [EMRSA-15] and 
ST36-MRSA-II {EMRSA-16]), which have been difficult to control using standard 
infection control procedures (104). More virulent MRSA strains are more likely to 
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cause BSI in colonised patients- in the UK, patients colonised with one virulent MRSA 
strain (ST239) were 4.5 times more likely to develop MRSA intravenous-line associated 
BSI, than patients colonised with other MRSA strains (105). ST22-MRSA-IV (EMRSA-15) 
emerged in Australia in 2001 (60) and quickly has become a common cause of 
nosocomial MRSA infection; ST36-MRSA-II (EMRSA-16) has not yet become 
established in Australia, but the first isolates have now been reported (61). ST93-
MRSA-IV, a clone with unique virulence characteristics (70), is increasingly being 
identified as a cause of hospital-onset infections (62). 
In summary, strains of MRSA vary in their virulence and transmissibility. Identification 
of clusters of highly pathogenic strains of MRSA in the hospital environment would 
warrant enhanced infection control measures, but monitoring for more virulent 
strains is not yet routinely employed in hospital infection control programs. 
2.4.3 Molecular typing for descriptive epidemiology 
MRSA populations in hospitals are not static. At any time, multiple strains are 
circulating, new ones appear, spread to varying degrees and may replace or co-exist 
with, endemic strains or disappear (63, 106, 107). Nosocomial outbreaks of non-
multiresistant MRSA, previously confined to the community, are increasingly 
recognised (91, 108). Though descriptive molecular epidemiology, in and of itself, may 
not be crucial to the day-to-day practice of infection control, molecular typing can 
offer insights into the evolution and emergence of new strains of bacteria in the 
hospital environment which are vital for our understanding of the pathogen (56, 107). 
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2.4.4 Should prospective molecular typing be performed routinely in 
hospital infection control? 
Routine bacterial typing, to identify outbreaks as they occur, has found a place in the 
domain of community public health, where control programmes for organisms such as 
Mycobacterium tuberculosis and Salmonella sp. rely on typing for initial identification 
of transmission events. Such an approach has only rarely been employed in hospital 
infection control, especially for MRSA. A study published in 1993 that used restriction 
enzyme analysis of plasmid DNA (REAP) typing found that routine typing of all hospital 
MRSA isolates led to identification of small clusters which would have gone 
unobserved if traditional epidemiologic surveillance, only, had been used (109). 
Likewise, routine pulse-field gel electrophoresis (PFGE) identified unsuspected 
nosocomial transmission of gram negative rods in a neonatal intensive care unit (110). 
Hacek eta/. described routine typing by restriction enzyme analysis (REA) of genomic 
DNA with conventional electrophoresis in a tertiary facility for isolates of MRSA, VRE 
and fluoroquinolone-resistant Pseudomonas aeruginosa. A decrease in nosocomial 
infections of 10% was seen in the 24 months after introduction of the system, 
compared with the 24 months before, with an estimated cost saving of US$4,368,100 
(111). Mascini eta/. used PFGE to distinguish epidemic from sporadic strains during a 
hospital outbreak of vancomycin resistant Enterococcus faecium, enabling infection 
control measures to be withheld for a large number of patients while still successfully 
terminating the outbreak (112). 
Mellman et al. incorporated spa typing of MRSA with spatiotemporal epidemiologic 
data in a German tertiary care facility to automatically generate prospective 'clonal 
alerts' which were found to identify clusters of MRSA transmission more reliably than 
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clusters identified by epidemiologic data alone or by the infection control practitioners 
after review of the microbial data and patient information (106). 
There are two main limitations for prospective, routine typing of MRSA in infection 
control. The first is the availability of an inexpensive, high throughput, discriminatory 
and easy to interpret typing method. However, the advent of PCR based technologies 
and the fall in cost of such techniques means that this limitation will soon be lifted. 
The second is the interpretation of the typing data in order to reliably identify 
t ransmission events. This is an important limitation, and so it is important to 
understand the limitations of the typing method and assess the results in conjunction 
with the available clinical epidemiology. 
2.5 Typing techniques for Staphylococcus aureus 
2.5.1 Background: Genetics of Staphylococcus aureus 
5. aureus evolves in a largely clonal fashion. That is, point mutations, 
duplications/insertions and deletions are much more common than recombination 
events, in contrast to some other species. One estimate places point mutations as 16 
times more common than recombination (113). However, recombination events do 
occur, and may be more common than originally thought (55, 113, 114). In general, 
though, the high level of clonality amongst 5. aureus strains and, in particular, 
nosocomial MRSA strains, means that typing methods used to determine t ransmission 
events must be extremely discriminatory. 
The structure of the 5. aureus genome can be divided into core genes, core-variable 
(CV) genes and mobile genetic elements (MGEs) (115). Core genes are common to all 
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isolates of 5. aureus and strain-to-strain variation in these genes is limited to 
occasional SNPs, usually synonymous substitutions. Core genes include housekeeping 
genes which are essential to bacterial cell metabolism. Assessment of variations in the 
core genome is useful to infer long-term phylogenetic relationships but is less useful in 
assessing the short-term relatedness of isolates. The CV genes, accounting for 
approximately 10% of the genome, show variability (in their presence or absence, or in 
sequence variation) from lineage to lineage but are generally conserved in isolates 
from the same lineage. These CV genes are not located on mobile elements: they are 
acquired or lost through recombination and insertion/deletion events. Many of these 
genes encode cell surface proteins and regulatory factors. MGEs include integrated 
prophages and plasmids, transposons, pathogenicity islands and chromosomal 
cassettes. These are derived from exogenous sources and frequently encode toxins, 
antimicrobial resistance genes and other putative virulence factors. There is 
considerable variation in MGEs, even between otherwise closely related strains (58, 
116). 
2.5.2 Assessment of typing techniques 
A number of characteristics of a typing technique must be considered when assessing 
the utility of a typing technique (117). 
2.5.2.1 Discriminatory power 
This is the ability of the technique to differentiate unrelated strains (118). 
Discriminatory power can be assigned a numerical value, Simpson's index of diversity 
(i), based on the number of types a technique assigns to a group of unrelated isolates 
while taking into account the frequency of those isolates in the population. The value 
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represents the probability that two randomly selected isolates from the population 
will be assigned into two different types, so a value of 1 indicates that all isolates are 
assigned into different groups, and a value of 0 indicates that all isolates have been 
assigned the same group (119). Confidence intervals should also be calculated for D 
(120). A more complex calculation can be used for typing ·methods where type 
designation may depend on varying the criteria used to define a type, especially when 
such variation produces a reciprocal variation in reproducibility (121). An arbitrary 
figure for good discriminatory ability is that the most common type occurs in less than 
5% of the population (118), or that Dis> 0.9 (119). Discriminatory value does not take 
into account inappropriately designating strains as different when they are in fact 
epidemiologically identical. 
Discriminatory power needs to be assessed against a gold standard. Ideally this should 
be robust clinical epidemiology that determines the relatedness of strains, and the 
molecular typing technique should be assessed against this clinical information. In 
reality, many studies simply compare one typing technique against another which is 
thought to be a gold standard (often pulse-field gel electrophoresis of 5mal digested 
genomic DNA in the case of MRSA typing). A most useful question is whether a typing 
technique can distinguish between two isolates which cannot be distinguished by 
other typing techniques, but which are known to be epidemiologically unrelated {118). 
Z.5.2.2 Concordance 
The selection of isolates for validation of a technique is crucial (117). Ideally, typing 
techniques should be assessed using a collection of isolates that are epidemiologically 
well-defined, that is, some related (part of an outbreak) and some unrelated in place 
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and time. With such a collection, the 'epidemiologic concordance' of the method can 
be established (122). Epidemiologic misclassification of the isolates can be a problem 
in this approach and attempts to minimise it should be made (122). Alternatively, a 
new method can be compared with a well-established method 'typing system 
concordance' (117). Important measures of concordance 6f typing systems include the 
Rand and Wallace co-efficients, both of which can be adjusted for the random 
occurrence of concordance (123, 124). 
2.5.2.3 Typeability 
This is the ability of the technique to assign each isolate a type. Inability to do so may 
arise due to mutations at primer binding sites in PCR-based typing techniques, or due 
to strains which lack the target characteristic (e.g. lack of plasmids in plasmid analysis). 
Non-typeability may also arise when there is a result but it is ambiguous or 
uninterpretable (118). 
2.5.2.4 Reproducibility 
This is the ability of a technique to give the same typing result on every occasion, 
either in the same laboratory or between laboratories (118). Reproducibility can be 
influenced by variation inherent in the technique or the user. 
2.5.2.5 Stability 
Stability refers to lack of variation in the typing result of the same strain over time. 
Stability can be measured by in vitro methods by repeated typing of an isolate after 
several passages in the laboratory, or by in vivo methods where isolates from 
colonised or infected individuals are sampled at intervals to assess for a change in 
type. lt is important to consider the clonality of MRSA infection and colonisation in 
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this context. It has long been thought that carriage of Staphylococcus aureus was 
generally clonal, such that only one strain of MSSA or MRSA would generally be found 
colonising a given host. However, a recent study has refuted this (125), which has 
implications for the validity of molecular typing of colon ising MRSA isolates. 
2.5.2.6 Other factors 
While the above three measures are integral to the performance of a typing 
technique, other factors also play a practical role in determining the utility of a given 
method ('convenience factors' (117)). These include ease of use, throughput, 
portability of results, turnaround time, flexibility and cost. 
2.5.3 Phenotypic Typing Methods 
2.5.3.1 Antibiotype 
The antibiogram is an important characteristic in defining a hospital outbreak of a 
bacterial pathogen and an increase in the number of isolates of a multi-resistant 
organism is often the first indicator of an outbreak. For many organisms, tracing the 
antimicrobial susceptibility pattern is sufficient to identify organisms which are part of 
the outbreak and to identify transmission events. However, when the background rate 
of colonisation and infection from the organism is high, the antibiogram becomes of 
limited value to determine transmission events and a more discriminatory method is 
required (126, 127). Such is the case with MRSA. The antibiogram may be useful as an 
initial screening method, however, to place isolates into broad groups, such as 
nonmultiresistant MRSA (defined as resistant to less than two non-beta-lactam 
antimicrobials) versus multiresistant MRSA. Sometimes an outbreak strain of MRSA 
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may have a characteristic susceptibility pattern which makes it easier to monitor, e.g., 
ciprofloxacin resistance in eMRSA-15 (128). 
2.5.3.2 Phage typing 
Phage typing involves determining the presence or absence of bacterial cell lysis when 
challenging the strain with a panel of lytic bacteriophages. Phage typing was for a long 
time the mainstay of typing for Staphylococcus aureus, and it contributed greatly to 
early developments in hospital infection control (129). However, a percentage of 
strains will be nontypeable with any given panel (that is, none of the phages in the 
panel will be lytic for that strain). Extended ranges of bacteriophages can be used but 
maintaining stocks of bacteriophages can be expensive, and this technique has been 
gradually replaced by more straightforward, discriminatory and reproducible 
genotypic methods. 
2.5.3.3 Matrix Assisted Laser Desorption/Ionization Time-of-Flight Mass 
Spectrometry 
Matrix assisted laser desorption/ionization time-of-flight mass spectrometry (MALDJ-
TOF) is a technology that has recently been taken up widely in in the clinical 
microbiology laboratory for rapid identification of bacterial and fungal species. MALDI-
TOF produces spectra that represent the proteome of the organism. By comparing the 
spectral peaks to those in a computerised library, different species, or potentially even 
strains within a species, can be distinguished. MALDI-TOF is very rapid (turnaround 
time measured in minutes) and price of consumables is very low. While the equipment 
represents a significant capital outlay, many clinical laboratories are acquiring this 
technology for routine bacterial identification. Boggs eta/. explored the use of MALO I-
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TOF to distinguish USA-300 (ST8-MRSA-IV) from non-USA-300 5. aureus strains. While 
the USA-300 isolates clustered together, there was some overlap with non-USA-300 
strains, leading to a sensitivity of 0.87 and specificity of 0.89 for detecting USA-300 
when utilising the three spectral peaks that provided highest discrimination {130). 
Another study also indicated that MALDI-TOF may be useful at classifying isolates into 
one of the major hospital associated clones {131). Whether MALO I-TOF may ultimately 
be useful for distinguishing a large number of strains within a clone, as can be 
achieved by pulse-field gel electrophoresis (below), remains to be seen 
2.5.3.4 Ramen spectroscopy 
This is another rapid phenotypic spectroscopic method which examines the chemical 
components of the bacterium. Wulf eta/. performed a retrospective study of 525 
stored MRSA isolates from a low-prevalence setting in the Netherlands, and compared 
the results of Ramen spectroscopy, spa typing and PFGE. In cases where an outbreak 
or nosocomial transmission event was suspected on the basis of PFGE, Ramen 
spectroscopy also demonstrated relatedness in 123 of 127 cases (97%) (132). While 
the turnaround time is short (2 hours) and reproducibility appears to be good, the 
output, as with MALDI-TOF, is a spectral fingerprint, which is not ideal for portability. 
2.5.3.5 Other Phenotypic methods 
Other phenotypic typing techniques such as serotyping, biotyping, bacteriocin typing, 
immunoblotting and multilocus enzyme electrophoresis are now rarely used for typing 
of MRSA. Since the advent of genotypic techniques which provide better stability and 
discriminatory value, they are rarely relied upon for epidemiologic investigation. 
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2.5.4 Genotypic typing methods without PCR amplification 
2.5.4.1 Restriction endonuclease analysis (REA) 
In this method, frequent cutting restriction enzymes are applied to purified 
chromosomal DNA and DNA fragments visualised by separating by conventional gel 
electrophoresis and stained. The number of bands produced is very large, making 
interpretation difficult and reproducibility poor. This technique is not routinely used 
for typing of 5. aureus. 
2.5.4.2 Probe-based REA 
The difficulties with REA alone can be improved by visualising only bands which 
contain particular DNA sequences using hybridisation with DNA probes via southern 
blotting. One particular DNA sequence frequently employed by this technique is a 
probe against ribosomal DNA, which is frequently present in multiple copies in the 
chromosome (133). Another commonly used technique is a probe for the gene 
encoding methicillin resistance (mecA) and the multicopy transposon Tn554 (134-
136). While these methods produce fingerprints that are easier to interpret than REA 
analysis, the discriminatory value is relatively poor (137). 
A novel adaptation of probe-based typing methods has been described by Van 
Leeuwen eta/. In this method, probes were designed based upon sequencing of 
variable fragments from RAPD (see below) to find target sequences that varied 
between isolates. Seven suitable targets were found, most of which did not have 
homologies for known genes. (138, 139). This was extended to 15 probes in a 
subsequent study, and the presence or absence of hybridisation of purified genomic 
DNA with each of the 15 probes form the basis of the typing system, producing binary 
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typing results. The resulting discriminatory value is similar to that of PFGE (140). The 
method has been adapted to a strip format (141). Although promising, problems with 
reproducibility of results were found with a multicentre comparison, however this was 
largely due to deviations from the hybridisation protocol (142). 
2.5.4.3 RFLP of genomic DNA with pulsed field gel electrophoresis (PFGE) 
This technique improves on REA by using a restriction endonuclease that cuts 
infrequently, producing a much smaller number of bands {143). The issue then 
becomes separating such large bands on an agarose gel. For this purpose, pulse-field 
gel electrophoresis (PFGE) is utilised, which involves periodically switching the 
direction of current across the gel through 60 degree angles (144). Over the course of 
the electrophoresis, the angle switching time lengthens: with initial short switching 
times, large DNA fragments do not migrate far since insufficient time is available for 
their polar re-orientation before they can start to move, while smaller fragments re-
orient quickly and begin to migrate in the short time before the angle switches. With 
longer switch times, later in the electrophoresis, both small and large fragments are 
able to migrate. 
Differences in PFGE patterns are produced by the loss or gain of restriction enzyme 
recognition sites, (which may occur due to point mutations, insertions or deletions} or 
by insertions or deletions that do not involve loss or gain of a restriction site but 
change the molecular weight of a band. A single genetic event may thus create up to 
three bands difference in PFGE (e.g. loss of a band with creation oftwo new smaller 
bands when a point mutation creates a new restriction site). Tenover eta/. describe 
interpretive guidelines for PFGE, whereby up to 6 bands difference (representing as 
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few as two genetic events) may occur for the isolates to still be considered possibly 
related (145). These theoretical guidelines have been validated in the field (146). It has 
been suggested that analysis of band intensity as well as position could improve the 
discriminatory value of PFGE further, but this approach has yet to be widely adopted 
(147). 
PFGE has proven to be a highly discriminatory typing method, and has become a 
favoured method for investigation of nosocomial transmission (microepidemiology) 
(146, 148). It has also been applied to broader, nationwide surveillance of MRSA 
epidemiology, an area where MLST combined with SCCmec typing is frequently used 
(149-151), although some studies dispute whether PFGE is suitable for this purpose 
(152). To this end, efforts have been made to standardise PFGE procedures to enable 
inter-laboratory comparisons (153-156). 
Despite its main advantage of high discriminatory power and its widespread and 
longstanding use, PFGE is not an ideal typing method based on many of the criteria 
discussed above. In particular, it rates poorly on ease of interpretation, turnaround 
time and ease of use. Furthermore, there can still be problems with portability of 
results (157) despite efforts to improve interlaboratory comparisons. An alternative 
approach to visualising fragments by PFGE has been fluorescent labelling of digests, 
separation by microfluidics and visualisation using confocal microscopy (158). This 
approach potentially could improve the turnaround time and portability of results of 
this approach. 
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2.5.4.4 Plasmid Profiling and REAP 
In plasmid profiling, plasmid DNA is separated from chromosomal DNA and then 
electrophoresed to determine the number and size of plasm ids that the bacterial 
strain contains. The discriminatory value of plasmid profiling can be increased using 
restriction enzyme digestion prior to electrophoresis. The technique is not very 
satisfactory, due to instability owing to mobility of plasm ids, and due to the fact that 
some strains may contain no plasmids, and therefore be nontypeable. 
2.5.5 Genotypic typing methods with PCR amplification and binary output 
Here PCR is used to determine the presence or absence of a gene locus. A single 
binary target will not be discriminatory, but the combination of many binary loci, or 
combining one or more binary targets with another typing method, can be effective. 
The advantage of binary typing is that it gives a concrete answer and the binary profile 
can easily be represented by a numeric code. Reactions for several targets can be 
multiplexed, and product detection can be by real-time PCR, gel electrophoresis (159), 
reverse line blot assay (160) or microarray (161). Furthermore, at the same time as 
typing the organism, depending on the targets utilised, it can give useful information 
about the susceptibility or virulence profile of the organism (161). 
2.5.5.1 Toxin Profiling 
A popular target for binary typing methods include known toxin genes, such as 
staphylococcal enterotoxins, of which at least 19 have been described, designated A 
through U (encoded by genes sea through seu) (162-164). Emergence of new epidemic 
MRSA strains has been associated with horizontal transfer of toxin genes (102, 165}, 
and while the value of toxin genes as markers that could subdivide types classified by 
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other methods (such as MLST, spa typing or PFGE) is not well established, there is 
some evidence of variability of toxin profiles within spa or MLST groupings (102, 164, 
166, 167). Some toxin genes such as Panton-Valentine leukocidin (PVL) and toxic shock 
syndrome toxin have a strong association with enhanced virulence (see below) and 
their inclusion in a typing method provides useful infor.mation above and beyond the 
discriminatory value. High-throughput toxin gene detection has been facilitated by 
reverse line blot assay (164} and microarray technology (161). 
2.5.5.2 Antibiotic resistance genotyping 
Detection of antibiotic resistance genes potentially has more value than the 
phenotypic antibiogram since multiple different genes can be responsible for a single 
phenotypic characteristic (e.g. ermA, ermC or msrA for macrolide resistance; tetM or 
tetK for tetracycline resistance). Furthermore, in some cases (e.g. methicillin 
resistance, clindamycin resistance) the genotypic result may be a more reliable 
predictor of in vivo treatment response (168). Oligonucleotide arrays now permit 
simultaneous detection of a large number of resistance genes (161, 169), but the 
discriminatory value of antibiotic resistance genes is not high. 
2.5.5.3 SCCmec typing 
2.5.5.3.1 SCCmec Evolution, Structure and Classification 
Variations in the genomic island that carries methicillin resistance, staphylococcal 
cassette chromosome mec (SCCmec), have been recognised for some time, and new 
variations are being described regularly (81, 135, 170-176). The three main elements 
of SCCmec are the cassette chromosome recombinase (ccr) complex, the mec gene 
complex and the three intervening J (junkyard) regions Jl-3 (54). 
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Eight different ccr complexes (1 to 8) have been described, with various ccr allotypes 
(table 2.2). The function of ccr is to facilitate site-specific integration of the cassette at 
the attBscc site in the chromosome. 
The mec gene complex comprises mecA (the gene encoding the alternate penicillin-
binding protein pbp2a), IS431mec and several other variable elements (mecRt 
lJmecRl and mec/, /5431mec, /51272), the presence or absence of which define a mec 
complex class (denoted A, Band C). mecRl and mec/ are regulatory elements that 
sense the presence of beta-lactam antibiotics and control mecA transcription in 
response (54). Deletion or modification of these genes can lead to unrepressed mecA 
expression. The structures of the mec classes found in 5. aureus are outlined in table 
2.3. Subtypes of the mec class have been found, but not widely adopted into 
subtyping schemes (53). Recently, a variant of mecA (mecALGA2sd was described from 
human and animal isolates in the United Kingdom and Denmark, located on a newly 
described SCCmec type (XI). This mecA variant had only 70% homology with previously 
known human mecA genes, leading to false negative testing on standard PCR assays 
for MRSA (80, 81). 
The combination of ccr complex type and mec complex type define the SCCmec type 
of which eleven are named as types I to XI or types lB, 2A, 3A, 2B, 5C2, 4B, 5Cl, 4A, 
1C2, 7Cl or 8E {respectively) depending on the nomenclature system used {table 2.4). 
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subtyping include pis, kdp, pUBllO (a resistance determinant conferring kanamycin, 
tobramycin and bleomycin resistance), 151182, pT181 (conferring tetracycline 
resistance), ips, Tn4001 (181, 182), pl258 (encoding penicillin and heavy metal 
resistance) and Tn554 (carrying ermA, which confers macrolide resistance) (54). An 
additional letter appended to the SCCmec type is comrimnly used to indicate the 
subtype. An alternative nomenclature has been proposed in which the ccr complex 
type, the mec class and variation in the three J regions are reported in sequence, e.g. 
2B.3.1.4 for SCCmec type IVE (182, 183). 
2.5.5.3.2 SCCmec typing methods 
A number of multiplex PCR methods have been described to rapidly define the 
SCCmec type (184-189) based primarily on the combination of the ccr complex and 
mec complex, without J region targets for subtyping. Other studies have also included 
targets on the J region to determine subtype while predicting the type (180, 190, 191). 
Most of these studies have found a number of isolates which have been non-
classifiable according to the described method, due to variations in the targeted 
sequences. The most comprehensive scheme describes 6 multiplex PCR reactions with 
a total of 42 primers to comprehensively look at all regions (183). However, a number 
of new SCCmec types have been described since this assay was introduced. 
These studies have mainly used gel electrophoresis for product detection. Real time 
PCR assays have focused on determining SCCmec type, but not subtype (185, 186). 
While diversity of SCCmec is fairly limited, it is frequently included in typing protocols 
due to its broader epidemiological associations. However, some regions of SCCmec 
show a higher degree of diversity. Hugyens eta/. described a typing method based on 
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binary typing for 7 variable elements of SCCmec including HVR, pUBllO, lns117, 
pT181, pl258, mecRl and 15256, with gel-based detection. 13 different patterns were 
seen among 65 isolates, 62 of which were nonmultiresistant strains (190). The 
hypervariable region of the SCCmec element has also been examined for its utility in 
typing. PCR-RFLP and examination of amplicon length have been used (192). Length 
polymorphisms occur largely due to variation in the number of repeats in the dru 
repeat region, but it is of limited discriminatory value. 
Z.5.5.4 Phage-derived open reading frames 
One application of binary typing has utilised the presence of phage-derived open 
reading frames, which, because of the mobility of phages, create substantial variability 
even amongst closely related strains. In a method detecting the presence or absence 
of 16 binary targets including 13 phage-derived open reading frames (ORFs), a 
discriminatory value similar to PFGE was obtained. This method has been named 
phage open reading frame typing and has been described using gel-based detection. 
Problems with this procedure include potential instability of the genotype due to gain 
or loss of prophages and the need to adapt the target phage ORFs according to local 
ecology, which may change over time. The advantage is that it is potentially highly 
discriminatory, has a numerical output and rapid turn-around time (159). 
Z.5.5.5 Other binary targets 
AI-Zahrani et at. described a binary typing method where the targets were restriction 
sites for the Smal enzyme, variations in which are exploited in PFGE. A multiplex PCR 
assay with agarose gel detection was devised that examined for the presence or 
absence of 9 restriction sites. This method had a discriminatory power that fell 
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between that of MLST and PFGE (193). A binary typing method based on length 
polymorphisms of the 165-235 ribosomal DNA interspace region has also been 
described. Multiple copies (typically 5 or 6) of this target are present in 5. aureus. The 
presence or absence of each of the 16 most common spacer lengths was assessed by 
PCR and gel electrophoresis. Discriminatory power was·similar to MLST and there was 
good correlation with MLST clonal complex (194). Suzuki eta/. described a binary 
typing method targeting small genomic islets (SGis): collections of up to five ORFs that 
are conserved within MLST clonal complexes but vary between them. By interrogating 
16 informative SGis to produce an 'islet profile', prediction of the MLST clonal complex 
could be made with good reliability (195). 
2.5.5.6 Combinations of binary targets 
Different classes of binary targets can be examined within a single typing system. In 
particular, many toxin genes, antibiotic resistance genes and other putative virulence 
factors may be located on mobile genetic elements (MGEs) which may show 
considerable strain-to-strain variation, even within otherwise closely related isolates. 
McCarthy eta/. used microarray analysis of mobile genetic elements to demonstrate 
that, within the ST22-MRSA-IV clone, considerable variation in MGEs was found and 
that this approach can be used to identify nosocomial transmission events (196). 
2.5.6 Genotypic typing methods with PCR amplification and fingerprint 
output 
These methods improve on the slow turnaround times of non-amplified fingerprint 
based methods by utilising PCR amplification. While improvements have been made 
with computer-assisted fingerprint normalisation and interpretation, portability of 
results is still inferior when compared to binary methods or sequenced based -typing. 
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2.5.6.1 PCR-RFLP 
In this technique, a target gene is amplified by PCR, and then the product is digested 
using a restriction endonuclease. The resulting fingerprint will vary, not only due to 
mutations in restriction sites, but also due to length polymorph isms of the fragments. 
Sequences which are made up of a motif that is repeatea a variable number of times 
(variable number of tandem repeats, VNTR) are particularly suited to this method, 
since relatively large changes in fragment length occur due to duplications or deletions 
of the repeat units. In Staphylococcus aureus, this technique has been applied to the 
spa gene (197) and coa gene (198) and ribosomal DNA sequences. The fingerprint 
produced is usually interpreted using the same criteria suggested for PFGE (145). 
These methods suffer from a lack of discriminatory value, requirement for a restriction 
step and poor portability of results, and have largely been replaced by multilocus 
VNTR analysis or sequence typing. 
2.5.6.2 AP-PCRjRAPD 
Here the primer used for amplification is not directed at a particular gene target, but is 
chosen at random. Shorter primers and less stringent PCR conditions are used in an 
attempt to produce amplification at multiple sites through the bacterial genome, each 
of varying length, and resolvable by gel electrophoresis as a fingerprint. In 
development of the technique, various primers are tria lied, with varying PCR 
conditions until a protocol that produces a suitable number of fragments of varying 
length is found. Due to this reliance on low stringency amplification, reproducibility 
and inter-lab variability is a problem with AP-PCR. Contamination with extraneous 
DNA can also be more of a problem than with other PCR-based techniques (199). 
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Studies in MRSA have generally found that it is less discriminatory than PFGE (192, 
200), although the results are not always concordant, and a combined approach has 
been advocated (201). 
2.5.6.3 MLVA 
Many studies have looked at typing using primers against specific targets, multiplexed 
to produce a fingerprint when the products are examined by gel electrophoresis. 
Genes targeted have included mecA, dru, enterobacterial repetitive intergenic 
consensus sequences (ERIC), In some cases these specific primers were combined with 
arbitrary primers (202, 203). This has also been done with a combination of spa, coa 
and the hypervariable region adjacent to mecA (204}. The most successful use of this 
approach, however, has been with VNTR targets in multi-locus variable number of 
tandem repeats analysis (MLVA). 
like most prokaryotic (and eukaryotic) genomes, repeat regions have been identified 
in the S. aureus genome. These consist of sequences ranging from a single base 
through to tens or hundreds of bases in length, either repeated directly (tandem 
repeats) or at various places in the genome. Direct repeats are prone to duplications 
or deletions of repeats, due to strand slippage during replication. These sites, 
therefore, are often highly polymorphic in repeat number, but also because the 
sequence ofthe repeat is often degenerate (205). Such polymorphisms have formed 
the basis for typing strategies, such as with the repeat region in the staphylococcal 
protein A (spa) gene consisting of 2 to 15 units of a 24-base pair repeat. 
The function of these repeats is largely unknown, but in some instances it has been 
elucidated. For example, variation in repeat number in the hifA-hifB promoter region 
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of Haemophi/us influenzae resu Its in changes in expression of fim brial proteins and 
variations in repeat number in the alpha C protein gene of group B streptococcus lead 
to changes in immunogenicity of the organism (205). In Staphylococcus aureus, direct 
repeats are often found in genes encoding microbial surface components recognising 
adhesive matrix molecules (MSCRAMMs), including protein A, clumping factor, 
fibronectin and others. The location of the peptides encoded by the repeat region is 
within the cell wall and it is speculated that increases in repeat length may present the 
binding domain further from the cell surface and facilitate interaction with the target 
molecule, while decreases in repeat length may bring this domain closer to the cell 
surface and reduce immunogenicity (205). Thus variation in the repeat number in 
these domains may be associated with alterations in organism virulence. However 
there is currently no evidence that the chance, severity or nature of invasive disease 
may be predicted based on the direct repeat profiles of an isolate. 
Multi locus variable-number of tandem repeat analysis combines PCR amplification of 
a number VNTR regions, (most often sspA, spa, sdrC, sdrD, sdrE, c/fA, clfB, fnbA, fnbB, 
coa and/or cna) to determine the length of the amplicon at each locus, which reflects 
the number of repeats at each locus (206-208). Hardy eta/. describe another group of 
VNTR loci named staphylococcal interspersed repeat units (SIRU) (209). Detection of 
product length is usually by gel electrophoresis (207), although capillary sequencing 
has also been described, which facilitates better resolution and higher throughput 
(210-212). A commercial capillary gel based method (QIAxel, Qiagen) has also been 
utilised for more accurate sizing (213). 
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When the PCR reactions for each target are multiplexed and the result visualised as a 
gel-based fingerprint, the method has been dubbed multilocus variable-number of 
tandem repeat fingerprinting (MLVF) (214). Alternatively, by using single PCR reactions 
or by tagging the various amplicons with different coloured dyes the amplicon size of 
each target can be individually assessed, and the results expressed as numbers of 
repeats for each target (212, 215). 
MLVA/MLVF with well-chosen targets gives similar discrimination as PFGE, and 
isolates cluster into groups similar to those found with MLST and spa sequence typing 
(206). It appears more discriminatory than spa sequence typing (206), and other PCR-
based typing methods (216). Differences of up to four bands correlate with differences 
of up to 3 bands by PFGE (206). In vitro stability has been demonstrated, and 
typeability approaches 100% (207). 
Tenover eta/. compared MLVA (gel-based detection) with PFGE and found that MLVA 
could not be used to predict the PFGE types due to clustering differences with the two 
methods, although MLVA was able to distinguish epidemiologically distinct strains that 
were of the same PFGE type in some cases. However, using a similarity cut-off of 75% 
after clustering, the authors found that MLVA could be useful for short term, 
microepidemiological studies. 
In a study by Holmes et al., MRSA typing by MLVA using the originally described 
method (207) was compared with an MLVA method targeting a number of non-coding 
VNTR loci in addition to sspA_ coa and spa (212) with tagged product detection using 
capillary electrophoresis and assignment of repeat number to each locus. The authors 
found that the fingerprint-based MLVA method had a higher discriminatory power and 
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typeability and was able to distinguish strains within the dominant nosocomial clones 
of ST22 (EMRSA-15) and ST36 (EMRSA-16) (214). 
The disadvantage of MLVA is the difficulty with comparability of data across 
laboratories or between runs due to its electrophoresis-based format (216). Unlike 
sequencing, electrophoresis may not reliably predict repeat number, due to the small 
repeat size of some amplicons. 
2.5.6.4 Amplified fragment length polymorphism typing 
Amplified fragment length polymorphism typing (AFLP) involves digesting genomic 
DNA using two restriction enzymes that produce overhanging sequence at either end 
of the DNA fragment that is complementary to short double-stranded adapter 
sequences. These adapters are then ligated to either end, and serve as the primer 
binding sites for subsequent amplification of the fragments. While the amplification is 
thus arbitrary, the difference from AP-PCR is that stringent PCR amplification 
conditions can be used, making AFLP more reproducible than AP-PCR. It has a high 
discriminatory power, approaching PFGE, but still relies on gel-based fingerprint 
interpretation (217), although fluorescent labelling has been used to assist this (218). 
2.5.6.5 Repetitive sequence based PCR typing 
In repetitive sequence based PCR typing (Rep PCR) primers specific for an element 
that is found repeatedly interspersed throughout the genome are used for 
amplification. The direction of the primers is such that the intervening sequence, not 
the repetitive sequence is the element amplified. Several targets have been described, 
including IS256, Mycoplasma pneumoniae repetitive sequence (MP3) and 
'Staphylococcus aureus repeat' (STAR) (219). The discriminatory value is good, but not 
60 
Chapter 2: Review of Methicillin resistant Staphylococcus aureus strain typing methods 
as high as PFGE (220, 221), and reproducibility has been questioned (216). 
Nevertheless, this method has been commercialised as the Diversilab platform 
(BioMerieux) with product identification using microfluidics and software for analysis 
of fingerprints including comparison to a library. Thus the assay is highly standardised 
to assist interpretation and inter-laboratory comparisons·. ~n a study from Switzerland, 
106 MRSA isolates from one hospital over a 12 year period were typed by PFGE, spa 
typing and Diversilab typing. Diversilab had the lowest discriminatory power of the 
three methods, and overall concordance with PFGE was poor, but there was some 
correlation between Diversilab result and spa clonal clusters (222). In another study, 
Diversilab again had lower discriminatory power than spa, but the clustering 
produced was similar to spa and PFGE. The cost per isolate typed (including labour) 
was $74 Canadian dollars (223}. The Diversilab method has the advantage of being 
applicable to a wide range of pathogens, but the performance characteristics are 
perhaps better for organisms other than MRSA (224). 
2.5.7 Genotypic typing methods with PCR amplification and sequence based 
output 
2.5. 7.1 spa typing 
2.5.7.1.1 spa structure and function 
Staphylococcal protein A (encoded by spa) is a constituent of the cell-wall of S. aureus, 
covalently linked at the C-terminal end to cell-wall peptidoglycan, with an NH3-
terminal end at the outer surface which binds the Fe fragment of lgG. The C-terminal 
end (region X) has a constant domain and a polymorphic domain. The polymorphic 
domain consists of a variable number of repeats of an 8-amino acid sequence, 
encoded by a number of 24 (occasionally 21 or 27) base-pair repeat sequences {225, 
61 
Chapter 2: Review of Methicillin resistant Staphylococcus aureus strain typing methods 
226). Typically, between 3 and 15 repeats are harboured in this region. In a small 
study, it was found that more than seven repeats were associated with an MRSA strain 
being classified as 'epidemic'- that is associated with nosocomial spread (197). 
However, this was not the case for all strains examined, and this finding has not been 
repeated in other studies (127, 227). 
2.5. 7.1.2 spa typing method 
As well as the determination of the number of repeats in spa by RFLP analysis (see 
above), the sequence of individual repeats can be determined, as a more 
discriminatory typing method. Each unique repeat sequence is given a code, and the 
spa sequence can thus be simplified by the individual letters or numbers representing 
these sequences (228). An internet-based service for submission of sequence data and 
designation of spa repeats is available which simplifies and standardises the spa typing 
process (229, 230). 547 different repeat units combining to produce over 10,000 
unique spa types have been identified. The PCR product length depends on the 
number of repeats and ranged from 250-637 bp in one study (231). Typeability and 
reproducibility approach 100% (216, 231), although occasional isolates will need 
alternate primers to achieve amplification of the target (232). The method has in vivo 
and in vitro stability (228, 231) and excellent inter-laboratory reproducibility {233). spa 
typing performed well in an external quality assurance assessment of S. aureus typing 
(234). 
The discriminatory power of spa typing is high, exceeding that of phage typing (228, 
231), standard MLST {206, 235), and other single-locus sequence based techniques. 
PFGE of 5mal digested genomic DNA is more discriminatory than spa typing {206, 229, 
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231, 235, 236), but suffers from longer turn-around times and lower inter-laboratory 
reproducibility. MLVA was more discriminatory than spa typing in one study (206), but 
since it relies on determination of length of PCR products without sequencing, it may 
also be prone to lower inter-laboratory reproducibility. 
There has been some debate as to whether the rate of evolution of spa sequence 
makes this typing technique suitable for short term epidemiologic studies of hospital 
outbreaks, longer term evolutionary studies or both. Sequence variation arises from 
deletions or duplications of the repeat sequences, as well as point mutations, 
although the latter are usually synonymous substitutions (231, 232). In one study of 
longitudinal MRSA carriage, average times to a spa mutation was 5.8 years, with 
duplications and deletions of repeats being more common than point mutations which 
are usually synonymous (237). It is this dual-speed clock that has led some to suggest 
that the spa locus is suitable for short term epidemiologic studies as well as longer-
term phylogenetic studies (151, 232). MLST types circulating for up to 40 years 
remained associated with the same, or closely related, spa types in several studies 
(238-240). However, in other studies strains that otherwise appeared closely related 
had quite disparate spa types, which has led some authors to argue that the molecular 
clock is too fast to usefully reflect epidemiologic relationships, event in short term 
studies (241). Recombination events, while thought to be relatively infrequent in 
Staphylococcus aureus, can also lead to spa typing results which are discordant with 
other typing methods, particularly MLST, and so phylogenetic analysis based on a 
single locus like spa must take such events into account (55, 151, 235). One example is 
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the presumed appearance of MRSA MLST-ST239 as a result of recombination of a 
segment of the ST30 genome into the ST8 genome (55). 
Since variation in the spa locus occurs not only by point mutations but also excisions 
and duplications of entire repeats, traditional pairwise sequence alignment techniques 
do not accurately determine relatedness. Clustering analyses must therefore consider 
point mutations within repeats separately from deletions and duplications of repeats 
(231, 232, 242, 243). One such method (242), subsequently designated as BURP 
(based upon repeat pattern), has been incorporated into commercially available 
software (Ridom Staphtype, Ridom GmbH, Wurzburg, Germany) to allow simultaneous 
designation of spa type and clustering analysis directly from sequence output (229, 
235). 
While spa typing provides useful discrimination in the setting of analysis of nosocomial 
outbreaks of MRSA, showing good concordance amongst epidemiologically linked 
strains (231, 244), spa typing alone will not always provide sufficient discrimination for 
this purpose (245). While the finding of discordant spa types may be useful to 
disprove transmission events (229), resolution may be insufficient to reliably infer 
transmission just because the spa types are identical. In an attempt to increase the 
discriminatory value in this setting, several studies have combined spa typing with 
other methods such as clfB typing (243), SCCmec typing, antibiotic resistance genes, 
TSST-1 typing (151), and Tn554:mecA southern blot hybridisation (231). In the absence 
of sufficient discrimination, it has been suggested that an algorithm for determining 
the probability of transmission could be developed based on the prevalence of a 
particular spa type in the local environment (229). 
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2.5. 7.2 clfB typing 
The serine-aspartate {SD) repeat region of the clumping factor B gene (responsible for 
binding keratin and fibrinogen) represents another VNTR locus that has been assessed 
as a sequence-based typing method. The region contains a variable number of 18 bp 
repeats, each encoding 3 SD dipeptides (SDSDSD). The aveFage number of repeats in 
one study was 38 (range 24 to 46), giving a total amplicon size of up to 1011 bp.{246) 
However, just the 500bp 3' segment can be studied without great loss in 
discriminatory power.(243) It has generally been analysed in combination with other 
methods, particularly spa typing, rather than as a method in its own right (commonly 
referred to as double locus sequence typing, DLST) (247). Koreen eta/. found that 
combining spa and clfB typing produced an index of diversity of 99.5% (separating 36 
genetically diverse isolates into 35 types).{246) On its own it was less discriminatory 
than spa typing. However in one study of the hospital setting, where spa typing was 
insufficiently discriminatory to determine the precise microepidemiology, clfB typing 
did not add any additional discrimination; PFGE results were not reported for these 
isolates {245). On the other hand, Kuhn eta/., found 8 spa types, 11 500bp-c/fB types 
and 17 combined spa-clfB types among 48 related isolates with 17 PFGE types. 
Recombination may occur frequently in clfB, and so discordance with other typing 
methods is apparent in macroepidemiogic studies, but this may help differentiate 
amongst closely related strains (246). However, Basset eta/. found reasonable 
concordance with PFGE for DLST (247). Reproducibility and in vivo stability appear to 
be good (243, 246). 
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2.5. 7.3 dru typing 
Another VNTR locus- the direct repeat unit (dru) located on the SCCmec element has 
been studied as a sequence-based typing target (248). Variation was evident amongst 
otherwise highly clonal isolates and addition of dru typing to PFGE and spa typing 
improved discriminatory power compared with either typing method alone or in 
combination (249}. While a promising target, the dru locus is not present in all isolates 
of MRSA, so typeability is imperfect. 
2.5.7.4 MLST 
Multi-locus sequence typing in 5. aureus involves determining the sequence of seven 
housekeeping genes (arcC, aroE, g/pF, gmk, pta, tpi and yqiL). These genes are chosen 
because their relatively slow molecular clock allows the determination of long-term 
phylogenetic relationships. Therefore, MLST is not generally regarded as a useful tool 
for investigation of nosocomial outbreaks. Each unique combination of alleles defines 
a sequence type. Approximately 2400 unique sequence types have now been 
described, and multicentre comparison of data is facilitated by web-based submission 
and comparison (http://saureus.mlst.net). 
Although generally regarded as a tool to examine long-term epidemiologic 
relationships, one study suggested that MLST was as useful as PFGE for examining 
local epidemiology (250). The study found around 28 different MLST types in isolates 
from 80 patients, although 96% of the isolates were MSSA. Hence the result cannot be 
extrapolated to examining nosocomial MRSA epidemiology which is generally limited 
to a handful of MLST in a given institution. Additionally, since the method involves 
sequencing of seven separate loci, it is a relatively expensive and labour intensive 
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technique which restricts it from routine use. An alternative to full sequencing is 
determination of a number of informative SNPs located amongst the seven MLST 
genes which can distinguish the common MLSTs and clonal complexes. The selection 
of the SNPs and interrogation using fifteen real-time PCR reactions was initially 
described by Robertson eta/. (251). It has been used to describe the MLST distribution 
of strains in a number of settings, including in a collection of 249 community-acquired 
MRSA isolates from Queensland and New South Wales where 16 different MLST types 
were distinguished (252). Subsequently the method was adapted to a 8-reaction 
kinetic PCR platform (253), high-resolution melt curve analysis (254) and then to a 
MALO I-TOF based SNP detection using the Sequenom MassAR RAY iPLEX platform 
(255). The SNP-based MLST was also combined with seven binary targets (PVL, cna, 
sdrE, tst pUBllO, pl258 and pT181) for additional discriminatory power (256). 
2.5. 7.5 Whole genome sequence-based methods 
The increase in the accessibility of whole genome sequencing coupled with a fall in 
costs and advances in bioinformatics has enabled typing based on the whole genome 
to begin to be utilised for the investigation of outbreaks. Harris eta/. first 
demonstrated the utility of whole genome sequencing in describing global and local 
MRSA epidemiology simultaneously (57). Koser eta/. performed whole genome 
sequencing on 9 MRSA isolates from babies in a neonatal intensive care unit, and 5 
isolates from patients in other wards of the same hospital. Clustering based on the 
SNPs found in in the whole genome sequences supported the hypothesis that 7 of the 
nine babies in the unit were part of an outbreak of nosocomial transmission (already 
suspected on the basis of temporal clustering and antibiograms), and that isolates 
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from other two babies, as well as the 5 isolates from patients outside the NICU did not 
cluster with the outbreak isolates. The outbreak isolates differed by up to 51 SNPs 
while the non-outbreak isolates differed from the outbreak isolates by 102 SNPs. This 
highlights the difficulty with establishing cut-offs for relatedness when using whole-
genome sequencing for outbreak investigation. The auth-ors suggest that examination 
of clusters based on phylogenetic analysis will be necessary to identify related isolates, 
rather than a simple cut-off of the number of SNPs by which isolates differ (257). 
NObel eta/. predict that whole genome sequencing will soon become the gold 
standard in 5. aureus genotyping for both short- and long-term epidemiologic 
purposes and suggest that there will be a consequent shift from interpreting 
genotyping results from type assignment to expressing relatedness and evolution on 
trees (258). Whole genome sequencing is also likely to drastically improve our 
understanding of the virulence determinants of 5. aureus strains (259). 
2.6 Virulence determinants of Staphylococcus aureus 
Different strains of 5. aureus appear to differ in virulence, which has implications for 
monitoring for MRSA strains which have a higher disease-causing potential. Variation 
of various virulence factors, particularly exotoxins and MSCRAMMs have been 
implicated in the observed difference in virulence. In addition to predicting the 
disease causing potential of a particular strain, variations in these loci have the 
potential to form the basis of discriminatory typing methods. This section will discuss 
the evidence supporting the concept that variation in particular loci account for 
variation in virulence of clinical isolates in an attempt to identify targets to incorporate 
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into a typing system which could be used to simultaneously identify transmission 
events and monitor for virulent strains. 
2.6.1 Panton-Valentine leukocidin 
Panton-Valentine leukocidin (PVL) is a heptameric toxin, made up of the three LukF-PV 
subunits and four Luk5-PV subunits. These genes are located on an integrated 
bacteriophage- a number of different carrier bacteriophages have been identified 
(260). 
After secretion, the subunits assemble upon contact with a polymorphonuclear 
leukocyte (PMN), after which the toxin is phosphorylated by the PMN, and interacts 
will cell membrane for form Ca2+ ion channels, leading to lysis or apoptosis (if bound 
to mitochondrial membranes) of the PMN. This action is specific for PMNs: PVL is not a 
haemolysin. Accompanying this action is release of cytokines with promote and 
inflammatory response {261). This toxin was first identified in 1932 (262), but has 
recently gained widespread attention as the putative cause of increased virulence of a 
number of emerging community acquired MRSA clones (263). However, there remains 
debate about the role of PVL in the pathogenesis of 5. aureus infections (264, 265). 
A mouse model of 5. aureus pneumonia suggested that the presence of PVL is 
associated with necrotizing disease (266). This study also found that PVL up-regulated 
expression of MSCRAMMs such as protein A, which may contribute to increased 
virulence by promoting adherence and inflammation, while at the same time, 
decreasing production of secreted proteins (266). 
69 
Chapter 2: Review of Methici llin resistant Staphylococcus aureus strain typing methods 
In contrast, a study using mouse models of sepsis and skin infection found no 
difference in disease severity between PVL positive and knockout strains of ST8-MRSA-
IV (USA 300) and ST1-MRSA-IV (USA400). Furthermore, in vitro PMN lysis and sublytic 
pore formation was no different between PVL+ and PVL- strains, despite evidence of 
PVL production in the former (267), although these firrdings have been called into 
question (268, 269). Mouse neutrophils are less susceptible to PVL than human and 
rabbit neutrophils; it is argued that rabbit models are thus a better way to assess 
virulence. However, there has also been conflicting data for the significance of PVL in 
rabbit models of infection (270). A clinical study of S. aureus pneumonia (in which 8% 
of cases were due to a PVL positive strain) did not show any correlation between PVL 
production and outcome (271, 272). The epidemiologic association between PVL 
producing isolates and furuncular disease is strong, however (273), and this has 
recently been supported by a rabbit model of S. aureus skin infection using isogenic 
PVL-knockout isolates (272). 
In summary, there is general consensus that PVL is an important virulence marker in S. 
aureus, and specific treatment recommendations for infections due to PVL producing 
isolates have been produced 
In addition to PVL, other similar leukocidins such as lukED (274) and lukAB (275) have 
been implicated as virulence factors for S. aureus infection. 
2.6.2 Enterotoxins 
At least 19 enterotoxins or enterotoxin-like toxins have been described in 
Staphylococcus aureus. They share the characteristic of being superantigenic- that is 
they are exotoxins which cross link the MHC class II molecular on antigen presenting 
70 
Chapter 2: Review of Methicillin resistant Staphylococcus aureus strain typing methods 
cells to the T-cell receptor on T-helper cells to produce unrestrained T-cell activation 
and proliferation. Together with toxic shock syndrome toxin, they form the group of 
exotoxins known as pyrogenic toxin superantigens (PTSAgs). A number of S. aureus 
enterotoxins (but not all) have been linked to food poisoning, and are potent emetic 
agents, as well has causing mucosal inflammation in the stomach and small intestine 
(276). 
Enterotoxins G, I, M, N and 0 are encoded in a single locus called the enterotoxin 
gene cluster (egc), and presence of the Staphylococcal enterotoxin M (sem) gene 
strongly correlates with the presence of the genes coding the other 4 enterotoxins in 
·this cluster (277). New enterotoxins can arise by recombination of the genes within 
the cluster (278). Genes for enterotoxins B, K and Q tend to be found together on 5. 
aureus pathogenicity island-3 (SaPI -3) (279). likewise, sed and sej are found together 
(280). 
The presence of egc is closely related to the clonal complex, with it being found in 
>90% of isolates from clonal complexes 5, 22 (which includes ST22-MRSA-IV 
[eMRSA15]), 25, 30, and 45. It was not found in CCs 1, 7, 8 (which includes ST239-
MRSA-III) and 15 (277). The distribution of enterotoxin genes tends to be fairly 
uniform within the major clones, but there are exceptions (164, 165, 281, 282). 
A negative association has been made between the presence of egc and bacteraemia 
compared with nasal colonisation (277). The enterotoxins found in the egc cluster 
have not been closely linked with food poisoning (277). Ferry found in a study from 
France that sea was more commonly found in isolates causing septic shock than 
bacteraemia without shock, while egc was less common (280). 
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In summary, several enterotoxins have a strong association with particular diseases, 
and the presence of the various enterotoxins is not uniform across all 5. aureus 
strains, although particular enterotoxin genes are linked with each other. This 
variability combined with the large number of identified enterotoxins has made them 
the basis of strain typing in several reports. 
2.6.3 Toxic Shock Syndrome Toxin 
Toxic shock is a syndrome made up of fever, hypotension, organ dysfunction and an 
erythematous rash that usually results in desquamation 1-2 weeks after onset, which 
was first described in 1978 (276). It has since been determined that the majority of 
cases are caused by elaboration of toxic shock syndrome toxin- 1 (TSST-1) from a 
colonising or infecting 5. aureus isolate. TSST-1 is encoded by the tst gene, and like 
staphylococcal enterotoxins (above) is a superantigen. The exact pathogenesis of toxic 
shock syndrome has not been fully elucidated, but it is thought that the T-cell 
activation caused by the superantigen action may sensitise the immune system to 
minute amounts of gram negative endotoxin, resulting in the onset of shock and organ 
failure. Antibodies to TSST-1 appear to give protection against the development of 
toxic shock syndrome. 
The frequency of tst in clinical isolates of 5. aureus is generally around 10-20% (283, 
284). In MRSA, it has generally been less common; however Durand eta/. describe the 
emergence of tst positive MRSA strains in diverse regions in France during 2002-03, 
associated with a variety of clinical manifestations including 5 definite and 9 possible 
cases of toxic shock syndrome in 30 isolates examined. Most of the isolates belonged 
to STS-MRSA-IV (and spa type t002) (102). tst is also found within ST36-MRSA-II 
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(EMRSA-16) (165). Another report describes an outbreak of toxic shock syndrome in a 
NICU in Tokyo associated with TSST-1-producing MRSA (285). 
Given its strong disease associations and the recent emergence ofTSST-1 producing 
nosocomial MRSA strains, inclusion of tst detection in a strain typing scheme would be 
of potential value. 
2.6.4 Exfoliative toxins 
Exfoliative toxins A, Band D (encoded by eta, etb and etd) are well established as 
causes of staphylococcal scalded skin syndrome (SSSS). This disease mainly affects 
children and is characterised by an erythematous rash which develops into areas of 
large bullae formation. The extent and severity is variable, but secondary 
complications such as superinfection and hypotension from fluid loss can occur. There 
is often an associated localised pyogenic 5. aureus infection. Exfoliative toxins are 
serine proteases which are thought to cleave demoglein-1, which is necessary for 
epidermal cell-cell adhesion (286). The frequency of exfoliative toxin producing strains 
of 5. aureus is reported at around 5% in several studies, higher in patients with skin 
inflammatory disorders (287, 288). These toxins have been reported in MRSA, but they 
are not found commonly (164, 165, 282), although eta was found in an emerging 
· MRSA clone in Japan (289). One study found that the presence of etd in MSSA isolates 
of similar genetic backgrounds was more common in invasive disease isolates (282). 
2.6.5 Accessory gene regulator locus 
The accessory gene regulator is a quorum sensing system encoded by a locus made up 
of 5 genes (hid, agrB, agrD, agrC and agrA) which act in concert to control the 
expression of virulence genes such as haemolysins (290). Another locus with a similar 
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function has also been recognised (mgrA) {291). Upregulation of agr appears to be 
associated with decreased biofilm formation, which is in contrast to other quorum 
sensing systems {292). 
Polymorphisms in the agrC and agrD locus can be used to define an agr genotype. In 
one study from a Korean tertiary care facility, 49.3% of 158 MRSA isolates were agr 
group I, 44% were group 2, and 6.7% were group Ill {293). A small number showed 
more than one agr genotype. Similar distributions were found in MRSA carriage 
isolates from a hospital in Japan {294). A study by Hallin from Belgium showed that agr 
group I was the most common type in MRSA and MSSA {295), while in a study from 
Tunisia, agr group Ill was the most common {296). While agr genotype is usually linked 
to the PFGE type (165, 281), function can vary (as measured by delta-haemolysin 
production). In a study from the united states, while 86% of hospital acquired MRSA 
were of agr group II (and 75% were PFGE type USA-100), 48% of these had 
dysfunctional agr expression (297). 
Mutation in the agr locus has been shown to be associated with variation in the 
production of various virulence determinants. A study in a Korean tertiary care facility 
looked at 158 MRSA isolates, and compared agr locus with site of infection. In 
multivariate analysis, only ear infections were significantly different, being more 
common in agr group I strains than non-group I (odds ratio of 4.7). Host factors were 
considered in the multivariate analysis but not bacterial factors (i.e. no further 
characterisation of the strains was performed), so this result cannot be used to infer 
that agr genotype confers the site specificity. Not all studies support a role for agr in 
infection pathogenesis {292). A study from Tunisia found that agr group I was over-
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represented in invasive disease, however they did not control for confounding factors 
(296). In a study of 287 cases of S. aureus pneumonia, agr dysfunction was not 
associated with outcome (271). A Japanese study showed that agr type 2 was over-
represented in invasive isolates from nosocomial infections compared to colonisation 
isolates, and biofilm production was higher in agr type 2 isolates (294). Some links 
have been made with development of glycopeptide resistance and agr genotype. agr 
knockout strains develop resistance more easily when exposed to sub lethal 
vancomycin concentrations (298). 
Yoon eta/. describe amplification of an 1884 bp segment which includes most of agrB, 
agrD and most of agrC, with subsequent restriction enzyme digestion and visualisation 
with gel electrophoresis (293) to determine agr type. Francois describe a multiplex 
real-time PCR for agr genotyping, however this method misclassified 2 of 20 agr type I 
strains as agr type IV (299). Function of agr can also be assessed using delta-
haemolysin production, Sakoulas AAC 46:1492. 
2.6.6 Saul restriction modification (RM) system 
The function of the Saul-RM system appears to be protection of S. aureus from 
transformation by foreign DNA. The system is made up of two enzymes, a restriction 
enzyme which recognises a particular restriction site on foreign DNA and digests it, 
and a modification enzyme which methylates self-DNA at the same site, preventing 
digestion by the restriction enzyme. 
Sung eta/. have identified point mutations in the saulhsdS gene of the Sau1-RM 
system which produce an early stop codon, resulting in dysfunction of the Saul-RM 
system and a phenotype which readily accepts foreign DNA. This has been found in 
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wild-type strains of ST-151, to date only found in bovines. Other hyper-recipient 
strains were also examined, including 8111, the laboratory strain in which VanA was 
first introduced in vitro, but none of these carried the mutations identified in the ST-
151 strains (300). 
A simple PCR method for distinguishing 6 variants of the RM system has been 
described (301, 302) and Avarellos eta/. found that combining assessment for RM 
system variants with SCCmec typing and assessment for PVL could reliably classify 
MRSA strains into the prevalent hospital and community acquired clones (303). 
While variant strains are hyper-recipient to foreign antimicrobial resistance genes in 
vitro, there is as yet no evidence of a link between variations in the Saul-RM function 
and in vivo antimicrobial resistance development. The fitness cost associated with a 
dysfunctional Sau1-RM system has not been assessed. Furthermore, the gene 
polymorph isms that have been linked to hyper-recipience have not been found in 
human isolates as yet. 
2.6.7 Serine-Aspartate Repeat 
Serine-Aspartate Repeat (sdr) proteins are MSCRAMMs encoded for by sdrC, sdrD or 
sdrE genes, all found together in the sdr locus. SdrE has an allelic variant known as 
bone sialo-binding protein (bbp) but ligands for SdrC, SdrD and SdrE proteins have not 
been established (304). 
sdrC is found in all S aureus strains tested; sdrD and sdrE are variably present. The 
absence of both sdrD and sdrE has been linked to decreased bone infection in MSSA, 
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and the absence of the two genes was not linked to MLST type (304). 5drC, D and E are 
VNTR loci included in the MLVA typing method. 
2.6.8 Phenol Soluble Modulins 
Phenol soluble modulins (PSMs) are peptides produced by 5. aureus that have 
cytolytic activity, including against neutrophils. While their presence varies little from 
strain to strain of S. au reus, their expression is variable, and high levels of production 
of PSM has been found in USA-300 (ST8-MRSA-IV) and USA-400 (STl-MRSA-IV) 
community associated MRSA strains. In mouse models of infection using isogenic 
knockout strains, PSMs appear to be an important virulence determinant (305, 306). 
While PSMs generally are a component of the core genome of 5. aureus, one PSM 
variant (PSM-mec) has been shown to be located on SCCmec types II, Ill and VIII (307). 
2.6.9 Other variable virulence factors 
Haemolysins are thought to be important for the virulence of 5. aureus, and four have 
been described (a-, ~-, 6-, y-haemolysins, encoded for by h/a, hlb, hid and hlg 
respectively). Variation in expression, due to changes in regulatory systems may be 
associated with variation in strain virulence (308). However, the haemolysin genes 
exhibit little inter-strain variability and so haemolysin genotyping is unlikely to be a 
·useful predictor of virulence or offer discriminatory value in a typing method (165). 
Likewise capsular type is a known virulence factor, but almost all clinical 5. aureus 
strains belong to either type 8 or type 5 shown to be more virulent in one study (309). 
Microbial surface components recognising adhesive matrix molecules (MSCRAMMs) 
are a family of cell surface virulence factors that play an important role in 
pathogenesis by binding to host molecules such as fibronectin. Fibronectin binding 
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protein A (FnbA) is one such factor. A recent study demonstrated that 5. aureus 
isolates from infected implantable cardiac devices had amino acid substitutions in 
FnbA which led to higher affinity binding and likely promotes formation of biofilm 
(310)- an important part of pathogenesis of such infections. Epidermal cell 
differentiation inhibitors (EDINs) are exotoxins which target host Rho GTPase and so 
affect host cell movement and disrupt intercellular junctions. It is thought that EDINs 
may promote haematogenous dissemination of 5. aureus. Munro et al. found a 
prevalence of EDINs of 14% amongst 5. aureus isolates, and an association between 
deep-seated infection and the presence of EDIN-C (311). 
2.6.10 Differences in virulence not linked to a particular virulence factor 
Some studies have identified strain-specific variations in virulence through typing 
methods, but without identifying the locus responsible. Such studies are important, 
because they highlight the potential usefulness of molecular typing methods to 
identify and track hypervirulent clones of MRSA. 
One study found that certain MLST clonal complexes (and corresponding spa types) 
were over-represented in cases of complicated haematogenous 5. aureus infection. 
Narrow case definitions of colonisation, uncomplicated infection and complicated 
in"fection were used to reduce confounding by patient factors. MLST types implicated 
in more severe disease were STS, STlS and ST36, falling within clonal complexes CCS 
and CC30, while the spa types were t002 and t016. These associations remained even 
after stratifying for presence of methicillin-resistance (312). Another study found that 
CC30 was over represented amongst isolates recovered from patients with persistent 
bacteraemia despite appropriate antibiotic therapy (313). In a study comparing 
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isolates from patients with infective endocarditis or soft tissue infections, isolates 
associated with infective endocarditis were more likely to belong to CC30 (314). 
In a study in a London ICU, patients who acquired ST-239-MRSA-111 were 4.5 times 
more likely to develop vascular access device related bacteraemia compared with 
patients who acquired MRSA of other MLST types (mostly ST-22-MRSA-IV [eMRSA-15] 
and ST-36-MRSA-11 [eMRSA-16]) (105). 
In a study from the Netherlands, attempts at correlation between S aureus genotype 
and infection were made, but the only significant finding was an under-representation 
of CC45 isolates in invasive isolates, although there was no correction for underlying 
disease (315). 
A study from Brazil, showed that a particular PFGE subtype of the Brazilian epidemic 
MRSA clone (ST239-MRSA-III) was found to have enhanced biofilm production and 
epithelial adherence than other PFGE subtypes ofthe same clone and other clones 
(103). Melles eta/. found that a particular AFLP genotype of Staphylococcus aureus 
was associated with nasal colonisation in passive smoking children (316). 
Cheng et at. linked spa type with the likelihood of transmission in a Hong Kong 
hospital where routine admission and twice weekly screening was performed for all 
adult patients. They found that the incidence densities for nosocomial transmission 
were markedly higher for spa types t1081 and t037 compared with the less frequent 
spa types encountered (317). 
The USA300 clone (ST8-MRSA-IV) has also been associated with poorer patient 
. outcomes compared with other isolates in a number of studies (318, 319). 
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2.7 Summary 
In summary, molecular typing of S. aureus can be useful to detect person-to-person 
transmission and to monitor the epidemiology of circulating strains both locally and 
globally. The fall in cost and development of high-throughput molecular methods 
opens the way for routine, prospective typing. A number of methods are available that 
would be possible to employ in this manner; binary typing methods have the 
advantage of being inexpensive, fast, and producing an unambiguous numerical result 
that is easily comparable between runs and between laboratories. A large number of 
potential binary targets are available; selecting which to include in novel binary typing 
scheme required assessment of discriminatory power and stability of the targets. 
There are few virulence markers which stand out as useful binary targets; either they 
are of limited discriminatory power, or the association with virulence is not strong. 
PVL and TSST-1 are two possible exceptions. 
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3.1 Introductory comments 
Based on the literature review findings presented in Chapter 2, binary typing was 
judged to be the most promising platform for a routine, prospective molecular typing 
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system for MRSA. Binary typing meets all of the 'convenience' requirements for a 
typing system: low cost, high throughput, rapid turnaround time, ease of 
interpretation and portability of results. 
One methodology for binary typing is multiplex PCR and reverse line blot hybridization 
(mPCR/RLB) (1}. This method has important advantages over gel-based detection 
methods. It is high throughput- up to 43 targets can be amplified in a single multiplex 
PCR reaction- the inefficiency of product amplification in such a 'megaplex' reaction 
is compensated by highly sensitive detection using probe hybridisation and it is highly 
specific- probe hybridisation reduces the risk of detection nonspecific amplification 
products. 
3.2 Aims 
The aim of this invited publication was to present the methodology of mPCR/RLB. It 
takes advantage of a novel publication style- a video-based peer reviewed journal. 
Such a publication serves as both a unique description ofthe method, as well as a 
useful training resource. 
3.3 Publication: Multiplex PCR and reverse line blot hybridization 
assay ( mPCR/RLB) 
Citation: 
O'Sullivan MV, Zhou F, Sintchenko V, Kong F, Gilbert GL. Multiplex PCR and 
reverse line blot hybridization assay (mPCR/RLB). Journal of visualized 
experiments: JoVE. 2011(54):e2781. 
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This paper is presented both as a written protocol (which follows), and as a video 
article, accompanying this thesis as an electronic file. The video article is alternatively 
available for viewing at the Journal of Visualized Experiments website: 
http://www.jove.com/video/2781/ 
Contribution of authors: 
MOS wrote the text, performed the recorded footage and refined the mPCR/RLB 
procedure. 
FZ, VS, FK and GLG provided feedback on the text and the video footage. 
FK and GLG were instrumental in developing the original mPCR/RlB method and 
provided expert review of the manuscript and video footage. 
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1. Kong F, Gilbert GL. Multiplex PCR-based reverse line blot hybridization assay 
(mPCR/RLB}--a practical epidemiological and diagnostic tool. Nat Protoc. 
2006;1(6):2668-80. 
139 
Chapter 3: Multiplex PCR and reverse line blot hybridization assay 
• JOVe Journal of Visualized Expenments WWW.JOVe.com 
Video Article 
Multiplex PCR and Reverse Line Blot Hybridization Assay (mPCRIRLB) 
Matthew V. N. O'Sullivan, Fe1 Zhou, Vitalt S1ntchenko, Fanrong Kong, Gwendolyn L. Gilbert 
Centre for InfectiOUs Diseases and Microboology, Universoly of Sydney 
Correspondence to Matthew V N O'Sull1van at matthew.osulhvan@swahs.health.nsw.gov.au 
URL htlpJiwww.JOVe.comlvldecl27811 
001 10.379112781 
Keywords: Molecular BIOlogy, Issue 54, Typ1ng, MRSA, macroarray, molecular epidemiology 
Date Published: 8/6/2011 
Th1s Is an open-access arllde d1stnbuted under the terms of the Creative Commons Attnbubon-NonCommercial License, which perm1ts non-
commen:ial use. d1stnbutJon, and reproductJon, proVIded the onginal worll1s property oted 
C1tallon: O'Sullivan. MVN , Zhou, F , S1ntcllenko. V. Kong, F G1lbert, G.L Mulllplex PCR and Reverse L1ne Blot HybridJZabon Assay (mPCRIRLB). 
J Vis. Elr.p. (54). e278110.3791/2781 001 10.379112781 (2011). 
Abstract 
Multiplex PCR/Reverse Line Blot Hybndizalion assay allows the detection of up to 43 molecular targets 1n 43 samples using one mulllplex 
PCR reaction followed by probe hybndiZatiOn on a nylon membrane, wh1ch IS re-usable. Probes are 5' am1ne mod1fied to allow fixallon 
to the membrane Pnmers are 5' blotm mod1fied wh1ch allows detecllon of hybnchzed PCR products usmg streptav1d1n-perox1dase and a 
chemllurn1nescent substrate VJa photosensitive film. With low setup and consumable costs, th1s techniQUe 1s 1nexpens1Ve (approx1mately USS2 
per sample), hiQh throughput (mult1ple membranes can be processed Simultaneously) and has a short turnaround lime (approximately 10 hours) 
The techniQUe can be utilized m a number of ways Multiple probes can be desJQned to detect sequence vanat100 w1th1n a smgle ampl1fied 
product, or mulbple products can be amplified Simultaneously, With one (or more) probes used for subsequent detecllon A comb1nabon of both 
approaches can also be used Within a s1ngle assay The ab11ity to 1ndude mulbple probes for a single target sequence makes the assay hiQhly 
specific. 
Published applications of mPCRIRLB 1nclude detection of antibiOtiC res1stance genes 1 2, typ1ng of melhletllin-res1stant Staphylococcus aureus"M> 
and Salmonella sp8 , molecular serotyping of Streptococcus pneumomae1 ·•, Streptococcus egalac/Jae9 and enterow\Jses 10· 11, 1denbficatJon 
of Mycobac:tenum sp 12, detecllon of geflllal 13-15 and respiratory tract 16 and other 17 pathogens and detectiOn and ldenbfJCabon of molhcutes 18• 
However the versab ty of the technoque means the appiJCabons are virtually hm,tJess and not restncted to molecular analys1s of mocro-orgamsms. 
The five steps 1n mPCRIRLB are a) Pnmer and Probe des1gn, b) DNA extracbon and PCR ampl1ficat1on c) Preparallon of the membrane, d) 
HybndizaUon and detect1on, and e) Regeneration of the Membrane. 
Video Link 
The VIdeo component of thos arllde can be found at http:Jiwww.jove.com/vldeo/27811 
Protocol 
Careful cons1derabon must be g1ven to pnmer and probe des1gn. All ava1lable sequences of the targets of 1nterest from databases such as 
GenBank should be utll1zed to Identify conserved areas wh1ch are su1table targets. Where a large number of targets are bemg amplified in 
a Single mPCR assay, each amplified sequence should be of s1milar length, and should not exceed 300 base palfs to avoid competition. An 
alternative appl1ca1100 of the method IS to amplify one longer target USifiQ pnmers aga1nst conserved reg10ns and to use mulbple probes to 
identify sequence vanat10n WJthon the amphcon In th1s 1nstance, the amplified PCR product may be longer Pnmer annealing temperatures 
should all be Similar, With PCR cond1bons adjusted accordlfiQiy. Pnmers which form strofiQ secondary structure or pnmer d1mer should be 
avoided The SIQma Aldnch DNA calculator (httpJiwww.sJQma-genosys.com/calc/ONACalc.asp) can be used to reliably pred1ct these features. 
DNA probes should be des1gned to have anneahfiQ temperatures close to 50•c . To maJOmiZe speetfiCity, two probes for each target of interest 
can be 1nduded 1n the assay, one hybndiZJfiQ to the forward DNA strand adjacent to the reverse pnmer btndifiQ srte, and the other to the reverse 
strand adjacent to the forward pnmer bondong s1te In th1s case, both forward and reverse pnmers must be b10bn-mod1fied. If only one probe per 
amplified target1s be1ng used, then only one pnmer need be b1olln mod1fied. 
When des1gmng pnmers and probes for the mPCRIRLB assay 11 is strongly adv1sed to use m sillco methods to pred1ct PCR products and probe 
hybrid1zabon to correlate w1th the m vrtro results Ideally this 1S done USifiQ ISOlates for wh1ch the whole genome sequence is ava1lable. Software 
such as FastPCR (avaolable at http 1/pnmerdiQotal.comtrastpcrhtml) can be used for th1s purpose Weak or absent probe SIQnal can be prediCted 
where 111 SJ/rco analySis 1ndJCales base paor ITllsmatches resulllfiQ 1n low probe anneahfiQ temperatures 
Copynght C> 2011 Creallve Commons Attnbubon-NonCommerc1al L1cense August2011 1 54 I e2781 I Page 1 of 5 
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DNA extraction techniques will vary depending on the samples being tested, and PCR conditions will be dependent on primer design. Readers 
are referred to publications on individual assays for more information regarding DNA extraction and PCR reagents and conditions 1-19. 
Each assay ts run with appropriate controls to provide at least one positive and one negative probe signal for each probe on the membrane. 
as well as a DNA-free control. Furthermore it is beneficial to include a probe at the top of the membrane that is expected to be positive for all 
samples (eg: a species or genus specific probe in the case of a micro-organism). This serves as a positive control probe, but also permits easy 
orientation of the results. 
1. Preparation of Membrane 
1. Prepare the following solutions: 
100ml 0.5M NaHC03 (pH 8.4) 
1 00 ml 0.5M NaHC03 
20 ml16% EDAC 
250 ml 0.1 M NaOH 
250 ml 2xSSPE 
250 ml 2xSSPE/0.1% SDS - place in waterbath at60' C 
250 ml 20 mM EDTA. 
2. Pre-heat oven to 60' C. 
3. Clean the lmmunetics Miniblotter with 70% ethanol. 
4. Dilute the oligonucleotide probes in 0.5 M NaHC03 to a final concentration of 2 pmoVtJI and a volume of 200 IJI. 
5. Cut a BiodyneC nylon membrane to 15x15 em. Using a pencil and ruler, rule off a 0.5 em space across top of membrane and write details 
here. 
6. Seal membrane in plastic bag with 20 ml freshly made 16% EDAC solution and rock at room temperature for 10 minutes. 
7. Wash membrane in deionised water for 30 seconds. 
8. Place membrane in miniblotter with channels running across the membrane (parallel to pencil line). Put support cushion in place and close 
blotter. Aspirate fluid from channels. 
9. Fill lanes 1 and 45 with 150 IJI 0.5 M NaHC03. Use 150 IJI of each probe solution to fill lanes 2-44 in sequence, being careful to avoid air 
bubbles. If an air bubble does appear in the channel, keeping the pipette in place, rapidly aspirate the solution to allow the air bubble to float 
to the top of the pipette, then retry. Incubate at room temperature for 5 minutes. 
10. Aspirate probe solutions, remove membrane and wash in 250 ml 0.1 M NaOH at room temperature for 9 minutes. 
11 . Wash membrane in 250 ml 2xSSPE for 30 seconds. 
12. Wash membrane in 250 ml pre-warmed 2xSSPE/0.1% SDS In oven at 60'C for 5 minutes. 
13. If not being used for hybridization immediately, wash membrane in 240 ml 20 mM EDTA at room temperature for 20 minutes (reserving 
remaining 1 Oml), then seal membrane in plastic bag with remaining 10 ml 20 mM EDTA and store In refrigerator at4'C. 
14. Wash miniblotter with Pyroneg detergent and brush. Rinse and allow to dry. 
2. Hybridization and Detection 
1. Prepare the following solutions: 
250 ml 2xSSPE/0.1% SDS - store in water bath at so• c. 
500 ml 2xSSPE/0.5% SDS- store in water bath at 60'C 
500 ml 2xSSPE/0.5% SDS- store in oven at42'C 
500 ml 2xSSPE - keep at room temperature 
500 ml 1% SDS- store in water bath at60'C initially (for step 3) 
250 ml 20 mM EDTA - store at room temperature (for step 3). 
2. Tum on one oven at60'C and one oven to 42'C. Bring water to boil in a large beaker on a hotplate. 
3. Clean lmmunetics Miniblotter with 70% ethanoL 
4. Aliquot10 ml of 2xSSPE/0.1% SDS into a small container. Add 20 IJI of each PCR product to 150 ~-tl2xSSPE/0. 1 % SDS in numbered tubes. 
5. Boil PCR products for 10 min at 100'C using styrofoam holders. Place on ice immediately for at least 5 minutes. 
6. Wash membrane in remaining 240 ml2xSSPE/0.1% SDS in 6o•c oven for 5 minutes. 
7. Place membrane in miniblotter with backing cushion. Orientate so channels run vertically (perpendicu lar to pencil line). 
8. Suction excess liquid from miniblotter channels. 
9. Add remaining 150 IJI 2xSSPE/0.1% SDS to first and last channels. Add boiled PCR products to remaining channels (2-44) in sequence, 
being careful to avoid air bubbles. 
10. Place miniblotter flat in 60'C oven for 1 hour to allow hybridization to take place. 
11 . Aspirate liquid from ead1 d1annel then remove membrane from miniblotter. 
12. Wash twice in prewarmed 250 ml2xSSPE/0.5% SDS in 6o•c oven for 10 minutes. 
13. Moisten nylon separating mesh with 2xSSPE/0.5% SDS at 42'C and use it to roll up membrane. 
14. Place rolled up membrane into rol ler tube, and unfurl to ensure membrane abuts the interior surface. Add 3 IJI streptavidin-peroxidase 
conjugate (Roche Applied Science) to 15 ml2xSSPEI0.5% SDS at 42°C and add to roller tube. Screw cap on tightly and incubate in roller 
oven at 42•c for 60 minutes. Ensure direction of roll is such that membrane does not tighten. Check periodically for leaks. 
15. Wash mini blotter in Pyroneg detergent and water, rinse and allow to dry. 
16. Remove membrane from roller lube. Wash twice in remaining 2xSSPE/0.5% SDS at 42•c for 10 minutes. 
17. Wash twice in 2xSSPE at room temperature for 5 min. 
18. Tum oven up to ao•c and place 500ml1% SDS in oven to pre-warm. 
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19. Make up 15 ml Amersham ECL detection solution (7.5 ml of solution A and 7.5 ml of solution B). D1scard 2xSSPE and add detection solution. 
Rock gently by hand for 2 mmutes ensuring complete coverage of membrane with solution. Discard chemiluminescent solution. 
20. Cut two sheets of plastic transparency to fit exposure cartridge. Place membrane between the two sheets and place into exposure cartridge. 
21 Proceed to darkroom. Under red light, add ECL detection film to cartridge and expose for 5 minutes. Dog-ear lower right comer of film upon 
removal to allow correct onentation when viewing. 
22 Develop film w1th automated developer or chem1cal baths as per manufacture(s directions. 
23. Repeat exposure with longer or shorter exposure times if requ1red. 
3. Regeneration of Membrane 
1. Wash membrane in 250 ml1% SDS at so•c for 30 mmutes tw1ce. 
2. Wash membrane in 240 ml20 mM EDTA at room temperature for 15 minutes. 
3. Seal membrane in plastic bag with 10 ml20 mM EDTA and refrigerate at 4•c for future re-use. 
4. Representative Results: 
The results are best viewed by placing the film over a printed grid, or else scanning the •mage and importing into software such as BioNumencs 
(Applied Maths, Sint-Martens-Latem, Belgium). Each probe result should be interpreted with reference to positive and negative control probes. 
The results are best graded as negative, weak or positive. Positive results are where the signal is as strong as or stronger than the positive 
control probe. Negative results are where the s1gnal is absent or equal to the negative control (in the case of background signal). Weak results 
are where the signal1s fainter than the pos1hve control probe, but stronger than the negallve control Weak results may be the result of point 
mutat1ons leading to weak probe b1nding, or due to non-spec1fic signals from primer dimer formation. Us1ng two probes per target of interest 
can Improve the specificity, where a single weak result can safely be interpreted as non-specific signal. If any doubt remains, a single-plex 
PCR reaction can be performed w1th gel-based detection and sequencing of any amplified product to determine if the result is truly positive. A 
representative result IS shown •n figure 2. 
(P1) -1-*W- (P2) _.___,_ ) ) ) ~ ~ ~ 
: ' : I I I 
..,...._ ..,...._ 
---(P3) (P4) 
.......... . ,, 
c ·c~ --
\ ~ \ ) f \ 1 • • 
. . . .  ,. I I 
..,...._ ..,...._ 
Figure 1. The mPCR/RLB pnnc1ples (P1) Step 1.9. Amine modified probes are bound covalently to a nylon membrane. (P2) Step 2.10. Biotin 
mod1fied PCR products are hybnd1zed to the probes. (P3) Step 2.14. Streptav1dm, labeled with peroxidase, is incubated with the membrane and 
binds to biotin. (P4) Steps 2.19-2.21 . Peroxidase catalyses a reaction in the ECL detection reagents, producing light to which light sensitive film 
is exposed. The membrane is then washed for re-use. 
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sites may lead to weak or absent signals. Allowing two probes for each amplified product makes this easy to detect. This characteristic may be 
exploited with careful primer and probe design to detect small sequence variations in target DNA. 
In summary, while there are many methods of product detection following multiplex PCR reactions available, mPCRIRLB has the advantage of 
being high-throughput and inexpensive with low setup-costs. The flexibility of the method permits its use in for a wide range of applications. 
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Materials 
Name Company Catalog Number 
5' amine C6 modified Sigma-Aldrich 
ohgonucleot1de probes 
NaHC03 Sigma-Aldrich S-8875 
NaOH Sigma-Aldrich S5881 
20xSSPE buffer Amresco 0810-4L 
Sod1um dodecyl sulfate (SDS) Sigma-Aidnch L-4390 
Ethylenediam1netetraacetic acid Sigma-Aldrich E9884 
(EDTA) 
N-(3-Dimethylaminopropyi)-N€'- Sigma-Aldrich En 5o 
ethylcarbod1im1de hydrochloride 
(EDAC) 
BiodyneC 0.45 m nylon Membrane Pall Corporation 74480C 
20x20 em 
De1onised, purified water 
Liqu1d Pyroneg detergent Johnson Diversey HH12291 
Streptavidin-peroxidase conjugate Roche Group 11 089153 001 
Amersham ECL detection reagents GE Healthcare RPN2105 
Amersham ECL detection reagents GE Healthcare RPN2105 
OHP Transparency film Corporate Express EXP504 OHP 
Amersham hyperfilm ECL high GE Healthcare 28906837 
performance chemiluminescent 
film 18x24 em 
Ice 
Table 1. Consumables used in the mPCR/RLB assay. 
Hyba1d Shake'n'Stack Ovens (2) Thermo Fisher Scientific, Inc. HBSNSRS220 
roll1ng bottle and nylon separating 
mesh 
The Belly Dancer rock1ng platform Stovall Life Sciences, IBI Sciences Euro BDbo 
Miniblotter lmmunetics MN100-45 
Water bath 
Suct1on 
Hot plate 
Exposure cartridge Sigma-Aldrich Z36,009-0 
X-ray film developer 
Copyright© 2011 Creative Commons Attribution-NonCommercial License 
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Comments 
0.5 M solution made up to pH 8.4 
0.1M solution 
Make up 1 Oo/o stock solution, do 
not autoclave, should be kept for 1 
week max1mum before use 
Make up 0.5 M solution adjusted to 
pH 8.0 and autoclave 
Make up a 20 ml 16o/o solution just 
prior to use using 3.2 g EDAC and 
18 ml M1lhpore water 
Method can be performed w1th 
a single oven as long as there is 
facility for mamta1ning solutions at 
42"C and 60"C prior to use 
Can also use developer, fixer and 
water in trays in dark room tnstead 
of automated developer. Lum1no-
imager may also be used instead 
of Xray film 
----
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Table 2. Equipment required for the mPCR/RLB assay. 
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Figure: Schematic overview of the structure of this thesis 
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Chapter 1: The place of strain typing in 
infection control 
Chapter 5: Software for selection of 
informative targets 
Chapter 2: Assessment of exisiting strain 
typing methods for MRSA 
Chapter 6: Assesment of typing system 
stability using survival analsyis 
Chapter 7: Development and assessment of a novel binary typing system for MRSA 
Chapter 8: Identification and control of an outbreak of MRSA using routine prospective 
binary typing 
4.1 Introductory comments 
Phage-derived open reading frame typing (PDORF) is a binary typing method shown to 
have high discriminatory power. It assays the genome of MRSA for elements 
147 
Chapter 4: Phage-derived open reading frame typing enhanced by mPCR/RLB 
associated with integrated prophages. In the original description of the method (1), it 
was performed using a number of multiplex PCR reactions with product visualisation 
by gel electrophoresis. 
4.2 Aims 
The aim of this study was to adapt this previously published method to the mPCR/RLB 
platform and to assess the performance criteria of this method in a different setting 
from that in which it was first implemented (where the distribution of phage derived 
sequences may be different). 
4.3 Publication: Rapid identification of methicillin-resistant 
Staphylococcus aureus transmission in hospitals by use of phage-
derived open reading frame typing enhanced by multiplex PCR 
and reverse line blot assay 
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Rapid Identification of Methicillin-Resistant Staphylococcus aureus 
Transmission in Hospitals by Use of Phage-Derived Open 
Reading Frame Typing Enhanced by Multiplex PCR and 
Reverse Line Blot Assayv 
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The relatively high-level clonality of methicillin-resistant Staphy/()(()(CUS aureus (MRSA) and its frequent 
high-level endemicity in nosocomial settings complicate the development of methods for rapid subtyping 
of MRSA strains that are capable of identifying person-to-person transmission in hospitals. Phage-derived 
open reading frame (PDORF) typing is an MRSA typing method targeting mobile genetic elements that 
was recently described and evaluated using a geographically restricted set of isolates. The objective of this 
study was to develop a multiplex PCR-reverse line blot (mPCR!RLB) assay for PDORF typing and to test 
its applicability on a broad range of isolates and in an environment where MRSA is highly endemic. The 
16 targets were identified using a 23-primer-pair mPCR!RLB assay with two probes for each target. The 
method was evaluated using 42 MRSA reference strains, including those representing major international 
clones, and 35 isolates from episodes of suspected nosocomial transmission. In vivo stability was explored 
using 81 isolate pairs. Pulsed-field gel electrophoresis (PFGE) and spa typing were performed for com-
parison. Among the 42 reference strains, there were 33 PFGE subtypes, 30 PDORF types, and 22 spa types. 
Simpson's index of diversity was 0.987, 0.971, and 0.926 for PFGE subtyping, PDORF typing, and spa 
typing, respectively. Typing of clinical isolates by PDORF typing and PFGE demonstrated concordant 
results. mPCR/RLB-based PDORF typing has similar discriminatory power to that of PFGE, can assist in 
tracking MRSA transmission events in a setting of high-level endemicity, and has the advantage or being 
a high-throughput technique. 
A range of methods for rapid identification and subtyping of 
methicillin-resistant Staphylococcus aureus (MRSA), which can 
improve the effectiveness of infection control procedures, have 
been reported (9, 13, 15, 16). H owever, their ability to detect 
person-to-person transmission in settings with h igh-level ende-
micity has not been evaluated fully. Phage-derived open read-
ing frame (PDORF) typing is a typing method for MRSA that 
was recently described from Japan and was reported to have 
similar discriminatory power and stability to those of pulsed-
field gel electrophoresis (PFGE) (16). PDORF typing interro-
gates the presence or absence of 16 variable elements within 
the S. aureus genome: 13 from integrated prophages, 1 from a 
genomic island, and 2 from the SCOnec element. In its original 
form, PDORF typing involves fou r 4-p lex PCRs, each with 
product detection by agarose gel electrophoresis (16). 
R everse line blo t (RLB) assay is a high-throughput and 
inexpensive method for product detection from multiplex PCR 
(mPCR) assays (6). D ue to the high sensitivity of RLB probes, 
"megaplex" PCRs can be utilized, usually allowing amplifica-
tion of all targets in a single reaction tube. Up to 43 isolates can 
be interrogated with up to 43 probes on a single reusable 
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membrane. Several membranes can be processed simulta-
neously, with a total turnaround time of 12 h. The objectives of 
this study were to develop a high-throughput mPCR-based 
RLB assay (mPCR/RLB) for PDORF typing and to detennine 
whether PDORF typing would re tain its discriminatory power 
in other geographic settings or in a setting with high-level 
MRSA endemicity. 
MATERIALS AND METHODS 
Selectioo of isolates. Isolates studied fe lt into the following four groups: (i) 5 
S. aureus isolates for which whole genome sequence.< arc publicly available 
(MRSA isolates COL, MWZ. Mu3. and Mu50 [GenBank au:ession numbers 
CP000046, BA!K)()(J33, AP009324, and BA0000171 and methicillin·susceptihle S. 
aurtu.< strain NCfC8325 [GenBank au:ession number CP000253]), utilized for in 
5ilico ana lysis; (ii) 42 molecular ly well-<:ha racterized MRSA reference strains 
whkh were temporally and/or geographically unrelated and rcpre.•ented major 
clones circulating in Australia and overseas (2); (iii) 35 MRSA dinical isolates 
from two Sydney tertiary hospitals, collected between September 2006 and July 
2007; and (iv) pa irs of isolat~-. obtained from R I patients at intervals ranging from 
34 to 993 days (median, 146 days) for study of in vivo stability. The 35 clinical 
isola tes consisted of 14 isola tes from inpatients with nosocomial acquisition, that 
is, those who had had a d<K.'Umented negative MRSA screen (nose, axilla. and 
perineum) and subsequently aC(juircd MRSA infection or colonization during 
the same admission, along wi th isolates with matching antibiograms from 
MRSA-colonized patients wlto shared che same ward at che time of MRSA 
3C(juisition and thus were likely sources of transmission. Both hospital• have a 
high prevalence of MRSA colonization and infection. At one hospital, a recent 
point prevalence survey indicated that 25% of patient< within surgical wards 
carried MRSA. with a hospital-onse t MRSA bacteremia rate of approximate ly 
1.1 per I 0.000 OC<.'Upicd bed days fo r the whole facility. 
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TABLE 1. Primers and probes used in this study 
Target Oligonucleotide' Sequence (5'-3')' GenBank acces.~.lion no. 
Tn554 tnpB N046Fb 1746-TGATGGAGAGGAGTGGGATA-1765 X03216 
N046AP 1789-AGTT ACGTCT ATCCCAAACGTCTT-1766 X03216 
N046SP 2096-TGGAAGGACT ATTT AGTACCCTTCTT A-2122 X03216 
N046Rb 2143-GAACATCATCCCATTCTAGCC-2123 X03216 
Mu50 SaGim SA V0803 SAV0803Fb 881430-!;;AATATCCAAACCACGACCC-881411 BA000017 
SAV0803AP 881376-GATGAAAAGCAAATATACATATATAACTCTACATG-881410 BA000017 
SAV0803SP 881245-TCTTTTAATATTTCTTTATGATTGTATTTATTATATGTATA BA000017 
TG-881203 
SAV0803Rb 881183-AAAAATAGCGCCAACAGTCC-881202 BA000017 
<j>Mu50B SAV0881 SAV0881Fb 932269-IGCTTGTTGTCATATCGCC-932287 BA000017 
SAV0881AP 932316-TGTTTTGGTAACTAGCCACTGTATAGATA-932288 BA000017 
SAV0881SP 932418-TCAAATTTCTTTTTGAA TAGT AAGTCAGA-932446 BA000017 
SAV0881Rb 932468-CCTAGCTTGTATGTCTGCGCTA-93244 7 BA000017 Cl 
<j>Mu50B SA V0898 SAV0898Fb 24676-GAAGATGCAGTTGTAGATCGC-24696 AF424781 ~ 
SAV0898AP 24721-CAACTTCCCAAGCTTCATACAATA-24697 AF424781 ::J 0 SAV0898SP 24781-GGTTTCCACAATAAATTTGAATTAAAA-24807 AF424781 Q) 
SAV0898Rb 24829-CATCAATACCGTT AGCTTCTGC-24808 AF424781 c. (t) 
c. 
<j>PV83 ORF 2 PV830RF2Fb 1269-GGCGCTTCTTCTTACAGGAG-1288 AB044554 a PV830RF2AP 1323-CATTGTT AGATATTT ATATGGTATGT AACC.T AAAA-1289 AB044554 
PV830RF2Rinner 1356-GATAATCTTGII I I I I ICACTAACTAAACCTAT-1324 AB044554 3 
PV830RF2Finner 1625-TGTTTAATAACAACGGTAAACCAGTATTT-1653 AB044554 =r 
PV830RF2SP 1654-ATAGTTATTAAAGACTTTGAAAACAGAATCATT-1686 AB044554 = "0 PV830RF2R2b 1715-GAA TTATAGGTTTT AAGTTCACCCTCTTC-1687 AB044554 :....:._ 
.:;;-, 
<J>Mu50B SA V0858 SAV0858Fb 6334-ATCT AAATTGCCTGTCGAAGC-6314 AP001553 
{} 
3 
SAV0858AP 6294-TATTTGCGGC.TTTAGCGTAA-6313 AP001553 i» 
SAV0858SP 6063-CATTTGAGAAAGTCTTTTGTCGATACT-6037 AP001553 !II 
SAV0858Rb 6017-!;;CAAGAACAGGGACATCGA!;;-6036 AP001553 3 
0 
<j>Mu50A SAV1998 SAV1998Fb 2122883-CAGTAAACTCACGCCTCCAAG-2122903 BA000017 t3 
SAV1998AP 2122928-TGCATAGTTAAGCACAillllll GT-2122904 BA000017 
..._ 
0 SAV1998SP 2123071-CCGAAATGGTTAAAGCACCTAT-2123092 BA000017 ::J 
SAV1998Rb 2123111-IGCTAAATCATGTGGTGGG-2123093 BA000017 (... 
c: 
SCOnec II kpdC CN009F 80974-GGACAACAATGGACAGAACC-80993 BA000017 
::J (t) 
CN009AP 81019-CACTGATACGTCCATGGAAATATTTA-80994 BA000017 N 
CN009SP 81061-GGCGGACCTGCTTCAG-81076 BA000017 _..., 
CN009Rb 81097-AA TTGCCGTAGTTTGAGCC-81079 BA000017 N 
0 
<)>11 nt 4427-5251 phill-4563Fb 4563-GATATGCAAGATCAGACAATGCC-4585 AF424781 ..... N 
phill-4610AP 4610-CCTCGCTATCAACATGATTTCTAAT-4586 AF424781 CT 
phill-4632Rinner 4632-CT AAATTGGTGCGTCAGTTTGT-4611 AF424781 '< 
phi 11-5026Finner 5026-CAAACTACT ACACGAAGCT AGACT ACAAC-5054 AF424781 10 c: 
phill-5055SP 5055-GAAAAGT AAAT AAACAGTGGGTGCTTTA-5082 AF424781 (t) 
phi11-5103Rb 5103-CTCTTGCCCATGTGTTCTGAG-5083 AF424781 !e. 
<j>SLT ORF 257 SL Torf257Fb 26802-GTGTT ATCGCT ATGAGTGGTGAC-26824 EF462198 
SLTorf257AP 26855-TTAAAAAACTATTTTTGT GCATAAAAATAGT-26825 EF462198 
SLTorf257SP 27093-TCTCTAAAGAGCAATATAAGCGTTTC-27118 EF462198 
SLTorf257Rb 27142-CTTT AAATCTTCTGGGACGTTCTC-27119 EF462198 
<j>Mu50B SAV0850 SAV0850F2b 12192-ACCACAAGTIGACGTATGGC-12211 AF410775 
SAV0850AP 12236-TGAACTTCGATTGGTCTAAAAT GTT-12212 AF410775 
SAV0850SP 12419-GGAACTCACTATGGCGAGTATTCTATTA-1 2446 AF410775 
SAV0850Rb 12467-AAACTCTCAACGGCTCAAATG-12447 AF410775 
<!>SLT ORF 175 SLTorf175Fb 15837-AAATGCT AGAATGCCCGAAC-15856 EF462198 
SL Torf175AP 15878-CCTGCATCCGTCTT ATGATTTC-15857 EF 462198 
SLTorf175SP 15967-GGCT ATGTCGGGCTGTTAACT A-15988 EF462198 
SLTorf175Rb 16014-CGTTTT ACT ACTTACACCACT ACGG-15990 EF462198 
<j>N315 SA1801 SA1801Fb 5235-!;;AA TCAGCGGTCGAGAACT-5253 EF462197 
SA1801AP 5279-GAGTCTT AACCTCTAATGCTTGATGA-5254 EF462197 
Continued on following page 
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TABLE !-Continued 
Target Oligonucleotide" Sequence (5'- J')" GcnDank a~ssion no. 
SA1801Rinner 
SA1801Finner 
SA1801SP 
SA1801Rb 
5305-CATTCTITCAAACCATITITrGTATG-5280 
5687-CGCAGAITGTTTGAGTGGTTA-5707 
5708-CGTCAAAACGGATTCCTTATTAAA-5731 
5751-TTATAATCCACACCCTTGCG-5732 
EF462197 
EF462197 
EF462197 
EF462197 
cj>Mu50B SA V0913 SAV0913Fb 
SAV0913AP 
SAV0913SP 
SAV0913Rb 
958598-IT AITCAT AACGACGCAGGAAG-958619 
958636-CTGCTGITGCCCCTITG-958620 
958868-GCGCTAGAITGTTGAAAAAATG-958889 
BA000017 
BA000017 
BA000017 
BA000017 958910-TTTCTGTTTGCTGGTAATCCC-958890 
4>Mu50A SAV1974 SAV1974Fb 
SAV1974AP 
SAV1974SP 
SAV1974Rb 
211 0912-Q.CCACAAGAAAAGGCAGTG-2110894 
2110869-TGCITACAGCTACATCTGTTITGAT-2110893 
BA000017 
BA000017 
BA000017 
BA000017 
211 0719-GA T ATGAGT AACTITGGTCGGAGTC-2110695 
2110673-ATACTTTCCATCTATCCCAGCAG-2110694 
cj>SLT ORF 182 SLTorf182Fb 
SLTorf182AP 
SLTorfl82SP 
SLTorf182R2b 
1080359-AAATGATAGGAAAGCGACACG-1080379 
1080413-TTGATATAACCTITAATGTCTCITACTAAAITGT-1080380 
1080493-CAACCTTGTT ACCTACTAACCAAAAA-1080518 
1080540-GTTTGCT ACTATGTCGCAACCT-1080519 
CP000736 
CP000736 
CP000736 
CP000736 
mecA mecAP4b 
mecAAP 
mecASP 
mecAP7b 
1190-TCCAGATT ACAACITCACCAGG-1211 Y00688 
Y00688 
Y00688 
Y00688 
1236-TGCTGITAATATITITrGAGTTGAAC-1211 
1309-GAT AAATCITGGGGTGGTT ACAAC-1332 
1357--CAITTACCACITCATATCITGTAACG-1332 
• Oligonucleotides whose names end in "b" are 5'-hiotinylated primers. Oligonucleotides whose names end in "P" are 5' -amine-labeled probes. Inner primers 
were unlabeled . mecA primers were derived from the work of Oliveira e l al. ( I I ) . Primers and probes for 'IUC, tst, and pv/ were unchanged from I hose previously 
publi<hed (2). 
• Modilkalions of rhe primers originally published by Suzuki ct al. ( l (l) are indi<:ated by underlines. Numbers Hanking th~ sequences indicate the starting and 
ending nucleotide positions in the indicated GenBank sequence. 
Primer aod probe dtsiao. Primers were modified from the originally published 
set ( 16) to produce a melting temperature of approximately fl(fC. When neces· 
'"'1'· additional inner primers were designed to produce amplieon lengths of 
< 4()0 bp. In addition tO the PDORF targets, primers and probes for nuc, mecA, 
1,<1, and pvl were included in the mPCRJRLB assay. Two probes (one llensc and 
one antisense) were designed for each target. Primer modification and probe 
design were based on bacteriophage and gene sequences referenced In the 
original paper (16) and published in NCB! GcnBank (Table 1 ) . Primer and 
probe specificities were verified using BLASTn searches ol published sequences 
in NCB! GenBank. 
In siltro analysis. Rc>'Uits of the mPCR/RLB assay were predicted hy perform-
ing in .<ilico PCR and probe binding, using FastPCR software (PrimerDigital), 
against five publishc<.l 3. aureus genomes: MuJ, Mu50, MW2, COL, and 
N(..TU!325. Fir~ in .<ilico mPCR was performed to predict PCR producl~ for 
each genome. These products were then u.cd to predict probe binding. The 
predicted results were compared to the in vitro findings as part of assay valida-
lion. 
mPCR. and rtvtrst lim blot assay. DNA was extracted hy SUI1J"'nding I Ot 2 
cokmic.• in 400 ,..1 molecular-grade H20 and heating them to JOO'C for 10 min. 
Thi.< solutinn wa< fro<en a1 -20"C aod then thawed and centrifuged at 16,100 X 
~ fur 5 min before the supernatant was used as a PCN. template. A 23-plcx PCR 
and product detection by IU.ll assay were performed as described previously (6). 
The posi tive control consisted of isolates which, in combination, produced pos-
Itive results for ~ach probe (Mu3, COL, SJOG31J, and 14176-5170). The speci-
ficity of positive controls was confirmed by in si/ico analysis (Mu3 and COL) or 
hy single PCR and sequencing (SJOG30 and 14 176-5170). The negative control 
consisted of PCR master mix without a DNA template. 
Single PCR and sequtncing. The specificity of probe signals wa< confirmed 
where nece.~•ary by u.~ing single-primer-pair PCN., with sequencing of the product 
in the fmward and reverse directions on an Applied Bio;ystems 3730r/ DNA 
analyzer. 
lnttrp...,tation or "'suits. Probe signals were considered strong if they were 
equal to or ol greater intensity than the positive-rontrol rc>'Uit for the corre-
sponding probe. Probe signals were considered weak if they were present hut of 
clearly lower intensity than that of the positivc-<:ontrol result. Probes for which 
nu signal was detected were considered negative. Isolate.< belonging to the same 
PDORF type shared a unique pattern for the 16 genes. Since each gene wa< 
152 
represented by two probes. for the purposes of PDO RF type as.<ignment, a gene 
was considered present if at least one strong probe signal or !Wo weak probe 
signals were found and absent it only one weak probe signal or no probe signal 
was found (i.e., a solitary weak signal for one probe with a negative signal for the 
second probe was considered nonspecific). 
PFGE and spa typing. PFGE was performed according to the Harmony pro-
tocol (10), and fingerprint patterns were examined by Dionumerics v3.00 son -
ware (Applied Maths, Sint-Martens·Latcm, Belgium). Optimi7.ation wa< set at 
0.6%, with a band tolerance of 2% and a change toward the end of the fingerprint 
of 0.5%. Cluster analysis of PFGE patte rns was performed using the Dice 
C<>efficient and the unwcightcd-pair group method using average linkages 
(UPGMA). PFGE subtypes were defined by pancrns which were indistin-
guishable ( 100% similarity). spa sequencing and type assignment were per-
formed as previously published (2). 
Statistics. Simpson's index of diversity and 95% confidence interval~ (95% Cl) 
were calculated using standard methods (3, 4). 
RESULTS 
In silico analysis. Computational predictions confirmed in 
virro experiments for isolates Mu3, Mu50, MW2, COL, and 
NCTC8325 (Fig. 1). It was noted that weak signal strength was 
associated with amplicons of 341 bp or more (Tn554 tnpB, 398 
bp; Q>SLT ORF 257, 341 bp). No signal was found for the 
antisense probe for Q>Mu50B SA V0858 in isolates Mu3 and 
Mu50, despite in silica analysis predicting only a single base-
pair mismatch with the PCR product. However, this mismatch 
reduced the predicted melting temperature of the probe-PCR 
product binding from 52.1"C to 42.8°C, which was the likely 
explanation for the lack of signal on the RLB. This was con-
finned by single PCR and sequencing of Q>Mu50B SA V0858 in 
Mu3 and Mu50 in addition to isolate 14176-5170 (for which 
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FIG. 1. Comparison of in vitro and in silico analyses of five isolates. 
For each isolate, the in vitro analysis is shown on the left and the in 
silico analysis is shown on the right. For the in silico analysis, black 
squares indicate a 100% match, while gray squares indicate a one- or 
two-base-pair mismatch between the predicted amplicon and the 
probe. Sense probes are shown above the antisense probes for each 
target gene. 
both probes gave a strong signal and no mismatch was found 
using the antisense probe). 
For isolates Mu3 and Mu50, weak, nonspecific probe signals 
were noted for the antisense probe for ct>SLT ORF 182. Single 
PCR using primers against cj>SL T ORF 182 did not yield any 
PCR product for these isolates. 
Analysis of reference collection_ Analysis of the 42 refe rence 
strains revealed 33 PFGE subtypes (D = 0.9872; 95% CI, 
0.9765 to 0.9980) and 30 PDORF types (D = 0.9710; 95% CL 
0.9447 to 0.9973) (Fig. 2). There were two PFGE subtypes that 
were comprised of three isolates each and five subtypes that 
were comprised of two isolates each. The remaining 26 PFGE 
subtypes contained only one isolate each. The largest group of 
PDORF types contained six isolates. Four of the PFGE sub-
types with multiple members corresponded exactly with groups 
of PDORF types. For two of the PFGE subtypes, the isolates 
differed by a single PDORF target, while for one PFGE sub-
type, one isolate contained three PDORF targets that were 
absent in the other two isolates (Fig. 2). spa sequence typing 
produced 22 spa types (D = 0.9257; 95% Cl, 0.8791 to 0.9722), 
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and there were 15 types obtained by multilocus sequence typ-
ing (MLST) (D = 0.8815; 95% Cl , 0.8225 to 0.9405). 
Analysis of clinical isolates. Analysis of the epidemiologi-
cally restricted set of 35 clinical isolates demonstrated 19 
PFGE subtypes, 8 PDORF types, and 4 spa types (Fig. 3). All 
of these isolates were multiresistant, with 32 carrying spa type 
t037, which is typical of the MLST239-SCOnec Ill MRSA 
clone that is currently endemic in many Australian hospitals. 
Figure 4 shows data for the same isolates, with 14 isolates 
representing cases of nosocomial acquisition grouped with iso-
lates from MRSA carriers who had contact with the patients 
around the time of acquisition. In 8 of these acquisition events, 
an MRSA carrier with an identical PFGE subtype was identi-
fied. Of these, 6 also had identical PDORF types; for the 
remaining 2, the PDORF type differed only by the absence of 
one marker. There was only one instance when isolates from a 
newly colonized patient and his contact had identical PDORF 
types but different PFGE types (minimum similarity, 82.1% ). 
One novel spa type was identified, with the repeal sequence 
15-12-16-02-25- 17-12-16-02-25-17-24. 
In vivo stability and reproducibility. For 42 of the 81 stability 
isolate pairs, the typing results were identical by PFGE and 
PDORF typing, while for 9 pairs the typing results were dif-
ferent by both methods (Table 2). For 22 pairs, PDORF typing 
results were indistinguishable but PFGE results differed. For 6 
of these 22 pairs, the PFGE similarity was > 95%, equivalent to 
a single band difference; for another 14, the PFGE similarity 
was 80 to 95%. Eight isolate pairs had indistinguishable PFGE 
patterns but different PDORF patterns. Three ofthese differed 
by two PDORF targets, and the remaining five differed by one 
PDORF target. The median time between collections for pairs 
that had identical patterns for bo th PFGE and PDORF typing 
was 140.5 days; for those with different PDORF patterns, it was 
243 days, while it was 197 days for those that had different 
PFGE patterns (Mann-Whitney test; P = 0.99). 
Forty-two isolates had DNA extracted on two separate oc-
casions and were tested by PDORF typing, using two separate 
PCRs with product detection on two identical RLB mem-
branes prepared on different days. There was 100% concor-
dance between the results produced on the two occasions. 
DISCUSSION 
Despite a long turnaround time, low throughput level, and 
labor-intensive analysis procedure, PFGE remains the gold 
standard for typing of S. aureus outbreaks due to its high 
discriminatory power and its proven reflection of epidemio-
logic relationships. With the aim of overcoming the limitations 
of PFGE, newer, PCR-based typing methods have been devel-
oped, such as spa sequence typing (9), multilocus variable-
number-tandem-repeat analysis (MLVA) (14), and repetitive 
sequence-based PCR (rep-PCR) (13). However, no method 
has yet been accepted as superior to PFGE, since the newer 
methods either are less discriminatory, require analysis of a 
gel-based fingerprint, lack reproducibility, or are too expen-
sive. 
Binary typing involves interrogating the bacterial genome 
for the presence or absence of a set of markers. It has 
theoretical advantages over other typing methods because of 
the ability to express results as posit ive or negative for each 
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FIG. 2. PFGE, PDORF typing, spa typing, and MLST results for 42 reference strains. Clustering is based on the PFGE pattern. A black 
rectangle indicates detection of the relevant PDORF target by mPCR/RLB assay. 
marker, which facilitates harmonization of test protocols 
and creation of typing databases for interrun and interlabo-
ratory comparisons of results. Furthermore, no specialized 
equipment is needed, with the minimum requirements being 
a PCR cycler and detection of amplicons by agarose gel 
electrophoresis. 
w e· use the mPCR/RLB format for binary typing because 
it offers a number of advantages over other methods. The 
probe hybridization with chemiluminescence detection 
which is utilized in the mPCR/RLB assay is highly sensitive, 
permitting somewhat inefficient PCR amplification condi-
tions; this allows amplification of a large number of targets 
in a single megaplex PCR. At the same time, probe-based 
detection, particularly with two probes per product , is highly 
specific. The membrane and its attached probes can be re-
used more than 20 times (after a simple washing step), up to 
43 isolates may be tested on a single membrane, and mul-
tiple membranes can be processed simultaneously by one 
technician. This makes mPCR/RLB assay a cost-effective 
154 
(approximately $2 [U.S. currency) per sample) and high-
throughput option. Furthermore, the flexibility of the 
method allows for inclusion of additional targets of interest, 
such as pvl or tst ( 6). 
Comparative genomic techniques have demonstrated a sub-
stantial array of genetic loci that are variably present among 
even otherwise closely related strains of S. aureus, raising the 
prospect of a highly discriminatory binary typing system based 
on such targets (7). We previously developed mPCR/RLB bi-
nary typing methods for detection of antibiotic resistance 
genes (12), exotoxin genes (2), and SCOnec elements (1) in 
MRSA Another approach has been to identify discriminatory 
sequences by randomly amplified DNA analysis and then to 
clone sequences, label them, and interrogate their presence in 
genomic DNAs of test isolates by Southern blot hybridization 
(18, 19). This technique has also been adapted for reverse 
hybridization (17). Huygens et al. combined five binary targets 
(pv/, cna, sdrE, pUBllO, and pT181) and single nucleotide 
polymorphism (SNP)-based MLST for an MRSA typing SYS· 
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I II II I I I I II II • 072662009 1037 I 1111 II i II I • 62146498 1037 I II II II II II • 072421420 1037 I I I I I 111 11 11 •• • • • ..h. 62622200 1037 II II I I I Ill • • 65408511 1105 FIG. 3. PFGE, PDORF typing, and spa typing results for 35 clinical isolates. Clustering is based on the PFGE pattern. A black rectangle 
indicates detection of the relevant PDORF target by mPCRJRLB assay. 
tern with improved discriminatory power compared with that 
of the SNP-based method alone (5). 
Mobile genetic elements such as integrated prophages, 
transposons, and genomic islands have also attracted attention 
as potentially highly discriminatory typing targets (8). Such 
markers were used in the typing system developed by Suzuki et 
al. (16) that has been adapted in this study. In the original 
study, 60 ORFs were identified by comparative analysis of 
staphylococcal phage genomes, and locally circulating strains 
were surveyed for the presence or absence of these markers. A 
subset of the most discriminatory set of 16 markers was chosen 
for use in the typing system, which consisted of four 4-plex 
PCRs and product detection by electrophoresis on four aga-
rose gels. This phage-derived ORF typing system had a similar 
discriminatory power to that of PFGE (16). 
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Our findings confirmed that PDORF typing had a similar 
discriminatory power to that of PFGE for a large collection of 
epidemiologically unrelated isolates (D = 0.9710 versus 
0. 9872). In testing the clinical isolates, two of the targets were 
absent in all clinical isolates tested ( <!>Mu50 SAV1998 and 
SCOnec II kpdC), and three others contributed little to dis-
criminatory power (Mu50 SaGim SAV0803, N315 SA1801, 
and 4>Mu50B SAV0850). We did not survey locally circulating 
Australian strains for the relative frequencies of all 60 ORFs 
explored in the original study, but if this were done, there 
would be the potential to identify other binary targets that may 
further improve the discriminatory power of PDORF typing in 
our setting. 
Mobile genetic elements can be relatively unstable due to 
the high molecular clock speeds of those components of the 
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TABLE 2. Results of in vivo stability study of pairs of 
isolates from 81 patients 
No. of isolate pairs with 
I'DORF PFGE re.,ult (median time Total no. of isolate pain; 
resuit [days] between collections) (median time [days] between collections) 
Identical Di!!'crcnt 
Ide ntica l 42 (140.5) 22 (107.5) 64 (135) 
Different 8 (100) 9 (355) 17 (243) 
Total so (138) 31 (197) 81 (146) 
genome. While this is exactly what confers the high level of 
discriminatory power, it could also potentially result in mis-
classification of the epidemiologic relationships between iso-
lates. It is important that the stability of new typing systems based 
on mobile elements be assessed comprehensively to ensure that 
the loci remain unchanged, at least over time frames which are 
relevant to the proposed application of the method. Studies of in 
vivo stability seem more relevant for this purpose than in vitro 
studies, since the acquisition of exogenous DNA and evolutionary 
changes due to ecological pressures are unlikely to occur simply 
with serial passage in the laboratory. For the purposes of moni-
toring hospital epidemiology of MRSA over a short-term period 
(several months; this time frame is relevant for investigation of 
nosocomial outbreaks), we have shown that PDORF typing is at 
least as stable as PFG E, a similar finding to that of Suzuki et al. 
( 16 ). The binary format of this system lends itself to establishing 
databases of PDORF typing results, which can be useful for easy 
comparison of isolates from a suspected outbreak. However, the 
utility of PDORF typing for studying long-term epidemiology and 
evolution of MRSA and its relationship with other methods tra-
ditionally used for this purpose (such as MLSl) need further 
study. 
While PDORF typing separated 35 clinical isolates into fewer 
groups than PFGE subtyping did (8 versus 19), examination of 
subgroups of these isolates in an attempt to identify nosocomial 
transmission events suggested that the ability of PDORF typing to 
identify related isolates is similar to that of PFGE. Based on these 
data and the mobile nature of the loci utilized, we suggest that 
identical PDORF patterns can be used to define epidemiologi-
cally related isolates among isolates from an outbreak of MRSA 
A di11'erence at a single locus would suggest that the isolates are 
possibly related in this setting. 
Conclusions. PDORF typing of MRSA has a similar dis-
criminatory power to that of PFGE, but with better stability, 
can identify nosocomial transmission events in settings of high-
level endemicity, and is highly reproducible. mPCR!RLB-
based PDORF typing improves throughput compared with 
that of the original gel-based method. Its main advantages over 
PFGE include a short turnaround time, high throughput level, 
low cost, and binary result format. While the method as de-
scribed utilizes stable targets and is useful for identifying nos-
ocomial transmission events, surveying locally circulating 
strains for a wider range of phage-derived targets may identify 
additional markers which could be included in the system for 
further improvements in discriminatory power. 
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5.1 Introductory comments 
A vast array of potential targets is available for potential incorporation into a novel 
binary typing system for MRSA. These have been described in studies of MRSA 
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virulence (1). resistance mechanisms (2), typing methods (3-5) and comparative 
genomics (6). Choosing the most informative binary targets from this large array 
requires an assessment of the discriminatory power and concordance of all of the 
possible combinations of targets. In the past, such assessments have not been 
performed systematically. 
5.2 Aims 
The aim of this study was to i) develop computer software to assist in the selection of 
the most informative combinations of targets, be they binary or multistate or a 
combination thereof; and ii) apply the software to a number of datasets in order to 
validate its utility 
5.3 Publication: Software for selecting the most informative sets of 
genomic loci for multi-target microbial typing 
Citation: 
O'Sullivan MV, Sintchenko V, Gilbert GL. Software for selecting the most 
informative sets of genomic loci for multi-target microbial typing. Submitted 
for publication. 
The AuSeTIS software described in this publication is provided as an electronic 
attachment to this thesis, and is also available for download from 
http://www .cidmpu bl ichea lth .erg/pages/ a usetts. htm I 
The visual basic source code for this software is provided in the appendix to this 
thesis. 
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Contribution of authors: 
MOS developed the software, performed molecular typing on S. aureus isolates, 
conducted the data analysis and prepared the manuscript. 
GLG and VS provided expert guidance and edited the manuscript. 
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Abstract 
Background: High-throughput sequencing can identify numerous potential genomic 
targets for microbial strain typing, but identification of the most informative 
combinations requires the use of computational screening tools. This paper describes 
novel software - Automated Selection of Typing Target Subsets (AuSeTTS)- that 
allows intelligent selection of optimal targets for pathogen strain typing. The objective 
of this software is to maximise both discriminatory power, using Simpson's index of 
diversity (D) , and concordance with existing typing methods, using the adjusted 
Wallace coefficient (A W). The program interrogates molecular typing results for panels 
of isolates, based on large target sets, and iteratively examines each target, one-by-one, 
to determine the most informative subset. 
Results: AuSeTTS was evaluated using three target sets: 51 binary targets (13 toxin 
genes, 16 phage-related loci and 22 SCCmec elements), used for multilocus typing of 
153 methicillin-resistant Staphylococcus aureus (MRSA) isolates; 17 ML VA loci in 
502 Streptococcus pneumoniae isolates from the MLVA database (www.mlva.eu) and 
12 MLST loci for 98 Cryptococcus spp. isolates. 
The maximum D for MRSA, 0.984, was achieved with a subset of 20 targets and aD 
value of0.954 with 7 targets. Twelve targets predicted MLST with a maximum AWof 
0.9994. All 17 S. pneumoniae MLV A targets were required to achieve maximum D of 
0.997, but 4 targets reached D of0.990. Twelve targets predicted pneumococcal 
serotype with a maximum A W of 0.899 and 9 predicted MLST with maximum A W of 
0.963. Eight of the 12 MLST loci were sufficient to achieve the maximum D of0.963 
for Cryptococcus spp. 
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Conclusion: Computerised analysis with AuSeTTS allows rapid selection of the most 
discriminatory targets for incorporation into binary typing schemes. Output of the 
program is presented in both tabular and graphical formats and the software is available 
for free download from http://www.cidmpublichealth.org/pages/ausetts.html. 
Keywords: comparative genomics; multilocus sequence typing; MVLA; binary typing; 
software; microbial typing; MRSA; Cryptococcus; Staphylococcus aureus; 
Streptococcus pneumoniae 
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Background 
Microbial strain typing schemes, with variable discriminatory powers, are increasingly 
applied to study long-term evolution, detect emergence of new or hypervirulent clones, 
identify outbreaks and track transmission chains. New high-throughput DNA 
sequencing methods identify hitherto unrecognised variation in the genomes of even 
closely related isolates, which is a valuable source of targets for use in new microbial 
typing schemes. These genotyping systems can be tailored to have discriminatory 
power appropriate for the purpose [ 1] but systematic assessment of the characteristics of 
potential targets is required to ensure the quality and reliability of the resulting typing 
scheme. 
Existing typing systems involve interrogation of several genetic loci to determine 
sequence variation (e.g. multi-locus sequence typing, MLST), length polymorphisms 
(e.g. multi-locus variable number of tandem repeats analysis, MLVA) or the presence 
or absence of genetic targets (i.e. binary typing). Next generation sequencing 
technologies have yielded vast amounts of sequencing information for a wide variety of 
organisms, and bench top sequencers permit real-time subtyping of bacteria by 
sequencing small batches of bacteria in a matter of hours [2]. This has prompted some 
to advocate whole genome sequencing as a routine typing method (3], but limitations of 
data analysis and assigning cut-offs for relatedness mean that whole genome data is 
more commonly used to identify loci that may be useful to design informative typing 
systems [ 4]. A critical step in deciding which loci to incorporate into such typing 
systems is to estimate the discriminatory power and concordance with other typing 
systems that would be achieved with different combinations of loci. 
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The essential characteristics of a microbial typing system include appropriate 
discriminatory power for the research question being studied, consistency with both 
clinical epidemiology and established typing methods, stability, reproducibility, 
typeability, ease of use and interpretation, high throughput and low cost [5]. 
Discriminatory power is most frequently assessed using Simpson's index of diversity 
(D), which gives the probability that any two isolates selected from a population would 
differ using the typing method. 
A number of indices can likewise be used to measure concordance between typing 
systems or between a typing system and epidemiologic classifications. The Wallace 
coefficient ( W) estimates the probability that two isolates assigned the same type by the 
method under evaluation (M1) belong to the same type using the comparator method 
(M2). W is a directional measure; that is the results for the concordance ofM1 with M2 
are different from those ofthe concordance ofM2 with M1• 
When choosing targets identified by comparative genomics for incorporation into a new 
typing system, a good starting point is to select those that in combination give the most 
favourable results for these measures of discriminatory power and/or concordance using 
an existing collection of typed isolates. However, examination of every possible 
combination of candidate targets, individually, is often computationally expensive. For 
example, comparison of all possible subsets of 100 potential targets available for use in 
a typing system, to determine the most informative subset, would require 1030 
calculations, which is beyond the capacity of standard computers. Therefore, alternative 
approaches are required. Software has been developed to interrogate informative single 
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nucleotide polymorphisms (SNPs) in sequence based data (Minimum SNPs) but it is not 
designed to handle other forms of typing data [ 6, 7]. Furthermore, while it can be used 
to identify SNPs, which are most predictive of a user-nominated sequence type, it does 
not consider overall measures of concordance between typing systems. We report here a 
new computational approach selecting the most inform~tive sets of genomic loci for 
multi-target microbial typing and discuss its application to different typing methods for 
pathogenic bacteria and fungi. 
Implementation 
In constructing an approach for interrogating combinations of targets, which are either 
binary and/or multistate (where a target can assume any of>2 possible values), we 
developed a heuristic based on the stepwise accumulation of informative targets. Here 
'informative' means the combination of targets producing either the greatest 
discriminatory power or the greatest concordance with existing typing methods (as 
selected by the user). This heuristic assumes that the most informative combination of 
n+ 1 targets includes the most informative combination of n targets as a subset. While 
this assumption may not always hold true, it vastly reduces the number of combinations 
that need to be examined to determine the maximally informative subset of targets and 
it can be confirmed post-hoc for a given dataset. 
AuSeTTS (Automated Selection of Typing Target Subsets) is a software program 
designed to analyse a large array of typing data for a panel of isolates and determine the 
optimal combination of typing targets to maximise discriminatory power and/or 
concordance measures for a specified subset size. The analysis can be performed with 
(heuristic search) or without (exhaustive search) the heuristic described above. The 
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software was written in Microsoft Visual Basic for Excel (20 1 0); it is available for free 
download from http://www .cidmpublichealth.org/pages/ausetts.html. 
The input data consist of a table of typing results with the targets in columns and the 
isolates in rows. Each cell represents the result for a given target in a given isolate and 
is expressed as character-based data (for example 0 or 1 for binary data, allele numbers 
for MLST or numbers of repeats for MLV A data). One or more columns can be 
specified as the comparator typing method for calculating measures of concordance and 
typing results can be represented in the dataset multiple times by providing numbers of 
isolates for each row in a specified column. Non-informative targets (i.e. which have 
the same result for every isolate or are completely concordant with a second target) are 
automatically removed from the set before analysis. 
Using the heuristic search, the software initially ranks each target by their individual 
discriminatory power or concordance. It then examines all other targets in combination 
with the most informative target(s) to identify the most informative combinations of 
two targets. Further targets are then added iteratively until the whole dataset has been 
examined. When a 'tie' between combinations is encountered each of the tied 
combinations continue to be considered, with additional targets being added until the 
ties are broken. Once the ties are broken, the less informative combination(s) are 
abandoned. A 'threshold' is ultimately determined: the number of targets, beyond 
which adding more targets does not further increase discriminatory power or 
concordance. Figure l presents a schematic overview of the program. The output is a 
list of targets for each subset size that maximise discriminatory power or concordance, 
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with the results of these measures and 95% confidence intervals. The information is 
also presented graphically (Figure 2). 
Using an exhaustive search, the user specifies the number of targets to be included (the 
. 
subset size). The software then examines every possible combination of targets 
producing a subset of this size and calculates the discriminatory power (and, if 
specified, the concordance measures). The combinations with the highest achievable 
discriminatory power are returned, along with 95% confidence intervals. The 
exhaustive search gives a definitive result that is not dependent on the heuristic. It may 
not be feasible to examine very large datasets with an exhaustive search: on testing, 
examining a subset of 5 binary targets from a dataset of 20 targets for 100 isolates 
(15,504 possible combinations) took 20 seconds, while doubling the number of targets 
to 10 from the same dataset increases the number of combinations to be examined by 
more than 1 0-fold which led to a corresponding increase in the computing time. Thus 
the problem using the exhaustive search becomes NP-complete for very large datasets, 
and the heuristic approach becomes necessary. 
Formulas 
The formula used for calculating D was as follows: 
D=1- 1 s 
N(N -1) ~nj (nj -1) 
Where N is the number of isolates in the sample population, Sis the number of distinct 
types identified in the population and nj is the number of isolates of the type j [8] . The 
following formulas have been developed for calculating confidence intervals forD [9, 
10]: 
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<r' = ~[ r(~ )' -( r(~ rn 
CI = lo-2~,D+2W J 
Where ci is the variance and CI is the approximate 95% confidence interval. This 
formula used for variance is a large sample approximation; a non-approximated formula 
for variance has also been described [ 1 0]. 
To calculate W, the typing results for both methods for each isolate in the data set must 
be examined against those for every other isolate in the data set to see if they match or 
are discordant. The formula used for W is given by [ 11]: 
a 
W(MPM2)= a+ b 
Where a is the number of instances where two isolates of the same type by method M1 
are of the same type by method M2, while b is the number of instances where two 
isolates of the same type by method M 1 are of a different type by method M2• The 
Adjusted Wallace coefficient (A W) incorporates an adjustment to account for 
concordance that may occur by chance alone. The formula for A W is given by [ 12]: 
AW(M
1
,M
2
) = W(Mt,M2) + D(M2) -1 
D(M2 ) 
Where D (M2) is the Simpson's index of diversity of the dataset using typing method 
M 2• In addition, the Rand (R) , adjusted Rand (AR) and the approximate 95% confidence 
intervals of AWare also calculated [ 12, 13]. The analytical confidence interval 
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calculations for W may not be valid for W values of <0.5. An alternative method for 
calculation of confidence intervals for these measures of congruence is to use Jackknife 
resampling [14], for which an online tool is available [15]. 
Confidence intervals are provided for the purposes of comparison of results with other 
typing methods. However, in the algorithm, only the point estimates of D, A W, or AR, 
without confidence intervals, were used to determine the most informative values of 
each combination of targets. This approach reduces the complexity of the heuristic and, 
hence, the computation time required but the results relate only to the input dataset. The 
optimal combination of targets may therefore be different for larger sample sizes or 
samples from different populations of the same microbial species. 
Results and Discussion 
Validation 
To examine the robustness of the assumption that targets may be added in a stepwise 
fashion while maximising the parameter of interest (heuristic search), random datasets 
were generated and tested using both search types. These random datasets were defined 
by varying a) the number of targets, b) the number of different states each target could 
assume, c) the number of strain types and d) the number of isolates distributed 
(unevenly) amongst the strain types. 
For each dataset, a heuristic search was used to calculate the threshold subset size. The 
heuristic search result for a subset of one target less than the threshold was compared 
with an exhaustive search result specifying the same sized subset. If the resulting 
maximum parameter value, using the exhaustive search was the same as that of the 
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heuristic search, the heuristic was considered to be valid. If the maximal parameter 
value achieved by the heuristic search was less than that using the exhaustive search, 
the heuristic was considered not to have held. 25600 randomly generated datasets were 
examined for each of the 5 parameters of interest. The heuristic was valid in 79.4% 
(95% confidence interval 79-80), 98.2% (98-99), 83.4% (0.83-0.84), 92.9% (92-93) and 
93.6% (93-94) of random datasets forD, A W(A>B), A W(s>A), Rand AR, respectively. 
Factors associated with failure of the heuristic to identify the combination of targets that 
maximised D included: a value of D between 0.90 and 0.96, and a larger number of 
targets analysed. It performed best when the maximum D of the whole dataset was 1 
(87.8% 95% CI 87-89) .. The number of strain types, the number of isolates in the 
dataset and the number of states each target could assume did not influence the 
likelihood of the heuristic being valid. 
The heuristic performed well for all four concordance measures. Factors associated with 
a lower likelihood of the heuristic being valid for concordance measures included an 
increasing number of targets in the dataset, D value of the dataset between 0.9 and 
0.96, examination of a subset of close to half of the total number of targets and, for 
AW(A>B), a maximumAWvalue between 0.1-0.35. 
Full details of the validation are available in the supplementary material (additional file 
2). 
Application 
The software was used to analyse different forms of microbial typing data generated by 
well-validated methods, specifically, binary typing data for Staphylococcus aureus [16-
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18], MLVA for Streptococcus pneumoniae [19] and MLST for Cryptococcus spp. [20, 
21]. 
Selection of targets for Staphylococcus aureus strain typing. Typing results for 51 
binary targets in 153 methicillin-resistantS. aureus (MRSA) isolates (42 well 
characterised reference isolates and 111 clinical isolates from our institution) were 
available from previous experiments in our laboratory [16-18]. The targets comprised: 
13 toxin genes [17], 16 phage-derived open reading frames [18] and 22 SCCmec 
elements [ 16] which had been interrogated using multiplex-PCR reverse line blot assays 
[22, 23]. 
The maximum D value ofbinary typing with all 51 targets for this collection ofMRSA 
isolates was 0.984 (95% confidence interval 0.975-0.992). AuSeTTS heuristic search 
showed that this could be achieved with a subset of 20 binary targets, while a subset of 
just 7 targets achieved aD value of0.954 (0.941-0.967) (Figure 2A). When used to 
predict MLST (which had been determined by either the conventional [24] or SNP-
based [25] methods for all 153 isolates), a maximum Adjusted Wallace coefficient of 
concordance (AW) of0.9994 (0.999-1.000) was achieved with 12 targets (Figure 2B). 
One binary type consisted of two isolates with different MLST (which were single-
locus variants). Isolates within each of the remaining binary types all belonged to one 
MLST type. 
This data was used to develop a novel 19-target binary typing system for MRSA [26]. 
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Selection of targets for Streptococcus pneumoniae strain typing. Results of ML VA 
typing, using 17 loci, for 1449 Streptococcus pneumoniae isolates (representing 906 
possible MLVA types) were available from the MLVA online database (www.mlva.eu) 
[19] for analysis by AuSeTTS. A maximum D of0.997 (0.997-0.998) was achieved 
with all 17 loci but only 4 targets were required to achi~ve aD value of 0.990 (0.988-
0.991), which divided the isolates into 438 MLVA types. 
A subset of the isolates for which MLVA results were available also had been serotyped 
(537 isolates representing 43 serotypes and 398 MLVA types), and these we used to 
determine the combination ofMLVA loci which could best predict the serotype. A 
maximum AWof0.899 (0.857-0.942) for serotype was achieved using 12 of the MLVA 
loci. This particular combination of 12 targets divided the dataset into 370 MLVA 
types, 352 of which contained only one serotype, while 15 contained two, two 
contained one and one ML VA type represented by 6 isolates harboured 5 different 
serotypes. 
A similar analysis was performed with MLST data which were available for 96 of the 
isolates consisting of 27 sequence types (ST) and 77 possible ML VA types. A 
maximum A W of 0.963 (0.943-0.983) for ML VA to predict ST was achieved with 9 
targets which divided the 96 isolates into 60 ML VA types. One ML VA type consisted 
of 3 isolates with 3 different MLST types. All other ML VA types consisted of isolates 
with matching MLST types. 
Selection of targets for Cryptococcus species strain typing. Twelve MLST loci for 98 
Cryptococcus spp. isolates from a previously published study [21] were examined using 
AuSeTTS. Eight ofthe 12 MLST loci provided a maximum D of0.963 (0.945-0.981) 
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for Cryptococcus spp.in a heuristic search. The exhaustive search, specifying a subset 
size of seven loci, indicated the same maximal D value could be achieved with only 
seven loci; i.e. for this dataset, the heuristic was invalid but the most informative 
combination of targets could still be identified using an exhaustive search. This analysis 
was used, in part, to determine the recommended targets for an international consensus 
protocol for MLST typing of Cryptococcus spp. [27]. 
Discussion 
AuSeTTS has been successfully applied to develop typing schemes for MRSA [26] and 
Cryptococcus spp. [27] and would be useful to assess the discriminatory power of 
combinations of candidate targets for typing systems for other pathogens. It can be used 
for a wide range of data types, but for interrogation of informative SNPs, we 
recommend Minimum SNPs, which has been designed specifically for this purpose [ 6, 
7]. Minimum SNPs should be used to examine input data in the form of multiple 
sequence alignments. AuSeTTS can also be used to examine the level of concordance 
between results produced using subsets of candidate targets and those of existing 
phenotyping or genotyping methods or with epidemiologic classifications. Minimum 
SNPs does provide some functionality with regard to concordance measures (the "not-
N" mode), but does not calculate the Wallace or Rand coefficients or confidence 
intervals for the adjusted Wallace coefficient. 
While the algorithm used in the heuristic search may not always provide a definitive 
result for the minimum subset size required for the maximal D value, it will be correct 
in the majority of cases (92.6% on average). For smaller datasets, an exhaustive search 
can easily be undertaken to confirm the validity of the heuristic. This is particularly 
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recommended if the dataset has several features that were associated with a higher 
likelihood of the heuristic being invalid, such as low maximum D values, a threshold 
value close to 50% of the total number of targets, a number of states each target can 
assume of <8 and a large number of unique strain types. 
Conclusion 
Computerised analysis with AuSeTTS enables rapid, automated identification of the 
most informative targets for incorporation into novel molecular typing schemes for 
bacteria and fungi. Discriminatory power and concordance, while important, are only 
two of the many parameters that need to be considered when developing a new 
molecular typing technique. Reproducibility, stability, ease of use, ease of 
interpretation, throughput and cost are additional measures that require thorough 
assessment and comparison with existing methods during development and evaluation 
of novel typing techniques [5]. 
Availability and requirements 
Project name: AuSeTTS 
Project home page: http://www.cidmpublichealth.org/pages/ausetts.html 
Operating system(s): Microsoft Windows 
Programming language: Visual Basic for Applications 
Other requirements: Microsoft Excel for Windows 
License: Unrestricted Freeware 
List of abbreviations 
AR:adjusted Rand coefficient 
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A W: adjusted Wallace coefficient of concordance 
A W(A>B): adjusted Wallace coefficient of concordance for target combinations to predict 
the reference partitions 
A Wca>A): adjusted Wallace coefficient of concordance for the reference partitions to 
predict target combinations 
D: Simpson's index of diversity 
MLST: multilocus sequence typing 
ML VA: multilocus variable number of tandem repeats analysis 
PCR: polymerase chain reaction 
R: Rand coefficient 
SNPs: single nucleotide polymorphisms 
W: Wallace coefficient of concordance 
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Figure 1. Schematic overview of iterative assessment of typing targets conducted 
by AuSeTTS (heuristic search). 
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Figure 2 AuSeTTS graphical output. (A). Relationship between the number of target 
loci and the discriminatory power of molecular subtyping. Results for analysis of 
MRSA binary typing data. The maximum Simpson's Index of Diversity was achieved 
with a combination of 20 targets. (B). MRSA binary typing data analysis to maximise 
the Wallace coefficient. Maximum concordance of binary type to predict MLST was 
achieved with 12 binary targets, with anAWvalue of0.994. 
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Additional Files 
Additional file 1: AuSeTTSv6.xls.The AuSeTTS software file. 
Additional file 2: AuSeTTS validation.pdf. The full description of the heuristic 
search validation. 
Additional file 3: AuSeTTS worked example.pdf._A worked example using the 
dataset in additional file 4. 
Additional file 4: Sample AuSeTTS dataset.xls. A sample dataset used for the 
worked example. 
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AuSeTIS validation details 
The heuristic was validated by processing multiple random data sets for each of the 
parameters of interest. For each dataset, the heuristic mode was first used to 
establish the 11threshold" number of targets which, in combination, maximised the 
parameter of interest. The maximum parameter value by the heuristic method using a 
combination size which was one less than the threshold was noted. Next, the 
exhaustive mode was utilised on the dataset, again, examining a combination size of 
one less than the 11threshold". If the exhaustive mode yielded a maximum parameter 
value which was the same as that achieved by the heuristic for that combination size, 
the heuristic was recorded as being valid for that dataset, otherwise it was said to be 
invalid. 
For each of the validations of D, AW(A->BJ, AW(B->AJ. Rand AR, a new set of 25,600 
random datasets was generated .. Each of the four input variables for each dataset 
could assume one of four values (table 1) and 100 datasets for each unique 
combination of four values was generated (100 x 44 = 25,600 datasets in total for each 
parameter). 
Random dataset input variable 
Number of targets 
Number of states each target could assume 
Number of unique strain types* 
Ratio of number of isolates to the number of unique strain 
types in each dataset* 
Possible values 
4 5 6 7 
2 3 4 5 
10 12 14 16 
1 2 3 4 
Table 1. Parameters used to generate the random datasets. *These two parameters were 
multiplied to give the number of isolates within each random dataset. As a result the number 
of isolates could be one of 16 values ranging 10 through to 64. Datasets with 10-16 isolates 
therefore had one isolate per strain type. 
The influence of various dataset parameters on the likelihood that the heuristic was 
valid was examined, and is outlined in the five tables below. 
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Chapter 5: Software for selecting the most informative sets of genomic loci for multi-target microbial typing 
AuSeTTS- Automated Selection of Typing Target Subsets 
Worked Example 
Step 1: Download Files 
Download the files "AuSeTISv6.xls" and "Sample AuSeTIS dataset.xls" to your computer 
Step 2: Upload data 
Open the file "AuSeTISv6.xls". 
You may get a prompt to enable macros. Macros must be enabled for AuSeTIS to run: 
Serurity W.ning Macros have been disabled. L Enable Content 
You will be prompted to load typing data: 
-, 
AuSeTTS liiEiil ,, 
- -
CID\11 
Autolnillti!Jd SM!ction ofTYI*to Target subsets I! sYDNEY AuSeTTS 
_b,....._&.-.qy 
Publlc twollh 
for lnton.iltion and updates. please visit 
_ _ ddnlpubldlealthorg/~/ausetts.hbll ~ 
[ ___ ........ __ ..... --· --
---------
. - ---- --] = fi'om fie I P•tt fi'om dpboard (' Use previously loaded data (' Random Deta r. chncttr delnrttd ~ 0( (' (tab-delimittd ~ 0( Exczl 
farmaQ farmat) 
-·-
.. ---
eomto.e I c..crJ...tvirw~ d .. f!d: I 
Choose "Load from file" and click continue. 
Using the other options, you can also paste data from the clipboard, use the data 
already saved in the A uSe TTS file or create a random dataset. If you would like to view 
the results of an previously performed analysis that has been saved in the AuSeTTS file, 
click "Cancel and view spreadsheet". 
Browse to the file "Sample AuSeTIS dataset.xls" on your computer and click open. You are 
prompted to choose the worksheet in the file that contains the typing data. Choose "Sheet 1" 
and click OK. The data is then loaded: 
196 
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St ep 3: Define fields 
Worksh~ts 
St!lect the worksheet that cnntains the 
typing data: 
Sheetl 
Sheet2 
Sheet3 
OK 
Carta!~ 
The targets in the dataset are listed in 4 windows. Highlight "MLST" in the list of "Target(s) 
defining partitions". Concordance between different combinations of the binary targets and 
MLST will be calculated during the analysis. 
Define Fields 
Add Cllllbining ~ 
oflsoUtes 
Binary tz!rget 1 
Binary target 2 
Bl1ary tz!rget 3 
Binary target 4 
Binary target 5 
Binary target 6 
Bl1ary target 7 
Binary target 8 
Binary target 9 
Binary target 10 
Binary target 11 
Bl1ary tz!rget u 
Bl1ary 121rget 13 
Binary target 1" 
Binary target 15 
Binary target l6 
Binary tz!rget 17 
I'9..ST 
I Mode 
r. He.ristic s--en 
r Exhaustive s--en 
r ~Pl1111tions 
L 
P' Show PrO!J'ess Bar 
1 
I 
I 
I 
-IPQj 
rlo•re c ·e. c- ·'-n'- o e' e:· -a<'· ·· 
T11rget(s) to force ~~~dude 
Binary target 1 
Targd(s) to force Exdude 
Bl1ary target 1 
Targd(s) ~ Pil~ 
Binary tz!rget 1 
Binary target 2 Bl1ary target 2 Binary tz!rget 2 
Binary target 3 Bl1ary target 3 Binary target 3 
Binary target " Bl1ary target" Binary tz!rget " 
Binary target 5 Bl1ary target 5 Binary target 5 
Binary tz!rget 6 Binary target 6 Bl1ary target 6 
Binary tz!rget 7 Bl1ary target 7 Binary tz!rget 7 
Binary tz!rget 8 Binary targetS Binary target 8 
Binary tz!rget 9 Binary target 9 Binary tz!rget 9 
8lrwy target 10 Binary target 10 Binary target 10 
Binary tz!rget 11 Binary target 11 Binary target 11 
Binary tz!rget u Binary target u Binary tz!rget u 
Binary target 13 Binary target 13 Binary tz!rget 13 
Binary target 1" Binary target 14 Binary tz!rget 1" 
Binary tz!rget 15 Bl1ary target 15 Binary tz!rget 15 
Binary target l6 Binary target 16 Binary tz!rget 16 
Binary target l7 Binary target 17 Binary taroet 17 
I'9..ST I'9..ST 
Par.neter to Haximi9e limits 
r. Simpson's Index of Diversity ~ v._ can be left blank ID 
r Adj.Js~ Walaa's Coefficient (A->8) n.n a fu1 analYsis 
l.i'nit combilations per 1 l r ......,. w-.·,""""""' II>->AI st.bset size to: 
r Rand Coefficient Stop when paramete" I 
r Ad;.Js~ Rand Coefficient reaches: 
Done J Cleilr Selections I Cilncel I 
The window "Field containing number of isolates" is used where there is a single row in 
the dataset for each strain type, but you would each strain type to represent multiple 
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isolates. In this case the data set is formatted as one row per isolate, so no field 
containing the number of isolates needs to be specified. 
If there are particular target{s) of interest, these can be force included in the dataset 
using the second window. Force included targets will be automatically included in any 
combinations that are analysed. 
Targets can be excluded from the analysis by selecting them in the third column. 
Targets selected in the first or last windows are automatically excluded. 
Under "Mode" choose "Heuristic search". This will be a quick search of the dataset to find the 
combination of targets which appears to be most informative. 
Exhaustive search is used to examine every possible combination of targets in a 
particular subset size. "Predict partitions" produces a list which correlates the results 
for a specified combination of targets with the partition selected in column 4. 
Under "Parameter to maximise", choose "Simpson's index of diversity". 
The other 4 parameters can also be maximised in either a heuristic search or an 
exhaustive search. One or more targets defining partitions must be specified if a 
concordance measure is being maximised; this is not a requirement for Simpson's 
index of diversity. 
When large datasets are being examined, a number of steps can speed up the analysis. 
By specifying a value in "Limit combinations per subset size to:" the heuristic will 
randomly select that number of combinations with the maximal parameter value for 
analysis, rather than all possible combinations. "Stop when parameter reaches:" can 
be used to abort the analysis once a certain value is reached. If it is left blank, the 
analysis will continue until a maximum parameter value of 1 is reached. "Show 
progress bar" can also be unselected which can speed up the analysis. 
Click "Done". 
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Step 4: Heuristic analysis 
AuSeTIS has identified that binary targets 5 and 9 are non-contributary to the analysis and so 
are excluded. Click OK: 
I Exduded non informative targets --The foloM1g target(s) are non11formative sincr their ~(s) are constant across al isola 1M. They ha~ bee'! excluded: 
TARGET VALL£ 
Binary target 5 0 
Binary target 9 0 
AuSeTIS has identified that Binary target 13 and Binary target 17 are fully concordant, so only 
one needs to be included in the analysis. Select Binary target 17 to exclude and click OK:. 
Concordant Genes 'E• 
The folowing two targets were found to be 
lOOtMt CJOnaM'dant.. 
Please choose whidl target to cliscilnt 
(' Bmry target 13 
r. EWlary target 17 
I [::.·.-.~~~·.~~·.-.-~~.-.-.-.~~.·::.:·:.·.·.]1 
The analysis is then run, with a progress bar displaying the progress of the analysis. A warning 
is shown when the analysis is complete regarding the limitations of confidence intervals for 
the adjusted Wallace coefficient. Click OK: 
~ 
Microsoft Excel idi 
l Analysis complete. 
Adjusted Wallace confidence inti!Mlls may not be vaftd for point 
estimates <05. 
Alternative Jackknife resampling Ck can be cakui.Jted for measures of 
concordance at www.comparingpartitions.info. 
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Step 5: Heuristic search results. 
The results are shown on the " Results" worksheet of the AuSeTIS workbook: 
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These results show that the maximum Simpson's index of diversity is 0.942040816326531 and 
this could be achieved with a combination of 9 binary targets (the threshold, cell A10). There 
were two combinations of 9 targets that could produce this value, and they are listed in cells 
P21 and P22: 
Bina1y target 1, Binary target 3, Binary target 6, Binary target 8, Binary targ•t 12, Binary target 13, Binary target 14, Binary target 15, Binary target 16 
Binary targ~t 1. Binary target 3, Binary targ~t 8, Binary target 11, Binary targ~t 12. Binary target 13, Binary target 14, Binary target 15, Binary target 16 
Confidence intervals for Simpson's index of diversity are also shown, as well as other 
measures of diversity- the fraction in the largest group and the number of groups. 
Since a reference partition was also specified (MLST}, measures of concordance are 
also displayed for each combination of targets listed. These include the Rand, adjusted 
Rand and adjusted Wallace coefficients. Adjusted Wallace A>B indicates the ability for 
the given combination of binary targets to predict the MLST type; Adjusted Wallace 
B>A indicates the ability for the MLST type to predict the indicated combination of 
binary targets. 
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The results are also shown graphically on the "Chart" worksheet: 
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To save the results of the analyses, save the worksheet with a different name, using 
the "Save As ... 11 in the Excel File menu. 
Step 6: Exhaustive search 
The heuristic search indicates that a combination of 9 targets is the smallest subset that will 
maximise the Simpson's index of diversity. This can now be verified or refuted using an 
exhaustive search for a combination of 8 targets to see if subset size can provide the 
maximum Simpson's index of diversity. 
Press Ctri-M to launch the AuSeTIS program again. 
This time choose "Use previously loaded data" on the first popup screen. 
On the "Define Fields screen", choose "Exhaustive search" as the "Mode" and "Simpson's 
index of diversity" as the parameter to maximise. Highlight "MLST" in the list of "Target(s) to 
Force Exclude": 
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Define Fields 
Field ClllllbiiMng IIUIIIben 
olisolllts 
Blrwy target 1 
Blrwy target 2 
Blrwy target 3 
Blrwy target 1 
Blrwy target 5 
Blrwy target 6 
Blrwy target 7 
BNry ll!rget 8 
~yll!rget9 
~y target 10 
Blrwy target 11 
Blrwy ll!rget u 
Blrwy bwget 13 
Blrwy target 11 
Blrwy target 15 
Blrwy target 16 
BNry target 17 
llt.ST 
r Hode 
r He..nsbc Search 
(0 Exhllus~ Search 
r Predel Pnbons 
17 Show Progress Bar 
liiii 
'+"- •· o··ecnn ........ · •. ovle ··•:pi.,· ~·~ 
Target(s) to fclrc:e Jndude 
BNry target 1 
Target(s) to fclrc:e fxdude 
Bnllry target 1 
Target(s) defining partitions 
BNryta-get1 
BNry target 2 
en.y ll!rget 3 
en.y target 1 
BNry target 5 
BNry target 6 
BNry target 7 
BNry ll!rget 8 
BNry target 9 
BNry target 10 
BNry ll!rget 11 
Blrwy ll!rget u 
BNry ll!rget 13 
BNry target 11 
BNry target 15 
BNry ll!rget 16 
Blrwy ll!rget 17 
llt.ST 
Paralneter to Maximise 
lo Sirl1lsan's Index of Diversity 
en.y ll!rget 2 
Blrwy target 3 
Blrwy ll!rget 1 
BNry ll!rget 5 
BNry target 6 
en.y target 7 
~ytarget8 
BNry target 9 
BNry target 10 
Binary ll!rget 11 
BNry target l2 
Binary target 13 
Binary ll!rget 14 
BNry ll!rget 15 
BNry target 16 
enwv waet 17 
r Adjus~ Wt4aa's Coefficent (A->B) 
r M,a~ Wt4aa's Coeffldent (8->A) 
BNry target 2 
en.y ll!rget 3 
E!Nryta-get4 
BNry ll!rget 5 
en.y target 6 
Binary !a-get 7 
BNryta-get8 
E!Nryta-get9 
Brlary !a-get 10 
BNry target 11 
BNry target u 
BNry target 13 
E!Nryta-get 14 
E!Nryta-get15 
BNryta-get16 
BNry target 17 
llt.ST 
.-- L•m•ts --, 
- "::!:Jes can be .eft blan.lc to 
II 'iJ lr~VSlS 
Lmt cxr-b:'latio:ls pa l,....---
subset SlZe '-' 
r Rand Caefliclent 
r M,a~ Rand Coeffident I I Stop .:'ler parameter 1 reach~: 
___ __j 
~ I a-r~ l ~ 
If measuring concordance with a reference partition is not required, then force exclude 
the targets which represent the reference partition, rather than highlighting them in 
the fourth window. This will speed up the analysis. 
Click "Done". Again, the non informative targets are listed. Click "OK": 
Exduded non informative targets l 
The folowing target(s) are non~fonnative since ther 
v~(s) are constant across al isolates. They have been 
excluded: 
... I~.G.~;I ........................... --·····-·············Y.~.\,8; ................................................ .J 
Binary t!rget 5 0 
Binary target 9 0 
Again, the user is prompted to discard one of the concordant targets. Choose "Binary target 
17" and click "OK": 
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Concordant G~nes 
The folowing two targets were found to be 
1~ c:DnODrdant. 
Please dloose "'*" target to cliKard: 
r !~::~~!:~] 
r. Bi1ary target 17 
OK 
You are then prompted to choose the combination size to be examined. Since the heuristic 
search showed a threshold value of 9, choose one size less (ie: 8) to be examined in the 
exhaustive search: 
Number of targ~ts 
Th~~ ar~ 14 targds r~maining in th~ dataset. Ent~r ~ 
number of targds to b~ com bin~ 
--
Cancel 
fs 
You are warned about the analysis time. Click "OK" 
Microsoft Excel 'ibd 
3003 possible combinations. 
D~ analysis as ~t~ to talte a further 0 hours,. 0 mins and U seconds. 
Are you sur~ you wish to continue? 
I r.·::.·.·:.·::.·.·.·:.§~.·:.·.·.·:.·::.·~.JI Canc~l 
The analysis is then undertaken, and once complete, a warning about the confidence intervals 
for the AW coefficient is displayed. Click OK. 
Step 7: Results of exhaustive search 
The exhaustive search indicates that the maximum 0 value achievable with a combination of 8 
targets is 0.940408163265306 (cell ClO). Four different combinations of 8 targets was able to 
achieve this value (cells P10-P13). This D value is less than the maximum 0 value determined 
by the heuristic search, so the heuristic is found to be valid: 
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Columns H through 0 are blank since concordance measures were not assessed in this 
analysis. 
Choose "Save As ... " from the file menu to save the results of this analysis if required. 
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Chapter 6: Quantitative estimation of MRSA strain-typing system 
stability using Kaplan-Meier survival analysis 
Figure: Schemat ic overview of the structure of th is thesis 
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6.1 Introductory comments 
While mobile genetic elements such as phage-derived open reading frames, toxin 
genes and SCCmec components may add high discriminatory power to a binary typing 
system, they may at the same time, render the typing system unstable, since these 
elements may enter and leave the bacterial chromosome at a much faster rate than 
the molecular clock speed of the core genome (1). It is vital that a typing system based 
upon such elements undergo a thorough assessment for typing system stability; 
preferably using in vivo methods since in vitro passages are unlikely to replicate the 
environment in which gain or loss of mobile genetic elements occurs. Previous 
assessments of typing system stability (2) look only at the fraction of isolates that have 
a change in type upon re-sampling and do not consider the kinetics of that change. 
Incorporating the kinetics of change into assessment of stability has two inter-related 
benefits: it can indicate over what timescale it may be appropriate to infer relatedness 
of isolates using the typing system, and secondly it can provide important information 
about interpretative criteria for isolates which may be related but not 
indistinguishable using the typing system. 
6.2 Aims 
The aims of this study was i) to develop a method for measurement of in vivo stability 
of typing systems, using Kaplan-Meier survival analysis in order to examine the 
kinetics of change of the typing systems examined and ii) compare the in vivo stability 
of key typing systems available for the typing of MRSA. 
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6.3 Publication: Quantitative estimation ofMRSA strain-typing 
system stability using Kaplan-Meier survival analysis. 
Citation: 
O'Sullivan MV, Sintchenko V, Gilbert GL. Quantitative estimation of MRSA 
strain-typing system stability using Kaplan-Meier survival analysis. J Clin 
Microbiol. 2013; 51(1):112-6. 
Contribution of authors: 
MOS conceived the study, performed molecular typing on 5. aureus isolates, 
conducted the data analysis and prepared the manuscript. 
GLG and VS provided expert guidance and edited the manuscript. 
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Quantitative Estimation of the Stability of Methicillin-Resistant 
Staphylococcus aureus Strain-Typing Systems by Use of Kaplan-Meier 
Survival Analysis 
Matthew V. N. O'Sullivan, Vitali Sintchenko, Gwendolyn L. Gilbert 
Centre for Infectious Diseases and Microbiology, Sydney Medical School and Sydney Emerging Infections and Biosecurity Institute, UmverSity of Sydney, Westmead 
Hospital, New South Wales, Australia 
Knowledge concerning stability is important in the development and assessment of microbial molecular typing systems and is 
critical for the interpretation of their results. Typing system stability is usually measured as the fraction of isolates that change 
type after several in vivo passages, but this does not necessarily reflect in vivo stability. The aim of this study was to utilize sur-
vival analysis to provide an informative quantitative measure of in vivo stability and to compare the stabilities of various tech-
niques employed in typing methicillin-resistant Staphylococcus aurew (MRSA). We identified 100 MRSA pairs (isolated from 
the same patient ~1 month apart) and typed them using multilocus sequence typing (MLST), phage-derived open reading frame 
(PDORF) typing, toxin gene profiling (TGP), staphylococcal cassette chromosome mec (SCCmec) subtyping, pulsed-field gel 
electrophoresis (PFGE), and spa sequenu typing. Discordant isolate pairs, belonging to different MLST clonal complexes, were 
excluded, leaving 81 pairs for analysis. The stabilities of these methods were examined using Kaplan-Meier survival analysis, and 
discriminatory power was measured by Simpson's index of diversity. The probability percentages that the type remained un-
changed at 6 months for spa sequence typing, TGP, multilocus variable number of tandem repeats analysis (MLVA), SCCmec 
subtyping, PDORF typing, and PFGE were 95, 95, 88, 82, 71, and 58, respectively, while the Simpson's indices of diversity were 
0.48, 0.47, 0.70, 0.72, 0.89, and 0.88, respectively. Survival analysis using sequential clinkal isolates adds an important quantita-
tive dimension to the measurement of stability of a microbial typing system. Of the methods compared here, PDORF typing pro-
vides high discriminatory power, comparable with that of PFGE, and a level of stability suitable for MRSA surveillance and out-
break investigations. 
The stability of a new typing method is one of the key parame-ters defining its utility, along with discriminatory power, re-
producibility, ease of use and interpretation, cost, throughput, 
and concordance with both epidemiologic data and existing typ-
ing systems (1). Discriminatory power is usually estimated by 
Simpson 's index of diversity (2), concordance is usually measured 
by Wallace or Rand coefficients {3 ), and reproducibility is usually 
measured by Cohen's kappa. 
Stability relates to the likelihood that the measured character-
istic of an organism will change with time or in subsequent gen-
erationsof the organism. lf a typing system has low stability, it may 
incorrectly identify related isolates as being unrelated. It is impor-
tant to define the stability of a typing system so that guidelines for 
the interpretation of results can be established. If isolates typed by 
a highly stable system differ at one locus, it may indicate that they 
are unrelated strains, whereas if they are typed by an unstable 
system, they may need to differ at multiple loci before nonrelat-
edness can be inferred. 
Stability has been most commonly measured by observing the 
fraction of isolates in which the genotype remains unchanged after 
a fixed number ofin vitro passages (I). However, this approach is 
less applicable to epidemiologic studies and does not provide 
much relevant information about the natural rate of change over 
time. Here, we describe a method of measuring stability using 
Kaplan-Meier survival analysis and its application to the estima-
tion of in vivo stability of typing methods used to study the short-
term epidemiology of methicillin-resistant Staphylococcus aureus 
{MRSA) in hospital and community settings. 
MATERIALS AND METHODS 
Isolate coUection. A collection ofM RSA isolates fro m clinical and screen-
ing samples obtained between July 2005 and March 2009, routinely stored 
at the Centre for Infectious Diseases and Microbiology, Westmead Hos-
pital, Sydney, Australia, was used in the study. This co llection was sur-
veyed to find multiple isolates from the same patient ; patients were en-
rolled if they had two isolates collected ~ 1 month apart, irrespective of the 
anatomical site or type of specimen from which they were isolated. The 
multilocus sequence type (MLST) was p redicted using kinetic PCR for 
informative single-nucleotide polymorphisms (SNPs) (4), and patients 
were excluded if their isolates belonged to different MLST clonal com-
plexes (as it was assumed that this represented acquisition of a new strain 
rather than evolution of the initial strain ). 
DNA preparation. for PCR-based methods, one or two colonies from 
a pure subculture were suspended in 400 ~1 of molecular-grade water, 
which was boiled for LO min and fro2en. After thawing, the suspension 
was centrifuged at 10,000 rpm for 5 min, and the supernatant was used for 
a DNA template. The same lysate was used for aU methods. A sweep o f the 
pure subculture was used to make suspensions for pulsed-field gel elec-
trophoresis (PFGE). 
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Molecular typing. PFGE of $mal-digested genomic DNA was per-
formed according to the Harmony protocol (5) and analyzed using 
BioNumerics (Applied Maths NV, Belgium). A comparison ofPFGE pat-
terns in BioNumerics was performed using the Dice coefficient with the 
position tolerance set at 1.5% (change toward end of the fingerprint, 
0.75%), and a dendrogram was constructed using the unweighted-pair 
group method using arithmetic averages (UPGMA). The isolates were 
grouped using two similarity cutoffs: 100% (indistinguishable patterns) 
and 80% (PFGE-1 00 and PFGE-80, respectively), as 80% is commonly 
used to define PFGE patterns that are likely to be epidemiologically related 
(6). Multi locus variable number of tandem repeats analysis (MLVA) was 
perforn1ed as reported previously (7). Each MLV A locus was amplified 
using single-primer-pair PCRs, and the amplification products were de-
tected using gel electrophoresis with isolate pairs in adjacent lanes. The 
band sizes and matching bands between isolates were determined using 
BioNumerics and confirmed by visual inspection. ML VA patrerns were 
January 2013 Volume S 1 Number 1 
considered to be different if the molecular weights of one or more loci 
varied by at least the size of one repeat for that locus. spa sequence typing 
was performed as described previously (8), and spa types were assigned 
using the SpaServer (Ridom Bioinformatics) (9). Three multiplex PCRJ 
reverse line blot (mPCRJRLB) binary typing systems were employed ( 10, 
I I): (i) toxin gene profiling to target sea, seb, sec, sed, see, seg, seh, sei, eta, 
etb, eld, lsi, and lukS-PV (Panton-Valentine leukocidin) genes (8), (ii) 
phage-derived open reading frame typing (PDORF) to examine 16 loci 
derived from integrated prophages ( 12), and (iii) staphylococcal cassette 
chromosome mec (SCCmec) subtyping to determine the mec class and ccr 
type and to interrogate 14 loci in the three junkyard regions ( 13). Refer-
ence strains that, in combination, were positive fo r each probe and a 
DNA-free control were used as the positive and negative contro ls, respec-
tively. 
Data analysis. Stability was assessed by Kaplan-Meier survival analysis 
using SA$ for Windows 9.3. For the purposes of survival analysis, an 
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FIG 2 Kaplan-Meier survival curves for diff~rent genotyping methods. PFGE-100, PFGE-80: PFGE with similarity cutoffs of I 00% and 80%, respectively. For 
other typing method abbreviations, see the Fig. I legend. 
"event" was considered to have occurred when the members of the isolate 
pair had different results depending o n the typing m ethod under analysis. 
The time at which the "event" occurred was arbitrarily considered to be 
the midpoint between the collection times of the two isolates. An isolate 
pair was considered "censored" (at the time of collectio n of the second 
isolate) if the results for the typing m ethod for the two isolates were in-
distinguishable, i.e., the time required for a change in molecular type was 
unknown for that patient, but it was longer than the period of observation. 
Survival analysis was used to estimate the probability that a typing m ethod 
would remain unchanged for an isolate after 6 months. The log rank x2 
test was used to assess the differences in survival curves between methods, 
and P values were adjusted for multiple comparisons using the Sid~k 
method ( 14 ). The initial isolate of each pair was used to calculate Simp-
son 's index o f diversity (2) of the typing method. 
RESULTS 
One hundred pairs of MRSA isolates were identified from the 
culture collection, and the time between isolate collections for 
each of the pairs varied between 1 month and 2. 7 years. The mem-
bers of 19 isolate pairs belonged to different MLST clonal com-
plexes and therefore were excluded from further analysis. 
Of the remaining 81 isolate pairs, 37 had concordant results 
with all the methods (PFGE with 100% similarity [PFGE-100], 
PFGE with 80% similarity (PFGE-80] , phage-derived o pen read· 
ing frame typing [PDORF], SCCmec subtyping, toxin gene profil-
ing [TGP], spa sequence typing, and MLVA). Twenty-three isolate 
pairs differed by only 1 method (excluding PFGE-80): 13 for 
PFGE-100, 8 for PDORF, and 1 each for ML VA and SCCmec sub-
typing (Fig. I). Fourteen isolate pairs differed by 2 methods, and 
the remaining 7 differed by 3 or more methods. Five isolate pairs 
differed by PFGE-80: one of these pairs was concordant for all 
non-PFGE methods, and the remaining four differed by 1, 2, 3, 
and 5 non-PFGE methods. 
114 jcm.asm.org 
Kaplan-Meier survival curves show a clear separation ofPFGE-
100, PDORF, and SCCmec subtyping from the other more stable 
methods after as little as 3 months {Fig. 2). PFGE-100 was signif-
icantly less stable than all other methods tested (probability of no 
change at 6 months, 58%; 95o/o confidence interval [ CI ], 43 to 
70%). spa typing was the most stable (probability of no change at 
6 months, 95%; 95% CI, 82 to 99%), but this higher stability was 
significant only when compared with PFGE-100 and PDORF (P < 
0.0001 and P = 0.03, respectively). PFGE-BO was significantly 
more stable but less discriminatory than PFGE-100. ln general, 
there was an expected inverse relationship between stability and 
Simpson's index of diversity (Table 1 ). However, despite having a 
fractionally higher discriminatory power than PFGE-100 (Simp-
son's index of diversity, 0.89 versus 0.88), PDORF also had signif-
icantly higher stability, with a probability of no change at 6 
months of 71% (95% CI, 55 to 82%) (Table 1). 
DISCUSSION 
Stability has an inverse relationship with discriminatory power 
and is a function of the molecular "clock speed" of the genetic loci 
being interrogated by a typing system. Housekeeping genes, for 
example, which are utilized for multilocus sequence typing 
(MLST), have a low molecular clock speed, resulting in high sta-
bility but low discriminatory power. Genetic loci on mobile ge-
netic elements demonstrate a high molecular clock speed; utilizing 
these for typing may result in systems with low stability (possibly 
leading to misleading inferences about the relationships between 
isolates) but potentially high discriminatory power. The stability 
of a typing method has traditionally been measured by sampling 
strains at two time points and determining the fraction of strains 
that have the same results at each time point. Most commonly, 
sampling is performed before and after a given number of serial 
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TABLE I Stability and diversity measures of different genotyping methods 
Value for indicated genotyping method 
spa sequence SCCmec 
Attribute typing TGP PFGE-80 MLVA subtyping PDORF PFGE- 100 
No. (%) of pairs differing 3 (4) 5 (6) 5 (6) 9 ( II ) 11 (14) 17 (2 1) 31 (38) 
% probability of no change at 95 {82- 99) 95 (82- 99) 91 (76-96) 88 (74-95) 82 (68-90) 7 1 (55-82) 58 (43-70) 
6 mo (95%CI) 
Simpson's index of diversity 0.48 (0.35-0.62) 0.47 (0.34-0.60) 0.61 (0.50-0.73) 0.70 (0.57--{).82) 0.72 (0.64--{).79) 0.89 (0.85-0.94) 0.88 (0.81--{).94) 
(9S%CI) 
Log rank x2 test statistic ( P 40.2 (<0.0001) 34.8 (<0.0001) 35.0 ( < 0.0001) 25.1 (<0.0001) 21.2 (<0.0001 ) 10.3 (0.03) 
value} for comparison with 
PFGE-100 
passages of the organism in the laboratory (in vitro stability); less 
commonly, it is performed by culturing an organism in its natural 
environment at different time points, e.g., conducting repeat cul-
tures on a patient known to be colonized with the organism (in 
vivo stability). Measuring stability in vitro may lead to overestima-
tion of the stability of a pathogen in its natural host environment, 
since the opportunities for genetic changes through transforma-
tion, the acquisition of mobile genetic elements, or in response to 
environmental conditions, such as antibiotic therapy or immune 
pressure, will be absent. 
Our findings suggest that the consideration of stability of an 
MRSA typing system is especially important when one aims to 
measure the relatedness of MRSA isolates obtained in time inter-
vals of more than 3 months. With studies examining shorter time 
periods (e.g., during a hospital outbreak), highly discriminatory 
but relatively unstable methods, such as PDORF or PFGE, will be 
suitable for examining the microepidemiology of strains which 
may otherwise be closely related. Studies examining longer time 
periods (macroepidemiology) benefit from more stable methods, 
such as spa sequence typing or PFGE, which have similarity cutoffs 
of 80%. These findings are consistent with those of a recent study 
that utilized next-generation sequencing to examine the micro-
evolution of one geographically widespread MRSA clone (ST239) 
and which found an estimated molecular clock speed of one SNP 
mutation in the core genome every 6 weeks ( IS). 
Simultaneous carriage of multiple MRSA strains, or loss of one 
strain and recolonization with another, are potentially confound-
ing factors in studies of in vivo stability. Major changes in coloniz-
ing strains have been infrequent in other in vivo stability studies 
with MRSA ( 16-18 ), but the reported frequency of simultaneous 
carriage of multiple strains has varied in the literature ( 19). One 
report suggested that while simultaneous carriage of multiple me-
thicillin-sensitive Staphylococcus aureus (MSSA) strains may be 
common, this is not the case for MRSA (20). Of 100 isolate pairs 
initially identified in our study, 19 differed by their MLST clonal 
complex and so were assumed to represent recolonization/infec-
tion with different strains. 
The potential limitations of this study include the lack of serial 
sampling ofisolates, which may have impaired the accuracy of the 
stability measures; more frequent sampling would require a p ro-
spective clinical study. While attempts were made to exclude re-
infection/colonization by a different strain by excluding the iso-
late pairs belonging to different MLST clonal complexes, it is 
possible that some of the changes between isolate pairs repre-
sented reinfection with a different strain within the same clonal 
January 2013 Volume 51 Number 1 
complex rather than the evolution of the initial isolate or perhaps 
the carriage of multiple strains at different body sites, since a com-
bination of clinical and screening isolates was utilized for this 
study. This limitation may have led to an underestimate of stabil-
ity, particularly that of methods with higher discriminatory 
power. However, the majority of discordant pairs differed by only 
one method, suggesting that reinfection with a different isolate 
was probably infrequent in this cohort. Despite the limitations, 
the estimates produced in this study should reliably reflect the 
relative stability of different genotyping methods. 
In conclusion, PDORF offered greater stability than PFGE-100 
over a 12-month period but had a similar ability to discriminate 
between apparently unrelated isolates from different individuals; 
this indicates that PDORF may be a suitable substitute for PFGE in 
the investigation of MRSA outbreaks and infection control sur-
veillance. It also has additional advantages over PFGE, such as 
lower cost, faster turnaround time, higher por tability of results, 
and easier interpretation. All other methods were relatively more 
stable but had correspondingly limited discriminatory power. 
Survival analysis techniques provide a useful quantitative measure 
of stability for the assessment of novel genotyping targets. 
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7.1 Introductory comments 
This chapter describes the selection of targets for a novel binary typing system for 
MRSA, the development and assessment of the assay using the tools described in 
earlier chapters, and the utility of routine typing in a high-prevalence setting over 12-
month period. 
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Prospective Genotyping of Hospital-Acquired Methicillin-Resistant 
Staphylococcus aureus Isolates by Use of a Novel, Highly 
Discriminatory Binary Typing System 
Matthew V. N. O'Sullivan, Fei Zhou, Vitali Sintchenko, and Gwendolyn l. Gilbert 
Centre for Infectious Disease and Microbiology. Sydney Medical S<hool and Sydney Emerging lnfectrons and Biosecurity ln<t itute, University of Sydney, West mead 
Hosprtal, Sydney. New South Wales, Ausrralia 
In settings of high methicillin-resistant Staphylococcus aureus (MRSA) prevalence, detection of nosocomial transmission events can be 
difficult without strain typing. Prospective typing of all MRSA isolates could potentially identify transmission in a timely fashion, mak-
ing infection control responses to outbreaks more effective. We describe the development and evaluation of a novell9-target binary 
typing system for MRSA using the multiplex-PCR/reverse line blot hybridization platform. Pulse-field gel electrophoresis (PFGE), sp11 
typing, and phage-derived open reading frame (PDORF) typing were performed for comparison. The system was utilized to identify 
transmission events in three general surgical wards over a 12-month period. Initial MRSA isolates from 273 patients were differenti-
ated into SS unique binary types. One or more potential contacts colonized with the same MRSA strain were identified in 69 of87 cases 
(79%) in which definite or possible nosocomial MRSA acquisition had ocwrred. The discriminatory power of the typing system was 
similar to that ofPFGE (Simpson's index of diversity [D] = 0.994, versus 0.987) and higher than that of spa typing (D = 0.926). Strain 
typing reduced the total number of potential MRSA-colonized source contacts from 859 to 212 and revealed temporal clustering of 
transmission events. Prospective MRSA typing using this novel binary typing method can rapidly identify nosocomial transmission 
events, even in high-prevalence settings, which allows timely Infection control interventions. The system is rapid, inexpensive, discrim-
inatory, and suitable for routine, high-throughput use in the hospital microbiology laboratory. 
In settings of high prevalence of methicillin-resistant Staphylc· coccus au reus (MRSA) colonization and infection, it is difficult 
to determine without strain typing whether a newly identified case 
is the result of nosocomial acquisition. Traditionally, strain typing 
has been done, retrospectively, after identificatio n of a spatiotem-
poral cluster of cases, but this approach may delay infection con· 
trol interventions. New PCR-based high-throughput typing 
methods offer a rapid turnaround time, with lower costs and in 
many cases high discriminatory power (1, 7, 9, 15, 21 - 23). This 
makes possible the concept of prospective typing, where isolates 
are typed routinely and the results are examined for evidence of 
nosocomial transmission in near-real time, allowing faster, tar-
geted infection control interventions. High discriminatory power, 
ease of interpretation, and portability of results are essential ele-
ments of such a system. spa sequence typing has been used in this 
context ( II ) but in some settings has insufficient discriminatory 
power to reliably discern transmission events. 
We have developed a novel binary typing system specifically for 
prospective MRSA strain typing to detect transmission events. 
The m ost informative targets from three previous binary typing 
systems (toxin gene profiling [ 3], phage-derived open reading 
frame typing [ 13), and SCCmec subtyping [2 j) were selected and 
incorporated into a m ultiplex PCR/reverse line blot (rnPCRJRLB) 
assay platform. We describe the development and assessment of 
perform ance characteristics of the system , fo llowing established 
guidelines (1 9), and present results from I year of routine MRSA 
strain typing in a high-prevalence nosocomial setting. 
MATERIALS AND METHODS 
s~tting. Westmead Hospital is a 975-bed tertiary referral hospital in met· 
ropolitan Sydney, Australia. It has a relatively high prevalence of MRSA 
colonization and infection, with 26 inpatient and 9 health care-associated 
outpatient MRSA bacteremias in 2011 and an MRSA colonization rate of 
around 25% on point prevalence surveys of the three general surgical 
wards (total, 82 beds}. The general surgical wards largely house patients 
admitted for upper gastrointestinal, colorectal, and other intra-abdomi-
nal surgeries, and include a 16-bed high-dependency unit. Prior to the 
study period, no MRSA screening was performed routinely except for 
patients admitted to "high-risk" units (intensive care, renal/urology, or 
hematology) or for selected elective orthopedic and cardiothoracic surgi-
cal procedures. A program of screening all surgical patients for MRSA 
colonization at th~ preadmission clinic and/or on admission to three gen-
eral surgical wards was introduced in August 2010. Body sites screened 
were the nose, groin, and axillae, with the addition of wound or ulcer 
swabs where applicable. Swabs were pooled and examined for MRSA us-
ing the Staphyloccx:cus 4 rev I nucleic acid detection method (AusDiag-
nostics, Alexandria, Australia), with positiv~ samples confirmed by cul-
ture on Brilliance MRSA agar (Oxoid, Basingsroke, United Kingdom). 
Patients found to be colonized with MRSA were isolated in single rooms 
with contact precautions. 
Isolat~ collections used in d~vdopment and assessment of the typ· 
ing m~thod. (i) Reference isolates. Forty-two well-characteriud epide-
miologically unrelated MRSA reference isolates representing the domi· 
nant hospital· and community-associated clones in Australia and a 
number of important international clones were used; this collection has 
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been described in detail elsewhere (2, 3, 13) and includes two MRSA 
isolates with published whole-genome sequences (COL and MW2). 
(ii) Clinical isolates. Ninety-nine unselected MRSA clinical isolates 
from patients at two tertiary referral hospitals in Sydney between 2005 and 
2008 were included. 
(iii) Historical isolates. Twenty-four historical MRSA isolates col-
lected from patients at various Sydney hospitals from 1984 to 1997 were 
used. 
(iv) Stability isolates. Eight-one isolate pairs, each collected from in-
dividual patients at intervals of I month to 3 years, were used to assess in 
vivo stability; only pairs for which both isolates belonged to the same 
multilocus sequence type (MLST) were included. 
(v) Surveillance isolates. The first MRSA isolates from all colonized or 
infected patients admitted to the three general surgical wards were col-
lected over a 12-month period from November 2009 to October 2010. 
Since patients transferred into these wards may have had contact with 
colonized patients in other surgical wards prior to transfer to the general 
surgical ward, isolates were also collected from patients in these wards for 
the duration of the study. A total of 273 isolates from surgical patients 
were collected, s tored at - 80"C, and analyzed retrospectively. 
Selection of targets. The method used for selection of targets has 
been described in detail elsewhere (M. V. O 'Sullivan, V. Sintchenko, 
and G. L. Gilbert, submitted for publication). Briefly, the most dis-
crimindtory subset of 19 targets was selected from 51 used in three 
previously described mPCRIRLB binary typing assays for toxin genes 
(J), phage-derived open reading frame (PDORF) sequences (13), and 
SCCme.c subtypes (2), u sing typing results of the three assays for 165 
MRSA isolates (the reference isolates, clinical isolates, and historical 
isolates). This was achieved using specially developed software, 
AuSeTIS (available at hnp://www.cidmpublichealth.org/pages/ausetts 
.html) . This program systematically calculates Simpson's index of diver-
sity (D) for different combinations of genetic targets and identifies the 
most informative combination. A table outlining the 19 targets selected 
for the current binary typing assay is presented in the supplemental ma-
terial. 
A uSe 'ITS was also used todetermineconcordance of the binary typing 
result with MLST using a subset of 153 isolates for which the sequence 
types (STs) had been determined by standard (5) or single nucleotide 
polymorphism {SNP)-based (9) methods. Concordance was measured 
using the adjusted Wallace coefficient (AW), which estimates the proba-
bility that any two isolates that are the same using the binaty typing 
method will also be the same using MLST ( 17). The correlation between 
binary types and MLST was subsequent!)' utilized to predict MLST results 
for the "surveillance" isolates. 
mPCR/RLB. The primers and probes used in this study are listed in the 
supplemental material. We used previously published primers and probes 
(2, 3, 13), modified as necessary to avoid primer dimer formation and to 
produce amplicons of 100 to 200 bp which gave strong probe signals. Each 
target was represented by two probes on the membrane; nuc and mecA 
probes were used as controls. A positive-control panel, consisting of a 
combination of reference isolates (mu3, COL, E804531, 14176-5710, 
SJOG30, RDH81, and NCTC8325) known to give positive signals for al l 
probes, and a DNA-free negative control were tested with each run. 
DNA was extracted by suspending one colony of a 24-h growth of each 
isolate in 400 1'-1 of molecular-grade water, which was boiled at IOO"C for 
10 min, frozen at -20"C, thawed, and centrifuged fo r 5 minatl 6,100 X g. 
The supernatant was then used as a template in PC Rs. Multiplex PCR was 
performed in a single tube using all 61 primers, each at a concentration of 
0.25 J.I-M, with 3.5 mM MgCl,, 0.2 mM deoxynucleoside triphosphates 
(dNTPs), I X PCRbuffer, and 0.03 U/jl.l HotStarTaq polymerase ( Qiagen, 
Victoria, Australia). Two microliters of DNA template was used in each 
30- IJ.I reaction mixture. Cycling conditions were 95°C for 10 min of pre-
heating and 35 c-ydes of94°C for 30s, ss•c for 30s, and n•c for 60s, with 
a final extension at n·c for 10 min. 
RLB membrane preparation, probe hybridization, and product detec-
JS14 jcm.asm.org 
tion were performed as previously described (2, 3, 10, 13, 14 ). A probe 
signal was interpreted as positive if it was at least as strong as the control 
probe for that target. A probe signal was interpreted as weak if the signal 
was present but weaker than the control probe signal. Negative probes had 
no signal. A target was interpreted as being present if at leaSt one strong 
probe signal or two weak probe signals were present for that target. The 
result for a target thai. was identified as present was assigned a value o f I, an 
absent target was assigned a value o f 0, and the result fo r all targets was 
concatenated into a 19-digit binary number, wh ich was converted to a 
decimal number for ease of comparison. Isolates were said to be indistin-
guishable if the targets detected were the same, while the significance of a 
one-target difference between isolates was further investigated. 
Other typing methods. Pulse-field gel electrophoresis (PFGE) was 
performed according to the Harmony protocol ( 12). Interpretatio n was 
conducted using the software program Bionumerics v3.0 (Applied Maths, 
Sint-Martens-Latem, Belgium) with a position tolerance set at 2% and 
change toward the end of the fingerprint of 0.5%. Similarity was calcu-
lated using the Dice coefficient, and clustering was performed using the 
unweighted pair group method with arithmetic means. PDORF typing 
and spa sequence typing were performed and interpreted as previously 
described (3, 13). 
Data analysis. Simpson's index of diversity, D (8}, and 95% confi-
dence intervals (6) were calculated for all typing methods using the 42 
epidemiologically unrelated reference isolates. In vivo stability o f the 19 
selected targets was determined and compared with spa sequence typing, 
PDORF typing, and PFGE using the 81 pairs of stability isolates, In addi-
tion to the standard measurement of stability as the proportion of pairs 
which exhibited no change between isolates (19), stability was also mea-
sured as the probability of n o change in type at 6 months as determined by 
Kaplan-Meier survival analysis (14a}. Typing of the 42 reference isolates 
was repeated twice, with separate hybridization membranes and using 
DNA extracted on two occasions to test the reproducibility of the method. 
Reproducibility was expressed as the percentage of all isolates tested that 
had the same strain type on repeat testing (19). 
Identification oftransmission events. The utility of the binary typing 
method for detection of n osocomial transmission events was tested using 
isolates obtained from patients in the three general surgical wards. Pa-
tients were classified as "known carriers" (MRSA first isolated p rior to or 
within 48 h of current hospital admission), having "possible nosocomial 
acquisition" (MRSA first isolated at > 48 h after admission but with no 
previous negative MRSA screen), or having "definite nosocomial acquisi-
tion" (MRSA first isolated at > 48 h after admission with a previous neg-
ative MRSA screen in the same admission). The "window period" during 
which acquisition was assumed to have occurred was defined as the inter-
val between the last negative MRSA screen or admission, if there was no 
previous M RSA screen, and the time of first MRSA isolation. A suspected 
nosocomial MRSA transmission event was recorded when a patient with 
possible or definite nosocomial acquisition was in the same ward, during 
the window period, as one or more other patients with the same MRSA 
binary type, who were either known carriers or also in the window period 
at the time. These patients, who were possible sources of MRSA acquisi-
tion, were classified as "contacts" of the index case. 
RESULTS 
Binary assay performance. The results of comparison with other 
typing methods are shown in Fig. I and Table I. Based on testing 
of 42 epidemio logically unrelated MRSA isolates (isolate group i), 
the discriminatory power of binary typing was similar to that o f 
PFGE and PDORF typing but higher than that o f spa typing and 
MLST. In five cases, isolates with indistinguishable PFGE patterns 
could be resolved into different binary types, m ostly differing by one 
target (Fig. I ). Binary typing showed excellent concordance with 
MISf (AW, 0.993; 95% confidence interval [CI], 0.986 to 1.000). 
Two isolates with the same binary type belonged to different MIST 
types, which were MLST single-locus variants differing by a single 
Journal of Clinical Microbiology 
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FIG I Typing results for the 42 reference isolates. Clustering is based on PFGE pattern. A black rectangle represents detection of the relevant b inary typing target by 
mPCRIRLB. 
TABLE I Measures o f discriminato ry power and stability of typing 
methods assessed based o n typing o f 42 reference MRSA isolates (used 
to calculateD and no. o f types) and 81 pairs o f stability isolates 
Method 
MRSA binary 
t)'IJing 
PFGE 
PDORF 
spa typing 
MLST 
D(95%Cl)" 
0.994 (0.988-1.00) 
0.987 (0.977-{).998) 
0.971 (0.945-{).997) 
0.926 (0.879-{).972) 
0.882 (0.823-{).941 ) 
" D, Simpson's index of diversity. 
llo Concordant results within pairs. 
c Probability of .same rt.Sult at 6 months. 
No. (%) %probability 
No. of of pairs of no change' 
types unchanged• (95% Cl) 
37 
33 
30 
22 
IS 
57 (70) 68 (53- 79) 
50 (62) 
64 (79) 
78 (96) 
NAd 
58 (43-70) 
71 (55-82) 
95 (82-99) 
NA 
• NA, not analyzed; pairs which differed by MLST donal complex were excluded from 
tht analysis of in vi¥0 stability because these were assumed to rtprestnt rtinfcction. 
November 2012 Volume SO Number 11 
point mutation (ST239 and ST\28). Otherwise, all isolates with the 
same binary type also had the same MLST, indicating that binary 
typing may be useful for predicting MLST (but not vice versa). 
The in vivo stability of binary typing at 6 months was similar to 
that of PFGE and PDORF typing but lower than that of spa typing 
(Table l and Fig. 2). Sixteen of the twenty-four pairs for which the 
binary type changed were different by only one target. All methods 
had 100% typeability, and reproducibility of binary typing was 
100%. 
Nearly 5% of probe pairs among the 5,187 surveyed for the 273 
surveillance isolates gave a strong result for one probe and a neg-
ative result for the second probe. This has previously been found 
to be due to polymorphisms in one of the probe binding sites ( 13). 
Identification of nosocomial transmission even ts. The 273 
isolates from all surgical patients belonged to 55 binary types, of 
which 34 were represented by single isolates. There were 125 pre-
viously known MRSA carriers, whose isolates belonged to 45 bi-
jcm.asm.org J 5 15 
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nary types of which 25 were singletons. Isolates from 88 patients 
with definite, and 60 with possible, nosocomial acquisition be-
longed to 12 and 24 binary types, respectively. The distributions of 
binary types and predicted ST s are shown in Fig. 3. The majority of 
patients with possible or definite nosocomial acquisition had bi-
nary types that correlated with ST239 or ST22 (also known as 
AUS2/3 and UK-EMRSA 15, respectively), which are the two most 
common nosocomial MRSA clones in Australia. Three of those 
with definite nosocomial acquisition had binary types consistent 
with ST93, or the Queensland clone, a major community-associ-
ated strain prevalent in eastern Australia, which carries the Pan-
ton-Valentine leukocidin (PVL). 
When analysis was restricted to patients who may have ac-
quired MRSA while admitted in one of the three general surgical 
wards, there were 58 definite and 29 possible incidents of nosoco-
mial acquisition over the 1-year period of the study. Based on 
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MRSAcarriage data only, all but 2 of the 87 patients who acquired 
MRSA had possible contact with at least I other MRSA carrier who 
was in the same ward during their window period. The number of 
contacts per episode of nosocomial acquisition ranged from I to 
26 (median, 9); the total number of possible contacts for all 87 
episodes was 859 (since 1 patient could be a contact for many cases 
of nosocomial acquisition). However, when binary typing results 
were used to define MRSA contacts, 69 (50 of 58 definite and 19 of 
29 possible n osocomial acquisitions) cases were found to have had 
contact with at least 1 patient colonized with the same strain of 
MRSA during the window period. The number of strain-matched 
contacts per episode of nosocomial acquisition ranged from I to 
11 (median, 2); there were a total of 212 contacts. Binary typing 
therefore excluded 647 potential MRSA contacts. Figure 4 illus-
trates the application of binary typing to identifY the source con-
tact for one patient, with definite nosocomial MRSA acquisition. 
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FIG 3 Distribution of 55 binary types among 273 surgical isolates. PVL. Panton-Valentine leukocidin. MLST was predicttd based on the binary typing result. 
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FIG 4 Case study of binary typing to identifY MRSA contacts. Contacts were patients in the same ward as the index case during the latter 's window period 
(interval between last negative screen and first MRSA isolate). The figure at the right indicates a timdine during which potential contact with the index case 
occurred. Only contact I carried MRSA with the same binary type the index case. Contam 2 through I 9 were excluded as potential sources on the basis of binary 
typing. 
Of 18 incidents of possible or definite nosocomial acquisition, for 
which no contact with an identical strain type was identified, 4 had 
had contact with patients colonized with single-locus variants. 
The temporal distribution of nosocomial transmission events in 
the general surgical wards by binary type is shown in Fig. 5. 
DISCUSSION 
PFGE has long been considered the gold standard for MRSA typ-
ing to identify nosocomial transmission events. However, it is la-
bor-intensive and difficult to standardize between laboratories. 
spa sequence typing has advantages over PFGE, including faster 
turnaround time and lower cost; the sequence-based output 
makes interrun and interlaboratory comparisons straightforward. 
It has been used prospectively to identify nosocomial transmission 
events (II ). However, in some settings, including our own, its 
discriminatory power is inadequate to identify strains within the 
major nosocomial MRSA clones. For example, the majority of 
nosocomial MRSA isolates at our hospital belong to ST239-
SCCmec- III, and almost all of these harbor spa type t037 at our 
institution. 
Binary typing using mPCRJRLB has a number of favorable 
November 2012 Volume 50 Number 11 
characteristics for a typing method. It is inexpensive (consum-
ables, approximately US$2 per isolate) and does not require highly 
specialized equipment or sequencing. The total turnaround time 
is approximately 10 h (including 4 h of hands-on time for DNA 
extraction, multiplex PCR, probe hybridization, and product de-
tection ). Up to 42 isolates can be typed on a single membrane 
(including controls) , and multiple membranes can be processed 
simultaneously. It is highly reproducible, and the results, ex-
pressed in a numerical format, are portable. 
We have previously developed mPCRJRLB-based MRSA bi-
nary typing assays for toxin gene profiling, SCCmec subtyping, 
and PDORF typing (2, 3, 13). The strain-to-strain variability of 
some of the targets used in these assays was exploited to produce 
the final binary typing method described in this article, resulting 
in a combined discriminatory power which is similar to that of 
PFGE. 
Methods for binary typing of MRSA, using a variety of targets 
and platforms, have been published previously. van Leeuwen eta!. 
visually identified IS discriminatory amplicons from randomly 
amplified polymorphic DNA analysis, determined their se-
quences, and used them as the basis for a highly discriminatory 
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FIG 5 Temporal distribution of no.socomial acquisition events in the three general surgical wards. The top line indicates all 87 definite o r possible transmission 
events, regardless of MRSA type. Subsequent lines show transmission events for individual MRSA types, for which more than o ne transmission event occurred 
in the 12-month period. 
binary typing system using Southern blotting of EcoRl-ctigested 
genomic DNA (2 1, 22). The mPCR-RLB method for binary typing 
in the present study has the potential advantage of higher speci-
ficity, due to PCR amplification of the binary targets with specific 
primers, prior to probe hybridization, using two DNA probes ~r 
binary target. DNA preparation using the current method is also 
more straightforward, and targets were chosen systematically {us-
ing a computer algorithm comparing all possible combinations 
rather than simple visual inspection). The inclusion of a gene en-
coding PVL in the mPCR-RLB-based assay allows identification of 
an important virulence factor. 
Binary typing targeting five discriminatory targets, combined 
with detection of seven informative SNPs from housekeeping 
genes, which can be used to infer MLST clonal complex, has also 
been described using various platforms, including allele-specific 
PCR and matrix-assisted laser desorption-ionization time-of-
flight (MALDI-TOF) mass spectroscopy, using the Sequenom 
MassARRAY iPLEX platform (9, 18, 20). This approach has the 
advantage of providing more direct inference of the MLST donal 
complex but would be expected to have lower discriminatory 
power, lower throughput, and higher cost than the 19-target bi-
nary system presented in the current study. MALDI-TOF mass 
3518 j cm.a>m.org 
spectroscopy of bacterial protein components has also been used 
for typing of MRSA ( 16) but has limited discriminatory power. 
PCR ribotyping is another r apid-PCR-based typing method, 
based on amplicon size variation of the multicopy 165-235 rRNA 
gene spacer region, which has been applied to Staphylococws au-
reus, using both gel electrophoresis ( 4) and capillary electropho-
resis { I ) platforms. Capillary electrophoresis allows very accurate 
size determination and identification of the presence or absence of 
alleles of known sizes, so results can be presented in a binary for-
mat. While this method has good discriminatory power for all 
Staphylococcus aureus isolates, it has lower ability than PFGE to 
discriminate between isolates ofMRSA (4). 
Measurement of stability of a new typing method is important, 
particularly when the targets interrogated include mobile genetic 
elements, or MGEs, (such as those located on integrated pro-
phages}, in order to establish interpretive criteria for relatedness 
of strains. While it can be difficult to exclude colonization with a 
second strain when collecting multiple samples over time, we feel 
that in vivo stability measures, using sequential isolates, are pref-
erable to in vitro p assages, in which conditions are unlikely to 
mimic those that promote mobilization of MGEs in vivo. Exclu-
sion ofisolate pairs which differed by MLST clonal complex would 
Journal of Clinocal Mkro btology 
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have eliminated many cases of colonization with a second strffin, 
but it is possible that some of the isolate pairs still represent this 
scenario. Nevertheless, the analysis suggests that the stability of the 
binary typing method was similar to that of PFGE and therefore 
suitable for studying short-term epidemiology, applicable to iden-
tifying nosocomial transmission events. 
The high concordance with MLST suggests that the method is 
also sufficiently stable to predict longer-term epidemiology, not-
withstanding minor changes that occurred over time. While bi-
nary types correlated well with MLSTs in this study, the binary 
targets are independent of the housekeeping genes utilized in 
MLST, and concordance may not always hold. Further concor-
dance stud ies with a larger collection of samples from a wider 
range ofMLSTs are needed to explore this further. in vivo stability 
analysis showed that in most isolate pairs in which the binary type 
changed, the difference was at a single locus. Likewise, there were 
fo ur cases of nosocomial acquisition, in which there were no other 
patients with identical strains in the same ward at the same time, 
but there were patients colonized with single-locus variants in the 
vicinity, suggesting that the latter can be interpreted as possibly 
related for the purpose of outbreak investigation. 
While direct contact with contaminated environmental sur-
faces and the hands of health care workers is the main mode of 
acquisitio n of MRSA, these surfaces become con taminated from 
other colonized patients and health care workers. The novel bi-
nary typing method presented here was highly effective in exdud-
ing potential contact patients as nosocomial sources of MRSA 
acquisition; for the 87 possible or definite acquisition events stud-
ied, 859 potential source contacts (median, 9) were reduced to 212 
potential source contacts (median, 2). Sources of transmission 
were not found using molecular typing in 18 of 87 (21%) cases. 
Possible explanations include contact with MRSA-colonized pa-
tients, lack of identification due to a false-negative o r missed 
screening, contact with colonized staff (who were not screened), 
or environmental contamination. 
The method described in this study was designed to distinguish 
between strains of MRSA. The discriminatory power when ap-
plied to methicillin-susceptible isolates ofS. au reus (MSSA) would 
be expected to be lower, since six of the targets are found on the 
SCCmec element. However, the principles of binary typing using 
mPCR/RLB could be applied to MSSA, and indeed to a wide range 
of pathogens, with careful species-specific target selection. 
In conclusion, binary typing of MRSA using mPCRIRLB can 
assist in the identification and monitoring of nosocomial transmis-
sion events in high-prevalence settings. This has the potential to en-
hance surveillance ofhospital-acquired infection and enable prompt, 
targeted infection control interventions. Further studies evaluating 
the impact of prospective typing, including rapid feedback of results, 
on MRSA acquisition and infection rates are in progress. 
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SUPPLEMENTARY TABLE 
Reference 
Group Target Oligo Name Sequence Genbank Reference 
Accession 
nucSb 511-GCGATTGATGGTGATACGGTT ·531 V01281 (2) n 
nucA~ 558-CATTGGTTGACCTITGTACATTAA-535 V01281 (2) J Cl) 
nuc 
nucSp 7 45-GATGGAAAAATGGT AAACGAAG-766 V01281 (2) '0 ~ I'D 
nucAb 789-AGCCAAGCCTTGACGAACTAAAGC-766 V01281 (2) ~ Controls ..... 
mecAP4b 1190-TCCAGATT ACAACITCACCAGG-1211 Y00688 (3) .. , 
mecAAp 1264-CTAATGITITGITATITAACCCAATCAT-1237 Y00688 This study ~ 
mecA 0 Ill 
mecASp 1288-GATGGT AAAGGTTGGCAAAAA-1308 Y00688 This study '0 
I'D 
mecAP7b 1357-CATITACCACTTCATATCTTGTAACG-1332 Y00688 (3) n ,.. 
seaSb 487 -CCTTTGGAAACGGTT AAAACG-507 M18970 (2) ;::· I'D 
I'V seaSp 531-GGAGTTGGATCTTCAAGCAAGACG-554 M 18970 (2) (JQ I'V 1'1) 
I'V sea seaAp 613-TCTGAACCTTCCCA TCAAAAAC-592 M18970 (2) ::I 0 
seaAb 691· TTGA ATACTGTCCTTGAGCACC-670 M18970 (2) ~ < 
'0 
secSb 814-GATAAGTITGACCAATCTAAATATITAATG-843 X05815 This study ::I 
secAp 866-ACCGITITA TTGTCGTTGTACA T-844 X05815 This study OQ 0 sec 
secSp 889-GAAGTCCACCTTACAACAAAGAA T -912 X05815 This study ..... J 
secAb 935-TCAAAATCGGATTAACATTATCC-913 X05815 (2) 0 Toxin Genes Ill 
sedSb 332-CTAGTITGGTAATATCTCCTTTAAACG-358 M28521 (2) '0 ;::;: 
This study 
Ill 
sed sedAp 384-TGAA TCAA TGTTTTCA TTGGC-364 M28521 d. sedS~ 385-GTAAAAGAGAAAGAATTGCATAAAAAAT-412 M28521 This study n 
.c 
sedAb 462-ATCTGCATAAGAATGTITCATATTATITAG-433 M28521 This study 1:: :::;· 
pviSb 2651-TTTT AGGCTCAAGACAAAGCAAC-26 73 X72700 (2) I'D c.. 
lukS-PVL pviAp 2731-TACCTCTGGATAACACTGGCATTTT-2707 X72700 (2) s:: ~viSp 2733-CITCAA TCCAGAA TIT ATTGGTGT-2756 X72700 (2) 
"' VI pviAb 2783-TTTGCAGCGTTTTGTTTTCG-2764 X72700 (2) l> 
1:: 
N0465b 2031-TGCITCAA TITCCACTCTCG-2012 X03216 This study Ill Phage-derived open reading :r 
Tn554tnpB N046Ap 1987 -CAAGTTCAGAGAGT ACACCAA IT AA-2011 X03216 This study OQ frames c-
N046Sp 1948-GTCITTGGGCAA TATCACIT ACA TA-1924 X03216 This study_ s· 
Ill 
< 
~ 
< 
'0 
:r 
OQ 
N046Ab 1904-TGAACGTGGATAGCTTTTCC-1923 X03216 This study 
SAV0881Sb 932269-TGCTIGTIGTCATATCGCC-932287 BA000017 (3) 
Q>Mu50B SAV0881 SAV0881Ap 932316-TGTTTTGGT AACT AGCCACTGT AT AGAT A-93 2288 BA000017 (3) SAV0881Sp 932418-TCAAA TTTCTITTTGAA T AGT AAGTCAGA-932446 BA000017 (3) 
SAV0881Ab 932468-CCTAGCTIGT ATGTCTGCGCT A-93244 7 BA000017 (3) 
PV830RF2Sb 1269-GGCGCTICTICTI ACAGGAG-1288 AB044554 (3) 
PV830RF2Ap 1323-CATTGTTAGATATTTATATGGTATGTAACCTAAAA-1289 AB044554 (3) n '::F 
(3) Ql PV830RF2An 1356-GATAATCTTGTTTTTnCACTAACTAAACCTAT-1324 AB044554 "'C Q>PV83 ORF 2 ..... PV830RF2Sn 1625-TGTTT AA T AACAACGGT AAACCAGT A TTT -1653 AB044554 (3) Ill .., 
PV830RF2Sp 1654-ATAGTIATIAAAGACTTTGAAAACAGAATCATT-1686 AB044554 (3) ..... 
PV830RF2Ab 1715-GAA TT ATAGGTTTTAAGTICACCCTCTTC-1687 AB044554 (3) "'C .., 
SAV0858Sb 6334-ATCT AAA TIGCCTGTCGAAGC-6314 AP001553 (3) 0 Ill 
"'C 
SAV0858Ap 6294-TA TTTGCGGCTTT AGCGT AA-6313 AP001553 (3) Ill n 
SAV0858An 6266-GCGTTCA T AACA T ACGAA TT A TICAT -6291 AP001553 This study .... Q>Mu50B SAV0858 :;::· SAV0858Sn 6084-GAAGTCCGCAAAGTT AGCACT -6064 AP001553 This study Ill 
N OQ 
N SAV0858Sp 6063-CA TTTGAGAAAGTCTTTTGTCGA TACT -603 7 AP001553 (3) Ill w :::1 
SAV0858Ab 6017 -CCAAGAACAGGGACA TCGAC-6036 AP001553 (3) 0 ..... 
< phill-4563Sb 4563-GAT A TGCAAGA TCAGACAA TGCC-4585 AF424781 (3) "'C 
phill-4610Ap 4610-CCTCGCT ATCAACATGA TTTCT AA T -4586 AF424781 (3) :;· OQ 
phi 11-4632An 4632-CTAAATTGGTGCGTCAGTTTGT-4611 AF424781 (3) 0 Q>ll nt 4427-5251 -phi11-5026Sn 5026-CAAACT ACT ACACGAAGCT AGACTACAAC-5054 AF424781 (3) =r-0 
phill-5055Sp 5055-GAAAAGT AAA T AAACAGTGGGTGCTTT A-5082 AF424781 . (3) Ill "'C 
phi11-5103Ab 5103-CTmGCCCATGTGTICTGAG-5083 AF424781 (3) ;:::;: ~ 
Sl Torf257Sb 26802-GTGTT ATCGCT ATGAGTGGTGAC-2 6824 EF462198 (3) !lJ 
n 
SLTorf257Ap 26855-TTAAAAAACTATITTTGTGCATAAAAATAGT-26825 EF462198 (3) .0 s::: 
SLTorf257An 26880-GTCATAACCCATGAATTATGAATCA-26856 EF462198 This study ::;· Q>SLT ORF257 Ill SLTorf257Sn 27065-TT AGGAGCT AA TGAAA TAG CTGCT AGT A-27092 EF462198 This study c.. 
Sl Torf257Sp 27093-TCTCTAAAGAGCAATATAAGCGTTTC-27118 EF462198 (3) s: ;:~;) 
SLTorf257Ab 27142-CTTT AAATCTTCTGGGACGTTCTC-27119 EF462198 (3) Vl l> 
SA1801Ab 5235-CAATCAGCGGTCGAGAACT-5253 EF462197 (3) s::: 
., 
Q>N315 SA1801 SA1801Ap 5279-GAGTm AACCTCT AA TGCTTGATGA-5254 EF462197 (3) 
:;· 
OQ 
SA1801An 5305-CATTCTTTCAAACCATTTTTTGTATG-5280 EF462197 (3) 2: 
SA1801Sn 5687-CGCAGA TTGTTTGAGTGGTT A-5707 EF462197 (3) ::I Ill 
< 
..... 
< 
"'C 
:;· 
OQ 
SA1801Sp 5708-CGTCAAAACGGA TTCCTT A TT AAA-5731 EF462197 (3) 
SA1801Ab 5751-TTATAATCCACACCCTTGCG-5732 EF462197 (3) 
SAV1974Sb 2110912-GCCACAAGAAAAGGCAGTG-2110894 BA000017 (3) 
<flMuSOA 
SAV1974Ap 2110869--TGCTT ACAGCTACATCTGTTTIGAT ·2110893 BA000017 (3) 
SAV1974 SAV1974An 2110813-CGTTTIACTACTTACACCACTACGG-2110837 BA000017 This study 
SAV1974Sp 2110719-GAT A TGAGT AACTTTGGTCGGAGTC-2110695 BA000017 (3) 
SAV1974Ab 2110673-ATACTTTCCATCTATCCCAGCAG-2110694 BA000017 (3) () =r 
Ql 
SL Torf182Sb 1080396-CA TT AAAGGTT ATATCAAGGTTTT AGAGG-1080424 CP000736 This study "0 
... 
SL Torf182Ae 1080460-CTTCAAAGAAATTATGACTACTCAATTTTG-1080431 CP000736 This study ., IPSLT ORF 182 
.., 
SLTorf182Sp 1080493-CAACCTTGTT ACCT ACT AACCAAAAA-1080518 CP000736 (3) ...., 
SLTorf182Ab 1080540-GTTTGCT ACT A TGTCGCAACCT ·1080519 CP000736 (3) "'0 .., 
0 
lSb 24838-CAATCAAAACCTATATCATCAATCAGTACG-24867 AB033763 (1) "' "0 
ccrA1Ap 24890-TGGAAAGCTTTTCGAATTTGAT -24869 AB033763 (1) ., !4. 
ccrAB 1An 24944-TCATCAATATAGGGGTACAACATGTT-24911 
AB033763 (1) c:· 
(1) 
., 
N lklSn 25421-CAGGCAAGTT AA TGCTCCAG· 25440 AB033763 (IQ 
N ccrB1Sp 25497 ·CGGACAACGTCAAAGAG C-25514 AB033763 (1} ., ~ ::I 
l3cAb 25539-A TTGCCTTGA T AA TAGCC· 25522 AB033763 This study 0 ... < 
FSb 16318-AAACGTCTATTACAAGATGTTAAGGATAAT-16347 AB121219 (1) "2. 
::I 
ccrCAe 16375-ATTTCCAACTTAATACCATTTCGATT-16350 AB121219 (1) QQ 
Ran 16430-TTGAATTCATGAATAATATTAAACACGT-16403 AB121219 (1) 0 
-cere FaSn 167 41-ACGACAA TTCT AAA TCAAAAAGGA-16764 AB121219 (1) =r 0 
"' ccrCSp 16792-TCAGTGTTTGGCGTGAAAT-16810 AB121219 (1) "0SCCmec elements 
AB121219 ' 
;::+' 
RAb 16838-GCCTTT AT AGACTGGA TT A TTCAAAA TA-16812 (1) Ql 
mi6Sb 42866-CA T AACTTCCCA TTCTG CAGATG-42888 086934 (1) ~ n 
42924-GAGTTAATATAATGGATAATAAAACGTATGAAAT- ..c 
mecR1Ap 086934 (1) 1:: 
mecRl 42891 :; ., 
mecR1Sp 42927-TTTCTTTTAAAA TACGCTCAGAAA TTT -42953 086934 This study c.. 
mA7Ab 42971-ATGGCGAAAAAGCACAAC-42954 086934 (1} s: ;%1 
1a3Sb 5277 • TTTI AGGAGGT AA TCTCCTTGA TG· 5300 AB033763 (1} VI )> 
E007Ap 5328-TTTATAACATTGTCCTCTTTACCTTCAG-5301 AB033763 (1} c: E007 "' E007Sp 5387-AA T AAGCAT ACA TGGAGACGTTTT -5410 AB033763 (1) s· (IQ 
1a4Ab 5431-TTTTGCGTTTGCATCTCTACC-5411 AB033763 (1) g: 
CQ002 4a1Sb 4726-TTTGAATGCCCTCCATGAATAAAAT-4750 AB063172 (1) :J I» 
< ,... 
< 
"2. 
::I 
QQ 
N 
N 
V"l 
CQ002Ap 4777-CGGGTAATATGAGAATAAATAAAGAAG-4751 AB063172 (1) 
4a1An 4844-GCGTATIATGATACTAAGCAAAGTATIAAAATAG-4811 AB063172 (1) 
4a3Sn 5079-TIGAAA TCCTGGGAA TCT A TCACT-5102 AB063172 (1) 
CQ002Sp 5133-ACATGCTGTAGTCATTITATACTGTITG-5160 AB063172 (1) 
4a3Ab 5183-AGCATATAGAAAAGATAGAAGTICGAAAGA-5161 AB063172 (1) 
cad4Sb 16107 -A TIGCGA TICTTICCGAT ATGG-16128 AB037671 (1) 
cadBAp 16156-CTATITAATGCTACCAAAATAGTGGCTC-16129 AB037671 (1) 
cad4An 16213-TICCGT AAA TIGCACACATATAGTACTI ·16186 AB037671 (1) 
cadB 
mN55n 17537-CCCTCCCATATATATAACAAGTTTAGGA-17564 AB037671 (1) 
Z023Sp 17594-TGATCCACTAAGTGTACTGAAAAATACTIG-17623 AB037671 (1) 
mN5Ab 17646-TIGCTICGGGACTIACCTCTAGT ·17624 AB037671 (1) 
Supplementary Table. Oligonucleotides used in the study. Oligonucleotides ending in b are biotinylated primers, those ending in p are 
amine-labelled probes and those ending inn are unlabelled primers. Unlabelled oligonucleotides were used as internal primers for targets where 
the amplicon would otherwise be greater than 200bp (amplicons larger than this lead to weak probe signals). A: antisense, S: Sense. Numbers 
flanking the sequence indicate the location of the primer on the Genbank reference sequence. 
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8.1 Introductory comments 
In 2011, routine prospective typing of MRSA isolates at our hospital was introduced, 
using the novel binary typing method described in chapter 7. During this time, two 
lethal cases of MRSA infection were observed in the neonatal intensive care unit at 
our hospital, prompting enhanced surveillance and infection control measures. 
8.2 Aims 
The aim of this study is to describe the subsequent outbreak of MRSA infection and 
colonisation that occurred in the NICU, and to demonstrate the utility of the novel 
binary typing method in identifying the outbreak, identifying cases which were not 
part of the outbreak, and helping to direct the infection control interventions which 
ultimately halted transmission of this emergent clone of MRSA. 
8.3 Publication: Emergence and control of an outbreak of infections 
due to Panton-Valentine leukocidin positive, STZZ methicillin-
resistant Staphylococcus au reus in a neonatal intensive care unit 
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ORIGINAL ARTICLE 
Emergence and control of an outbreak of infections due to 
Panton-Valentine leukocidin positive, ST22 methicillin-resistant 
Staphylococcus aureus in a neonatal intensive care unit 
A. N. Pinto', R. Seth1 , F. Zhou 1, J Ta llon•, K. Dempsey•, M. Tracf•5 , G. L. Gilbert'·'·• and M. V. N. O'Sullivan'·' 
I) Centre for InfectiOUs DISeases and MICroboology, Westmead Hospttol, Sydney, 2) Centre for Newborn Care, Westmeod Hospital, Sydney, 
3) Sydney Emergmg lnf«tJJns and &osecunty lnstJtute, Untvemty of Sydney, 4) lnf«tJJn PreW!ntJon and Control Unit, Westmeod Hospital, Sydney and 
5) Deportment of PoediO!n<$ and Chold Health, Unoversny of Sydney, Sydney, Australia 
Abstract 
Methicillin resistant Staphylococcus oureus (MRSA) Infection can cause significant morbidity and mortality in neonates. We investigated a 
nosocomial MRSA outbreak in a neonatal intensive care unit (NICU), using a novel typing method. Following two fatal cases, in May 
20 I I. a prospective outbreak Investigation was conducted, involving neonates, mothers and healthcare workers in a large tertiary NICU 
in Sydney. MRSA isolates were characterized by antimicrobial susceptibility testing, a multiplex PCR-based reverse line blot (mPCRIRLB} 
binary typing system and other molecular typing methods. Over 7 months, I 4 neonates were colonized with MRSA and six infected: 
three with superficial lesions and three with life-threatening disease, including the two index cases, who died despite empirical treat· 
ment with vancomycon. Isolates from IS neonates were indistinguishable by RLB typing and Identified as a PVL-producing ST22 SCCmec 
IV MRSA scrain, which was resistant to gentamicin and trimethoprim-sulphamethoxazole. The outbreak strain was also isolated from 
one healthcare worker, one envoronmental swab and one father, but the source remained obscure. During the same period several dif-
ferent non-multiresistant and multiresistant MRSA strains were Isolated from five neonates, fove mothers (includong two whose infants 
were colonized with the outbreak scrain). one father, three healthcare workers and two environmental swabs. Rapid turnaround time 
of typing results allowed us to recognize and define the outbreak and implement targeted infection control interventions. PVL-producing 
ST22 SCCmec IV MRSA appears to be a virulent and highly transmissible pathogen In the NICU, which was difficult to control. 
Keywor ds: Control, MRSA, NICU, outbreak, typing 
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This Is the first descripuon or an outbreak due to • rare clone or 
MRSA using a novel typong system. This hoghly doscromonatory method 
is lnexpensove, high throughput. has a turnaround time or 12 h, and 
enabled targeted infection control interventions. 
Introduction 
Methicillin-resistant Staphylococcus aureus {MRSA) has the 
potential to cause severe disease and sustained nosocomial 
outbreaks [ 1- 3] among premature infants in neonatal 
intensive care units (NICUs). Its early recognition is essen-
tial to prevent transmission and ensure optimal treatment 
[4]. 
The mother is often assumed to be the source of MRSA 
in a colonized neonate, but nosocomial transmission from 
fomites or via healthcare workers (HCWs) also occurs. 
Transmission routes can be identified with the aid of molec-
ular typing [3]. 
In May 20 I I, two extremely premature (26 weeks gesta· 
Cion) infants developed fulminant MRSA sepsis and died 
within a few days of each other. This paper describes the 
outbreak investigation, using a novel rapid MRSA strain· 
typing method. 
C lO ll The Authors 
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2 Oinical Microbiology and Infection 
Methods 
Design 
This was a prospective study in which infection control inter-
ventions were based upon molecular typing data available in 
real time. 
Setting 
Westmead Hospital is a 980-bed teaching hospital in Sydney, 
Australia, serving a population of 1.5 million; there are c. 
5500 deliveries annually. The 39-bed NICU comprises 19 
high acuity ventilator cots and 20 lower acuity special care 
cots; in 20 I I there were 1635 admissions, including over 
I 00 infants < I 500 grams birth weight; I 066 patients were 
admitted during the outbreak period { 18 May 20 I I to 23 
January 2012). The standard nurse/bed ratio is 1:1- 1:4, 
depending upon staffing levels and patient acuity. There are 
no single cot isolation rooms. 
Patients and c.ase definition 
Outbreak cases were defined by isolation of the MRSA out-
break strain from any culture during the outbreak period. In 
these infants, infection was defined by clinical and laboratory 
criteria and a requirement for antimicrobial therapy, and col-
onization by absence of relevant symptoms. 
Interventions 
MRSA surveillance. . Previously, there had been no routine 
MRSA screening in the NICU because MRSA infections were 
rare. After two index cases were identified {Fig. I), all neo-
nates and NICU staff were screened and, subsequently, neo-
nates were swabbed on admission and weekly thereafter. 
Because of ongoing MRSA acquisitions. NICU staff screening 
was repeated and extended to delivery room staff in Sep-
tember 20 II . Swabs were collected from the anterior nares, 
umbilicus {if moist) and perineum of neonates and anterior 
nares, only, of staff. Mothers of colonized or infected neo-
C 20 12 The Authof'S 
CMI 
nates were screened using nose, throat. perineal and low 
vaginal swabs. Frequently touched environmental surfaces, 
including door handles, trolleys, computer keyboards, ultra-
sound probes and arterial blood gas and X ray machines, 
were swabbed in May and September 20 II , using sterile, dry 
swabs, which were inoculated directly into broth {see 
below). 
Decolonizotion regimen .. MRSA-colonized HCWs were trea-
ted with mupirocin 2% nasal ointment three times a day and 
daily triclosan I% body wash for 5 days. 
Culture and strain typing 
Surveillance swabs from individual infants and mothers were 
inoculated, together, into a single tube of methicillin, aztreo-
nam, mannitol salt {MAMS) broth. Environmental swabs 
were inoculated directly into MAMS broth. Broths were 
incubated for 18 to 24 h at 35"C and subcultured onto 
chromogenic BrillianceTM MRSA selective media (Oxoid, 
Basingstoke, Hants, UK). Molecular methods were also 
employed for rapid detection, using the MRSA4 Easy-Piex 
assay kit {AusDiagnostics, Sydney, Australia), which targeted 
nuc, mecA and SCCmec-orfX; all positive samples were con-
firmed by culture. Pure cultures were stored in nutrient 
broth with 20% glycerol at - 70"C. Isolates were identified 
by routine laboratory methods [5), including antibiotic sus-
ceptibility testing performed by BD Phoenix Automated 
Microbiology System {Becton Dickinson, Sparks, MD, USA). 
Molecular typing studies 
Isolates were typed using a novel binary typing system for 
MRSA (O'Sullivan MV, Sintchenko V, Gilbert GL; personal 
communication). The 19 targets for this assay were chosen 
from 51 utilized in previous assays for toxin gene (6), phage-
derived open reading frame [7) and SCCmec typing [8). 
Results of these assays. using a diverse local and international 
collection of 165 MRSA isolates, were analysed by a specially 
designed computerized algorithm {AuSeTTS, available at 
FIG. I. Chest radiographs of Cases I and 2. 
(a) Case I: rapidly progressive necrotizing 
pneumonoa. (b) Case 2: overwhelming seps1s. 
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http://www.cidmph.org.au/pages/AuSe TTS) (O'Sullivan MV, 
Sintchenko V, Gilbert GL; submitted for publication) to iden-
t ify the combination of targets with the highest discrimina-
to ry power, while maintaining concordance with multilocus 
sequence typing (MLST). Targets selected were four toxin 
genes (sea, sec, sed and lukS-PV), nine derived from integrated 
prophages (T n554[tlp8, q~MuSOB SAV0881 , q~PV83 ORF 2, 
q~Mu50B SAV0858, q~ ll nt 4427-5251 , q~SLT ORF 257, 
q~N315 SAI801 , q~Mu50A SAVI974 and q~SLT ORF 182) and 
six SCCmec elements (ccrAB, ccrC, mecRI , E007, CQ002 and 
cadB) plus nuc (S. oureus control) and mecA (MRSA control). 
All targets were amplified in a single multiplex PCR reaction; 
products were hybridized to probes on a reusable nylon 
membrane and detected by chemiluminesence, visualized on 
X-ray film [9). Results were expressed as a 19-digit binary 
number, converted to a decimal code for ease of interpreta-
tion. The method's discriminatory power (Simpson's index of 
diversity, 0 = 0.994; 95% Cl, 0.988--1.00) was similar to that 
of PFGE (0 = 0.987; 95% Cl, 0.977-0.998) and higher than 
that of spa typing (0 = 0.926; 95% Cl, 0.879- 0.972) and its 
concordance with MLST was high (adjusted Wallace coeffi-
cient 0.993; 95% Cl, 0.986-1.000 [10)). The assay was per-
fo rmed weekly and, during the outbreak investigation, 
selected isolates from the NICU were further characterized. 
Pulse field gel electrophoresis (PFGE) was performed 
according to the harmony protocol [I I); patterns were 
examined using BION U MERICS v3.00 software (Applied Maths, 
Sint-Martens-Latem, Belgium). PFGE types were defined by 
indistinguishable patterns (I 00% similarity). spa typing [6] and 
MLST [12] were performed according to previously pub-
lished methods. SCCmec subtyping was performed using 
mPCRIRLB assay [8]; subtypes were assigned as proposed by 
Chongtrakool et al. [ 13). 
Results 
Between 18 May 20 II and 23 January 2012, 20 MRSA colo-
nized or infected neonates (including three sets of twins) 
were identified in the NICU (Fig. 2). Fifteen were outbreak 
cases, of whom four had MRSA infection: one each w ith 
purulent ear discharge and severe pneumonia and the two 
index cases, with fatal sepsis. 
Case I had rapidly progressive sepsis and necrotizing 
pneumonia, with pneumatocoeles. MRSA was isolated from 
tracheal aspirate and urine but not blood. Case 2 developed 
overwhelming sepsis, with MRSA in blood and CSF, 2 days 
after MRSA had been isolated from a nasal lesion. Both 
infants were treated empirically with vancomycin at the 
onset of symptoms and later with linezolid and/or clindamy-
cin. Clinical presentations and outcomes of all 20 cases (see 
below) are summarized in Table I. 
In May 20 I I, surveillance cultures were collected from 
138 NICU HCW; two (staff A and B) were colonized and 
successfully decolonized. In June 20 II, a bundle of enhanced 
infection control measures was implemented: MRSA-
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colonized infants were placed on contact precautions and co-
horted until discharge: and a unit-wide review of hand 
hygiene practices, staff education on 'S Moments of Hand 
Hygiene' (Fig. 2) and enhanced environmental cleaning of the 
MRSA-colonized patient rooms were implemented. 
Despite these measures, there was ongoing MRSA acquisi-
tion, including by three infants (twins and a singleton) who were 
positive on admission to the NICU, following Caesarean section 
delivery. Therefore, a second bundle of measures was imple-
mented in September 20 II . Additional or repeat MRSA screen-
ing of NICU staff was extended to staff in the delivery suite. 
Two of 146 NICU HCW (20 doctors, I 07 nurses and 19 patient 
support assistants, technicians and cleaning staff) screened were 
colonized (staff C and D; both were negative in June). Two of 83 
delivery suite staff (26 obstetricians, 33 midwives, 23 anesthetic 
staff and one other) screened were colonized (staff E and F). All 
colonized staff were successfully decolonized. 
Accredited auditors performed daily 'S moments' hand 
hygiene audits and compliance improved from 81% in Sep-
tember to 95% in January 20 12; audits were subsequently 
performed weekly. Patient zones were physically demarcated 
to improve adherence to contact precautions. Additional 
environmental screening yielded MRSA from three of 52 
swabs: a blood gas machine, a milk trolley and a curtain. Five 
of 13 mothers (38%; 95% Cl 31-45%) and both of two 
fathers screened were MRSA colonized (see Table 2). 
Molecular typing results 
RLB binary typing identified 18 indistinguishable MRSA iso-
lates (the 'outbreak' strain) from IS neonates, one HCW 
(staff C), one father and one arterial blood gas machine swab 
(Table 2). This strain was PVL positive, ST 22, SCCmec sub-
type IV.3. 1.2 (or IVc) and spa type tOOS. The PFGE patterns 
o f these isolates were indistinguishable. 
All colonized mothers carried non-outbreak strains, three 
of which matched those of their infants. The other two 
were mothers of outbreak cases (6 and 7). Staff C. who was 
colonized with the outbreak strain, had cared for outbreak 
cases 3 and 4. Staff D was colonized with the same non-out-
break strain as case 8. whom she had nursed. This multi-
resistant strain was identified as ST772-V, spa type t657 
(Bengal Bay clone). Six non-outbreak isolates with indistin-
guishable RLB types were isolated from a midwife (Staff F), 
three babies (cases S, 9 and 14), one mother (9) and a deliv-
ery suite curtain. Apart from the mother/baby pair (case 9), 
there were no apparent epidemiological links; staff F was 
not involved in delivery of those babies. These strains were 
typical of ST I-IV (USA400 or W A-MRSA-1 ), which is the 
second most common community-associated MRSA clone in 
Australia [ 14]. 
Discussion 
We documented sustained nosocomial transmission of a vir-
ulent MRSA PVL-positive ST22-MRSA-IV in our NICU, affect-
ing 15 neonates, one father and one HCW over a 7 -month 
period. This is the first report of a nosocomial outbreak due 
to this clone in Australia. PVL which is thought to be impor-
tant in pathogenesis [ 15.16], probably contributed to fatal 
necrotizing pneumonia with pneumatocoele formation, in 
one index case, and to septic shock and bullous lung 
abscesses in the other. 
We demonstrated the utility of our novel mPCRIRLB typ-
ing method, to rapidly identify nosocomial transmission and 
define the outbreak by excluding MRSA-colonized infants 
carrying non-outbreak strains. Traditional MRSA typing 
methods are too expensive, too slow (PFGE, MLST) and/or 
have insufficient discriminatory power (MLST) for routine 
use. spa typing has been used, prospectively, to identify nos-
ocomial transmission events [ 17] but is unsuitable in our 
institution, where the dominant MRSA clone (ST239-111) 
belongs to a single spa type (t037). Our binary typing 
method has a turnaround time of 12 h and high discrimina-
tory power; it is inexpensive (~US$2 per isolate) and up to 
80 isolates can be typed in a single run, using two mem-
branes. It allows targeted infection control interventions to 
be implemented promptly. 
The index cases shared a room; it was not clear who was 
colonized first, but transmission between them, by HCW or 
fomites, was assumed. Their mothers were not screened; 
one may have acquired infection through vertical transmis-
sion or from an unidentified HCW. No common source for 
subsequent cases was found; it was unlikely to have been 
the HCW colonized with the outbreak strain, after a previ-
ously negative screen. The outbreak strain was isolated from 
only one of more than SO environmental swabs, but demon-
strates the potential for MRSA to be transmitted via fomites 
and the need for targeted environmental cleaning and 
enhanced hand hygiene. Twelve of IS outbreak cases were 
delivered by Caesarean section, including three colonized 
within 24 h of birth, suggesting acquisition by some from a 
delivery suite source, as well as transmission within the 
NICU. 
Further evidence favouring nosocomial, rather than verti-
cal, transmission was that mothers of two outbreak cases 
were colonized with non-outbreak strains, whereas colo-
nized mothers of babies with non-outbreak strains carried 
the corresponding strain. Several studies have suggested that 
maternal vaginal MRSA colonization leading to neonatal infec-
tion is uncommon [18-20]. 
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Binary typing showed, and formal MLST, spa and SCCmec 
typing confirmed, that the outbreak strain was PVL positive 
and unrelated to the usual nosocomial clones seen in our 
institution (AUS2/3 [ST239 MRSA-111] and UK-EMRSA 15 
(ST22-MRSA IV]). PFGE confirmed that the outbreak isolates 
were indistinguishable. PVL-positive ST22 MRSA has been 
rarely identified, previously, in Australia [ 14]. 
ST22-MRSA-IV is generally synonymous with UK-EMRSA-
15, which emerged in hospitals in the United Kingdom in 
1991 [21 ], was subsequently identified in Germany where it 
has become the predominant MRSA clone [22] and has 
spread to hospitals and long-term care facilities, worldwide. 
It is characteristically ciprofloxacin resistant and gentamicin 
susceptible, may produce enterotoxin C but rarely PVL. har-
bours SCCmec subtype IVh and has spa type t022 or t032 
(or a related variant} [23]. 
Our outbreak strain differs from EMRSA-15; it has a 
different SCCmec subtype (IV3.1.2 or IVc), spa type (cOOS), 
antibiogram (resistant to gentamicin and crimethoprim-
sulphamethoxazole but susceptible to ciprofloxacin) and 
produces PVL, but not enterotoxin C. It ha.s been reported 
in the United Kingdom [24,25] and Japan [26], where the 
index case reported recent travel to India. An outbreak of 
breast abscesses in postpartum women in Mumbai, India, was 
due to a similar MRSA clone, differing only by a single nucle-
otide polymorphism in one spa repeat [27]. There was no 
known link with the Indian subcontinent in our cases, but 
staff and patients at our institution come from a broad range 
of ethnic backgrounds, so recent importation of this clone 
remains a possibility. 
Considering the large number of differences in the non-
core genome, this clone probably arose from ST22-MSSA, 
independently of EMRSA- 15 [24]. An outbreak of PVL-posi-
tive ST-22 MSSA with the same spa type and antibiogram has 
been reported from Italy, also amongst postpartum women 
and neonates [28]. 
The methods we used for MRSA screening included both 
PCR and broth enrichment to optimize turn-around time 
and sensitivity, followed by subculture. Previous studies sug-
gest that PCR-based screening has high sensitivity but low 
reproducibility in neonates and that a combined approach, 
with confirmatory culture, is preferable [29]. For optimal 
neonatal screening, the combination of umbilical and nasal 
swabs has a reported sensitivity of >90% [30]. The screening 
protocol we used (pooled ear. nose, umbilicus and peri-
neum) should have similar sensitivity. However, only nasal 
swabs we re collected from staff, which may explain the 
major limitation of this investigation, namely our failure to 
identify a source, despite extensive screening of those 
involved in delivery and care of these infants. 
Among the mothers of colonized infants screened for 
MRSA, the car riage rate (of non-outbreak strains) was high 
(38%). Previous reports suggest overall anovaginal MRSA car-
riage rates of 2-4%, with low races of vertical transmission 
of MRSA infection to neonates [ 18,19]. Systematic screening 
is required to determine the true MRSA carriage rates in 
our antenatal population but was beyond the scope of this 
study. 
Non-multiresistant MRSA is an emerging pathogen in the 
NICU, and can cause outbreaks with significant mortality. 
The virulent PVL-positive ST 22-MRSA-IV strain that caused 
this outbreak was difficu lt to control, despite timely use of a 
novel typing system, which allowed accurate definition of the 
outbreak, and implementation of targeted infection control 
interventions that have, apparently, finally terminated the 
outbreak. At the time of writing there have been no new 
acquisitions of the outbreak strain for more than 4 months. 
EMRSA-15 is not the only ST22-MRSA-IV clone with epi-
demic potential. 
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9.1 Discussion 
Hospital acquired infection is an enormous burden on our healthcare system despite 
infection control programmes. Person to person spread of nosocomial pathogens 
often goes undetected since routine surveillance procedures cannot distinguish 
between hospital and community acquisition of highly endemic organisms, without 
strain typing. 
The overall aim of this thesis was to develop and implement a strain typing system for 
MRSA that was inexpensive and practical enough for routine, prospective, high-
volume use but at the same time was informative enough to reliably identify 
nosocomial transmission events and to describe the molecular epidemiology of MRSA 
clones circulating at our institution. It was evident from a review of the literature 
(Chapters 1 and 2) that no reported typing method met these needs adequately, and 
so a new method was developed that built upon previous work done using multiplex 
PCR/reverse line blot hybridisation (Chapters 3 and 4) and incorporated binary targets 
that were selected using the aid of a newly developed computer program (AuSeTIS, 
Chapter 5). 
Mindful that a typing system reliant on mobile genetic elements as targets could 
potentially be unstable, a new method for studying typing method stability in detail 
was developed. This provided more detail about the kinetics of changes in type over 
time by employing Kaplan-Meier survival analysis (Chapter 6). 
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The method underwent comprehensive assessment, following recommended 
guidelines (1). using reference strains and stored clinical isolates from a large culture 
collection. The results for each probe in the assay were validated by comparing known 
reference strain results from previous assays that incorporated these probes. It was 
then validated using isolates collected over a 12 month period in a highly endemic 
setting (Chapter 7). 
The assay is highly suited to routine, prospective typing due to its high discriminatory 
power, fast turnaround time (10 hours) and low cost. The consumable cost is 
approximately US$2 per isolate with a labour time of 8 hours per run (approximately 
$5 per isolate with a single-membrane run of 40 isolates or $2.50 per isolate with two 
membranes processed simultaneously assuming an hourly wage of $25 per hour). In 
comparison, PFGE has a turnaround time of at least days and a per-isolate cost which 
is approximately 10 times greater (2). The capital outlay for the reverse line blot assay 
is also low, the main piece of equipment being a mini blotter which costs 
approximately US$2000. It also has the advantage of reliably detecting Panton-
Valentine leukocidin, an important Staphylococcal virulence factor. 
This method has now been introduced routinely at our institution as part of an 
ongoing research project (see below). Soon after its introduction, identification of an 
outbreak of an emergent clone of MRSA was detected in the neonatal intensive care 
unit at our institution. The typing method was instrumental in describing this 
outbreak, guiding infection control interventions, and, ultimately, terminating 
transmission (Chapter 8). Despite extensive screening of staff in t he neonatal and 
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obstetric units and the environment, no source for the initial introduction of the 
outbreak strain of MRSA was identified. Subsequent to acceptance of the paper 
presented in Chapter 8, one further staff member was identified who was infected 
with the outbreak strain. She had been screened earlier in the outbreak with nasal 
swabs which were negative for MRSA; however she had had furuncular lesions on one 
lower limb for some months, which she failed to disclose at the time of screening. 
These lesions were subsequently found to be due to MRSA and binary typing indicated 
that the infecting strain matched that causing the NICU outbreak. The staff member 
was treated, and since that time, there have been no further cases of colonisation or 
infection in the NICU with the outbreak strain of MRSA. It is likely that unidentified 
colonisation and skin infection of this staff member contributed to the persistence of 
the outbreak for some time despite enhanced infection control measures, and it is 
plausible, but unproven, that she was the previously unidentified source of the 
outbreak. 
Other examples where infection control interventions have been guided by the results 
of molecular typing have occurred since routine use of this typing method. A case of 
peripheral intravenous cannula associated bloodstream infection with MRSA occurred 
in a previously well man admitted with urinary retention secondary to benign 
prostatic hypertrophy. This progressed to severe sepsis, requiring prolonged intensive 
care unit admission; he also developed destructive hip osteomyelitis requiring 
repeated surgical debridement and ultimately excision of the femoral head with a 
Girdlestone's procedure. Molecular typing indicated that the infecting MRSA strain 
was indistinguishable from that carried by another patient who had vacated the bed 
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adjacent to the index case the day before the index case was admitted. This indicated 
environmental contamination and/or inadequate hand hygiene as a likely source of 
acquisition, and enabled targeted education of cleaning staff, in addition to 
implementation of a peripheral cannula insertion education campaign. 
In another case, a nosocomial bacteraemic MRSA infection occurred in a patient 
admitted with a head injury to the neurosurgical high dependency ward. The patient 
had recovered sufficiently from the head injury that he was mobilising in the ward. 
Prior to the onset of this patient's infection a woman with postpartum sepsis due to 
MRSA had been admitted to the adjacent intensive care unit with septic shock. She 
had also recovered sufficiently that she was mobilising in the unit; however due to 
insufficient beds in the step-down ward she remained in the ICU. Molecular typing 
indicated the isolates from these two patients was indistinguishable, and represented 
a strain not previously seen amongst over 1000 isolates typed from our hospital. This 
suggested a high likelihood of transmission between the two patients. Subsequent 
investigation indicated that the bathroom facilities for mobile patients in the intensive 
care and surgical high dependency wards were grossly inadequate, with only two 
bathrooms for 48 beds. These two patients had been sharing a bathroom while they 
were mobile, with no infection control precautions in place. This utilisation of a shared 
bathroom was likely the key factor leading to nosocomial transmission. 
9.2 Study limitations 
There were some limitations with this project. Firstly, the typing system was 
implemented in a single geographic location. Ideally, the typing system would be 
assessed across a wide variety of settings, since the distribution of the binary targets 
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utilised in the typing system will vary according to the dominant circulating MRSA 
clones. Likewise, the dominant clones circulating in our geographic setting are likely to 
change with time, and it is possible that the utility of the typing system may vary as a 
result. However, one of the advantages of the mPCR/RLB platform is its flexibility: 
targets can easily be substituted to improve the performance of the assay if required. 
Another limitation of this study was the limited number of binary targets that were 
assessed for inclusion in the study. Targets were chosen from those for which 
mPCR/RLB based assays had already been developed, in addition to phage-derived 
open reading frame targets. There are a large number of additional binary targets that 
have been described, and ongoing whole genome sequencing studies will no doubt 
uncover more in the future. Once again, if other binary targets are found to be of 
value in the future, these can easily be incorporated into the mPCR/RLB assay. 
We have not demonstrated that the introduction of prospective molecular typing has 
reduced MRSA colonisation and infection rates. This will require a large prospective, 
preferably multi centre study which was beyond the scope of this project, but which 
will form the basis of future research. 
9.3 Future research directions 
9.3.1 Ongoing studies 
The MRSA typing system introduced in this thesis is a key component of two ongoing 
projects, funded by National Health and Medical Research Council (NHMRC) project 
grants. 
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9.3.1.1 Microevolution and transmission of MRSA in a hospital setting 
NHMRC #APP1010452 Chief Investigators: Gilbert G, Sintchenko V, O'Sullivan M , 
Iredell J. 
In this project, routine prospective molecular typing using the novel binary typing 
system described in this thesis has been introduced into three large teaching hospitals 
in metropolitan Sydney. MRSA typing data will be combined with patient bed 
movement data and laboratory information in a 'real-time' fashion using an 
automated system. This system will generate an alert when a transmission event is 
identified with high likelihood. Alerts will be sent to infection control practitioners and 
clinicians so that action can be taken to address the factors associated with the 
transmission event. The impact of this feedback on improved infection control 
practices and MRSA acquisition rates will be a key outcome measure. 
Concurrently, detailed clinical information is being collected from patients infected 
and colonised with MRSA, regarding risk factors for colonisation or infection, co-
morbidities, treatment and outcomes. Combining this data with strain-typing data will 
enable assessment for virulence and transmissibility of individual strains of MRSA. 
Strains will be selected for further typing, including MLST, SCCmec and whole genome 
sequencing. 
9.3.1.2 Strengthening clinicians' capacity for infection control: a multi-
method study to reduce MRSA infection and transmission 
NHMRC # APP1009178 Chief investigators: /edema R, Gilbert G, Hooker C, CYSullivan 
M, Jorm C. 
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The key intervention in this study is video-reflexive ethnography. This involves 
embedding a videographer in a clinical unit, who captures footage of staff carrying out 
their normal work duties. The footage captured will be then edited to highlight key 
events, and this will be then viewed by groups of staff in reflexive sessions. The aim of 
these sessions is to highlight, to staff, factors that contribute to transmission of 
hospital pathogens, which they may be otherwise unaware of and to heighten their 
awareness. The reflexive sessions will also be an opportunity to give feedback 
regarding MRSA transmission events identified by typing-based surveillance using the 
binary typing system introduced in this thesis. A key outcome is whether these 
interventions lead to a change in behaviour that reduces MRSA transmission events, 
as confirmed by the binary typing system. 
9.3.2 Potential future research 
9.3.2.1 Evaluation of the binary typing method in other settings 
The typing method was evaluated with a range of isolates from various settings, 
including international reference strains and historical isolates from Sydney, but the 
largest group of isolates were recent clinical isolates from our institution. It remains to 
be proven that the typing system, with its current binary targets, will maintain the 
same discriminatory power and concordance with other typing systems in different 
geographic settings, and over time. It would be of value to utilise the typing system 
using large panels of isolates from other parts of the world to verify its utility in a 
broad range of settings. Furthermore, the binary typing system is flexible enough to 
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allow targets to be added or substituted to reflect characteristics of local MRSA 
strains. 
9.3.2.2 Rapid prospective molecular typing systems for other pathogens 
While the typing targets utilised in this study are specific for MRSA, the concept of a 
rapid binary typing system that can be used routinely and prospectively for rapid 
identification of nosocomial transmission events would be applicable to a number of 
key pathogens. The mPCR/RLB platform is also versatile enough to form the basis for 
binary typing systems for other pathogens. It has been used by our group for 
genotyping of group B streptococcus, Streptococcus pneumoniae, and Salmonella 
Typhimurium. The most value would be gained from targeting pathogens, which are 
of relatively high prevalence in the hospital environment. This may vary from 
institution to institution, but examples may include Clostridium difficile and 
vancomycin resistant Enterococcus spp. In addition, organisms for which surveillance 
for nosocomial acquisition has not been routinely performed in the past could be 
targeted with such a high throughput discriminatory typing system. An important 
example of this would be methicillin susceptible Staphylococcus aureus (MSSA). MSSA 
causes a large number of hospital onset infections, but it is not well understood how 
often nosocomial MSSA infection is preceded by nosocomial acquisition of MSSA 
colonisation, compared w ith infection due to a strain that the patient was carrying at 
the time of admission to hospital. It is possible that acquisition of nosocomial MSSA 
strains is as much of a problem as nosocomial MRSA transmission and a typing system, 
similar to the one presented in this thesis, but with targets chosen specifically for 
MSSA, would be the ideal platform to investigate this. 
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9.3.2.3 Whole genome sequencing: the future of typing for nosocomial 
surveillance? 
While not yet in routine use for nosocomial surveillance, studies are now emerging 
that explore the utility of whole genome sequencing (WGS) in this setting. It has been 
predicted that current molecular typing methods will be replaced by WGS in the 
coming years, once the hurdles of cost, turnaround time and data analysis have all 
been overcome. Much work will need to be done on how best to analyse the results of 
WGS to rapidly infer relatedness and identify nosocomial transmission events. The 
typing system presented in this thesis will form an excellent basis on which to explore 
the introduction of WGS into nosocomial surveillance. To date, over 2000 MRSA 
isolates have been typed with the novel binary typing method; all of these isolates are 
stored. This will be an extremely valuable collection for assessment of any future 
typing strategies. 
9.4 Conclusions 
This thesis has outlined the development and implementation of a novel binary typing 
system for nosocomial surveillance of MRSA transmission. It has fulfilled the aims set 
out in the introduction, specifically: 
1} Using specially developed software, the most discriminatory combination of 
binary targets was identified that maintained concordance with existing typing 
methods. 
2} These targets were incorporated into a highly discriminatory mPCR/RLB based 
binary typing system that was rapid, high throughput and inexpensive- suitable for 
routine, high-volume use. 
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3) The typing system was assessed in a 12 month study of MRSA isolates from a 
high-prevalence setting and it was shown that the system could be used to identify 
transmission events and describe the molecular epidemiology of MRSA at a local level. 
4) It was demonstrated that, when utilised prospectively, the typing method 
could identify transmission events, define outbreaks and inform infection control 
interventions in a timely manner. 
Future research directions will include the development of such strategies for other 
nosocomial pathogens, the implementation of prospective M RSA typing in other 
locations and the introduction of whole genome sequencing for infection control 
surveillance. 
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Appendix 1: Visual Basic Code for AuSeTTS software 
Script written in Microsoft Visual Basic 6.5 for Excel 2007 
As Double ' The number of Targets (columns) in 
Op tion Explic _l 
Priva te intNumTarge ts 
the input data 
Private intNumSamples 
input data 
As Double 'The number of s amples (rows) in the 
Private intNumStates As Double ' the number of states a target can have used 
for random dataset generation 
Private intNumTotalSamples As Double ' the total number of isolates from random 
dataset generation after applying a weighting 
Pr ivate intNumOriginal Samples As Double 
Private intNumOriginalTarge t s As Doubl e 
Priva te arrinputData () As String ' A two-dimensional array that h o lds t he 
input data plus 7 extra r o ws as below 
Pr_vate rowExclude As I nteger ' !:columns not to be inc l uded in the 
analysis 
Private rowFI As I nteger 
Private rowNI As I n teger 
Private rowConcord As I nteger 
concordance 
Private rowUDG As Integer 
defined groups 
Priva te rowWt As I n teger 
Private rowincl As I n tege r 
included in the analysis 
' 2 :indicates Force inc lude data 
' 3 : noninfo rmative Targets 
' 4 : Targets excluded on the basis o f 
' 5 : excluded c o lumns that define t he user-
'6 : column tha t defines weighting 
'7: columns that have been progressively 
Private arrinputTargetNames () As String 
holds the Target names 
' A one-dimensiona l array that 
Private arrfitargetnumbers () As String ' A one - dimensional array containing 
the Target numbers t o be force i nc luded 
Private InputTargetNamesConcat As String 'A string containing a l l the input 
Target names separated by c ommas 
Priva te ExcludeFieldNamesConc at As String ' A string containing the i nput Fi eld 
names to be i gnored, separated by commas 
Priva te WeightFieldName As String ' A string containing the name of the fie l d 
that defines the weightings 
Private boolWe i ght As Boolean ' true if weightings applied 
Private intNumExclFields As Integer ' an integer containing the number o f inpu t 
fields that are to be ignored 
Private FITargetNamesConcat As String ' A string containing all the Target 
names to force include separated by commas 
Private NITargetNamesConcat As Str1ng ' A string containing a ll the Target 
names which are non informative , separated by commas 
Private NI FITargetnamesConca t As String ' A string containing the 
noninformative but force-included target names 
Private ConcordTargetNamesConcat As S tr~ ng ' A string containing the Targets 
names excluded on the basis of concordance 
Private FIConcordTargetNamesConca t As String ' A string c o ntaining t he forc e-
included concordant targets 
Private i ntNumNITargets As I ntege r ' The number of noninformative Targets 
Private i ntNumFITargets As Integer ' The number of force include Targets the 
user selects 
Private intNumConcordTargets As Integer ' the numbe of Targets exluded on the 
basis o f concordanc e 
Private arrResults () As Variant 'An array containing the final resul t s 
Private intResultLeadColumns As Integer 
Priva te intResultLeadRows As I n teger 
Private i ntDeepNumGenes As Integer 
data 
Private intDeepNumSampl es As Double 
input data 
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Priva te intDeepNumTargets 
the combination 
As Integer 'The number of targets wanted i n 
Private intDeepTargetNum 
whose results are being 
Private intDeepRow 
As Integer ' The number of the c ur r ent target 
added to the combination 
As Double 
f o r the next combi nation 
Private i , j , k 
Private intDepth 
Private i ntLoopRange 
Private arr () 
t o r e c urs ivel y l oop 
As Double 
As Double 
As Integer 
'A number holding the row number 
' counters 
' Number of loops that are r unn i ng 
' Number o f iterat i ons i n a ny one l oop 
' An arra y o f variables tha t are used 
Private s t rOutput As String ' An out put string f o r debuggi ng 
purposes- easire t o read number s and check them 
'Note tha t t he r e are onl y so many 
l ines i n the debug window, s o you may no t see 
combinations 
Private arrDeep i nputData () As Variant 
Private arrCombi nations As Variant 
Pr ivate in t DeepExpected As Double 
Private arrDeepResults () As Variant 
Private dblDeepSID As Double 
' all result s f o r a large number o f 
Private Parti t ionFieldNamesConca t As String 'a string containing t he field 
names that comprise the pre-exisiting partitions 
Private arrUDGSID () As Variant 
Private arrUDG () As Varia nt 
Private boolUDG As Boolean 'True if Partitions are defined 
Private arrCalc () As Variant 'array to hold the concatenated dat a f o r a l l 
samples in second dimension in the SID function 
Private intMaxParam As Integer 'Variable that determines parameter to 
maximise: 1 SID, 9=Wallace I 
Private intWeightField As Integer 'integer c ontai ni ng the number of t he f i e l d 
containing weights 
Private intLimit As Integer ' an integer indicated how many random branches of 
the algorithm will be persued 
Private dblMaxParam As Double ' Stop analys is when paramete r to maximise 
reac hes t his value 
Private strWtFi eld As String 'Name of the column that defines the i s olate 
weightings 
Private strUDG As String 
Private s t rMode As St r i ng 
Private intLas t Threshold As Integer ' Value for the last threshold 
Private arrNormalvDeepResul ts () As Variant 
Private intiterationsRemai ning As Intege r 
Private boolRandom As Boolea n 
Private dblHours As Double 
Private dblMinutes As Double 
Private dblSeconds As Double 
Private boolFirstCombo As Boolean 
Private dblMaxSID As De 'ub_e 
Private dblMaxConcordanceMeasure As Double 
Private arrFI () As Variant 
Private strFINames As String 
Sub DeepAnalys i s () 
'This s ub analyses the data in Deep mode 
i ntDepth = 0 
i nt DeepRow = 0 
i ntLoopRange = 0 
i ntDeepNumGenes = 0 
i ntDeepNumSamp l es = 0 
dbl DeepSID = 0 
dblMaxConcordanceMeasure = - 1000 
ReDim arrFI (intNumSamples , 0 ) 
strFINames = 
' Determine how many targets need to be analysed 
For i = 1 To UBound (arrlnputData , 1) 
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:f arrinputData (i , UBound (arrinputData , 2 ) - rowincl ) <> ·~1 " And 
arrinputData (i , UBound (arrinputData , 2 ) - rowFI ) <> The n 
intDeepNumGenes = intDeepNumGenes + 1 
I f arrinputData (i , UBound (arrinputData , 2 ) - rowFI ) = ·• " Then 
strFINames = strFINames & arrinputData ( i , 0 ) & 
ReD~m Preserve arrFI (intNumSamples , UBound (arrFI , 2 ) + 1 ) 
Fo r j = 1 To intNumSamples 
arrFI ( j , UBound (arrFI , 2 )) = arrinputData ( i , j ) 
Next j 
End If 
Ne xt i 
' Determine how many samples are to be analysed 
intDeepNumSamples = intNumSamples 
'Transfer data to be analysed into a new array for analysis 
ReDim arrDeepinputData (intDeepNumGenes , intDeepNumSamples ) 
k = 0 
Fo r i = 1 To UBound (arrinputData , 1 ) 
T f arrinputData ( i , UBound (arrinputData , 2 ) - rowincl ) 
arrinputData ( i , UBound (arrinputData , 2 ) - rowFI ) <> 
k = k + 1 
For j = 0 To UBound (arrDeepinputData , 2 ) 
arrDeepinputData (k , j ) = arrinputData ( i , j ) 
Ne x t j 
End If 
Next i 
<> ' ,r" And 
Then 
'create an array of consecutive target numbers which will be used in 
TestAllCombinations 
Dim arrDeepTargetNumbers () As :nteger 
ReDim arrDeepTargetNumbers (UBound (arrDeepinputData , 1 )) 
For i = 1 To UBound (arrDeepTargetNumbers , 1 ) 
arrDeepTargetNumbers ( i ) = i 
Next i 
'Determine how many targets needed in the output dataset (user entry or if 
standard mode being compared to deep mode , use one target less than the 
threshold) 
intLastThreshold = intDeepNumGenes + UBound (arrFI , 2 ) 
Dim intTemp As Va r i ant 
GetTargetNumber : 
intTemp = InputBox ( y & ( intDeepNumGenes + UBound (arrFI , 2 )) & 
" Num.t·0r <"I£'• , intLastThreshold ) 
I f intTemp = fhe n Cal l MainProgram 
I f IsNumer~c ( in tTemp ) = False Or intTemp > intDeepNumGenes + UBound (arrFI , 
2 ) Or intTemp < 1 ~hen 
MsgBox ( qe,.. equ .. l tv JT" :fi'ss • 
" & ( intDeepNumGenes + UBound (arrFI , 2 )) & o 
GoTo GetTargetNumber 
End If 
If intTemp < UBound (arrFI , 2 ) The n 
MsgBox ( u· •IL 
t~rC'C' •r 1/d~i.IC" m•wr cc :::r le 
GoTo GetTargetNumber 
End If 
& UBound (arrFI , 2 ) & 
& UBound (arrFI , 2 ) & o 
intDeepNumTargets Abs (Int ( intTemp)) - UBound (arrFI , 2 ) 
' Determine how many combinations will be examined, estimate the time taken and 
warn user 
intDeepExpected = Application.Combin ( intDeepNumGenes , intDeepNumTargets ) 
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' Label progress bar with number of iterations 
If FormDefineFields . chkProgressBar = True Then CounterForm. LabelS . Caption 
' & intiterationsRemaining 
'Initialises progress bar 
I! FormDefineFields . chkProgressBar = ~rue Then 
CounterForm . LabelProgress . Width = 0 
CounterForm . TotalComb . Caption = intDeepExpected 
CounterForm . Show 
CounterForm . Repaint 
End If 
' start timer 
Dim dblStart, dblFinish, dblTemp As Double 
dblStart = Timer 
' Loop through each required combination and call AnotherComboLoop for analysis 
boolFirstCombo = True 
Ca l l TestAllCombinations (arrDeepTargetNumbers , intDeepNumTargets ) 
' intLoopRange = intDeepNumGenes- intDeepNumTargets + 1 
'Do 
'AnotherComboLoop (0) 
' Loop While intDepth > 0 
'stop timer 
dblFinish = Timer 
dblTemp = dblFinish - dblStart 
dblHours = Int (dblTemp I 3660) 
dblMinutes = Int ((dblTemp - (dblHours * 3660 )) I 60 ) 
dblSeconds = Round ((dblTemp - (dblHours * 3660 ) - (dblMinutes * 60 )) , 0 ) 
arrResults (1 , 1 ) = arrResults (1 , 1 ) & c.·1~~ r. & dblHours & & 
dblMinutes & & dblSeconds & 
'hide Progress bar and go to results tab 
I f FormDefineFields . chkProgressBar = True Then Unload CounterForm 
Worksheets ( l ) .Activate 
End Sub 
Sub MainProgram () 
'This is the initial sub that runs when the file is opened or Ctrl-M is 
pressed 
Sheets ( 
Sheets ( 
Sheets ( " 
ult ) . Visible = Excel.XlSheetVisibility . xlSheetVisible 
) . Visible = Excel .XlSheetVisibility . xlSheetVisible 
lJI " ) .Visible = Excel .XlSheetVisibility . xlSheetVisible 
Application .Visible = 
I f Worksheets ( " lJ 
Fa~se ' Hides the worksheets 
) . Cells (1 , 1 ) <> 'And 
Worksheets ( PU~· I ) . Cells (2 , 1 ) <> Then ' Checks if there is input 
data already loaded 
FormStartup . OpLoaded . Value 
Else 
FormStartup . OpLoaded . Value 
End If 
True 
Fa l se 
FormStartup . Show ' Get user input using the startup form 
Application .Visible = True ' Show the worksheets 
' Clear the previous input data 
ClearData 
' Load the new input data 
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ReadData 
' Determine which mode to be used and run the appropriate subs 
I f FormDefineFields . opModePredict = True The n 
Predict Partitions 
Else 
End I f 
IdentifyNonlnformative 
IdentifyConcordant 
StartResults 
' Commence Deep or Standard analysis 
If FormDefineFields . opModeDeep = ~rue Then 
DeepAnalysis 
Els e 
TestSID 
End I f 
PrintResults 
Application . Visible ~ rue 
' Show results 
If FormDefineFields . opModePredict = True The n 
Sheets ( r.r ~ J ) • Se l ect 
Sheets ( ~~· ) . Visible = Excel .XlSheetVisibility . xlSheetHidden 
Sheets ( lJi ) .Visible = Excel . XlSheetVisibility . xlSheetHidden 
Else 
Sheets ( ·~" ' ) . Se l e ct 
Sheets ( ·n 'J , .. l' ) . Visible = 
Excel . XlSheetVisibility.xlSheetHidden 
Sheets ( 1~. ) . Visible = Excel . XlSheetVisibility . xlSheetHidden 
End :f 
If FormDefineFields . opModeNormal = True Then 
Sheets ( " - ~ ) .Visible = Excel . XlSheetVisibility .xlSheetVisible 
End I f 
If FormDefineFields . opModePredict = Fa lse Then 
Dim temp As Vari a nt 
temp = MsgBox ( ri •. v ~": _rrplr't & Chr (lO ) & Chr (13) & Chr (lO ) & Chr (13) & 
& Chr (lO ) & Chr (13) & 
vbExclamation) 
Else 
MsgBox ( •'-' .. y 
End I f 
End Sub 
~-rnJC~VP Jl~KRfl[ mr.:1n'1' H 
r<t,1n a Wl'ril .. !!'pdr~;,J;ar•.l. ·.1.cn .~r 
Func tio n ComparePartitions (arrPartl () As Var ian t , arrPart2 () As Varian t ) As 
Varia nt 
' This function calculates the measures of concordance between the target 
combination being analysed , and the user defined reference typing method 
' The input is the two arrays of results to be compared 
' each array is in the format (columns, rows) column 0 contains the 
concatenated type for each isolate, column 2 contains the number of 
isolates with the same type 
' column 1 is a container to say that isolate has been counted 
' row 0 is empty, the first isolate is row 1 
Dim arrCompPartResult () As Varian t 
Dim a , b , c , d As Doub_e 
a = 0 ' a is the number of instances where two selected types are the same by 
method A and by method B 
b = 0 ' b is the number of instances where two selected types are the same by 
method A and different by method B 
c = 0 ' c is the number of instances where two selected types are different by 
method A and the same by method B 
d = 0 ' d is the number of instances where two selected types are different by 
method A and different by method B 
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Dim Rand As Double 
Dim RandAdj As Doub le 
Dim n As Double 
Dim nc As Double 
Dim Enisq As Double 
Dim Enjsq As Double 
Dim EninjsqDivn As Double 
Dim EMijOnAi3 As Double ' part of Wallace CI calculation 
Dim EMijOnAi2 As Double ' part of Wallace CI calculation 
Dim ai As Double ' part of Wallace CI calculation 
Dim bi As Doubl e ' part of Wallace CI calculation 
Dim varSIDBAi As Double ' part of Wallace CI calculation 
Dim varWalNum As Double ' part of Wallace CI calculation 
Dim varWalDen As Double 'part of Wallace CI calculation 
Dim varWallacei As Doubl e 'part of Wallace CI calculation 
Dim varWallaceii As Double ' part of Wallace CI calculation 
Dim Wallacei As Double 
Dim Wallaceii As Double 
Dim arrPartlNames As Variant ' these are the <types> ie : the concatenated 
typing results for each isolate in arrPartl 
Dim arrPart2Names As Vari ant ' these are the <types> ie : the concatenated 
typing results for each isolate in arrPart2 
Dim strCurrName As String 
Dim arrWCT As Variant 
Dim r As Integer 'number of partitions in first array 
Dim S As I nteger ' number of partitions in second array 
Dim adjWallacei As Double 
Dim adjWallaceii As Doubl e 
Dim iWallacei As Double ' wallace coefficient under interdependence, used for 
adjusted wallace 
Dim iWallaceii As Double ' wallace coefficient under interdependence, used for 
adjusted wallace 
Dim arrPartlTransposed () As Variant 
Dim arrSIDPartl () As Variant ' simpsons index of diversity for partition 1 -
SID is in (1) 
Dim ii , jj As I nteger 
n = UBound (arrPartl, 2 ) 
If n <> UBound (arrPart2, 2) Then 
MsgBox ( : : ltFlYS h~ve ~ F~crer·• 
End 
End If 
Re Dim arrPartlNames (n) 
ReD~m arrPart2Names (n ) 
For i = 1 To n 
arrPartlNames (i ) 
arrPart2Names (i ) = 
Ne xt i 
arrPartl (0 , i ) 
arrPart2 (0 , i ) 
' ) 
' reformats arrPartl so that it matches the format of the array needed in the 
SID function, ie : (rows , columns) 
ReDim arrPartlTransposed (UBound (arrPart l, 2) , 1 ) 
For ii = 1 To UBound (arrPartlTransposed , 1 ) 
arrPartlTransposed (ii , 1 ) = arrPartl (O, ii ) ' column 0 of arrpartl contains 
the concatenated typing results for each isolate which need to be in row 1 
for the SID function 
Next ii 
' Replace concatenated typing results aka <names> with numbers 
r = 0 
For i = 1 To n 
arrPartlNames (i ) <> Then 
strCurrName = arrPartlNames (i ) 
r = r + 1 
For j = i To n 
T. arrPartlNames (j ) = strCurrName Then 
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arrPartl (O, j ) = r 
arrPartlNames ( j ) 
End If 
Next j 
j = 0 
End If 
Next i 
i = 0 
s = 0 
For i = 1 To n 
:f arrPart2Names (i ) <> ~hen 
strCurrName = arrPart2Names (i ) . 
s = s + 1 
For j = i To n 
If arrPart2Names ( j ) = strCurrName Then 
arrPart2 (0 , j ) = S 
arrPart2Names ( j ) 
End If 
Next j 
j = 0 
End If 
Next i 
i = 0 
' calculate a,b , c and d for the concordance formulas 
ReDim arrWCT ( r , S ) 
For i = 1 To n 
For j = 1 To n 
If i = j Then arrWCT (arrPartl (O, i ), arrPart2 (0 , j )) = arrWCT (arrPartl (O, i ), 
arrPart2 (0 , j )) + 1 
If j > i Then 
If arrPartl (O, i ) = arrPartl (O, j ) And arrPart2 (0 , i ) = arrPart2 (0 , j ) 
Then a = a + 1 
If arrPartl (O, i ) 
Then b = b + 1 
arrPartl (O, j ) And arrPart2 (0 , i ) <> arrPart2 (0 , j ) 
If arrPartl (O, i ) <> arrPartl (O, j ) And arrPart2 (0 , i ) arrPart2 (0 , j ) 
Then c = c + 1 
If arrPartl (O, i ) <> arrPartl (O, j ) And arrPart2 (0 , i ) <> arrPart2 (0 , j ) 
Then d = d + 1 
End If 
If j = 1 And arrPartl (2 , i ) > 0 Then Enisq = Enisq + (arrPartl (2 , i ) A 2 ) 
If i = 1 And arrPart2 (2 , j ) > 0 ~hen Enjsq = Enjsq + (arrPart2 (2 , j ) A 2 ) 
:f arrPartl (2 , i ) > 0 And arrPart2 (2 , j ) > 0 Then EninjsqDivn = EninjsqDivn + 
(((arrPartl (2 , i ) A 2 ) * (arrPart2 (2 , j ) A 2 )) I n ) 
Next j 
Next i 
'calculate row and column sums for arrWCT and put them in column 0 and row 0 
respectively 
For i = 1 To UBound (arrWCT, 1 ) 
For j = 1 To UBound (arrWCT , 2 ) 
arrWCT ( i , 0 ) = arrWCT ( i , 0 ) + arrWCT ( i , j ) 
arrWCT (O, j ) = arrWCT (O, j ) + arrWCT ( i , j ) 
Next j 
Next i 
' calculate the 
varSIDBAi = 0 
varWalNum = 0 
varWalDen = 0 
varWallacei = 0 
other components of the formulas for measures of concordance 
For i = 1 'I'o r 
EMij0nAi3 = 0 
EMij0nAi2 = 0 
ai = arrWCT (i, 0 ) 
For j = 1 To S 
EMijOnAi3 = EMijOnAi3 + ((arrWCT ( i, j ) I ai ) A 3 ) 
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EMijOnAi2 = EMijOnAi2 + (( arrWCT (i , j ) I ai ) A 2 ) 
Next j 
If ai > 1 Then 
varSIDBAi = (( 4 * ai * (ai - 1 ) * (ai - 2 ) * EMij0nAi3 ) + (2 * ai * (ai -
1 ) * EMij0nAi2 ) - ( 2 * ai * (ai - 1 ) * ( ( 2 * ai ) - 3 ) * (EMijOnAi2 A 2 ))) I 
((ai * (ai - 1 )) A 2 ) 
Else 
0 varSIDBAi 
End If 
varWalNum 
varWalDen 
varWalNum + (((ai * (ai - 1 )) A 2 ) * varSIDBAi ) 
= varWalDen + (ai * (ai - 1 )) 
Next i 
If varWalDen = 0 Then 
varWallacei = 0 
Else 
varWallacei 
End If 
varWalNum I (varWalDen A 2 ) 
varWalNum = 0 
varWalDen = 0 
For j = 1 To S 
EMij0nAi3 = 0 
EMij0nAi2 = 0 
bi = arrWCT (O, j ) 
E'or i = 1 To r 
EMij0nAi3 = EMijOnAi3 + (( arrWCT (i , j ) I bi ) A 3 ) 
EMijOnAi2 = EMijOnAi2 + (( arrWCT (i , j ) I bi ) A 2 ) 
Next i 
If bi > 1 Then 
varSIDBAi = (( 4 * bi * (bi - 1 ) * (bi - 2 ) * EMijOnAi3 ) + (2 * bi * (bi -
1 ) * EMijOnAi2 ) - (2 * bi * (bi - 1 ) * ( (2 * bi ) - 3 ) * (EMijOnAi2 A 2 ))) I 
((bi * (bi - 1 )) A 2 ) 
Else 
varSIDBAi = 0 
End If 
varWalNum = varWalNum + (((bi * (bi - 1 )) A 2 ) * varSIDBAi ) 
varWalDen = varWalDen + (bi * (bi - 1 )) 
Next j 
varWallaceii = varWalNum I (varWalDen A 2 ) 
nc = (( n * (( n A 2 ) + 1 )) - ((n + 1 ) * Enisq) - (( n + 1 ) * Enjsq) + (2 * 
EninjsqDivn)) I (2 * ( n - 1 )) 
If a + b + c + d - nc <> 0 Then 
RandAdj = (a + d - nc) I (a + b + c + d - nc ) 
Else 
RandAdj = 0 
End If 
If a + b + c + d <> 0 Then 
Rand = (a + d ) I (a + b + c + d ) 
Else 
Rand = 0 
End If 
If a + b <> 0 Then 
Wallace! = a I (a + b ) 
Else 
Wallace! = 1 
End If 
If a + c <> 0 Then 
Wallaceii = a I (a + c ) 
Else 
Wallaceii = 0 
End If 
'calculations for Adjusted Wallace 
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' Calculate SID of the first partitions using the SID function 
ReDim arrSIDPartl (S) 
arrSIDPartl = SID (arrPartlTransposed ) 
iWallacei = 1 - arrUDGSID (1 ) ' SID of partition 2 - already calculated in 
another sub 
iWallaceii = 1 - arrSIDPart1 (1 ) 
adjWallacei = (Wallace! - iWallacei ) I (1 - iWallacei ) 
adjWallaceii = (Wallace!! - iWallaceii ) I (1 - iWallaceii ) 
ReDim arrCompPartResult (7 ) 
arrCompPartResult (O) = Rand 
arrCompPartResult (1 ) = RandAdj 
arrCompPartResult (2 ) = adjWallacei 
arrCompPartResult (3 ) = adjWallaceii 
If varWallacei <> 0 Then arrCompPartResult ( 4 ) = adjWallacei - (2 * (1 I 
arrUDGSID (1 )) * Sqr (varWallacei )) ' lower 95% CI for Wallace! 
I f varWallacei <> 0 Then arrCompPartResult (S) = a d jWallacei + (2 * (1 I 
arrUDGSID (1 )) * Sqr (varWallacei )) ' upper 95% CI for Wallace! 
Tf varWallaceii <> 0 Then arrCompPartResult ( 6) = adjWallaceii - (2 * (1 I 
arrSIDPartl (1 )) * Sqr (varWallaceii )) ' lower 95% CI for Wallace! 
If varWallaceii <> 0 Then arrCompPartResult (7 ) = adjWallaceii + (2 * (1 I 
arrSIDPart l (1 )) * Sqr (varwallaceii )) ' upper 95% CI for Wallace! 
' output 
ComparePartitions arrCompPartResult 
End Function 
Sub ClearData () 
' clear results worksheet and variables in standard mode 
intNumTargets = 0 
intNumSamples = 0 
InputTargetNamesConcat 
FITargetNamesConcat = 
NITargetNamesConcat = 
ConcordTargetNamesConcat 
i n t NumFITargets = 0 
intNumNITargets = 0 
i n tNumConcordTargets = 0 
Worksheets ( ) . Range ( ) . CurrentRegion . Value = Null 
Worksheets ( ) . Range ( " " ) . CurrentRegion . Value 
End Sub 
Sub ReadData () 
Null 
' Data is read into an array from an excel worksheet or from a file , or else 
random data is generated 
On Error GoTo FileReadError 
Dim i As Double 
Dim j As Double 
If FormStartup . OpRandom 
If FormStartup . OpRandom 
~rue Then boolRandom = True 
False Then boolRandom = False 
' This section allows the user to upload the dataset from a file 
FileRead : 
boolUDG = False 
D~m strFilePath As String 
If FormStartup . OpFile = True Then 
Unload FormStartup 
strFilePath = Application . GetOpen Filename ( .1 Fil~>f• (* . •1 . •. 
' procedure if the file is character-delimited 
If Right (strFilePath , 4 ) = ". txt " Or Right (strFilePath , 4 ) = 
D~m strDelimiter As S r_ng 
If Right (strFilePath , 4 ) = c:•r " Then 
strDelimiter 
Else 
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strDelimiter = InputBox ( vp~ the ·JE''tm•t.nC' ·•.tracter "cr 
. ) 
If strDelimiter = " ·t- Then strDelimiter = Chr ( 9 ) 
End If 
' load the file 
Di m fnum As I nteger 
Dim whole_file As String 
fnum = FreeFile 
Open strFilePath For Input As fnum 
whole_file = Input$ (LOF (fnum ) 1 ~fnum) 
Close fnum 
' break the file into lines 
Dim lines As Varian t 
lines = Split (whole file , vbCrLf ) 
' dimensio n the array 
Dim num_rows As Long 
Dim one line As Variant 
Dim num_cols As Long 
num_rows = UBound (lines ) 
one_line = Split (lines (O) 1 strDelimiter) 
num_cols = UBound (one_line) 
ReDim arrinputData (num_cols 1 num_rows + 7 ) 
' copy the data into the array 
Dim r As Long 
Dim c As Long 
FormLoad ing . LabelProgress . Width = 0 
FormLoading . Show 
FormLoading . Repaint 
For r = 0 To num rows 
With FormLoading 
. LabelProgress . Width = Int ((( r + 1 ) I (n um_rows + 1 )) * 
( . FrameProgress . Width - 16)) 
. Repaint 
End With 
If InS t r (lines ( r ) 1 strDelimiter ) <> 0 Then 
one_line = Split ( lines (r ) , strDelimiter) 
For c = 0 To num col s 
arrinputData (c , r ) = one line (c ) 
Ne x t c 
Else 
r = num rows 
End If 
Nex t r 
Unload FormLoading 
' procedure if file is an excel file 
Else 
Then 
If Right (strFilePath 1 4 ) = ". xl·~ " Or Right (strFilePath 1 4 ) 
Dim objExc As Excel . Application 
Dim objWbk As Excel . Workbook 
Dim objWsh As Excel . Worksheet 
Dim arrWsh () As Str i ng 
Dim strWshName As Str ing 
ReDim arrWsh (O) 
Set objExc = New Excel . Application 
Set objWbk = objExc . Workbooks . Open ( strFi l ePath ) 
' select the relevant worksheet from the file 
For Each objWsh In objWbk . Worksheets 
arrWsh (UBound (arrWsh )) = objWsh . Name 
ReDim Preserve arrWsh (UBound (arrWsh) + 1 ) 
Nex t 
If UBound (arrWsh ) > 2 Then 
ReDim Preserve arr Wsh (UBound (arrWsh ) - 1 ) 
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With formWorksheets 
. listSheets . List 
. Show 
End W~ th 
arrWsh 
' copy the data from the selected worksheet into the i npu t data 
array 
Then 
If IsNull ( formWorksheets . listSheets . Value ) = False Then 
strWshName = formWorksheets . listSheets . Value 
Else 
If MsgBox ( ,., r k 
GoTo FileRead 
Else 
Else 
End 
End If 
End If 
strWshName 
End If 
intNumSamples = 
arrWsh (O) 
, vbRetryCancel ) vbRetry 
objWbk . Worksheets (strWshName ) . Range ( ' ) . CurrentRegion . Rows . Count - 1 
'calculates the number of the Targets in the input dataset 
intNumTargets = 
objWbk . Worksheets (strWshName ) . Range ( ) . CurrentRegion . Columns . Count 
'calculates the number of the samples in the input dataset 
ReDim arrinputData ( intNumTargets , intNumSamples + 7 ) 
ReDim arrinputTargetNames ( intNumTargets ) 
FormLoading . LabelProgress . Width = 0 
FormLoading . Show 
FormLoading . Repaint 
For i = 1 To intNumTargets 
For j = 0 To intNumSamples 
arrinputData ( i , j ) 
objWbk . Worksheets (strWshName ) . Cells ( j + 1 , i ) 
Nex t j 
arrinputTargetNames ( i ) 
objWbk . Worksheets (strWshName) .Cells (1 , i ) 
With FormLoading 
. LabelProgress . Width = Int (( i I intNumTargets ) * 
(. FrameProgress . Width - 16)) 
. Repaint 
End W-Lh 
Next i 
Else 
Unload FormLoading 
objExc . Workbooks . Close 
I~ MsgBox ( t u, '::::)( 
vbRetryCancel ) = vbRetry Th e n 
GoTo FileRead 
Else 
End 
End If 
End I f 
End If 
cl 
' paste the data into the inputdata worksheet 
f d.r"'t.tr i "~ . .L'J 
Worksheets ( 1p.~ ) . Range ( " ) . CurrentRegion . Value = Nul l 
Else 
For i = 1 ; o UBound (arrinputData , 1 ) 
For j = 0 To UBound (arrinputData , 2 ) 
Worksheets ( ) . Cells ( j + 1 , i ) = arrinputData ( i , j ) 
Ne xt j 
Next i 
' stop the error handling procedure for reading file 
On Error GoTo 0 
On Error GoTo 0 
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If FormStartup . OpPaste = 
Worksheets ( •t 1 
Worksheets ( " •P'Ir >ot 
Worksheets ( , .. u • :J" 
Worksheets ( •oJ'I• ·1.:..' 
True Then ' use data that is in the clipboard 
) . Activate 
" ). Range ( " 
) . Cells (1 , 
) . Paste 
" ) . CurrentRegion . Value = Null 
1 ) . Select 
End If 
If FormStartup . OpRandom 
intNumSamples = 0 
intNumTargets = 0 
intNumStates = 0 
intNumTotalSamples = 0 
7rue Then ' generate random data 
intNumOriginalSamples = 0 
intNumOriginalTargets = 0 
RandominputData 
For i = 1 To UBound (arrinputData , 1 ) 
For j = 0 To UBound (arrinputData , 2 ) 
Worksheets ( ). Cells ( j + 1 , i ) arrinputData ( i , j ) 
Next j 
Next i 
End If 
' use the data that the is in the inputdata worksheet 
Unload FormStartup 
intNumSamples = 
Worksheets ( 1 ) . Range ( ) . CurrentRegion . Rows . Count - 1 
' calculates the number of the Targets in the input dataset 
intNumTargets = 
Worksheets ( t ) . Range ( ) . CurrentRegion . Columns . Count ' calculates 
the number of the samples in the input dataset 
ReDim arrinputData ( intNumTargets , intNumSamples + 7 ) 
ReD_m arrinputTargetNames (intNumTargets ) 
For i = 1 To intNumTargets 
For j = 0 To intNumSamples 
arrinputData ( i , j ) = Worksheets ( ~f_.'[ !! ) . Cells ( j + 1 , i ) 
Next j 
arrinputTargetNames (i ) = Worksheets ( ~ t[~! ) . Cells (1 , i ) 
Nex t i 
End If 
' repeated to fix bug where this was missing if loaded from text file 
intNumSamples = Worksheets ( :r-· ~~ ) . Range ( ) . CurrentRegion . Rows . Count -
1 ' calculates the number of the Targets in the input dataset 
intNumTargets = 
Worksheets ( ut '1'-'' ) . Range ( ' ' ) . CurrentRegion . Columns . Coun t ' calculates 
the number of the samples in the input dataset 
' These are extra rows added to the input data to specify if particular targets 
meet certain criteria : 
rowExclude = 6 'l:columns not to be included in the analysis 
rowFI = 5 ' 2:indicates Force include data 
rowNI = 4 ' 3 : noninformative Targets 
rowConcord = 3 ' 4 : Targets excluded on the basis of concordance 
rowUDG = 2 ' 5 : excluded columns that define the user-defined groups 
' 6: column that defines weighting rowWt = 1 
rowincl = 0 
analysis 
' 7 : columns that have been progressively included in the 
' puts row labels of added rows in first column (ie : O) 
arrinputData (O, UBound (arrinputData () , 2 ) - rowExclude ) 
arrlnputData (O, UBound (arri nputData () , 2 ) - rowFI ) = 
arrinputData (O, UBound (arrinputData () , 2 ) - rowNI ) = 
arrinputData (O, UBound (arrinputData () , 2 ) - rowConcord) 
arrinputData (O, UBound (arrinputData (), 2 ) - rowUDG ) = ' I 
arrinputData (O, UBound (arrinputData () , 2 ) - rowWt ) = 
arrinputData (O, UBound (arrinputData () , 2 ) - rowincl ) = 
= lr'" !',- . r l!"~l·J ... ~lCra" 
:r~r ..... UC""" 
lc I NI" 
= ,x_·lu1r l 
[ ..1>1-f.( 
~ht•nq" 
n _·luieJ" 
Jt< 1p•. " 
' Create a list of field names from first row and insert them on the 
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FormDefineFields 
Dim a r rFieldNames () As Va ria n t 
ReDim arrFieldNames ( UBound (arrinputData , 1 ) - 1 ) 
For i = 0 To UBound (arrinputData () , 1 ) - 1 
arrFieldNames ( i ) = arrinputData (i + 1 , 0 ) 
Ne xt i 
' put a dummy line at the end of the list since the scroll bars don't a l ways 
extend to the bottom 
If i > 32 Then 
ReDim Preserve arrFieldNames (UBound (arrFieldNames () , 1) + 1 ) 
arrField.Names (UBound (arrFieldNames () , 1 )) = "" 
End If 
With FormDefineFields 
' put target names into the lists on FormDefineFields 
. ListWeight . List = (arrFieldNames ) 
. ListFEx . List = (arrFieldNames ) 
. ListFI . List = (arrFieldNames ) 
. ListUDG . List = (arrFieldNames ) 
' Define the height of the lists on FormDefineFields 
If i > 33 Then i = 33 
. ListWeight . Height = (( i + 1 ) * 10 ) + 5 
. ListFEx . Height = (( i + 1 ) * 10 ) + 5 
. ListFI .Height = (( i + 1 ) * 10) + 5 
. ListUDG .Height = (( i + 1 ) * 10 ) + 5 
. ButtonDone . Top = . ListWeight . Height + 152 
. btnClearSelections . Top = . ListWeight . Height + 152 
. chkProgressBar . Top = . ListWeight . Height + 152 
. btnCancel . Top = . ListWeight . Height + 152 
. Height = (( i + 1 ) * 10 ) + 212 . 25 
. FrameMax Param . Top = (( i + 1 ) * 10 ) + 38 
. FrameLimits . Top = (( i + 1 ) * 10 ) + 38 
. frMode . Top = (( i + 1 ) * 10 ) + 38 
. opModeNormal . Value = True 
' automatically select weighting field if random data was en t e r ed 
If boolRandom = True Then 
. ListWeight . Selected (UBound (arrFieldNames () , 1 )) = True 
End If 
End With 
DefineFields : 
FormDefineFields . Show 
' make sure dummy line is not s elected 
If i = 33 Then 
If FormDefineFields . ListWeight . Selected (UBound (arrFieldNames () , 1 )) = True 
Then FormDefineFields . ListWeight . Selected (UBound (arrFieldNames () , 1 )) 
False 
If FormDefineFields . ListFEx . Selected (UBound (arrFieldNames (), 1 )) = True Then 
FormDefineFi elds . ListFEx . Selected (UBound (arrFieldNames (), 1 )) = Fa l se 
If FormDefineFields . ListFI . Selected (UBound (arrFieldNames () , 1 )) = True Then 
FormDefineFields . ListFI . Selected (UBound (arrFieldNames () , 1 )) = False 
If FormDefineFields . ListUDG . Selected (UBound (arrFieldNames (), 1 )) = True Then 
FormDefineFields . ListUDG . Selected (UBound (arrFieldNames () , 1 )) = False 
ReDim Preserve arrFieldNames (UBound (arrFieldNames (), 1 ) - 1 ) 
End If 
strUDG = ' 
Excl udeFieldNamesConcat = "" 
FITargetNamesConcat = " 
If FormDefineFields . OpWallii . Value = True And 
FormDefineFields . opModeNormal . Value = True Then MsgBox ( " 
·H ~· IE " & Chr (10) & Chr (13) & 
" "lC>ilSC> v•;l'.Ja+-co re>-:;ul+-r; u~1na or C>:.rh~!Js+-ivo ..>C'Jr, " ) 
' Perfo rm weighting based on s elected field 
strWtField = i ntNumSamples & " r JW:3 u 
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If IsNull (FormDefineFields . ListWeight . Value) = False Then 
Weight 
Else 
boolWeight = False 
End If 
'Mark fields that are selected for partitions, force include and force exclude 
boolUDG = false 
Dim arrTemp () As Integer 
ReDim arrTemp (O) 
For i = 1 To UBound (arrFieldNames ) + 1 
If FormDefineFields . ListUDG . Selected ( i - 1 ) = True ~hen 
arrinputData (i, UBound (arrinputData (), 2 ) - rowUDG) = ·,, " 
boolUDG = True 
strUDG = strUDG & ", " & arrinputData (i , 0 ) 
ReDim Preserve arrTemp (UBound (arrTemp , 1 ) + 1) 
arrTemp (UBound (arrTemp , 1 )) = i ' creates an array with the UDG field 
numbers 
End If 
If FormDefineFields . ListFEx . Selected (i - 1 ) = True And 
FormDefineFields . ListFI . Selected (i - 1 ) = True Then 
MsgBox ( ~t- .r, ( . .... ·-- ..... n'" ....... '" .... ~r, 1r, i 
t'X( . ·) ) 
GoTo DefineFields 
End :f 
If FormDefineFields . ListFEx . Selected (i - 1 ) = True Then 
arrinputData (i, UBound (arrinputData () , 2 ) - rowExclude ) = " :E·'" 
arrinputData (i, UBound (arrinputData () , 2 ) - rowlncl ) = 
ExcludeFieldNamesConcat = ExcludeFieldNamesConcat & arrinputData (i, 0 ) 
& 
End If 
If FormDefineFields . ListFI . Selected (i - 1 ) = True Then 
arrinputData (i , UBound (arrinputData (), 2 ) - rowFI ) = ' 
FITargetNamesConcat = FITargetNamesConcat & arrinputData ( i , 0 ) & 
End If 
Next i 
If FormDefineFields . BoxLimit.Value <> Then 
If IsNumeric (FormDefineFields . BoxLimit . Value ) = True Then 
intLimit = Int (FormDefineFields . BoxLimit . Value ) 
Else 
MsgBox ( ntrv f' ~r ' L t~ ' ,~,•r.l':)c.n:o JJ<:r ~!10 •t>• lll:t' t ~ =' 
m•J.Jt !?t• _r 
Else 
GoTo DefineFields 
End If 
intLimit = 0 
End If 
If FormDefineFields . BoxMaxParam.Value <> Then 
If IsNumeric (FormDefineFields . BoxMaxParam . Value ) = True Then 
:f FormDefineFields . BoxMaxParam . Value <= 1 And 
FormDefineFields.BoxMaxParam . Value > 0 7hen 
dblMaxParam = FormDefineFields . BoxMaxParam . Value 
Else 
MsgBox ( :r l.' •1 rara::-· •Pr Pu t•~ ,Jrcu•{ .r th"'.r z• r i:ll'.<l 
tb ; r ' ) 
GoTo DefineFields 
End If 
Else 
MsgBox C 1~1t 
fJdn r r ' 
Else 
GoTo DefineFields 
End If 
dblMaxParam = 0 
End If 
p.n_mett-r ·~u·t b<: .Fc.Jt..:r th<·r ·•0 nd ll 
261 
Appendix 1: Visual Basic Code for AuSeTIS software 
' Determine which column in arrResults is to be maximised 
If FormDefineFields . OpSID . Value = True Then intMaxParam = 1 
If FormDefineFields . OpWalli . Value = True Then intMaxParam = 9 
If FormDefineFields . OpWallii . Value = True Then intMax Param = 10 
I f FormDefineFields . OpRand . Value = True Then intMaxParam = 7 
If FormDefineFields . OpAdjRand . Value = True Then intMax Param = 8 
If FormDefineFields . opModeNormal = True Then 
I f intMaxParam <> 1 And boolUDG = False Then 
MsgBox ( " 
GoTo DefineFields 
End If 
End If 
!"~ 
~ ~-F ' · r 1 n J p t ~ t t- Jr -) "IU._. t \.lE' 
r.dn 
"'~· ' ) 
'create array with defined partitions and test the SID of it 
If boolUDG = True Then 
n jr )( 
ReDim arrUDG (intNumSamples , 1 ) 'creates array with the user defined groups 
for each isolate 
Fo r i = 1 To intNumSamples 
Fo r j = 1 To UBound (arrTemp , 1 ) 
If j = 1 Then 
arrUDG (i , 1 ) = arrinputData (arrTemp ( j ), i ) 
Else 
arrUDG (i , 1 ) arrUDG (i , 1 ) & " " & arrinputData (arrTemp ( j ), i ) 
End If 
Next j 
Next i 
' calculates simpson ' s index of diversity for UDGs 
ReDim arrUDGSID (S ) 
arrUDGSID () = SID (arrUDG) 
'reformats arrUDG so that it matches the format of the array produced in 
the SID function - arrCalc - that will 
' be used to compare partitions 
Re Di m arrUDG (UBound (arrCalc , 1 ), UBound (arrCalc, 2 )) 
For i = 0 To UBound (arrCalc , 1 ) 
Fo r j = 0 To UBound (arrCalc, 2 ) 
arrUDG ( i , j ) = arrCalc (i , j ) 
Ne xt j 
Ne x t i 
El se 
boolUDG = Fal se 
intMaxParam = 1 
End If 
Exi t Sub 
FileReadError : 
objExc . Workbooks.Close 
If MsgBox ( ' 1•r1• reJdina t~e ~' 1 e '" , vbRetryCancel ) = vbRetry 
Th e n 
GoTo FileRead 
Els e 
End 
End If 
End Sub 
Sub IdentifyNoninformative () 
'checks for Targets where all the samples have the same result so t hese can be 
excluded from the analysis 
'because they will not contribute to diversity 
'the noninformative Targets have [Yes) output to their second-last field in 
the array 
' skips Targets which are to be force included 
Dim i As Double 
Dim j As Do uble 
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Dim k As Doubl e 
Di m 1 As Double 
Dim strTemp As String 
Dim arrExcl As Variant 
ReDim arrExcl (1 , 0 ) 
T" arrExcl (O, 0 ) = 
arrExcl (1 , 0 ) = .... 
Dim arrFI As Variant 
ReDim arrFI (1 , 0 ) As Variant 
arrFI (O, 0 ) = 
arrFI (1 , 0 ) = PL0~ " 
Dim arrExcl2 As Var ian t 
Dim arrFI2 As Var iant 
For i = 1 ro intNumTargets 
strTemp = arrinputData (i , 1 ) 
For j = 2 To intNumSamples 
If strTemp <> arrinpu t Data ( i , j ) Then 
GoTo EndOfLoop 
End If 
Nex t j 
If arrinputData (i , UBound (arrinputData () , 2 ) - rowExclude ) <> E r: " Then 
If arrinputData (i , UBound (arrlnputData (), 2 ) - rowFI ) <> ·e~" Then 
arrlnputData ( i , UBound (arrinputData () , 2 ) - rowNI ) = 
arrlnputData (i , UBound (arrlnputData () , 2 ) - rowlncl ) 
NITargetNamesConcat = NITargetNamesConcat & arrlnputData ( i , 0 ) & 
' constructs a list of noninformative Targets for the report 
ReDim Preserve arrExcl (1 , UBound (arrExcl , 2 ) + 1 ) 
arrExcl (O, UBound (arrExcl , 2 )) = arrl nputData (i , 0 ) 
arrExcl (1 , UBound (arrExc l , 2 )) = arrlnputData (i , 1 ) 
:f arrExcl (1 , UBound (arrExcl , 2 )) = ' Then arrExcl (1 , UBound (arrExcl , 2 )) 
Else 
i ntNumN I Targets = i n tNumNITargets - 1 
ReD_m Preserve arrFI (1 , UBound (arrFI, 2 ) + 1 ) 
arrFI (O, UBound (arrFI , 2 )) = arrinputData ( i , 0 ) 
NIFITargetnamesConcat = NIFITargetnamesConcat & arrinputData ( i , 0 ) & ' 
arrFI (1 , UBound (arrFI , 2 )) = arrinputData ( i , 1 ) 
If arrFI (1 , UBound (arrFI , 2 )) = 7hen arrFI (1 , UBound (arrFI , 2 )) 
" <n· .. 
End If 
Else 
intNumNITargets 
End If 
intNumN I Targets 
EndOfLoop: 
Nex'" i 
i n tNumNITargets - 1 
i n t NumNITargets + 1 
ReDim arrExcl2 (UBound (arrExcl , 2 ) , UBound (arrExcl , 1 )) 
For i = 0 To UBound (arrExcl , 2 ) 
For j = 0 To UBound (arrExcl , 1 ) 
arrExcl2 ( i , j ) = arrExcl ( j , i ) 
Next j 
Next i 
ReD1m arrFI2 (UBound (arrFI , 2 ) , UBound (arrFI , 1 )) 
For k = 0 To UBound (arrFI , 2 ) 
For 1 = 0 To UBound (arrFI , 1 ) 
arrFI 2 ( k , 1 ) = arrFI ( l , k ) 
Next 1 
Ne x t k 
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If ( k > 1 Or i > 1 ) Then 
With FormNoninformative 
. ListExcl . List = arrExcl2 
.Listincl.List = arrFI2 
If i > 15 Then i = 15 
If k > 15 Then k = 15 
.Show 
End With 
End If 
End Sub 
Sub IdentifyConcordant () 
'checks all possible pairs of Targets to see if any have concordant results so 
that one of the pair can be excluded from the analysis 
'if one of a concordant pair is a Target chosen to be force included, then the 
other Target is excluded 
' if neither is a Target chosen to be force included, the user is prompted to 
choose the Target to exclude 
'noninformative Targets are skipped since they are excluded anyway 
Dim i As Double 
Dim j As Double 
Dim k As Double 
' ArrayA and Arrays are temporary arrays - each represents 1 of 2 results for 
Targets being compared to see if they are the same 
Dim ArrayA () As String 
ReDim ArrayA (intNumSamples ) 
Dim ArrayS () As String 
ReDim ArrayS (intNumSamples ) 
'checks to makes sure the Target hasn ' t already been excluded 
For i = 1 To intNumTargets 
-r arrinputData ( i , USound (arrinputData () , 2 ) - rowincl ) = 
GoTo LoopToi 
End If 
For j = i + 1 To intNumTargets 
:f arrinputData ( i , USound (arrinputData () , 2 ) - rowincl ) 
GoTo LoopToJ 
End If 
For k = 1 To intNumSamples 
ArrayA ( k ) = arrinputData ( i , k ) 
ArrayS ( k) = arrinputData ( j , k ) 
Next k 
If Join (ArrayA, ) = Join (ArrayB, ) :'hen 
" Then 
" Then 
If arrinputData ( i , UBound (arrinputData (), 2 ) - rowFI ) = ••l " And 
arrinputData ( j , UBound (arrinputData () , 2 ) - rowFI ) <> " Then 
arrinputData ( j , usound (arrinputData (), 2 ) - rowConcord) = '' 
arrinputData ( j , UBound (arrinputData () , 2 ) - rowincl ) = 
ConcordTargetNamesConcat = ConcordTargetNamesConcat & arrinputData ( j , 
0 ) & 
intNumConcordTargets = intNumConcordTargets + 1 
Go .·o LoopToJ 
End If 
If arrinputData ( i , UBound (arrinputData () , 2 ) - rowFI ) <> " ('·, " And 
arrinputData ( j , UBound (arrinputData () , 2 ) - rowFI ) = ·· " Then 
arrinputData (i , UBound (arrinputData (), 2 ) - rowConcord) = ~~ " 
arrinputData (i , UBound (arrinputData () , 2 ) - rowincl ) = 
ConcordTargetNamesConcat = ConcordTargetNamesConcat & arrinputData ( i , 
0 ) & 
intNumConcordTargets = intNumConcordTargets + 1 
GoTo LoopToi 
End If 
If arr!nputData ( i , UBound (arrinputData () , 2 ) - rowFI ) 
arrinputData ( j , UBound (arr!nputData () , 2 ) - rowFI ) = 
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Then 
f>..??endi~ 1:. \li!">\.ra\ 'Oa!">ic Code \m f>..uSeTIS !">Ott'Hafe 
MsgBox & arrinputData ( i , 0 ) & ·• a" I & arri nputData ( j , 0 ) 
' 
& Chr (10) & ~ 
••l€''1 : r ~I r f ' ) 
FIConcordTargetNamesConcat = FIConcordTargetNamesConcat & 
arrinputData ( i , 0 ) & & arrinputData (j, 0 ) & 
GoTo LoopToJ 
End If 
ConcordantTargets . Targetl . Caption = arrinputData ( i , 0 ) 
ConcordantTargets.Target2 . Caption = arrinputData ( j , 0 ) 
ConcordantTargets . Target2 . Value = True 
ConcordantTargets . Show 'prompts user to ask which of the two Targets to 
delete unless NormalvDeep mode is running 
If Concordan tTargets . Target2 . Value = True The n 
arrinputData ( j , UBound (arrinputData () , 2 ) - rowConcord) = 
arrinputData ( j , UBound (arrinputData (), 2 ) - rowincl ) = 
ConcordTargetNamesConcat = ConcordTargetNamesConcat & a r rinputData ( j , 
0 ) ' 
intNumConcordTargets = intNumConcordTargets + 1 
Else 
arrinputData ( i , UBound (arri nputData () , 2 ) - rowConcord) = 
arrinputData ( i , UBound (arrinputData () , 2 ) - rowi ncl ) = 
ConcordTargetNamesConcat = ConcordTargetNamesConcat & arrinputData ( i , 
0 ) ' 
intNumConcordTarge t s = intNumConcordTargets + 1 
End If 
LoopOut : 
End If 
LoopToJ : 
Nex t j 
LoopToi : 
Next i 
End Sub 
Sub StartResults () 
'this defines the results array and fills in the headers 
intResultLeadColumns = 15 ' the number of c o lumns before the target listing 
starts 
i ntResultLeadRows = 8 
ReDi m arrResults ( intResultLeadColumns + 1 , i n tResultLeadRows + 2 ) 
arrResults (1 , 1 ) = 
y & Now () 
arrResults (1 , 2 ) = strWtField 
arrResults (1 , 3 ) = intNumTargets & " 'nl.1-r .:.:. , Jer t I r , •· e d.;• 
If ExcludeFieldNamesConca t <> Th en 
arrResults (1 , 3 ) = arrResults (1 , 3 ) & 
t • II 
& Left (ExcludeFieldNamesConcat , Len (ExcludeFieldNamesConcat ) -
1 ) ' 
Else 
arrResults (l , 3 ) = arrResults (1 , 3 ) & 
End If 
If FI TargetNamesConcat <> 7hen 
arrResults (1 , 3 ) = arrResults (l , 3 ) & 
cc, umns Wt! f Jr- xr ~t..de·l." 
~.. & Left (FITargetNamesConcat , Len (FITargetNamesConcat ) - 1 ) & 
Else 
arrResults (1 , 3 ) = arrResults (1 , 3 ) & 
End If 
If NITargetNamesConcat <> ''" Then 
arrResults (1 , 5 ) = 
~Jt ': ,£~r, .. - W( r f,~)! ... r .. l . -I~d." 
ex & Left (NITargetNamesConcat , Len (NITargetNamesConcat ) - 1 ) & 
If NIFITargetnamesConcat <> • Then 
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arrResults (1 1 5 ) = arrResults (1 1 5 ) & 
Len (NIFITargetnamesConcat ) - 1 ) & " " 
End : f 
Else 
If NIFITargetnamesConcat <> ' Then 
arrResults (1 1 5 ) = 
" & Left (NIFITargetnamesConca t 1 
.r: ~ . .-i~d : " & Left (NI FITargetnamesConca t 1 Len (NI FITargetnamesConca t ) - 1 ) & 
Else 
arrResults (1 1 5 ) = 
End If 
End If 
r .'l rqe>t 
If ConcordTargetNamesConcat <> "" The n 
arrResul ts (1 1 6 ) = 1w 
t-.'ert• nc)r, rf , .. rn_t"~r .. 
'1 w~. r l l d r • 
& 
Left (ConcordTargetNamesConcat 1 Len (ConcordTarge t NamesConcat ) - 1 ) & 
I f FIConcordTargetNamesConcat <> Then 
r 
arrResults (1 1 6 ) = arrResults (1 1 6 ) & ' t l.l >'~Lrl<l D ,l.J:" >' •.H 4 
we '' & 
Left (FIConcordTargetNamesConcat 1 Len (FIConcordTargetNamesConcat ) - 1 ) & 
End If 
Else 
If FIConcordTargetNamesConcat <> 
arrResults (1 1 6 ) = 
Then 
& LefL (FIConcordTargetNamesConcat 1 
Len (FIConcordTargetNamesConcat ) - 1 ) & " 
Else 
arrResults (1 1 6 ) = 
End If 
End If 
x· 
r, - r; Ha! llJ 
" 
l " 
r i 
If boolUDG = ~rue Then 
arrResults (1 1 7 ) = 
& strUDG & f. t h 
t•r.ct D 
par & Round (arrUDGSID (1 ) 1 5 ) & 
Else 
arrResults (1 1 7 ) = "1 , preexL:>t 1n.1 P-' 
End :f 
it' _,r \oil;'rp rPfJ.nr•d DY t'·~ u~ .. r ." 
If FormDefineFields . opModeDeep 
arrResults (1 , 8 ) = x 
t 
Else 
~("> w 
':'rue Then 
'r(t. A)t~J . 
x _lm r0d t--r·Y t-
r~!:; .... · ... t ·f 
mr :t , r I-
:.:·· n ..... , · r 
.. l Vf• " 
f 
arrResults (1 , 8 ) rL;t!.C' ::..f'.J>"(.h USP<.1 : It w~::: ,_ ~5\mt> l ~l-J,, th<:: '">$ 1• 
f . ~~ n taJ:,~t !'; if> ;.i r ; Jbr·et- I [ t h<"" (), ,._ .A.fl .. \[ffidt l. J 
r n .... 1 ,.. 1r.-iE""·r~ " 
End If 
Dim strParameterName As String 
If FormDefineFields . OpSID = True Then strParameterName = l I < Ir'i ·x ·f 
If FormDefineFields . OpRand = True Then strParameterName = 
If FormDefineFields . OpAdj Rand = True Then strParameterName 
t (' cL.:: ... r~iE! fJ._ " 
l "'!l'•tl'u fUr. I 
If FormDefineFields . OpWalli = True Then strParameterName = <."L.,- .. ,,j Wt'L.l.;t 
If FormDef ineFields . OpWallii = True Then strParameterName = ' •. J 1•ut~: l w ~ 1' ;( E' 
n• 
'If FormDefineFields. opModeDeep : True Then strParameterName = "Simpson's 
Index of Divers ity" 
arrResul ts (1 I 4 ) = Ux 1 r i .f?j J:....:.I _me':cr 10 -; '"r,r· & s trParamet erName & 
arrResults (1 1 intResultLeadRows + 1 ) = 
arrResults (2 1 intResultLeadRows + 1 ) 
arrResul t s (3 1 intResultLeadRows + 1 ) 
h>-
oU!"l.e,. 
;.mp 
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+ 1 ) 
+ 1 ) = 'f P' r ~.., (I I .. 
arrResults (4 , intResultLeadRows 
arrResults (S , intResultLeadRows 
arrResults (6 , intResultLeadRows 
arrResults (7 , intResultLeadRows 
arrResults (intResultLeadColumns 
arrResults (2 , intResultLeadRows 
arrResults (3 , intResultLeadRows 
arrResults (4 , intResultLeadRows 
arrResults (S , intResultLeadRows 
arrResults ( 6 , intResultLeadRows 
arrResults (7 , intResultLeadRows 
+ 1 ) = ·r ;c ~ i . n , r ~t,'lt:! ........ CfY(}UP " 
+ 1 ) = "• 
+ 1 , intResultLeadRows + 1 ) = 
+ 2 ) = 0 
+ 2 ) = 0 
+ 2 ) = 0 
+ 2 ) = 0 
+ 2 ) = 1 
+ 2 ) = 1 
~f boolUDG = True The n 
arrResults (S , intResultLeadRows + 1 ) = " (Jnd rr...ef" ·1er t" 
arrResults (9 , intResultLeadRows + 1 ) = lj._-, .. c I "1r 1 ."( p F t' 
arrResults (10 , intResultLeadRows + 1 ) = ,rj 1 H t r I ~;-tl~.:t<..." Jl. 
arrResults (11 , intResultLeadRows + 1 ) = .JW~I 
arrResults (12 , intResultLeadRows + 1 ) = 'r ::>r:r .)') . 
arrResults ( l3 , intResultLeadRows + 1 ) = ,j•~JtEd W 
arrResults (14 , intResultLe adRows + 1 ) = ,, •• iJ( r ·l"l· 
Else 
arrResults (15 , intResultLeadRows + 1 ) = 
arrResults (S , intResultLeadRows + 2 ) = 0 
arrResults (9 , intResultLeadRows + 2 ) = 0 
arrResults (10 , intResultLeadRows + 2 ) = 0 
arrResults (11 , intResultLeadRows + 2 ) = 0 
arrResults (12 , intResultLeadRows + 2 ) = 0 
arrResults (13 , intResultLeadRows + 2 ) = 0 
arrResults (14 , intResultLeadRows + 2 ) = 0 
arrResults (15 , intResultLeadRows + 2 ) = 0 
arrResults (S , intResultLeadRows + 1 ) = 
arrResults ( 9 , intResultLeadRows + 1 ) = 
arrResults (10 , intResultLeadRows + 1 ) 
arrResults (11 , intResultLeadRows + 1 ) = 
arrResults (12 , intResultLeadRows + 1 ) 
arrResults ( l3 , intResultLeadRows + 1 ) = 
arrResults (14 , intResultLeadRows + 1 ) = 
arrResults (15 , intResultLeadRows + 1 ) 
End If 
End Sub 
Function SID (arrSID () As Variant ) As Varia nt 
ppt·r 
' note that arrSID is in the format (rows , columns) 
j 
"""!" 
.. I II 
._~.r'l~t 
r '" .. t-tl 
" 
Dim arrSIDResult As Var i an t ' one dimensional array for result of the function 
ReDim arrSIDResult (S) 
Dim intG As Double ' number of columns (Targets) in input array 
Dim intS As Double ' number of rows (samples) in input array 
Dim numTypes As Doubl e ' number of unique types in input array 
Dim pcLargestGroup As Doub le ' percentage of samples in the largest type group 
in array 
Dim SumnjXnjml As Doub le ' portion of SID formula : sum [nj X (nj - 1)] 
Di m SumFsqrd As Doub le ' for standard deviation of SID calculation 
Dim SumFcubed As Doub l e ' for standard deviation of SID calculation 
intG = UBound (arrSID , 2 ) 
intS = UBound (arrSID , 1 ) 
Dim arrTemp () As Str _ng 'array to hold the data for a single sample , required 
so Join function can be used? 
ReDim arrTemp {intG) 
ReDi m arrCalc (2 , inLS ) 
Dim i As Dou b _e 
Dim j As Double 
For ~ = 1 To intS 
Fo r j = 1 To intG 
arrTemp ( j ) = arrSID ( i , j ) ' transfer data for one sample from input array to 
arrTemp 
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Next j 
arrCalc (O, i ) = Join (arrTemp , ) ' concatenate data from arrTemp and put it 
in the first dimension of arrCalc 
'nb arrCalc is a global variable - it is also used for the ComparePartitions 
function 
Next i 
For i = 1 7o intS 
If arrCalc (1 , i ) <> · y•nt<' i " Then 
arrCalc (1 , i ) = a " ' mark as counted 
arrCalc (2 , i ) = 1 ' keep track of number of unique types 
For j = i + 1 To intS 
~f arrCalc (O, i ) = arrCalc (O, j ) Then 
arrCalc (2 , i ) = arrCalc (2 , i ) + 1 ' keep track of number of unique types 
arrCalc (1 , j ) = " ')'Jr1 ' ' mark as counted 
End If 
Next j 
numTypes = numTypes + 1 ' count total number of types 
SumnjXnjml = SumnjXnjml + (arrCalc (2 , i ) * (arrCalc (2 , i ) - 1 )) ' portion of 
SID formula 
SumFsqrd = SumFsqrd + ((arrCalc (2 , i ) I intS ) ~ 2 ) 
SumFcubed = SumFcubed + ((arrCalc {2 , i ) I intS ) ~ 3 ) 
If arrCalc (2 , i ) I intS > pcLargestGroup Then pcLargestGroup 
intS 'keep track of pic in largest group 
End If 
Next i 
arrSIDResult (O) = UBound (arrSID , 2 ) 
arrCalc (2 , i ) I 
arrSIDResult (1 ) = 1 - ( (1 I (intS * ( intS - 1 ))) * SumnjXnjml ) 'calculate SID 
If (CDbl ((SumFcubed ~ 0 . 5 )) - CDbl (SumFsqrd)) < 0 . 00000000000001 Then 
'prevents error when SD is very low 
arrSIDResult (2 ) 
arrSIDResult (3 ) = 
Else 
arrSIDResult (2 ) = arrSIDResult (1 ) - 2 * ((( 4 I intS ) * (SumFcubed -
(SumFsqrd ~ 2 ))) ~ 0 . 5 ) ' lower 95% ci 
:f arrSIDResult {2 ) < 0 Then arrSIDResult (2 ) = 0 
arrSIDResult (3 ) = arrSIDResult (1 ) + 2 * ((( 4 I intS ) * (SumFcubed -
(SumFsqrd ~ 2 ))) ~ 0 . 5 ) ' upper 95~ ci 
-f arrSIDResult (3 ) > 1 7hen arrSIDResult (3 ) = 1 
End _f 
arrSIDResult ( 4 ) = 
arrSIDResult (S ) 
pcLargestGroup 
numTypes 
' output results - row 2 is the SID, row 2 and 3 are the lower and upper 95% 
Cis row 4 the in the largest group and 5 is the number of types 
SID = arrSIDResult 
End Function 
Sub TestSID () 
'Used in Standard mode , this sub determines combinations of targets and tests 
them, outputing results to arrResults 
Dim arrDataSIDA () As Variant 'a temporary array for data to send to the SID 
function 
ReDim arrDataSIDA (intNumSamples , 0 ) 
Dim arrDataSIDB () As Varian~ ' a temporary array for calculate the maximum SID 
Dim arrSIDA () As Variant ' a temporary array for the results of the SID 
function 
ReD~m arrSIDA (S) 
Dim - As In eger 
Dim j As Integer 
Dim k As Integer 
Dim n As Integer 
Dim o As Integer 
Dim m As Integer 
D~m p As Integer 
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Dim intCombsRemaining As Integer ' for the counter 
Dim z As Integer ' number of rows in the last block 
Dim intThreshold As Integer 
Dim PercentComplete As Double 
Dim arrCompPart () As Variant ' a temporary array for the results of the compare 
partitions function 
Dim arrRand () As Integer 
Dim arrRandResults () As Variant 
Dim intMaxParamRes As Integer 'adjusts intmaxparam so that it works with 
arrResults 
If intMaxParam > 6 Then intMaxParamRes 
If intMaxParam < 6 Then intMaxParamRes 
' start timer 
Dim dblStart , dblFinish As Double 
dblStart = Timer 
ReDim arrCompPart (S) 
z = 0 
intMax Param + 1 
intMaxParam + 2 
' populate arrDataSIDB with all of the targets to be tested to determine 
maximum possible SID 
ReD: m arrDataSIDB (intNumSamples , 0 ) 
For i = 1 ~o UBound (arrinputData , 1 ) 
If arrinputData (i , UBound (arrinputData , 2 ) - rowincl ) <> Then 
ReDim Preserve arrDataSIDB (intNumSamples , UBound (arrDataSIDB , 2 ) + 1 ) 
For j = 1 ~o intNumSamples 
arrDataSIDB ( j , UBound (arrDataSIDB , 2 )) = arrinputData ( i , j ) 
Next j 
End If 
N' XL i 
arrSIDA () = SID (arrDataSIDB) 
arrResults (1 , intResultLeadRows + 2 ) = arrSIDA (1 ) ' store maximum possible SID 
in the threshold cell in arrResults for now 
dblMax SID = arrSIDA (1 ) 
If FormDefineFields . OpSID = True Then arrResults (1 , 4 ) arrResults (1 , 4 ) & 
v',. 1~· ;:. )=- & dblMax SID & 
If FormDefineFields . opMod eNormal = True Then 
If dblMax Param <> 0 And dblMax Param <> 1 Then 
arrResults (1 , 4 ) = arrResults (1 , 4 ) & 
r•d' tht~ p,Jr J & dblMax Param & 
End If 
If intLimit > 0 Then 
arrResults (1 , 4 ) 
mt..ina 
End If 
End If 
If intMaxParam = 1 Then 
arrResults (1 , 4 ) & 
& i n tLimit & 
r 1 r ~ _., "' 
e!' 'ir:-,, t£:J n 
If dblMaxParam = 0 Then dblMax Param = arrSIDA (1 ) ' if no maximum is 
defined by user and the maximising parameter is SID then make the maximum 
equal to the maximum SID 
If dblMax Param > arrSIDA (1 ) Then dblMaxParam = arrSIDA (1 ) ' if the 
maximising parameter .s SID but the defined maximum is > the maximum 
possible SID, set it to the maximum 
Else 
If dblMaxParam = 0 Then dblMax Param = 1 ' if a concordance measure is the 
maximising parameter and no maximum defined , set maximum as 1 
End If 
'determine number of targets to be included in the analysis 
Di m intNumTargetsToCheck As Integer 
For i = 1 To UBound (arrinputData , 1 ) 
:f arri nputData ( i , UBound (arrinputData , 2 ) - rowincl ) <> • 
intNumTargetsToCheck = intNumTargetsToCheck + 1 
Next i 
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' Initialises progress bar 
If FormDefineField s . chkProgressBar = True Then 
CounterForm. LabelPr ogress . Wid th = 0 
CounterForm . TotalComb . Caption = intNumTargetsToCheck 
CounterForm . Show 
CounterForm . Repai nt 
End :f 
' starts with calculating results for the force 
For i = 1 To UBound (arrinputData , 1 ) 
included targets 
If arrinputData ( i , UBound (arrinputData , 2 ) 
z = 1 ' make the last block size = 1 
- rowFI ) .., " Then 
ReDim Preserve arrDataSIDA (intNumSamples , UBound (arrDataSIDA , 2 ) + 1 ) 
For j = 1 To intNumSamples 
' populate array for the SID calculation for force i ncluded targets 
arrDataSIDA (j , UBound (arrDataSIDA , 2 )) = arrinputData ( i , j ) 
Next j 
' do the SID calculation and put results in results array for force 
included targets 
+ 1 ) 
arrSIDA = SID (arrDataSIDA ) 
ReDim Preserve arrResults (UBound (arrResults , 1 ) , UBound (arrResults , 2 ) 
arrResults (2 , UBound (arrResults , 2 )) = arrSIDA (O) 
arrResults (3 , UBound (arrResults , 2 )) = arrSIDA (1 ) 
arrResults (4 , UBound (arrResults , 2 )) = arrSIDA (2 ) 
arrResults (S , UBound (arrResults , 2 )) = arrSIDA (3 ) 
arrResults (6 , UBound (arrResults , 2 )) = arrSIDA (4 ) 
arrResults (7 , UBound (arrResults , 2 )) = arrSIDA (S) 
If boolUDG = rue 7hen 
arrCompPart = ComparePartitions (arrCalc , arrUDG ) 
arrResults (B, UBou nd (arrResults , 2 )) = arrCompPart (O) 
arrResults (9 , UBound (arrResults , 2 )) = arrCompPart (1 ) 
arrResults (10 , UBound (arrResults , 2 )) = arrCompPart (2 ) 
arrResults (11 , UBound (arrResults , 2 )) = arrCompPart (4 ) 
arrResults (12 , UBound (arrResults , 2 )) = arrCompPart (S) 
arrResults (13 , UBound (arrResults , 2 )) = arrCompPart (3 ) 
arrResults (14 , UBound (a r rResults , 2 )) = arrCompPart (6 ) 
arrResults (15 , UBound (arrResults , 2 )) = arrCompPart (7 ) 
End If 
'update counter bar 
PercentComplete = arrResults (2 , UBound (arrResults , 2 )) I 
intNumTargetsToCheck 
10) 
If PercentComplete > 1 Then 
PercentComplete = 1 
End If 
If FormDefineFields . chkProgressBar = True Then 
With CounterForm 
. FrameProgress . Caption = Format ( PercentComplete , 
. LabelProgress . Width = PercentComplete * ( . FrameProgress . Width -
. Repaint 
End W.Lh 
End If 
' mark target as having been used in the inputdata array 
arrinputData ( i , UBound (arri nputData , 2 ) - rowincl ) 
For k = 1 To UBound (a r rinputData , 1 ) 
:f arrinputData ( k , UBound (arrinputData , 2 ) - rowi ncl ) 
:hen arrResults ( intResultLeadColumn s + 1 , UBound (arrResults , 2 )) = 
arrResults (intResultLeadColumns + 1 , UBound (arrResults , 2 )) & k & 
Next k 
End If 
Next i 
'calculate Parameters for combinations of rest of targets to be included 
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Dim arrBlock () As Variant 'a "block" is a list of several target subsets each 
of the same size 
Di m strTemp As String 
Dim w As Integer 
Dim x As :n eger 
x = intNumTargetsToCheck - UBound (arrDataSIDA , 2 ) 'x is the number of targets 
left to check 
Fo r w = 1 To x 
If z <> 0 Then 'z=O if there were no force included targets 
ReDim arrBlock ( intResultLeadColumns , ( intNumTargetsToCheck - arrResults (2 , 
UBound (arrResults , 2 ))) * z ) ' subsequent block sizes depend on the size of 
the last block 
Else 
ReDim arrBlock ( intResultLeadColumns , intNumTargetsToCheck ) ' if no fi 
targets, inital block size is the number of targets 
End If 
ReDim Preserve arrDataSIDA (intNumSamples , UBound (arrDataSIDA , 2 ) + 1 ) 
If z = 0 Then 'creates the initial block (ie : one target on each line) when 
there are no fi targets 
For j = 1 ~o UBound (arrBlock , 2 ) 
For i = 1 7o UBound (arrinputData , 1 ) 
arrinputData ( i , UBound (arri nputData, 2 ) - rowincl ) <> 
arrinputData ( i , UBound (arrinputData , 2 ) - rowincl ) <> Then 
arrinputData (i , UBound (arrinputData , 2 ) - rowincl ) = 
For k = 1 To intNumSamples 
arrDataSIDA ( k , UBound (arrDataSIDA , 2 )) = 
arrinputData ( i , k ) 
Next k 
arrSIDA = SID (arrDataSIDA) 
arrBlock (6 , j ) = i & 
arrBlock (O, j ) = arrSIDA (O) 
arrBlock (1 , j ) = arrSIDA (1 ) 
arrBlock (2 , j ) = arrSIDA (2 ) 
arrBlock (3 , j ) = arrSIDA (3 ) 
arrBlock (4 , j ) = arrSIDA (4 ) 
arrBlock (S , j ) = arrSIDA (S ) 
If boolUDG = True Then 
arrCompPart = ComparePartitions (arrCalc , arrUDG ) 
arrBlock (7 , j ) = arrCompPart (O) 
arrBlock (B, j ) = arrCompPart (1 ) 
arrBlock (9 , j ) = arrCompPart (2 ) 
arrBlock (10 , j ) = arrCompPart (3 ) ' change 
arrBlock (11 , j ) = arrCompPart (4 ) 
arrBlock (12 , j ) = arrCompPart (S) 
arrBlock (13 , j ) = arrCompPart (6 ) 
arrBlock (14 , j ) = arrCompPart (7 ) 
End T" 
i = UBound (arrlnputData , 1 ) 
End If 
Next i 
Next j 
' unmark the rows as being included 
Fo r i = 1 To UBound (arrinputData , 1 ) 
" And 
I f arrinputData ( i , UBound (arrinputData , 2 ) - rowincl ) 
arrinputData ( i , UBound (arrinputData , 2 ) - rowincl ) 
" Then 
Next i 
Else ' creates subsequent blocks using each line of the previous block 
p = 1 ' p is the current row of arrBlock 
For i = 1 To z ' z is the number of rows in the last block in arrResults 
strTemp 
'remove the i ' s from arrinputData : 
For j = 1 To UBound (arrinputData, 1 ) 
:f arrinputData ( j , UBound (arrinputData , 2 ) - rowincl ) = 
arrinputData (j, UBound (arrinputData , 2 ) - rowincl ) = 
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Nex t j 
' put the i ' s in to arrinputData for each row of the block (i=l to z) : 
For j = 1 ~o Len (arrResults ( intResultLeadColumns + 1 , 
(UBound (arrResults , 2 ) - z ) + i )) ' j is the point in the target string 
-f M~d ( arrResults ( intResultLeadColumns + 1 , (UBound (arrResults, 2 ) 
- z ) + i ) , j , 1 ) <> The n 
strTemp = strTemp + Mid (arrResults ( intResultLeadColumns + 1 , 
(UBound (arrResults , 2 ) - z ) + i ) , j , 1 ) 
Else 
arrinputData (strTemp , UBound (arrinputData , 2 ) - rowinc l ) = " 
'marks the targets in arrinputData that were used in the current row of the 
last block 
strTemp = 
End If 
Ne x t j 
For k = 1 To UBound (arrinputData , 1 ) 
'mark the next target: 
If arrinputData ( k , UBound (arrinputData , 2 ) - rowincl ) <> 
arrinputData (k, UBound (arrinputData, 2 ) - rowincl ) <> ,. The n 
arrinputData ( k , UBound (arrinputData , 2 ) - rowincl ) = 
n = 1 
" And 
' populate arrDataSIDA to determine SID for this combinatio n 
using the marks ("I " ) in arrinputData 
urn Then 
For o = 1 To UBound (arrinputData , 1 ) 
: f arrinputData (o, UBound (arrinputData , 2 ) - rowincl ) 
arrBlock (6 , p ) = arrBlock (6 , p ) & o & 
For m = 1 To intNumSamples 
arrDataSIDA (m, n ) = arrinputData (o, m) 
Next m 
n = n + 1 
End I f 
Nex t o 
' test SID for this combination and add it to t he arrBlock row 
arrSIDA = SID (arrDataSIDA) 
arrBlock (O, p ) = arrSIDA (O) 
arrBlock (1 , p ) = arrSIDA (1 ) 
arrBlock (2 , p ) = arrSIDA (2 ) 
arrBlock (3 , p ) = arrSIDA (3 ) 
arrBlock ( 4 , p ) = arrSIDA (4 ) 
arrBlock (S , p ) = arrSIDA (S) 
If boolUDG = True The n 
arrCompPart = ComparePartitions (arrCalc , arrUDG) 
arrBlock (7 , p ) = arrCompPart (O) 
arrBlock (S , p ) = arrCompPart (1 ) 
arrBlock ( 9 , p ) = arrCompPart (2 ) 
arrBlock (10 , p ) = arrCompPart (3 ) ' change 
arrBlock (11 , p ) = arrCompPart (4 ) 
arrBlock (12 , p ) = arrCompPart (S) 
arrBlock (13 , p ) = arrCompPart ( 6 ) 
arrBlock (14 , p ) = arrCompPart (7 ) 
End If 
p = p + 1 
' unmark the target that was just tested 
arrinputData (k , UBound (arrinputData , 2 ) - rowincl ) 
End If 
Ne x t k 
If FormDefineFields . chkProgressBar 
With CounterForm 
. Label3 . Caption = r• •. Ldt.rn 
.Repaint 
End With 
End If 
Nex t i 
= True Then 
K : & ( z - i ) 
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End If 
' determine the maximum of the nominated parameter that is in the arrBlock that 
was just created 
Dim dblMaxBlockParam As Double 
dblMaxBlockParam = - 1000 
Fo r i = 1 To UBound (arrBlock , 2 ) 
: f arrBlock (intMaxParam, i ) > dblMaxBlockParam Then dblMaxBlockParam = 
arrBlock (intMaxParam, i ) 
Next i 
' add block row to results array if the parameter for that row is equal to the 
maxparameter for the block and the combination hasn ' t already appeared 
z = 0 
Di m boolTemp As Boolean 
boolTemp = Fa l se 
Fo r i = 1 ~o UBound (arrBlock , 2 ) 
Tf arrBlock (intMaxParam, i ) = dblMaxBlockParam Then 
I f z > 0 Then 
For j = 0 To z 
If arrResults ( intResultLeadColumns + 1 , UBound (arrResults , 2 ) 
- j ) = arrBlock (6 , i ) The n boolTemp = True ' make boolTemp true if this 
combination already appears in arrResults 
Ne xt j 
End If 
If boolTemp = False Then 'if the combination wasn ' t already found in 
arrResults, then add it 
z = z + 1 
ReDim Pre s e r ve arrResults (UBound (arrResults , 1 ), 
UBound (arrResults , 2 ) + 1 ) 
arrResults (2 , UBound (arrResults, 2 )) 
arrResults (3 , UBound (arrResults , 2 )) 
arrResults ( 4 , UBound (arrResults , 2 )) 
arrResults (S , UBound (arrResults , 2 )) 
arrResults ( 6 , UBound (arrResults , 2 )) 
arrResults (7 , UBound (arrResults , 2 )) 
arrResults ( intResultLeadColumns + 1 , 
arrBlock (O, i ) 
arrBlock (1 , i ) 
arrBlock (2 , i ) 
arrBlock (3 , i ) 
arrBlock ( 4 , i ) 
arrBlock (5 , i ) 
arrBlock (6 , i ) 'put in target numbers - to be 
UBound (arrResults , 2 )) = 
replaced by names later 
If boolUDG = Tru e Then 
arrResults ( B, UBound (arrResults , 2 )) = arrBlock (7 , i ) 
arrResults (9 , UBound (arrResults , 2 )) = arrBlock ( B, i ) 
arrResults (lO , UBound (arrResults, 2 )) = arrBlock (9 , i ) 
arrResults (11 , UBound (arrResults , 2 )) = arrBlock (ll , i ) 
arrResults (12 , UBound (arrResults , 2 )) = arrBlock (12 , i ) 
arrResults (13 , UBound (arrResults , 2 )) = arr8lock (10 , i ) 
arrResults (14 , UBound (arrResults , 2 )) = arrBlock (13 , i ) 
arrResults (15 , UBound (arrResults , 2 )) = arrBlock (14 , i ) 
End If 
' update counter bar 
i n tCombsRemaining = z 
PercentComplete = arrResults (2 , UBound (arrResults, 2 )) I 
intNumTargetsToCheck 
- 10) 
Else 
If PercentComplete > 1 Then 
PercentComplete = 1 
End I f 
If FormDefineFields . chkProgressBar = True The n 
With CounterForm 
.FrameProgress . Caption = Format (PercentComplete , " ) 
. LabelProgress . Width = PercentComplete * (. FrameProgress . Width 
. Label2 . Caption 
. Label3 . Caption 
. Repaint 
End Wi th 
End If 
u•rPrr •,,t .!'" _•:-e: & arrBlock (O, i ) 
rnt ~r 1 • i 'r, ~ ' _.n..- _. ~ & z 
boolTemp 
End If 
False 
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' this is used where the user had limited the number of subsets to be examined 
I f intLimit > 0 And z > intLimit Then 
' Generate random list of z nonduplicate numbers 
ReDim arrRand ( z ) 
For i = 1 To z 
arrRand ( i ) = i 
Ne x t i 
D~m max , a , b , v As In teg e r 
max = UBound (arrRand) 
For a = max To 1 Step - 1 
b = Int (Rnd () * a ) + 1 ' pick o ne to switch 
v = arrRand (a ) 
arrRand (a ) = arrRand (b ) 
arrRand (b ) = v 
Next a 
' take first intLimit o f the random numbers 
ReDim Preserve arrRand (intLimit) 
ReDim arrRandResu l ts (UBound (arrResults , 1 ), intLimit ) 
Fo r j = 1 ~o intLimit 
For i = 1 To UBound (arrResults , 1 ) 
arrRandResults ( i, j ) = arrResults ( i , UBound (arrResu l ts , 2 ) -
(arrRand ( j ) - 1 )) 
Nex t i 
Nex t j 
For i = 1 ~o UBound (arrRandResults , 1 ) 
For j = 1 To intLimit 
arrResults ( i , UBound (arrResults , 2 ) - ( z - j )) = arrRandResults ( i , 
j ) 
Next j 
Next i 
' remove rows from the block on array results according the the users limit 
ReDim Preser ve arrResults (UBound (arrResults , 1 ) , UBound (arrResults , 2 ) -
( z - in t Limit )) 
z = intLimit 
End If 
' if max parameter has been reached then stop analysis 
n = 0 
If arrResults ( intMaxParamRes , UBound (arrResults , 2 )) >= dblMaxParam Then 
arrResults (1 , intResultLeadRows + 2 ) = arrResults (2 , UBound (arrResults , 
2 )) ' put in the threshold 
If w <> x ~hen 
w = x ' ie : effectively exits the For w =1 to x cycle 
k = 0 
'put the i ' s in to arrinputData for each row of the block (i=l t o z) 
For j = 1 To Len (arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults , 2 ))) ' j is the point in the target string 
:f Mid (arrResults ( intResultLeadColumns + 1 , UBound (arrResults , 
2 )), j , 1 ) <> The n 
strTemp = strTemp + Mld (arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults , 2 )) , j , 1 ) 
Else 
arri nputData (strTemp , UBound (arrinputData , 2 ) - rowincl ) = ' :" 
' marks the targets in arrinputData that were used in the current row of the 
last block 
k = k + 1 
'populate arrDataSIDA 
For n = 1 To intNumSamples 
arrDataSIDA (n, k ) = arrinputData (strTemp , n ) 
Ne xt n 
strTemp 
End If 
Next j 
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'This code continues with remaining targets one at a time and 
calculates parameters until none left 
I f FormDefineFields . BoxMaxParam = 1 Or FormDefineFields . BoxMaxParam 
""Or IsNull (FormDefineFields . BoxMaxParam) = True Or 
FormDefineFields . BoxMaxParam = 0 Then 
For m = 1 To UBound (arrinputData , 1 ) 
If arrinputData (m, UBound (arrinputData , 2 ) - rowinc l ) <> " Cr.~ " And 
arrinputData (m, UBound (arrinputData , 2 ) - rowincl ) <> Then 
arrinputData (m, UBound (arrinputData , 2 ) - rowincl ) = 
ReDim Preserve arrDataSIDA (intNumSamples , UBound (arrDataSI DA, 
2 ) + 1 ) 
For n = 1 To i ntNumSamples 
arrDataSIDA ( n , UBound (arrDataSIDA , 2 )) arrinputDa t a (m, 
n ) 
Nex t n 
ReDim Preserve arrResul ts (UBound (arrResu l ts , 1 ) , 
UBound (arrResults , 2 ) + 1 ) 
arrSIDA () = SID (arrDataSIDA) 
arrResults (2 , UBound (arrResults , 2 )) = 
arrResults (3 , UBound (arrResults , 2 )) 
arrResults (4 , UBound (arrResults , 2 )) 
arrResults (S , UBound (arrResults , 2 )) 
arrResults (6 , UBound (arrResults , 2 )) 
arrResults (7 , UBound (arrResults , 2 )) = 
If boolUDG = ~rue Then 
arrSIDA (O) 
arrSIDA (1 ) 
arrSIDA (2 ) 
arrSIDA ( 3 ) 
arrSIDA (4 ) 
arrSIDA {S ) 
arrCompPart = ComparePartitions (arrCalc , arrUDG) 
arrResults (S , UBound (arrResults , 2 )) = arrCompPart (O) 
arrResults (9 , UBound (arrResulLs , 2 )) = arrCompPar t (1 ) 
arrResults (10 , UBound (arrResul ts , 2 )) = arrCompPart (2 ) 
arrResul t s (11 , UBound (arrResults , 2 )) = arrCompPart (4 ) 
arrResults (12 , UBound (arrResults , 2 )) = arrCompPart (S ) 
arrResults (13 , UBoun d (arrResults , 2 )) = arrCompPart (3 ) 
arrResults (14 , UBound (arrResults , 2 )) = arrCompPart (6 ) 
arrResults (15 , UBound (arrResults , 2 )) = arrCompPart (7 ) 
End If 
' update counter bar 
PercentComplete = arrResults (2 , UBound (arrResults , 2 )) I 
intNumTargetsToCheck 
:f PercentCompl ete > 1 Then 
PercentComplete = 1 
End If 
If FormDefineFie l ds . chkProgressBar = True Then 
With CounterForm 
. FrameProgress . Caption = Format ( PercentComplete , " t 
. LabelProgress . Width = PercentComplete * 
( . FrameProgress . Width - 10 ) 
. Repaint 
End With 
End I f 
For n = 1 To UBound (arrinputData , 1 ) 
:f arrinputData ( n , UBound (arrinputData , 2 ) - rowincl ) 
" " Then strTemp = strTemp & n & 
Nex t n 
arrResults ( i n tResultLeadColumns + 1 , UBound (arrResults , 2 )) 
strTemp 
strTemp 
End If 
Nex t m 
End If 
End If 
End If 
Next w 
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'replace target numbers with target names 
strTemp = 
Dim strTemp2 As String 
For i = intResultLeadRows + 3 To UBound (arrResults , 2 ) 
For j = 1 To Len (arrResults ( intResultLeadColumns + 1 , i )) ' j is the point 
in the target string 
If M~d (arrResults ( intResultLeadColumns + 1 , i ) , j , 1 ) <> ~hen 
strTemp = strTemp + Mid (arrResults (intResultLeadColumns + 1 , 
i ) , j , 1 ) 
Next j 
Else 
strTemp2 = strTemp2 & arri nputData (strTemp , 0 ) & 
strTemp 
End If 
arrResults ( intResultLeadColumns + 1 , i ) 
2 ) 
Left (strTemp2 , Len (strTemp2 ) -
strTemp2 
Next i 
dblFinish = Timer 
Dim dblTemp As Double 
dblTemp = dblFinish - dblStart 
dblHours = Int (dblTemp I 3660) 
dblMinutes = Int ((dblTemp - (dblHours * 3660)) I 60 ) 
dblSeconds = Round ((dblTemp - (dblHours * 3660) - (dblMinutes * 60 )) , 0 ) 
arrResults (l , 1 ) = 
dblMinutes & 
arrResults (l , 1 ) & 
& dblSeconds & 
F- ••:J: & dblHours & 
' put in the t hreshold if parameter to maximise is other than SID 
' If intMaxParamRes <> 3 Then 
Dim dblMaximumFound As Double 
dblMaximumFound = 0 
For j = intResultLeadRows + 2 To UBound (arrResults , 2 ) 
:: arrResults (intMaxParamRes , j ) > dblMaximumFound 7hen 
arrResults (1 , intResultLeadRows + 2 ) = arrResults (2 , j ) ' put in 
the threshold 
dblMaximumFound = arrResults (intMaxParamRes , j ) 
End If 
Next j 
' End If 
' hide Progress bar and go to results tab 
If FormDefineFields . chkProgressBar = True Then Unload CounterForm 
Worksheets ( ,.: ) . Activate 
End Sub 
Sub PrintResults () 
' Transfers the results array to the results worksheet in Excel 
Dim i As Double 
Di m j As Double 
Dim strSheet As String 
If FormDefineFields . opModePredict = True Then 
strSheet = rd...lr. -~ 
Else 
strSheet = l0':"'l' 
End If 
'This prints results 
For i = 1 To UBound (arrResults , 2 ) 
For j = 1 _ UBound (arrResults , 1 ) 
Worksheets (strSheet ) . Cells ( i , j ) = arrResults ( j , i ) 
Next j 
Next i 
End Sub 
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Sub PredictPartitions () 
' This sub lists all the possible typing results , and indicates how the 
reference method results compare 
' Create an array with two columns with the typing results for the combined 
targets in the first column , and the results for the partitions in the 
second and each isolate with its own row 
Dim i , j As In teg er 
Dim arrTypes () As Variant 
ReDi m arrTypes (2 , intNumSamples ) 
For i = 1 ~o UBound (arrinputData , 1 ) 
If arrinputData (i , UBound (arrinputData , 2 ) - rowFI ) = 
arrTypes (1 , 0 ) = arrTypes (1 , 0 ) & arrinputData (i , 0 ) & 
For j = 1 ~o intNumSamples 
Then 
arrTypes (1 , j ) = arrTypes (1 , j ) & arrinputData (i , j ) & 
Ne x t j 
End I f 
If arrinputData (i , UBound (arrinputData , 2 ) - rowUDG) = 
arrTypes (2 , 0 ) = arrTypes (2 , 0 ) & arrinputData ( i , 0 ) & 
For j = 1 ~o intNumSamples 
Then 
.. 
arrTypes (2 , j ) = arrTypes (2 , j ) & arrinputData ( i , j ) & 
Ne x t j 
End If 
Ne x t i 
'get rid of extra comma at end of each cell in array 
For i = 1 To UBou nd (arrTypes , 1 ) 
For j = 0 To UBound (arrTypes , 2 ) 
arrTypes (i , j ) = Left (arrTypes ( i , j ), Len (arrTypes ( i , j )) - 1 ) 
Ne x t j 
Next i 
Dim arrTypesA () As Varian t 
Re Dim arrTypesA (1 ) 
Dim arrType s B () As Varian t 
ReDim arrTypesB (1 ) 
Dim boolFound As Boolean 
boolFound = False 
arrTypesA (1 ) = arrTypes (1 , 1 ) 
For j = 1 To UBound (arrTypes , 2 ) 
For i = 1 To UBound (arrTypesA , 1 ) 
If arrTypes (1 , j ) = arrTypesA ( i ) Then 
boolFound = True 
i = UBound (arrTypesA , 1 ) 
End If 
Next i 
If bool Found = !alse The n 
ReDim Preserve arrTypes A ( UBound (arrTypesA , 1 ) + 1 ) 
arrTypesA (UBound (arrTypes A, 1 )) = arrTypes (1 , j ) 
End If 
boolFound 
Nex t j 
False 
arrTypesB (1 ) = arrTypes (2 , 1 ) 
For j = 1 ~o UBound (arrTypes , 2 ) 
For i = 1 To UBound (arrTypesB , 1 ) 
If arrTypes (2 , j ) = arrTypesB ( i ) Then 
boolFound = True 
i = UBound (arrTypesB , 1 ) 
End T 
Next i 
If boolFound = Fa~se Then 
ReDi m Preserve arrTypesB ( UBound (arrTypesB , 1 ) + 1 ) 
arrTypesB (UBound (arrTypesB , 1 )) = arrTypes (2 , j ) 
End If 
boolFound = False 
Next j 
Dim a r rPred ic tTypes () As Varian t 
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ReDim arrPredictTypes (UBound (arrTypesB , 1 ) + 1 , UBound (arrTypesA , 1 )) As 
Variant 
For i = 1 To UBound (arrTypesB , 1 ) 
arrPredictTypes (i, 0 ) = arrTypesB ( i ) 
Next i 
For i = 1 To UBound (arrTypesA , 1 ) 
arrPredictTypes (O, i ) = arrTypesA ( i ) 
Next i 
For k = 1 To UBound (arrTypes , 2 ) 
For i = 1 To UBound (arrPredictTypes , 1 ) 
: r arrTypes (2 1 k ) = arrPredictTypes ( i ~ 0 ) Then 
Fo r j = 1 To UBound (arrPredictTypes 1 2 ) 
If arrTypes (1 , k ) = arrPredictTypes ( 0 1 j ) Then 
arrPredictTypes ( i , j ) = arrPredictTypes ( i 1 j ) + 1 
arrPredictTypes (UBound (arrPredictTypes 1 1 ) 1 j ) = 
arrPredictTypes (UBound (arrPredictTypes 1 1 ) 1 j ) + 1 
j = UBound (arrPredictTypes 1 2 ) 
i = UBound (arrPredictTypes , 1 ) 
End If 
Next j 
End If 
Next i 
Next k 
For i = 1 ~o UBound (arrPredictTypes 1 1 ) - 1 
For j = 1 To UBound (arrPredictTypes 1 2 ) 
If arrPred ictTypes (i 1 j ) > 0 Then 
arrPredictTypes ( i 1 j ) = 
arrPredictTypes ( i 1 j ) & 
arrPredictTypes (UBound (arrPredictTypes 1 
End If 
& arrPredictTypes (i 1 0 ) & & 
& Round ((arrPredictTypes ( i 1 j ) I 
1 )1 j )) * 100 1 2 ) & 
Next j 
Ne xt i 
i ntResultLeadRows = 5 
ReDim arrResults (4 1 UBound (arrPredictTypes 1 2 ) + 1 + intResultLeadRows ) 
arrResults (1 , 1 ) = >t !Ll J'~ 
& Now () 
arrResults (1 1 2 ) = strWtField 
arrResults (1 1 3 ) = & arrTypes (1 1 0 ) 
arrResults (1 1 4 ) = < ~"< .L ., & 
arrTypes (2 1 0 ) & 
5 ) & 
w & Round (arrUDGSID (1 ) 1 
arrResults (1 , 5 ) 
Dtl.tl ... 
r 
r 1cnc '-1od e: I'yp i r ~ I 
-o.ncd w t!"! tyr.lrq r<'rt_J}t f p~~:-rlt;f jrp·i 
• Typ_r.~ r 
t 
arrResults (1 , intResultLeadRows + 1 ) 
arrResults (2 1 intResultLeadRows + 1 ) 
arrResults (3 1 intResultLeadRows + 1 ) .1 It 1 :- L l ~ { c; Yf ' : N 11U: 
Fo r j = 1 To UBound (arrPredictTypes 1 2 ) 
arrResults (1 1 intResultLeadRows + 1 + j ) = arrPredictTypes (0 1 j ) 
arrResults (2 1 intResultLeadRows + 1 + j ) = 
arrPredictTypes (UBound (arrPredictTypes 1 1 ) , j ) 
For i = 1 To UBound (arrPredictTypes 1 1 ) - 1 
I f arrPredictTypes (i, j ) <> Th e n arrResults (3 1 intResultLeadRows + 
1 + j ) = arrResults (3 1 intResultLeadRows + 1 + j ) & arrPredictTypes ( i 1 j ) & 
Nex ~ i 
arrResults (3 1 intResultLeadRows + 1 + j ) = Left (arrResults (3 1 
intResultLeadRows + 1 + j ) 1 Len (arrResults (3 1 intResultLeadRows + 1 + j )) -
2 ) 
Next j 
End Sub 
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Sub RandominputData () 
' Generates random input data according to user-defined parameters 
Worksheets ( ) . Range ( ) . CurrentRegion . Value = Null 
If intNumSamples = 0 Then intNumSamples = InputBox ( f !'" ~r I,~·. ,.,,F 
intNumOriginalSamples = intNumSamples 
If intNumTotalSamples = 0 ':'hen intNumTotalSamples = InputBox ( " _!"'.t ••! < f 
.: •• 'itt' & intNumSamples & w • .l. ·ypr. l!L 
• Eo " & intNumSamples & " , , intNumSamples ) 
If intNumTargets = 0 Then intNumTargets = InputBox ( ~r. hn, t<li 
intNumOriginalTargets = in t NumTargets 
If intNumStates = 0 Then intNumStates = InputBox ( 1mr~·~ 1~ · ra.u·~, E?l.:-h 
) 
If intNumTotalSamples < intNumSamples Then i n tNumSamples = intNumTotalSamples 
ReDim arrinputData ( intNumTargets + 1 , intNumSamples + 7 ) 
Dim i , j As Integer 
'generate random data 
For i = 1 To intNumTargets 
For j = 1 ~o intNumSamples 
arri nputData {i , j ) = Round (Rnd () * ( intNumStates - 1 ) , 0 ) 
Ne x t j 
arrinputData (i , 0 ) = urapr & i 
Nex t i 
' generate random weightings 
arrinputData (intNumTargets + 1 , 0 ) = l•J-,.,E"!r" 
Dim intSamplesRemain i ng As Integer 
intSamplesRemaining = intNumTotalSampl es 
For j = 1 To intNumSamples 
arrinputData ( intNumTargets + 1 , j ) = 1 
intSamplesRemaining = i ntSamplesRemaining - 1 
Next j 
For i = 1 To i n t SamplesRemai ning 
j = Round (Rnd () * (int NumSamples - 1 ), 0 ) + 1 
arrinputData ( i n tNumTargets + 1 , j ) = arrinputData ( i n tNumTargets + 1 , j ) + 
1 
Next i 
End Sub 
Sub Weight () 
' Done to perform weightings 
intWeightFi eld = FormDefi neFi elds . Li stWeight . Value + 1 
arrinpu t Dat a ( FormDefi neFields . Lis t Weight . Value + 1 , UBound (arrinputDa t a , 
2 ) - rowWt ) = " 
a rrinputDat a ( FormDefi neFi elds . Lis t Weight . Va l ue + 1 , UBound (arrinputData , 
2 ) - rowincl ) = 
arrinputDa t a ( FormDefineFi eld s . Lis t Wei ght . Value + 1 , UBound (ar r inputData , 
2 ) - rowExclude ) = 
strWtFi eld = I i & 
arri nputData (FormDefineFields . ListWeight . Value + 1 , 0 ) & 
b oolWeight = True 
D~m j As In eger 
Dim k As I nteger 
Dim m As I n teger 
Dim i n t Or igNumSamples As I n teger 
i ntOrigNumSamples = intNumSamples 
D~m arr i nputTemp {) As Variant 
ReDim arr i nputTemp (UBound (arri nput Data , 1 ) , 0 ) 
For k = 1 To UBound (arri nputData , 1) 
arrinputTemp ( k , 0 ) = arrinputData ( k , 0 ) 
Nex t k 
Fo r k = 1 To intNumSamples 
IsNumeric (arri nputData ( intWe ightField , k )) = False Then 
a rrinputData ( intWeight Fi eld , k ) = 1 
If arrinputData ( i n tWeightField , k ) <> 0 The n 
If arrinputData ( intWeightField , k ) > 0 Then 
!or j = 1 To Round (arri nputData ( i ntWeightFie l d , k ) , 0 ) 
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ReD . . m Pr serve arrinputTemp (UBound (arrinputData , 1 ) , 
UBound (arrinputTemp , 2 ) + 1 ) 
For m = 0 To UBound (arrinputData , 1 ) 
arrinputTemp (m, UBound (arrinputTemp , 2 )) 
arrinputData (m, k ) 
Nex t m 
Next j 
Else 
ReDim Pres erve arrinputTemp (UBound (arrinputData , 1 ) , 
UBound (arrinputTemp , 2 ) + 1 ) 
For m = 0 To UBound (arrinputData , 1 ) 
arrinputTemp (m, UBound (arrinputTemp , 2 )) = arrinputData (m, 
k ) 
Nex t m 
End If 
End If 
Next k 
intNumSampl es = UBound (arrinputTemp , 2 ) 
strWtField = intOrigNumSamples & <),;!-iJ.~<·t • r.J' r ! 
r & 
arrinputData (FormDefineFields . ListWeighl . Value + 1 , 0 ) & 
& intNumSamples & 
For k = intOrigNumSamples + 1 To UBound (arrinputData , 2 ) 
ReDim Preserve arrinputTemp (UBound (arrinputTemp , 1 ) , 
UBound (arrinputTemp , 2 ) + 1 ) 
for j = 0 To UBound (arrinputData , 1 ) 
hl , , t f:!:l 
arrinputTemp ( j , UBound (arrinputTemp , 2 )) = arrinpu t Data ( j , k ) 
Ne xt j 
Nexl k 
ReDim arrinputData (UBound (arrinputTemp , 1 ) , UBound (arrinputTemp, 2 )) 
For j = 0 To UBound (arrinputData , 1 ) 
F'or k = 0 To UBound (arrinputData , 2 ) 
arrinputData ( j , k ) = arrinputTemp ( j , k) 
Nex t k 
Next j 
End Sub 
Sub AllCombinations () 
D: m intCombs , k As In~eger 
D m arrDat () As Integer 
intCombs = 43 
ReDim arrDat (45 ) 
For k = 1 To UBound (arrDat ) 
arrDat ( k ) = k 
Next k 
Call TestAllCombinations (arrDat , intCombs ) 
End Sub 
Public Sub TestAllCombinations (ByRef pool () As Integer , ByVal r As Integer ) 
Dim n As Integer 
Dim arrCurrentCombination () As Integer 
ReDim arrCurrentCombination (r ) 
n = UBound (pool ) - LBound (pool ) + 1 
' Pl ease do add error handling for when r>n 
Dim idx () As Integer 
ReD1m idx (1 ro r ) 
For i = 1 ro r 
idx ( i ) = i 
Next i 
Dim arrDeepSID () As Variant 
Dim arrTestDeepSID () As Variant 
ReDim arrTestDeepSID (S) 
ReDim arrDeepSID (intDeepNumSamples , intDeepNumTargets + UBound (arrFI , 2 )) 
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Dim arrCompPart () As Variant ' a temporary array for the results of the 
compare partitions function 
ReDi m arrCompPart (5 ) 
Dim dblConcordanceMeasure As Double 
I f FormDefineFields . chkProgressBar = ~rue Then 
Dim PercentComplete As Double ' for progress bar 
Dim LastPercentComplete As Double ' for progress bar 
Dim intDeepRow As In t eger 
intDeepRow = 0 
End If 
arrResults ( intResultLeadColumns + 1 , UBound (arrResults () , 2 )) = strFINames 
Do 
Then 
If boolFirstCombo = ~rue Then 
Dim dblFirstStart , dblFirstFinish , dblFirstTemp As Doubl e 
dblFirstStart = Timer 
End I f 
' update counter bar 
I f FormDefineFields . chkProgressBar = True The n 
intDeepRow = intDeepRow + 1 
PercentComplete = intDeepRow I intDeepExpected 
If Round ( PercentComplete , 2 ) > Round (LastPercentComplete , 2 ) 
It PercentComplete > 1 Then 
PercentComplete = 1 
End If 
Wi t h CounterForm 
. FrameProgress . Caption = Format (PercentComplete , " 
. LabelProgress . Width = PercentComplete * 
( . FrameProgress . Width - 10) 
. Repaint 
End With 
End If 
LastPercentComplete = PercentComplete 
End I~ 
' Write current combination 
Fo r j = 1 ~o r 
arrCurrentCombination ( j ) = pool ( idx ( j )) 
Ne x t j 
Fo r j = 1 ~o intDeepNumTargets 
F· r i = 1 ~o intDeepNumSamples 
arrDeepSID ( i , j ) = 
arrDeepinputData (arrCurrentCombination ( j ) , i ) 
Nexr i 
Next j 
If UBound (arrFI, 2 ) > 0 Then 
UBound (arrFI, 2 ) 
Fo r j = intDeepNumTargets + 1 To intDeepNumTargets + 
For i = 1 To intDeepNumSamples 
arrDeepSID ( i , j ) = arrFI ( i , j - intDeepNumTargets ) 
Nex t i 
Next j 
End If 
I f intMaxParam = 1 Then 
' create array of results for this combination and test the SID 
arrTestDeepSID = SID (arrDeepSID) 
' if the current combination is the highest SID so far, then 
delete all other results from the results page and write this cominations 
to results page 
I f arrTestDeepSID (1 ) > dblDeepSID Then 
dblDeepSID = arrTestDeepSID (1 ) 
ReD im Preserve arrResults (intResultLeadColumns + 1 , 
intResultLeadRows + 2 ) 
2 )) = strFINames 
arrResults (intResultLeadColumns + 1 , UBound (arrResults () , 
Fo r j = 1 To intDeepNumTargets 
arrResults (intResultLeadColumns + 1 , 
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UBound (arrResults (), 2 )) = arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults (), 2 )) & arrDeepinputData (arrCurrentCombination ( j ) , 0 ) & 
Ne x t j 
arrResults (2 , UBound (arrResults , 2 )) 
arrResults (3 , UBound (arrResults, 2 )) 
arrResults ( 4 , UBound (arrResults, 2 )) 
arrResults (S , UBound (arrResults , 2 )) 
arrResults (6 , UBound (arrResults , 2 )) 
arrResults (7 , UBound (arrResults , 2 )) 
If boolUDG = True 7hen 
arrTestDeepSID (O) 
arrTestDeepSID (1 ) 
arrTestDeepSID (2 ) 
arrTestDeepSID (3 ) 
arrTestDeepSID (4 ) 
arrTestDeepSID (S) 
arrCompPart = ComparePartitions (arrCalc , arrUDG ) 
arrResults (S , UBound (arrResults , 2 )) = arrCompPart (O) 
arrResults (9 , UBound (arrResults , 2 )) = arrCompPart (1 ) 
arrResults (10 , UBound (arrResults , 2 )) = arrCompPart (2 ) 
arrResults (11 , UBound (arrResults , 2 )) = arrCompPart (4 ) 
arrResults (12 , UBound (arrResults , 2 )) = arrCompPart (S) 
arrResul t s (13 , UBound (arrResu l ts , 2 )) = arrCompPart (3 ) 
arrResults (14 , UBound (arrResults , 2 )) = arrCompPart (6 ) 
arrResults (15 , UBound (arrResults , 2 )) = arrCompPart (7 ) 
End If 
Else 
' if the current combinatio n is the equal highest , t hen 
preserve previous results and add this one t o this list 
If arrTestDeepSID (1 ) = dblDeepSID Then 
ReDim Preserve arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults , 2 ) + 1 ) 
arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults () , 2 )) = strFINames 
For j = 1 To intDeepNumTargets 
arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults , 2 )) = arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults , 2 )) & arrDeepinputData (arrCurrentCombi nation ( j ) , 0 ) & 
arrTestDeepSID (O) 
arrTestDeepSID (1 ) 
arrTestDeepS I D(2 ) 
arrTestDeepSID (3 ) 
arrTestDeepSID (4 ) 
arrTestDeepSID (S) 
arrCompPart (O) 
arrCompPart (1 ) 
arrCompPart (2 ) 
ar r CompPart ( 4 ) 
arrCompPart (5 ) 
arrCompPart (3 ) 
arrCompPart ( 6) 
arrCompPart (7 ) 
Ne x t j 
arrResults (2 , UBound (arrResults , 2 )) 
arrResults (3 , UBound (arrResults , 2 )) 
arrResults (4 , UBound (arrResults , 2 )) 
arrResults (S , UBound (arrResults , 2 )) 
arrResults (6 , UBound (arrResults , 2 )) 
arrResults (7 , UBound (arrResults , 2 )) 
If boolUDG = Tr ue Then 
arrCompPart = ComparePartitions (arrCalc , arrUDG ) 
arrResults (8 , UBound (arrResults , 2 )) 
arrResults (9 , UBound (arrResults, 2 )) 
arr Results (10 , UBound (arrResults , 2 )) 
arrResults (11 , UBound (arrResul t s , 2 )) 
arrResults (12 , UBound (arrResults , 2 )) = 
arrResults (13 , UBound (arrResults , 2 )) 
arrResults (14 , UBound (arrResults , 2 )) = 
arrResults (15 , UBound (arrResults , 2 )) 
End If 
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Else 
maximised 
End If 
End If 
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' code to use if one of the concordance parameters is to be 
' create array of results for this combination and test the 
concordance parameters 
arrTestDeepSID = SID (arrDeepSID) 
arrCompPart = ComparePartitions (arrCalc , arrUDG) 
If intMaxParam = 9 Then dblConcordanceMeasure = arrCompPart (2 ) 
' AdjustedWallaceA>B 
If intMaxParam = 10 Then dblConcordanceMeasure = 
arrCompPart (3 ) ' AdjustedWallaceB<A 
If intMax Param = 7 Then dblConcordanceMeasure = arrCompPart (O) 
' Rand 
If intMaxParam 8 Then dblConcordanceMeasure arrCompPart (1 ) 
' adjustedrand 
' if the current combination is the highest concordance measure 
so far, then delete all other results from the results page and write this 
cominations to results page 
If dblConcordanceMeasure > dblMaxConcordanceMeasure Then 
dblMaxConcordanceMeasure = dblConcordanceMeasure 
ReDim Preserve arrResults ( intResultLeadColumns + 1 , 
intResultLeadRows + 2 ) 
arrResults (intResultLeadColumns + 1 , UBound (arrResults () , 
2 )) = strFINames 
For j = 1 To intDeepNumTargets 
arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults () , 2 )) = arrResults (intResultLeadColumns + 1 , 
UBound (arrResults () , 2 )) & arrDeepinputData (arrCurrentCombination ( j ) , 0 ) & 
Else 
Next j 
arrResults (2 , UBound (arrResults , 2 )) 
arrResults (3 , UBound (arrResults , 2 )) 
arrResults (4 , UBound (arrResults , 2 )) 
arrResults (S , UBound (arrResults , 2 )) 
arrResults (6 , UBound (arrResults , 2 )) 
arrResults (7 , UBound (arrResults , 2 )) 
arrResults (8 , UBound (arrResults , 2 )) 
arrResults (9 , UBound (arrResults , 2 )) 
arrResults (10 , UBound (arrResults , 2 )) 
arrResults (11 , UBound (arrResults , 2 )) 
arrResults (12 , UBound (arrResults , 2 )) 
arrResults (13 , UBound (arrResults , 2 )) 
arrResults (14 , UBound (arrResults , 2 )) 
arrResults (15 , UBound (arrResults , 2 )) 
arrTestDeepSID (O) 
arrTestDeepSID (1 ) 
arrTestDeepSID (2 ) 
arrTestDeepSID (3 ) 
arrTestDeepSID (4 ) 
arrTestDeepSID (S) 
arrCompPart (O) 
arrCompPart (1 ) 
arrCompPart (2 ) 
arrCompPart (4 ) 
arrCompPart (S ) 
arrCompPart (3 ) 
arrCompPart ( 6 ) 
arrCompPart (7 ) 
'if the current combination is the equal highest, then 
preserve previous results and add this one to this list 
If dblConcordanceMeasure = dblMaxConcordanceMeasure Then 
ReDim Preserve arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults , 2 ) + 1 ) 
arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults () , 2 )) = strFINames 
For j = 1 To intDeepNumTargets 
arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults , 2 )) = arrResults ( intResultLeadColumns + 1 , 
UBound (arrResults , 2 )) & arrDeepinputData (arrCurrentCombination ( j ) , 0 ) & " 
Next j 
arrResults (2 , UBound (arrResults , 2 )) 
arrTestDeepSID (O) 
arrResults (3 , UBound (arrResults , 2 )) 
arrTestDeepSID (1 ) 
arrResults (4 , UBound (arrResults , 2 )) 
arrTestDeepSID (2 ) 
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arrResults (S , UBound (arrResults , 2 )) 
arrTestDeepSID (3 ) 
arrResults (6 , UBound (arrResults , 2 )) 
arrTestDeepSID (4 ) 
arrResults (7 , UBound (arrResults , 2 )) 
arrTestDeepSID (S) 
arrResults (S , UBound (arrResults , 2 )) 
arrResults (9 , UBound (arrResults , 2 )) 
arrResults (10 , UBound (arrResults , 2 )) 
arrResults (11 , UBound (arrResu l ts , 2 )) 
arrResults (12 , UBound (arrResults , 2 )) 
arrResults (13 , UBound (arrResults , 2 )) 
arrResults (14 , UBound (arrResults , 2 )) 
a r rResults (15 , UBound (arrResults , 2 )) 
End If 
End If 
End If 
' Debug.Print J oin(arrCurrentCombinatio n) 
' Locate last non-max index 
i = r 
Wh __ e (idx (i ) = n - r + i - 1 ) 
i = i - 1 
If i = 0 The n 
arrCompPart (0 ) 
arrCompPart (1 ) 
arrCompPart (2 ) 
arrCompPart ( 4 ) 
= arrCompPart (S) 
arrCompPart (3 ) 
arrCompPart (6 ) 
arrCompPar t (7 ) 
' All indexes have reached their max, so we ' re done 
Exit Sub 
End I f 
Wend 
' Increase it and populate the following indexes accordingly 
i dx ( i ) = idx ( i ) + 1 
For j = i + 1 To r 
i dx ( j ) = idx ( i ) + j - i 
Next j 
'estimate time remaining after first iteration and check to m ake sure 
it i s o k 
- 1 ) 
If bool FirstCombo = ~rue Then 
dblFirstFinish = Timer 
dblFirstTemp = (dblFirstFinish - dblFirstStart ) * (intDeepExpected 
dblHours = Int (dblFirstTemp I 3660 ) 
dblMinutes = I n t ((dblFirstTemp - (dblHours * 3660 )) I 60 ) 
dblSeconds = Round ((dblFirstTemp - (dblHours * 3660 ) - (dblMi nutes 
* 60 )) , 0 ) 
:f MsgBox (intDeepExpected & 
I an 
dblMinutes & r 1 
n 
Loop 
End Sub 
End 
End If 
boolFirstCombo 
End .:.f 
& dblSeconds & 
, vbOKCancel ) 
False 
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